id	sid	tid	token	lemma	pos
aji-166	1	1	_	_	PUNCT
aji-166	2	1	_	_	PUNCT
aji-166	3	1	_	_	PUNCT
aji-166	4	1	_	_	PUNCT
aji-166	5	1	_	_	PUNCT
aji-166	6	1	_	_	PUNCT
aji-166	7	1	_	_	PUNCT
aji-166	8	1	_	_	PUNCT
aji-166	9	1	_	_	PUNCT
aji-166	10	1	_	_	PUNCT
aji-166	11	1	_	_	PUNCT
aji-166	12	1	_	_	PUNCT
aji-166	13	1	_	_	PUNCT
aji-166	14	1	_	_	PUNCT
aji-166	15	1	_	_	PUNCT
aji-166	16	1	_	_	PUNCT
aji-166	17	1	_	_	PUNCT
aji-166	18	1	_	_	PUNCT
aji-166	19	1	_	_	PUNCT
aji-166	20	1	_	_	PUNCT
aji-166	21	1	_	_	PUNCT
aji-166	22	1	_	_	PUNCT
aji-166	23	1	_	_	PUNCT
aji-166	24	1	_	_	PUNCT
aji-166	25	1	_	_	PUNCT
aji-166	26	1	_	_	PUNCT
aji-166	27	1	_	_	PUNCT
aji-166	28	1	_	_	PUNCT
aji-166	29	1	_	_	PUNCT
aji-166	30	1	_	_	PUNCT
aji-166	31	1	_	_	PUNCT
aji-166	32	1	_	_	PUNCT
aji-166	33	1	_	_	PUNCT
aji-166	34	1	_	_	PUNCT
aji-166	35	1	_	_	PUNCT
aji-166	36	1	_	_	PUNCT
aji-166	37	1	_	_	PUNCT
aji-166	38	1	_	_	PUNCT
aji-166	39	1	_	_	PUNCT
aji-166	40	1	_	_	PUNCT
aji-166	41	1	_	_	PUNCT
aji-166	42	1	_	_	PUNCT
aji-166	43	1	_	_	PUNCT
aji-166	44	1	_	_	PUNCT
aji-166	45	1	_	_	PUNCT
aji-166	46	1	_	_	PUNCT
aji-166	47	1	_	_	PUNCT
aji-166	48	1	_	_	PUNCT
aji-166	49	1	_	_	PUNCT
aji-166	50	1	_	_	PUNCT
aji-166	51	1	_	_	PUNCT
aji-166	52	1	_	_	PUNCT
aji-166	53	1	_	_	PUNCT
aji-166	54	1	_	_	PUNCT
aji-166	55	1	_	_	PUNCT
aji-166	56	1	_	_	PUNCT
aji-166	57	1	_	_	PUNCT
aji-166	58	1	_	_	PUNCT
aji-166	59	1	_	_	PUNCT
aji-166	60	1	_	_	PUNCT
aji-166	61	1	_	_	PUNCT
aji-166	62	1	_	_	PUNCT
aji-166	63	1	_	_	PUNCT
aji-166	64	1	_	_	PUNCT
aji-166	65	1	_	_	PUNCT
aji-166	66	1	_	_	PUNCT
aji-166	67	1	_	_	PUNCT
aji-166	68	1	_	_	PUNCT
aji-166	69	1	_	_	PUNCT
aji-166	70	1	_	_	PUNCT
aji-166	71	1	_	_	PUNCT
aji-166	72	1	_	_	PUNCT
aji-166	73	1	_	_	PUNCT
aji-166	74	1	_	_	PUNCT
aji-166	75	1	_	_	PUNCT
aji-166	76	1	_	_	PUNCT
aji-166	77	1	_	_	PUNCT
aji-166	78	1	_	_	PUNCT
aji-166	79	1	_	_	PUNCT
aji-166	80	1	_	_	PUNCT
aji-166	81	1	_	_	PUNCT
aji-166	82	1	_	_	PUNCT
aji-166	83	1	_	_	PUNCT
aji-166	84	1	_	_	PUNCT
aji-166	85	1	_	_	PUNCT
aji-166	86	1	_	_	PUNCT
aji-166	87	1	_	_	PUNCT
aji-166	88	1	_	_	PUNCT
aji-166	89	1	_	_	PUNCT
aji-166	90	1	_	_	PUNCT
aji-166	91	1	_	_	PUNCT
aji-166	92	1	_	_	PUNCT
aji-166	93	1	_	_	PUNCT
aji-166	94	1	_	_	PUNCT
aji-166	95	1	_	_	PUNCT
aji-166	96	1	_	_	PUNCT
aji-166	97	1	_	_	PUNCT
aji-166	98	1	_	_	PUNCT
aji-166	99	1	_	_	PUNCT
aji-166	100	1	_	_	PUNCT
aji-166	101	1	_	_	PUNCT
aji-166	102	1	*	*	PUNCT
aji-166	102	2	corresponding	correspond	VERB
aji-166	102	3	author	author	NOUN
aji-166	102	4	:	:	PUNCT
aji-166	102	5	e	e	NOUN
aji-166	102	6	-	-	NOUN
aji-166	102	7	mail	mail	NOUN
aji-166	102	8	:	:	PUNCT
aji-166	102	9	samueladavba@gmail.com	samueladavba@gmail.com	NOUN
aji-166	102	10	;	;	PUNCT
aji-166	102	11	cite	cite	VERB
aji-166	102	12	as	as	ADP
aji-166	102	13	:	:	PUNCT
aji-166	102	14	adavba	adavba	PROPN
aji-166	102	15	,	,	PUNCT
aji-166	102	16	samuel	samuel	PROPN
aji-166	102	17	adinoyi	adinoyi	PROPN
aji-166	102	18	.	.	PUNCT
aji-166	103	1	2025	2025	NUM
aji-166	103	2	.	.	PUNCT
aji-166	104	1	“	"	PUNCT
aji-166	104	2	the	the	DET
aji-166	104	3	role	role	NOUN
aji-166	104	4	of	of	ADP
aji-166	104	5	monocytes	monocyte	NOUN
aji-166	104	6	and	and	CCONJ
aji-166	104	7	macrophages	macrophage	NOUN
aji-166	104	8	in	in	ADP
aji-166	104	9	the	the	DET
aji-166	104	10	pathogenesis	pathogenesis	NOUN
aji-166	104	11	of	of	ADP
aji-166	104	12	non	non	ADJ
aji-166	104	13	-	-	ADJ
aji-166	104	14	aids	aids	ADJ
aji-166	104	15	defining	define	VERB
aji-166	104	16	events	event	NOUN
aji-166	104	17	:	:	PUNCT
aji-166	104	18	mechanisms	mechanism	NOUN
aji-166	104	19	and	and	CCONJ
aji-166	104	20	therapeutic	therapeutic	ADJ
aji-166	104	21	implications	implication	NOUN
aji-166	104	22	”	"	PUNCT
aji-166	104	23	.	.	PUNCT
aji-166	105	1	asian	asian	ADJ
aji-166	105	2	journal	journal	NOUN
aji-166	105	3	of	of	ADP
aji-166	105	4	immunology	immunology	NOUN
aji-166	105	5	8	8	NUM
aji-166	105	6	(	(	PUNCT
aji-166	105	7	1):120	1):120	NUM
aji-166	105	8	-	-	SYM
aji-166	105	9	33	33	NUM
aji-166	105	10	.	.	PUNCT
aji-166	106	1	https://doi.org/10.9734/aji/2025/v8i1166	https://doi.org/10.9734/aji/2025/v8i1166	PROPN
aji-166	106	2	.	.	PUNCT
aji-166	107	1	asian	asian	PROPN
aji-166	107	2	journal	journal	PROPN
aji-166	107	3	of	of	ADP
aji-166	107	4	immunology	immunology	NOUN
aji-166	107	5	volume	volume	NOUN
aji-166	107	6	8	8	NUM
aji-166	107	7	,	,	PUNCT
aji-166	107	8	issue	issue	NOUN
aji-166	107	9	1	1	NUM
aji-166	107	10	,	,	PUNCT
aji-166	107	11	page	page	NOUN
aji-166	107	12	120	120	NUM
aji-166	107	13	-	-	SYM
aji-166	107	14	133	133	NUM
aji-166	107	15	,	,	PUNCT
aji-166	107	16	2025	2025	NUM
aji-166	107	17	;	;	PUNCT
aji-166	107	18	article	article	NOUN
aji-166	107	19	no.aji.136909	no.aji.136909	NOUN
aji-166	107	20	the	the	DET
aji-166	107	21	role	role	NOUN
aji-166	107	22	of	of	ADP
aji-166	107	23	monocytes	monocyte	NOUN
aji-166	107	24	and	and	CCONJ
aji-166	107	25	macrophages	macrophage	NOUN
aji-166	107	26	in	in	ADP
aji-166	107	27	the	the	DET
aji-166	107	28	pathogenesis	pathogenesis	NOUN
aji-166	107	29	of	of	ADP
aji-166	107	30	non	non	ADJ
aji-166	107	31	-	-	ADJ
aji-166	107	32	aids	aids	ADJ
aji-166	107	33	defining	define	VERB
aji-166	107	34	events	event	NOUN
aji-166	107	35	:	:	PUNCT
aji-166	107	36	mechanisms	mechanism	NOUN
aji-166	107	37	and	and	CCONJ
aji-166	107	38	therapeutic	therapeutic	ADJ
aji-166	107	39	implications	implication	NOUN
aji-166	107	40	samuel	samuel	PROPN
aji-166	107	41	adinoyi	adinoyi	PROPN
aji-166	107	42	adavba	adavba	PROPN
aji-166	108	1	a	a	PRON
aji-166	108	2	*	*	PUNCT
aji-166	108	3	a	a	DET
aji-166	108	4	kaduna	kaduna	PROPN
aji-166	108	5	state	state	PROPN
aji-166	108	6	university	university	PROPN
aji-166	108	7	,	,	PUNCT
aji-166	108	8	kaduna	kaduna	PROPN
aji-166	108	9	,	,	PUNCT
aji-166	108	10	nigeria	nigeria	PROPN
aji-166	108	11	.	.	PUNCT
aji-166	109	1	author	author	PROPN
aji-166	109	2	’s	’s	PART
aji-166	109	3	contribution	contribution	NOUN
aji-166	109	4	the	the	DET
aji-166	109	5	sole	sole	ADJ
aji-166	109	6	author	author	NOUN
aji-166	109	7	designed	design	VERB
aji-166	109	8	,	,	PUNCT
aji-166	109	9	analysed	analyse	VERB
aji-166	109	10	,	,	PUNCT
aji-166	109	11	interpreted	interpret	VERB
aji-166	109	12	,	,	PUNCT
aji-166	109	13	and	and	CCONJ
aji-166	109	14	prepared	prepare	VERB
aji-166	109	15	the	the	DET
aji-166	109	16	manuscript	manuscript	NOUN
aji-166	109	17	.	.	PUNCT
aji-166	110	1	article	article	NOUN
aji-166	110	2	information	information	PROPN
aji-166	110	3	doi	doi	PROPN
aji-166	110	4	:	:	PUNCT
aji-166	110	5	https://doi.org/10.9734/aji/2025/v8i1166	https://doi.org/10.9734/aji/2025/v8i1166	PROPN
aji-166	110	6	open	open	ADJ
aji-166	110	7	peer	peer	NOUN
aji-166	110	8	review	review	NOUN
aji-166	110	9	history	history	NOUN
aji-166	110	10	:	:	PUNCT
aji-166	110	11	this	this	DET
aji-166	110	12	journal	journal	NOUN
aji-166	110	13	follows	follow	VERB
aji-166	110	14	the	the	DET
aji-166	110	15	advanced	advance	VERB
aji-166	110	16	open	open	ADJ
aji-166	110	17	peer	peer	NOUN
aji-166	110	18	review	review	NOUN
aji-166	110	19	policy	policy	NOUN
aji-166	110	20	.	.	PUNCT
aji-166	111	1	identity	identity	NOUN
aji-166	111	2	of	of	ADP
aji-166	111	3	the	the	DET
aji-166	111	4	reviewers	reviewer	NOUN
aji-166	111	5	,	,	PUNCT
aji-166	111	6	editor(s	editor(s	NOUN
aji-166	111	7	)	)	PUNCT
aji-166	111	8	and	and	CCONJ
aji-166	111	9	additional	additional	ADJ
aji-166	111	10	reviewers	reviewer	NOUN
aji-166	111	11	,	,	PUNCT
aji-166	111	12	peer	peer	NOUN
aji-166	111	13	review	review	NOUN
aji-166	111	14	comments	comment	NOUN
aji-166	111	15	,	,	PUNCT
aji-166	111	16	different	different	ADJ
aji-166	111	17	versions	version	NOUN
aji-166	111	18	of	of	ADP
aji-166	111	19	the	the	DET
aji-166	111	20	manuscript	manuscript	NOUN
aji-166	111	21	,	,	PUNCT
aji-166	111	22	comments	comment	NOUN
aji-166	111	23	of	of	ADP
aji-166	111	24	the	the	DET
aji-166	111	25	editors	editor	NOUN
aji-166	111	26	,	,	PUNCT
aji-166	111	27	etc	etc	X
aji-166	111	28	,	,	PUNCT
aji-166	111	29	are	be	AUX
aji-166	111	30	available	available	ADJ
aji-166	111	31	here	here	ADV
aji-166	111	32	:	:	PUNCT
aji-166	111	33	https://pr.sdiarticle5.com/review-history/136909	https://pr.sdiarticle5.com/review-history/136909	PROPN
aji-166	111	34	received	receive	VERB
aji-166	111	35	:	:	PUNCT
aji-166	111	36	25/03/2025	25/03/2025	NUM
aji-166	111	37	published	publish	VERB
aji-166	111	38	:	:	PUNCT
aji-166	111	39	06/06/2025	06/06/2025	NUM
aji-166	111	40	abstract	abstract	ADJ
aji-166	111	41	monocytes	monocyte	NOUN
aji-166	111	42	and	and	CCONJ
aji-166	111	43	macrophages	macrophage	NOUN
aji-166	111	44	play	play	VERB
aji-166	111	45	a	a	DET
aji-166	111	46	pivotal	pivotal	ADJ
aji-166	111	47	role	role	NOUN
aji-166	111	48	in	in	ADP
aji-166	111	49	the	the	DET
aji-166	111	50	pathogenesis	pathogenesis	NOUN
aji-166	111	51	of	of	ADP
aji-166	111	52	hiv	hiv	PROPN
aji-166	111	53	infection	infection	NOUN
aji-166	111	54	,	,	PUNCT
aji-166	111	55	contributing	contribute	VERB
aji-166	111	56	not	not	PART
aji-166	111	57	only	only	ADV
aji-166	111	58	to	to	ADP
aji-166	111	59	viral	viral	ADJ
aji-166	111	60	persistence	persistence	NOUN
aji-166	111	61	but	but	CCONJ
aji-166	111	62	also	also	ADV
aji-166	111	63	to	to	ADP
aji-166	111	64	the	the	DET
aji-166	111	65	development	development	NOUN
aji-166	111	66	of	of	ADP
aji-166	111	67	non	non	ADJ
aji-166	111	68	-	-	ADJ
aji-166	111	69	aids	aids	ADJ
aji-166	111	70	-	-	PUNCT
aji-166	111	71	defining	define	VERB
aji-166	111	72	events	event	NOUN
aji-166	111	73	(	(	PUNCT
aji-166	111	74	nades	nade	NOUN
aji-166	111	75	)	)	PUNCT
aji-166	111	76	in	in	ADP
aji-166	111	77	people	people	NOUN
aji-166	111	78	living	live	VERB
aji-166	111	79	with	with	ADP
aji-166	111	80	hiv	hiv	PROPN
aji-166	111	81	(	(	PUNCT
aji-166	111	82	plwh	plwh	NOUN
aji-166	111	83	)	)	PUNCT
aji-166	111	84	.	.	PUNCT
aji-166	112	1	these	these	DET
aji-166	112	2	innate	innate	ADJ
aji-166	112	3	immune	immune	ADJ
aji-166	112	4	cells	cell	NOUN
aji-166	112	5	act	act	VERB
aji-166	112	6	as	as	ADP
aji-166	112	7	long	long	ADV
aji-166	112	8	-	-	PUNCT
aji-166	112	9	lived	live	VERB
aji-166	112	10	viral	viral	ADJ
aji-166	112	11	reservoirs	reservoir	NOUN
aji-166	112	12	,	,	PUNCT
aji-166	112	13	driving	drive	VERB
aji-166	112	14	chronic	chronic	ADJ
aji-166	112	15	inflammation	inflammation	NOUN
aji-166	112	16	through	through	ADP
aji-166	112	17	persistent	persistent	ADJ
aji-166	112	18	immune	immune	ADJ
aji-166	112	19	activation	activation	NOUN
aji-166	112	20	,	,	PUNCT
aji-166	112	21	oxidative	oxidative	ADJ
aji-166	112	22	stress	stress	NOUN
aji-166	112	23	,	,	PUNCT
aji-166	112	24	and	and	CCONJ
aji-166	112	25	tissue	tissue	NOUN
aji-166	112	26	-	-	PUNCT
aji-166	112	27	specific	specific	ADJ
aji-166	112	28	damage	damage	NOUN
aji-166	112	29	.	.	PUNCT
aji-166	113	1	hiv	hiv	PROPN
aji-166	113	2	-	-	PUNCT
aji-166	113	3	infected	infect	VERB
aji-166	113	4	monocytes	monocyte	VERB
aji-166	113	5	infiltrate	infiltrate	ADJ
aji-166	113	6	tissues	tissue	NOUN
aji-166	113	7	,	,	PUNCT
aji-166	113	8	including	include	VERB
aji-166	113	9	the	the	DET
aji-166	113	10	cardiovascular	cardiovascular	ADJ
aji-166	113	11	system	system	NOUN
aji-166	113	12	,	,	PUNCT
aji-166	113	13	liver	liver	NOUN
aji-166	113	14	,	,	PUNCT
aji-166	113	15	kidneys	kidney	NOUN
aji-166	113	16	,	,	PUNCT
aji-166	113	17	and	and	CCONJ
aji-166	113	18	central	central	ADJ
aji-166	113	19	nervous	nervous	ADJ
aji-166	113	20	system	system	NOUN
aji-166	113	21	,	,	PUNCT
aji-166	113	22	where	where	SCONJ
aji-166	113	23	they	they	PRON
aji-166	113	24	differentiate	differentiate	VERB
aji-166	113	25	into	into	ADP
aji-166	113	26	macrophages	macrophage	NOUN
aji-166	113	27	and	and	CCONJ
aji-166	113	28	release	release	VERB
aji-166	113	29	proinflammatory	proinflammatory	ADJ
aji-166	113	30	cytokines	cytokine	NOUN
aji-166	113	31	(	(	PUNCT
aji-166	113	32	e.g.	e.g.	ADV
aji-166	113	33	,	,	PUNCT
aji-166	113	34	tnf	tnf	PROPN
aji-166	113	35	-	-	PUNCT
aji-166	113	36	α	α	PROPN
aji-166	113	37	,	,	PUNCT
aji-166	113	38	il-6	il-6	NUM
aji-166	113	39	)	)	PUNCT
aji-166	113	40	,	,	PUNCT
aji-166	113	41	reactive	reactive	ADJ
aji-166	113	42	oxygen	oxygen	NOUN
aji-166	113	43	species	specie	NOUN
aji-166	113	44	(	(	PUNCT
aji-166	113	45	ros	ros	PROPN
aji-166	113	46	)	)	PUNCT
aji-166	113	47	,	,	PUNCT
aji-166	113	48	and	and	CCONJ
aji-166	113	49	matrix	matrix	NOUN
aji-166	113	50	metalloproteinases	metalloproteinase	NOUN
aji-166	113	51	(	(	PUNCT
aji-166	113	52	mmps	mmp	NOUN
aji-166	113	53	)	)	PUNCT
aji-166	113	54	.	.	PUNCT
aji-166	114	1	these	these	DET
aji-166	114	2	mediators	mediator	NOUN
aji-166	114	3	promote	promote	VERB
aji-166	114	4	endothelial	endothelial	ADJ
aji-166	114	5	dysfunction	dysfunction	NOUN
aji-166	114	6	,	,	PUNCT
aji-166	114	7	fibrosis	fibrosis	NOUN
aji-166	114	8	,	,	PUNCT
aji-166	114	9	and	and	CCONJ
aji-166	114	10	organ	organ	NOUN
aji-166	114	11	damage	damage	NOUN
aji-166	114	12	,	,	PUNCT
aji-166	114	13	underpinning	underpin	VERB
aji-166	114	14	conditions	condition	NOUN
aji-166	114	15	such	such	ADJ
aji-166	114	16	as	as	ADP
aji-166	114	17	atherosclerosis	atherosclerosis	NOUN
aji-166	114	18	,	,	PUNCT
aji-166	114	19	neurocognitive	neurocognitive	ADJ
aji-166	114	20	disorders	disorder	NOUN
aji-166	114	21	,	,	PUNCT
aji-166	114	22	and	and	CCONJ
aji-166	114	23	review	review	NOUN
aji-166	114	24	article	article	NOUN
aji-166	114	25	https://doi.org/10.9734/aji/2025/v8i1166	https://doi.org/10.9734/aji/2025/v8i1166	PROPN
aji-166	114	26	https://pr.sdiarticle5.com/review-history/136909	https://pr.sdiarticle5.com/review-history/136909	PROPN
aji-166	114	27	adavba	adavba	PROPN
aji-166	114	28	;	;	PUNCT
aji-166	114	29	asian	asian	PROPN
aji-166	114	30	j.	j.	PROPN
aji-166	114	31	immunol	immunol	PROPN
aji-166	114	32	.	.	PROPN
aji-166	114	33	,	,	PUNCT
aji-166	114	34	vol	vol	NOUN
aji-166	114	35	.	.	PROPN
aji-166	114	36	8	8	NUM
aji-166	114	37	,	,	PUNCT
aji-166	114	38	no	no	INTJ
aji-166	114	39	.	.	NOUN
aji-166	114	40	1	1	NUM
aji-166	114	41	,	,	PUNCT
aji-166	114	42	pp	pp	ADJ
aji-166	114	43	.	.	PUNCT
aji-166	115	1	120	120	NUM
aji-166	115	2	-	-	SYM
aji-166	115	3	133	133	NUM
aji-166	115	4	,	,	PUNCT
aji-166	115	5	2025	2025	NUM
aji-166	115	6	;	;	PUNCT
aji-166	115	7	article	article	NOUN
aji-166	115	8	no.aji.136909	no.aji.136909	NOUN
aji-166	115	9	121	121	NUM
aji-166	115	10	hepatorenal	hepatorenal	ADJ
aji-166	115	11	disorder	disorder	NOUN
aji-166	115	12	.	.	PUNCT
aji-166	116	1	emerging	emerge	VERB
aji-166	116	2	evidence	evidence	NOUN
aji-166	116	3	highlights	highlight	VERB
aji-166	116	4	the	the	DET
aji-166	116	5	role	role	NOUN
aji-166	116	6	of	of	ADP
aji-166	116	7	macrophage	macrophage	ADJ
aji-166	116	8	polarization	polarization	NOUN
aji-166	116	9	(	(	PUNCT
aji-166	116	10	m1	m1	NOUN
aji-166	116	11	/	/	SYM
aji-166	116	12	m2	m2	PROPN
aji-166	116	13	imbalance	imbalance	NOUN
aji-166	116	14	)	)	PUNCT
aji-166	116	15	and	and	CCONJ
aji-166	116	16	epigenetic	epigenetic	ADJ
aji-166	116	17	modifications	modification	NOUN
aji-166	116	18	in	in	ADP
aji-166	116	19	sustaining	sustain	VERB
aji-166	116	20	inflammation	inflammation	NOUN
aji-166	116	21	despite	despite	SCONJ
aji-166	116	22	antiretroviral	antiretroviral	ADJ
aji-166	116	23	therapy	therapy	NOUN
aji-166	116	24	(	(	PUNCT
aji-166	116	25	art	art	NOUN
aji-166	116	26	)	)	PUNCT
aji-166	116	27	.	.	PUNCT
aji-166	117	1	understanding	understand	VERB
aji-166	117	2	these	these	DET
aji-166	117	3	mechanisms	mechanism	NOUN
aji-166	117	4	provides	provide	VERB
aji-166	117	5	critical	critical	ADJ
aji-166	117	6	insights	insight	NOUN
aji-166	117	7	for	for	ADP
aji-166	117	8	developing	develop	VERB
aji-166	117	9	targeted	target	VERB
aji-166	117	10	therapies	therapy	NOUN
aji-166	117	11	,	,	PUNCT
aji-166	117	12	including	include	VERB
aji-166	117	13	immunomodulators	immunomodulator	NOUN
aji-166	117	14	(	(	PUNCT
aji-166	117	15	e.g.	e.g.	ADV
aji-166	117	16	,	,	PUNCT
aji-166	117	17	il-6	il-6	NOUN
aji-166	117	18	inhibitors	inhibitor	NOUN
aji-166	117	19	)	)	PUNCT
aji-166	117	20	,	,	PUNCT
aji-166	117	21	antioxidant	antioxidant	ADJ
aji-166	117	22	agents	agent	NOUN
aji-166	117	23	,	,	PUNCT
aji-166	117	24	and	and	CCONJ
aji-166	117	25	reservoirelimination	reservoirelimination	NOUN
aji-166	117	26	strategies	strategy	NOUN
aji-166	117	27	.	.	PUNCT
aji-166	118	1	this	this	DET
aji-166	118	2	review	review	NOUN
aji-166	118	3	synthesizes	synthesize	VERB
aji-166	118	4	current	current	ADJ
aji-166	118	5	knowledge	knowledge	NOUN
aji-166	118	6	on	on	ADP
aji-166	118	7	monocyte	monocyte	ADJ
aji-166	118	8	/	/	SYM
aji-166	118	9	macrophage	macrophage	NOUN
aji-166	118	10	-	-	PUNCT
aji-166	118	11	driven	drive	VERB
aji-166	118	12	pathogenesis	pathogenesis	NOUN
aji-166	118	13	in	in	ADP
aji-166	118	14	hiv	hiv	PROPN
aji-166	118	15	-	-	PUNCT
aji-166	118	16	associated	associate	VERB
aji-166	118	17	nades	nade	NOUN
aji-166	118	18	.	.	PUNCT
aji-166	119	1	it	it	PRON
aji-166	119	2	explores	explore	VERB
aji-166	119	3	plausible	plausible	ADJ
aji-166	119	4	novel	novel	ADJ
aji-166	119	5	therapeutic	therapeutic	ADJ
aji-166	119	6	approaches	approach	NOUN
aji-166	119	7	to	to	PART
aji-166	119	8	mitigate	mitigate	VERB
aji-166	119	9	chronic	chronic	ADJ
aji-166	119	10	inflammation	inflammation	NOUN
aji-166	119	11	and	and	CCONJ
aji-166	119	12	improve	improve	VERB
aji-166	119	13	clinical	clinical	ADJ
aji-166	119	14	outcomes	outcome	NOUN
aji-166	119	15	in	in	ADP
aji-166	119	16	plwh	plwh	NOUN
aji-166	119	17	.	.	PUNCT
aji-166	120	1	keywords	keyword	NOUN
aji-166	120	2	:	:	PUNCT
aji-166	121	1	hiv	hiv	PROPN
aji-166	121	2	;	;	PUNCT
aji-166	121	3	monocyte	monocyte	NOUN
aji-166	121	4	;	;	PUNCT
aji-166	121	5	macrophages	macrophage	NOUN
aji-166	121	6	;	;	PUNCT
aji-166	121	7	inflammation	inflammation	NOUN
aji-166	121	8	;	;	PUNCT
aji-166	121	9	immune	immune	ADJ
aji-166	121	10	activation	activation	NOUN
aji-166	121	11	;	;	PUNCT
aji-166	121	12	viral	viral	ADJ
aji-166	121	13	reservoirs	reservoir	NOUN
aji-166	121	14	;	;	PUNCT
aji-166	121	15	tissuespecific	tissuespecific	NOUN
aji-166	121	16	damage	damage	NOUN
aji-166	121	17	;	;	PUNCT
aji-166	121	18	non	non	ADJ
aji-166	121	19	-	-	ADJ
aji-166	121	20	aids	aids	ADJ
aji-166	121	21	-	-	PUNCT
aji-166	121	22	defining	define	VERB
aji-166	121	23	events	event	NOUN
aji-166	121	24	;	;	PUNCT
aji-166	121	25	reservoir	reservoir	NOUN
aji-166	121	26	elimination	elimination	NOUN
aji-166	121	27	.	.	PUNCT
aji-166	122	1	1	1	X
aji-166	122	2	.	.	X
aji-166	122	3	introduction	introduction	NOUN
aji-166	122	4	human	human	ADJ
aji-166	122	5	immunodeficiency	immunodeficiency	NOUN
aji-166	122	6	virus	virus	NOUN
aji-166	122	7	(	(	PUNCT
aji-166	122	8	hiv	hiv	NOUN
aji-166	122	9	)	)	PUNCT
aji-166	122	10	infection	infection	NOUN
aji-166	122	11	continues	continue	VERB
aji-166	122	12	to	to	PART
aji-166	122	13	pose	pose	VERB
aji-166	122	14	a	a	DET
aji-166	122	15	significant	significant	ADJ
aji-166	122	16	global	global	ADJ
aji-166	122	17	health	health	NOUN
aji-166	122	18	challenge	challenge	NOUN
aji-166	122	19	,	,	PUNCT
aji-166	122	20	despite	despite	SCONJ
aji-166	122	21	the	the	DET
aji-166	122	22	remarkable	remarkable	ADJ
aji-166	122	23	success	success	NOUN
aji-166	122	24	of	of	ADP
aji-166	122	25	art	art	NOUN
aji-166	122	26	in	in	ADP
aji-166	122	27	reducing	reduce	VERB
aji-166	122	28	aids	aid	NOUN
aji-166	122	29	-	-	PUNCT
aji-166	122	30	related	relate	VERB
aji-166	122	31	morbidity	morbidity	NOUN
aji-166	122	32	and	and	CCONJ
aji-166	122	33	mortality	mortality	NOUN
aji-166	122	34	.	.	PUNCT
aji-166	123	1	individuals	individual	NOUN
aji-166	123	2	living	live	VERB
aji-166	123	3	with	with	ADP
aji-166	123	4	hiv	hiv	PROPN
aji-166	123	5	now	now	ADV
aji-166	123	6	face	face	VERB
aji-166	123	7	an	an	DET
aji-166	123	8	increased	increase	VERB
aji-166	123	9	risk	risk	NOUN
aji-166	123	10	of	of	ADP
aji-166	123	11	certain	certain	ADJ
aji-166	123	12	chronic	chronic	ADJ
aji-166	123	13	illnesses	illness	NOUN
aji-166	123	14	collectively	collectively	ADV
aji-166	123	15	referred	refer	VERB
aji-166	123	16	to	to	ADP
aji-166	123	17	as	as	ADP
aji-166	123	18	non	non	ADJ
aji-166	123	19	-	-	ADJ
aji-166	123	20	aids	aids	ADJ
aji-166	123	21	defining	define	VERB
aji-166	123	22	events	event	NOUN
aji-166	123	23	(	(	PUNCT
aji-166	123	24	nades	nade	NOUN
aji-166	123	25	)	)	PUNCT
aji-166	123	26	,	,	PUNCT
aji-166	123	27	which	which	PRON
aji-166	123	28	are	be	AUX
aji-166	123	29	disproportionately	disproportionately	ADV
aji-166	123	30	common	common	ADJ
aji-166	123	31	among	among	ADP
aji-166	123	32	plwh	plwh	NOUN
aji-166	123	33	(	(	PUNCT
aji-166	123	34	deeks	deek	NOUN
aji-166	123	35	et	et	PROPN
aji-166	123	36	al	al	PROPN
aji-166	123	37	.	.	PROPN
aji-166	123	38	,	,	PUNCT
aji-166	123	39	2013	2013	NUM
aji-166	123	40	;	;	PUNCT
aji-166	123	41	serrano	serrano	PROPN
aji-166	123	42	-	-	PUNCT
aji-166	123	43	villar	villar	PROPN
aji-166	123	44	et	et	PROPN
aji-166	123	45	al	al	PROPN
aji-166	123	46	.	.	PROPN
aji-166	123	47	,	,	PUNCT
aji-166	123	48	2014	2014	NUM
aji-166	123	49	)	)	PUNCT
aji-166	123	50	.	.	PUNCT
aji-166	124	1	this	this	DET
aji-166	124	2	spectrum	spectrum	NOUN
aji-166	124	3	includes	include	VERB
aji-166	124	4	cardiovascular	cardiovascular	ADJ
aji-166	124	5	disease	disease	NOUN
aji-166	124	6	,	,	PUNCT
aji-166	124	7	neurocognitive	neurocognitive	ADJ
aji-166	124	8	disorders	disorder	NOUN
aji-166	124	9	,	,	PUNCT
aji-166	124	10	liver	liver	NOUN
aji-166	124	11	/	/	SYM
aji-166	124	12	kidney	kidney	NOUN
aji-166	124	13	fibrosis	fibrosis	NOUN
aji-166	124	14	,	,	PUNCT
aji-166	124	15	metabolic	metabolic	NOUN
aji-166	124	16	syndrome	syndrome	NOUN
aji-166	124	17	,	,	PUNCT
aji-166	124	18	and	and	CCONJ
aji-166	124	19	non	non	ADJ
aji-166	124	20	-	-	ADJ
aji-166	124	21	aids	aids	ADJ
aji-166	124	22	cancers	cancer	NOUN
aji-166	124	23	,	,	PUNCT
aji-166	124	24	which	which	PRON
aji-166	124	25	can	can	AUX
aji-166	124	26	arise	arise	VERB
aji-166	124	27	despite	despite	SCONJ
aji-166	124	28	effective	effective	ADJ
aji-166	124	29	art	art	NOUN
aji-166	124	30	,	,	PUNCT
aji-166	124	31	contributing	contribute	VERB
aji-166	124	32	to	to	ADP
aji-166	124	33	morbidity	morbidity	NOUN
aji-166	124	34	and	and	CCONJ
aji-166	124	35	mortality	mortality	NOUN
aji-166	124	36	in	in	ADP
aji-166	124	37	the	the	DET
aji-166	124	38	post	post	ADJ
aji-166	124	39	-	-	ADJ
aji-166	124	40	art	art	ADJ
aji-166	124	41	era	era	NOUN
aji-166	124	42	(	(	PUNCT
aji-166	124	43	deeks	deek	VERB
aji-166	124	44	et	et	PROPN
aji-166	124	45	al	al	PROPN
aji-166	124	46	.	.	PROPN
aji-166	124	47	,	,	PUNCT
aji-166	124	48	2013	2013	NUM
aji-166	124	49	)	)	PUNCT
aji-166	124	50	.	.	PUNCT
aji-166	125	1	these	these	DET
aji-166	125	2	conditions	condition	NOUN
aji-166	125	3	occur	occur	VERB
aji-166	125	4	in	in	ADP
aji-166	125	5	plwh	plwh	NOUN
aji-166	125	6	at	at	ADP
aji-166	125	7	a	a	DET
aji-166	125	8	younger	young	ADJ
aji-166	125	9	age	age	NOUN
aji-166	125	10	than	than	ADP
aji-166	125	11	in	in	ADP
aji-166	125	12	the	the	DET
aji-166	125	13	general	general	ADJ
aji-166	125	14	population	population	NOUN
aji-166	125	15	.	.	PUNCT
aji-166	126	1	they	they	PRON
aji-166	126	2	are	be	AUX
aji-166	126	3	driven	drive	VERB
aji-166	126	4	mainly	mainly	ADV
aji-166	126	5	by	by	ADP
aji-166	126	6	chronic	chronic	ADJ
aji-166	126	7	immune	immune	ADJ
aji-166	126	8	activation	activation	NOUN
aji-166	126	9	,	,	PUNCT
aji-166	126	10	inflammation	inflammation	NOUN
aji-166	126	11	,	,	PUNCT
aji-166	126	12	and	and	CCONJ
aji-166	126	13	immune	immune	ADJ
aji-166	126	14	dysregulation	dysregulation	NOUN
aji-166	126	15	,	,	PUNCT
aji-166	126	16	in	in	ADP
aji-166	126	17	which	which	PRON
aji-166	126	18	monocytes	monocyte	VERB
aji-166	126	19	and	and	CCONJ
aji-166	126	20	macrophages	macrophage	NOUN
aji-166	126	21	play	play	VERB
aji-166	126	22	a	a	DET
aji-166	126	23	central	central	ADJ
aji-166	126	24	role	role	NOUN
aji-166	126	25	(	(	PUNCT
aji-166	126	26	campbell	campbell	PROPN
aji-166	126	27	et	et	PROPN
aji-166	126	28	al	al	PROPN
aji-166	126	29	.	.	PROPN
aji-166	126	30	,	,	PUNCT
aji-166	126	31	2014	2014	NUM
aji-166	126	32	;	;	PUNCT
aji-166	126	33	joseph	joseph	PROPN
aji-166	126	34	et	et	PROPN
aji-166	126	35	al	al	PROPN
aji-166	126	36	.	.	PROPN
aji-166	126	37	,	,	PUNCT
aji-166	126	38	2022	2022	NUM
aji-166	126	39	)	)	PUNCT
aji-166	126	40	.	.	PUNCT
aji-166	127	1	monocytes	monocyte	NOUN
aji-166	127	2	and	and	CCONJ
aji-166	127	3	macrophages	macrophage	NOUN
aji-166	127	4	,	,	PUNCT
aji-166	127	5	integral	integral	ADJ
aji-166	127	6	members	member	NOUN
aji-166	127	7	of	of	ADP
aji-166	127	8	the	the	DET
aji-166	127	9	myeloid	myeloid	ADJ
aji-166	127	10	lineage	lineage	NOUN
aji-166	127	11	,	,	PUNCT
aji-166	127	12	are	be	AUX
aji-166	127	13	hiv	hiv	PROPN
aji-166	127	14	tropic	tropic	NOUN
aji-166	127	15	and	and	CCONJ
aji-166	127	16	express	express	VERB
aji-166	127	17	hiv	hiv	PROPN
aji-166	127	18	entry	entry	NOUN
aji-166	127	19	receptors	receptor	NOUN
aji-166	127	20	,	,	PUNCT
aji-166	127	21	cd4	cd4	PROPN
aji-166	127	22	and	and	CCONJ
aji-166	127	23	ccr5	ccr5	PROPN
aji-166	128	1	(	(	PUNCT
aji-166	128	2	ancuta	ancuta	ADV
aji-166	128	3	et	et	PROPN
aji-166	128	4	al	al	PROPN
aji-166	128	5	.	.	PROPN
aji-166	128	6	,	,	PUNCT
aji-166	128	7	2008	2008	NUM
aji-166	128	8	)	)	PUNCT
aji-166	128	9	.	.	PUNCT
aji-166	129	1	these	these	DET
aji-166	129	2	cells	cell	NOUN
aji-166	129	3	not	not	PART
aji-166	129	4	only	only	ADV
aji-166	129	5	serve	serve	VERB
aji-166	129	6	as	as	ADP
aji-166	129	7	targets	target	NOUN
aji-166	129	8	for	for	ADP
aji-166	129	9	the	the	DET
aji-166	129	10	infection	infection	NOUN
aji-166	129	11	and	and	CCONJ
aji-166	129	12	propagation	propagation	NOUN
aji-166	129	13	of	of	ADP
aji-166	129	14	hiv	hiv	PROPN
aji-166	129	15	but	but	CCONJ
aji-166	129	16	also	also	ADV
aji-166	129	17	contribute	contribute	VERB
aji-166	129	18	to	to	ADP
aji-166	129	19	the	the	DET
aji-166	129	20	virus	virus	NOUN
aji-166	129	21	's	's	PART
aji-166	129	22	persistence	persistence	NOUN
aji-166	129	23	and	and	CCONJ
aji-166	129	24	disease	disease	NOUN
aji-166	129	25	progression	progression	NOUN
aji-166	129	26	over	over	ADP
aji-166	129	27	the	the	DET
aji-166	129	28	long	long	ADJ
aji-166	129	29	term	term	NOUN
aji-166	129	30	(	(	PUNCT
aji-166	129	31	campbell	campbell	PROPN
aji-166	129	32	et	et	PROPN
aji-166	129	33	al	al	PROPN
aji-166	129	34	.	.	PROPN
aji-166	129	35	,	,	PUNCT
aji-166	129	36	2014	2014	NUM
aji-166	129	37	;	;	PUNCT
aji-166	129	38	kruize	kruize	PROPN
aji-166	129	39	&	&	CCONJ
aji-166	129	40	kootstra	kootstra	PROPN
aji-166	129	41	,	,	PUNCT
aji-166	129	42	2019	2019	NUM
aji-166	129	43	)	)	PUNCT
aji-166	129	44	.	.	PUNCT
aji-166	130	1	following	follow	VERB
aji-166	130	2	their	their	PRON
aji-166	130	3	differentiation	differentiation	NOUN
aji-166	130	4	from	from	ADP
aji-166	130	5	monocytes	monocyte	NOUN
aji-166	130	6	,	,	PUNCT
aji-166	130	7	hiv	hiv	PROPN
aji-166	130	8	-	-	PUNCT
aji-166	130	9	infected	infect	VERB
aji-166	130	10	macrophages	macrophage	NOUN
aji-166	130	11	migrate	migrate	VERB
aji-166	130	12	into	into	ADP
aji-166	130	13	tissues	tissue	NOUN
aji-166	130	14	where	where	SCONJ
aji-166	130	15	they	they	PRON
aji-166	130	16	help	help	VERB
aji-166	130	17	spread	spread	VERB
aji-166	130	18	the	the	DET
aji-166	130	19	infection	infection	NOUN
aji-166	130	20	to	to	ADP
aji-166	130	21	nearly	nearly	ADV
aji-166	130	22	every	every	PRON
aji-166	130	23	tissue	tissue	NOUN
aji-166	130	24	in	in	ADP
aji-166	130	25	the	the	DET
aji-166	130	26	body	body	NOUN
aji-166	130	27	,	,	PUNCT
aji-166	130	28	including	include	VERB
aji-166	130	29	the	the	DET
aji-166	130	30	gut	gut	NOUN
aji-166	130	31	,	,	PUNCT
aji-166	130	32	testes	testis	NOUN
aji-166	130	33	,	,	PUNCT
aji-166	130	34	lung	lung	NOUN
aji-166	130	35	,	,	PUNCT
aji-166	130	36	gut	gut	NOUN
aji-166	130	37	-	-	PUNCT
aji-166	130	38	associated	associate	VERB
aji-166	130	39	lymphoid	lymphoid	ADJ
aji-166	130	40	tissue	tissue	NOUN
aji-166	130	41	,	,	PUNCT
aji-166	130	42	brain	brain	NOUN
aji-166	130	43	,	,	PUNCT
aji-166	130	44	liver	liver	NOUN
aji-166	130	45	,	,	PUNCT
aji-166	130	46	urethra	urethra	NOUN
aji-166	130	47	,	,	PUNCT
aji-166	130	48	and	and	CCONJ
aji-166	130	49	lymph	lymph	NOUN
aji-166	130	50	nodes	node	NOUN
aji-166	130	51	(	(	PUNCT
aji-166	130	52	tso	tso	PROPN
aji-166	130	53	et	et	PROPN
aji-166	130	54	al	al	PROPN
aji-166	130	55	.	.	PROPN
aji-166	130	56	,	,	PUNCT
aji-166	130	57	2018	2018	NUM
aji-166	130	58	;	;	PUNCT
aji-166	130	59	rose	rise	VERB
aji-166	130	60	et	et	PROPN
aji-166	130	61	al	al	PROPN
aji-166	130	62	.	.	PROPN
aji-166	130	63	,	,	PUNCT
aji-166	130	64	2016	2016	NUM
aji-166	130	65	;	;	PUNCT
aji-166	130	66	ganor	ganor	NOUN
aji-166	130	67	et	et	NOUN
aji-166	130	68	al	al	PROPN
aji-166	130	69	.	.	PROPN
aji-166	130	70	,	,	PUNCT
aji-166	130	71	2019	2019	NUM
aji-166	130	72	)	)	PUNCT
aji-166	130	73	.	.	PUNCT
aji-166	131	1	additionally	additionally	ADV
aji-166	131	2	,	,	PUNCT
aji-166	131	3	macrophages	macrophage	NOUN
aji-166	131	4	reside	reside	VERB
aji-166	131	5	in	in	ADP
aji-166	131	6	anatomical	anatomical	ADJ
aji-166	131	7	sanctuaries	sanctuary	NOUN
aji-166	131	8	with	with	ADP
aji-166	131	9	restricted	restricted	ADJ
aji-166	131	10	art	art	NOUN
aji-166	131	11	penetration	penetration	NOUN
aji-166	131	12	,	,	PUNCT
aji-166	131	13	which	which	PRON
aji-166	131	14	benefits	benefit	VERB
aji-166	131	15	viral	viral	ADJ
aji-166	131	16	persistence	persistence	NOUN
aji-166	131	17	even	even	ADV
aji-166	131	18	during	during	ADP
aji-166	131	19	therapy	therapy	NOUN
aji-166	131	20	(	(	PUNCT
aji-166	131	21	clayton	clayton	PROPN
aji-166	131	22	et	et	PROPN
aji-166	131	23	al	al	PROPN
aji-166	131	24	.	.	PROPN
aji-166	131	25	,	,	PUNCT
aji-166	131	26	2018	2018	NUM
aji-166	131	27	;	;	PUNCT
aji-166	131	28	borkham	borkham	NOUN
aji-166	131	29	-	-	PUNCT
aji-166	131	30	kamphorst	kamphorst	PROPN
aji-166	131	31	&	&	CCONJ
aji-166	131	32	weiskirchen	weiskirchen	NOUN
aji-166	131	33	,	,	PUNCT
aji-166	131	34	2016	2016	NUM
aji-166	131	35	)	)	PUNCT
aji-166	131	36	.	.	PUNCT
aji-166	132	1	human	human	ADJ
aji-166	132	2	monocytes	monocyte	NOUN
aji-166	132	3	were	be	AUX
aji-166	132	4	first	first	ADV
aji-166	132	5	identified	identify	VERB
aji-166	132	6	in	in	ADP
aji-166	132	7	1880	1880	NUM
aji-166	132	8	when	when	SCONJ
aji-166	132	9	paul	paul	PROPN
aji-166	132	10	ehrlich	ehrlich	PROPN
aji-166	132	11	and	and	CCONJ
aji-166	132	12	ilya	ilya	PROPN
aji-166	132	13	metchnikoff	metchnikoff	PROPN
aji-166	132	14	recognized	recognize	VERB
aji-166	132	15	them	they	PRON
aji-166	132	16	based	base	VERB
aji-166	132	17	on	on	ADP
aji-166	132	18	their	their	PRON
aji-166	132	19	distinct	distinct	ADJ
aji-166	132	20	morphological	morphological	ADJ
aji-166	132	21	features	feature	NOUN
aji-166	132	22	(	(	PUNCT
aji-166	132	23	teh	teh	NOUN
aji-166	132	24	et	et	NOUN
aji-166	132	25	al	al	PROPN
aji-166	132	26	.	.	PROPN
aji-166	132	27	,	,	PUNCT
aji-166	132	28	2023	2023	NUM
aji-166	132	29	;	;	PUNCT
aji-166	133	1	gramegna	gramegna	PROPN
aji-166	133	2	et	et	PROPN
aji-166	133	3	al	al	PROPN
aji-166	133	4	.	.	PROPN
aji-166	133	5	,	,	PUNCT
aji-166	133	6	2011	2011	NUM
aji-166	133	7	)	)	PUNCT
aji-166	133	8	.	.	PUNCT
aji-166	134	1	however	however	ADV
aji-166	134	2	,	,	PUNCT
aji-166	134	3	the	the	DET
aji-166	134	4	development	development	NOUN
aji-166	134	5	of	of	ADP
aji-166	134	6	flow	flow	NOUN
aji-166	134	7	cytometry	cytometry	NOUN
aji-166	134	8	in	in	ADP
aji-166	134	9	the	the	DET
aji-166	134	10	1970s	1970	NOUN
aji-166	134	11	enabled	enable	VERB
aji-166	134	12	the	the	DET
aji-166	134	13	creation	creation	NOUN
aji-166	134	14	of	of	ADP
aji-166	134	15	a	a	DET
aji-166	134	16	specific	specific	ADJ
aji-166	134	17	antibody	antibody	NOUN
aji-166	134	18	panel	panel	NOUN
aji-166	134	19	that	that	PRON
aji-166	134	20	classifies	classify	VERB
aji-166	134	21	monocytes	monocyte	NOUN
aji-166	134	22	according	accord	VERB
aji-166	134	23	to	to	ADP
aji-166	134	24	the	the	DET
aji-166	134	25	degree	degree	NOUN
aji-166	134	26	of	of	ADP
aji-166	134	27	expression	expression	NOUN
aji-166	134	28	of	of	ADP
aji-166	134	29	specific	specific	ADJ
aji-166	134	30	surface	surface	NOUN
aji-166	134	31	proteins	protein	NOUN
aji-166	134	32	,	,	PUNCT
aji-166	134	33	namely	namely	ADV
aji-166	134	34	the	the	DET
aji-166	134	35	pattern	pattern	NOUN
aji-166	134	36	recognition	recognition	NOUN
aji-166	134	37	receptor	receptor	NOUN
aji-166	134	38	cd14	cd14	PROPN
aji-166	134	39	and	and	CCONJ
aji-166	134	40	the	the	DET
aji-166	134	41	fc	fc	PROPN
aji-166	134	42	gamma	gamma	PROPN
aji-166	134	43	iii	iii	PROPN
aji-166	134	44	receptor	receptor	NOUN
aji-166	134	45	cd16	cd16	PROPN
aji-166	134	46	(	(	PUNCT
aji-166	134	47	kapellos	kapellos	NOUN
aji-166	134	48	et	et	PROPN
aji-166	134	49	al	al	PROPN
aji-166	134	50	.	.	PROPN
aji-166	134	51	,	,	PUNCT
aji-166	134	52	2019	2019	NUM
aji-166	134	53	)	)	PUNCT
aji-166	134	54	.	.	PUNCT
aji-166	135	1	this	this	DET
aji-166	135	2	parameter	parameter	NOUN
aji-166	135	3	categorizes	categorize	VERB
aji-166	135	4	circulating	circulate	VERB
aji-166	135	5	monocytes	monocyte	NOUN
aji-166	135	6	into	into	ADP
aji-166	135	7	three	three	NUM
aji-166	135	8	key	key	ADJ
aji-166	135	9	subpopulations	subpopulation	NOUN
aji-166	135	10	:	:	PUNCT
aji-166	135	11	classical	classical	ADJ
aji-166	135	12	,	,	PUNCT
aji-166	135	13	non	non	ADJ
aji-166	135	14	-	-	ADJ
aji-166	135	15	classical	classical	ADJ
aji-166	135	16	,	,	PUNCT
aji-166	135	17	and	and	CCONJ
aji-166	135	18	intermediate	intermediate	ADJ
aji-166	135	19	.	.	PUNCT
aji-166	136	1	these	these	DET
aji-166	136	2	subpopulations	subpopulation	NOUN
aji-166	136	3	,	,	PUNCT
aji-166	136	4	which	which	PRON
aji-166	136	5	differ	differ	VERB
aji-166	136	6	in	in	ADP
aji-166	136	7	abundance	abundance	NOUN
aji-166	136	8	and	and	CCONJ
aji-166	136	9	primary	primary	ADJ
aji-166	136	10	functions	function	NOUN
aji-166	136	11	,	,	PUNCT
aji-166	136	12	can	can	AUX
aji-166	136	13	be	be	AUX
aji-166	136	14	identified	identify	VERB
aji-166	136	15	by	by	ADP
aji-166	136	16	their	their	PRON
aji-166	136	17	size	size	NOUN
aji-166	136	18	,	,	PUNCT
aji-166	136	19	granularity	granularity	NOUN
aji-166	136	20	,	,	PUNCT
aji-166	136	21	and	and	CCONJ
aji-166	136	22	expression	expression	NOUN
aji-166	136	23	of	of	ADP
aji-166	136	24	these	these	DET
aji-166	136	25	specific	specific	ADJ
aji-166	136	26	surface	surface	NOUN
aji-166	136	27	markers	marker	NOUN
aji-166	136	28	(	(	PUNCT
aji-166	136	29	ziegler	ziegler	NOUN
aji-166	136	30	-	-	NOUN
aji-166	136	31	heitbrock	heitbrock	PROPN
aji-166	136	32	et	et	PROPN
aji-166	136	33	al	al	PROPN
aji-166	136	34	.	.	PROPN
aji-166	136	35	,	,	PUNCT
aji-166	136	36	2010	2010	NUM
aji-166	136	37	;	;	PUNCT
aji-166	136	38	liberale	liberale	PROPN
aji-166	136	39	et	et	PROPN
aji-166	136	40	al	al	PROPN
aji-166	136	41	.	.	PROPN
aji-166	136	42	,	,	PUNCT
aji-166	136	43	2020	2020	NUM
aji-166	136	44	)	)	PUNCT
aji-166	136	45	.	.	PUNCT
aji-166	137	1	classical	classical	ADJ
aji-166	137	2	monocytes	monocyte	NOUN
aji-166	137	3	,	,	PUNCT
aji-166	137	4	characterized	characterize	VERB
aji-166	137	5	by	by	ADP
aji-166	137	6	the	the	DET
aji-166	137	7	expression	expression	NOUN
aji-166	137	8	profile	profile	NOUN
aji-166	137	9	cd14++cd16−	cd14++cd16−	PROPN
aji-166	137	10	,	,	PUNCT
aji-166	137	11	constitute	constitute	VERB
aji-166	137	12	the	the	DET
aji-166	137	13	majority	majority	NOUN
aji-166	137	14	(	(	PUNCT
aji-166	137	15	80–90	80–90	NUM
aji-166	137	16	%	%	NOUN
aji-166	137	17	)	)	PUNCT
aji-166	137	18	of	of	ADP
aji-166	137	19	monocytes	monocyte	NOUN
aji-166	137	20	.	.	PUNCT
aji-166	138	1	they	they	PRON
aji-166	138	2	are	be	AUX
aji-166	138	3	the	the	DET
aji-166	138	4	first	first	ADJ
aji-166	138	5	responders	responder	NOUN
aji-166	138	6	to	to	ADP
aji-166	138	7	infections	infection	NOUN
aji-166	138	8	or	or	CCONJ
aji-166	138	9	tissue	tissue	NOUN
aji-166	138	10	damage	damage	NOUN
aji-166	138	11	and	and	CCONJ
aji-166	138	12	primarily	primarily	ADV
aji-166	138	13	initiate	initiate	VERB
aji-166	138	14	immune	immune	ADJ
aji-166	138	15	responses	response	NOUN
aji-166	138	16	through	through	ADP
aji-166	138	17	phagocytosis	phagocytosis	NOUN
aji-166	138	18	,	,	PUNCT
aji-166	138	19	antigen	antigen	ADJ
aji-166	138	20	presentation	presentation	NOUN
aji-166	138	21	,	,	PUNCT
aji-166	138	22	and	and	CCONJ
aji-166	138	23	the	the	DET
aji-166	138	24	release	release	NOUN
aji-166	138	25	of	of	ADP
aji-166	138	26	pro	pro	ADJ
aji-166	138	27	-	-	ADJ
aji-166	138	28	inflammatory	inflammatory	ADJ
aji-166	138	29	cytokines	cytokine	NOUN
aji-166	138	30	(	(	PUNCT
aji-166	138	31	zieglerheitbrock	zieglerheitbrock	NOUN
aji-166	138	32	et	et	PROPN
aji-166	138	33	al	al	PROPN
aji-166	138	34	.	.	PROPN
aji-166	138	35	,	,	PUNCT
aji-166	138	36	2010	2010	NUM
aji-166	138	37	;	;	PUNCT
aji-166	138	38	potula	potula	NOUN
aji-166	138	39	et	et	PROPN
aji-166	138	40	al	al	PROPN
aji-166	138	41	.	.	PROPN
aji-166	138	42	,	,	PUNCT
aji-166	138	43	2008	2008	NUM
aji-166	138	44	)	)	PUNCT
aji-166	138	45	.	.	PUNCT
aji-166	139	1	non	non	ADJ
aji-166	139	2	-	-	ADJ
aji-166	139	3	classical	classical	ADJ
aji-166	139	4	monocytes	monocyte	NOUN
aji-166	139	5	exhibit	exhibit	VERB
aji-166	139	6	a	a	DET
aji-166	139	7	cd14+cd16++	cd14+cd16++	ADJ
aji-166	139	8	expression	expression	NOUN
aji-166	139	9	pattern	pattern	NOUN
aji-166	139	10	and	and	CCONJ
aji-166	139	11	are	be	AUX
aji-166	139	12	the	the	DET
aji-166	139	13	least	least	ADV
aji-166	139	14	abundant	abundant	ADJ
aji-166	139	15	(	(	PUNCT
aji-166	139	16	2	2	NUM
aji-166	139	17	-	-	SYM
aji-166	139	18	8	8	NUM
aji-166	139	19	%	%	NOUN
aji-166	139	20	)	)	PUNCT
aji-166	139	21	.	.	PUNCT
aji-166	140	1	they	they	PRON
aji-166	140	2	respond	respond	VERB
aji-166	140	3	to	to	ADP
aji-166	140	4	viral	viral	ADJ
aji-166	140	5	infections	infection	NOUN
aji-166	140	6	,	,	PUNCT
aji-166	140	7	play	play	VERB
aji-166	140	8	a	a	DET
aji-166	140	9	crucial	crucial	ADJ
aji-166	140	10	role	role	NOUN
aji-166	140	11	in	in	ADP
aji-166	140	12	antibodydependent	antibodydependent	NOUN
aji-166	140	13	cellular	cellular	ADJ
aji-166	140	14	cytotoxicity	cytotoxicity	NOUN
aji-166	140	15	(	(	PUNCT
aji-166	140	16	adcc	adcc	NOUN
aji-166	140	17	)	)	PUNCT
aji-166	140	18	,	,	PUNCT
aji-166	140	19	patrol	patrol	VERB
aji-166	140	20	the	the	DET
aji-166	140	21	endothelial	endothelial	NOUN
aji-166	140	22	lining	lining	NOUN
aji-166	140	23	of	of	ADP
aji-166	140	24	blood	blood	NOUN
aji-166	140	25	vessels	vessel	NOUN
aji-166	140	26	,	,	PUNCT
aji-166	140	27	and	and	CCONJ
aji-166	140	28	participate	participate	VERB
aji-166	140	29	in	in	ADP
aji-166	140	30	tissue	tissue	NOUN
aji-166	140	31	repair	repair	NOUN
aji-166	140	32	and	and	CCONJ
aji-166	140	33	regeneration	regeneration	NOUN
aji-166	140	34	.	.	PUNCT
aji-166	141	1	the	the	DET
aji-166	141	2	intermediate	intermediate	ADJ
aji-166	141	3	subset	subset	NOUN
aji-166	141	4	,	,	PUNCT
aji-166	141	5	designated	designate	VERB
aji-166	141	6	cd14++cd16	cd14++cd16	PROPN
aji-166	141	7	+	+	PROPN
aji-166	141	8	,	,	PUNCT
aji-166	141	9	shows	show	VERB
aji-166	141	10	characteristics	characteristic	NOUN
aji-166	141	11	that	that	DET
aji-166	141	12	bridge	bridge	NOUN
aji-166	141	13	classical	classical	ADJ
aji-166	141	14	and	and	CCONJ
aji-166	141	15	non	non	ADJ
aji-166	141	16	-	-	ADJ
aji-166	141	17	classical	classical	ADJ
aji-166	141	18	monocytes	monocyte	NOUN
aji-166	141	19	(	(	PUNCT
aji-166	141	20	tanwar	tanwar	NOUN
aji-166	141	21	et	et	PROPN
aji-166	141	22	al	al	PROPN
aji-166	141	23	.	.	PROPN
aji-166	141	24	,	,	PUNCT
aji-166	141	25	2020	2020	NUM
aji-166	141	26	)	)	PUNCT
aji-166	141	27	.	.	PUNCT
aji-166	142	1	they	they	PRON
aji-166	142	2	possess	possess	VERB
aji-166	142	3	enhanced	enhanced	ADJ
aji-166	142	4	capabilities	capability	NOUN
aji-166	142	5	for	for	ADP
aji-166	142	6	antigen	antigen	ADJ
aji-166	142	7	presentation	presentation	NOUN
aji-166	142	8	,	,	PUNCT
aji-166	142	9	aid	aid	NOUN
aji-166	142	10	in	in	ADP
aji-166	142	11	tissue	tissue	NOUN
aji-166	142	12	repair	repair	NOUN
aji-166	142	13	and	and	CCONJ
aji-166	142	14	angiogenesis	angiogenesis	NOUN
aji-166	142	15	,	,	PUNCT
aji-166	142	16	and	and	CCONJ
aji-166	142	17	engage	engage	VERB
aji-166	142	18	in	in	ADP
aji-166	142	19	resolving	resolve	VERB
aji-166	142	20	adavba	adavba	NOUN
aji-166	142	21	;	;	PUNCT
aji-166	142	22	asian	asian	PROPN
aji-166	142	23	j.	j.	PROPN
aji-166	142	24	immunol	immunol	PROPN
aji-166	142	25	.	.	PROPN
aji-166	142	26	,	,	PUNCT
aji-166	142	27	vol	vol	NOUN
aji-166	142	28	.	.	PROPN
aji-166	142	29	8	8	NUM
aji-166	142	30	,	,	PUNCT
aji-166	142	31	no	no	INTJ
aji-166	142	32	.	.	NOUN
aji-166	142	33	1	1	NUM
aji-166	142	34	,	,	PUNCT
aji-166	142	35	pp	pp	ADJ
aji-166	142	36	.	.	PUNCT
aji-166	143	1	120	120	NUM
aji-166	143	2	-	-	SYM
aji-166	143	3	133	133	NUM
aji-166	143	4	,	,	PUNCT
aji-166	143	5	2025	2025	NUM
aji-166	143	6	;	;	PUNCT
aji-166	143	7	article	article	NOUN
aji-166	143	8	no.aji.136909	no.aji.136909	PROPN
aji-166	143	9	122	122	NUM
aji-166	143	10	inflammation	inflammation	NOUN
aji-166	143	11	,	,	PUNCT
aji-166	143	12	making	make	VERB
aji-166	143	13	them	they	PRON
aji-166	143	14	significant	significant	ADJ
aji-166	143	15	in	in	ADP
aji-166	143	16	various	various	ADJ
aji-166	143	17	inflammatory	inflammatory	ADJ
aji-166	143	18	diseases	disease	NOUN
aji-166	143	19	(	(	PUNCT
aji-166	143	20	wong	wong	PROPN
aji-166	143	21	et	et	PROPN
aji-166	143	22	al	al	PROPN
aji-166	143	23	.	.	PROPN
aji-166	143	24	,	,	PUNCT
aji-166	143	25	2011	2011	NUM
aji-166	143	26	)	)	PUNCT
aji-166	143	27	.	.	PUNCT
aji-166	144	1	macrophages	macrophage	NOUN
aji-166	144	2	are	be	AUX
aji-166	144	3	specialized	specialize	VERB
aji-166	144	4	,	,	PUNCT
aji-166	144	5	long	long	ADV
aji-166	144	6	-	-	PUNCT
aji-166	144	7	lived	live	VERB
aji-166	144	8	phagocytic	phagocytic	ADJ
aji-166	144	9	cells	cell	NOUN
aji-166	144	10	of	of	ADP
aji-166	144	11	the	the	DET
aji-166	144	12	innate	innate	ADJ
aji-166	144	13	immune	immune	ADJ
aji-166	144	14	system	system	NOUN
aji-166	144	15	involved	involve	VERB
aji-166	144	16	in	in	ADP
aji-166	144	17	recognizing	recognize	VERB
aji-166	144	18	,	,	PUNCT
aji-166	144	19	engulfing	engulfing	NOUN
aji-166	144	20	,	,	PUNCT
aji-166	144	21	and	and	CCONJ
aji-166	144	22	degrading	degrade	VERB
aji-166	144	23	cellular	cellular	ADJ
aji-166	144	24	debris	debris	NOUN
aji-166	144	25	,	,	PUNCT
aji-166	144	26	pathogens	pathogen	NOUN
aji-166	144	27	,	,	PUNCT
aji-166	144	28	and	and	CCONJ
aji-166	144	29	other	other	ADJ
aji-166	144	30	foreign	foreign	ADJ
aji-166	144	31	substances	substance	NOUN
aji-166	144	32	.	.	PUNCT
aji-166	145	1	until	until	ADP
aji-166	145	2	recently	recently	ADV
aji-166	145	3	,	,	PUNCT
aji-166	145	4	they	they	PRON
aji-166	145	5	were	be	AUX
aji-166	145	6	thought	think	VERB
aji-166	145	7	to	to	PART
aji-166	145	8	differentiate	differentiate	VERB
aji-166	145	9	solely	solely	ADV
aji-166	145	10	from	from	ADP
aji-166	145	11	monocytes	monocyte	NOUN
aji-166	145	12	,	,	PUNCT
aji-166	145	13	but	but	CCONJ
aji-166	145	14	newer	new	ADJ
aji-166	145	15	findings	finding	NOUN
aji-166	145	16	have	have	AUX
aji-166	145	17	shed	shed	VERB
aji-166	145	18	light	light	NOUN
aji-166	145	19	on	on	ADP
aji-166	145	20	the	the	DET
aji-166	145	21	complexities	complexity	NOUN
aji-166	145	22	of	of	ADP
aji-166	145	23	their	their	PRON
aji-166	145	24	differentiation	differentiation	NOUN
aji-166	145	25	and	and	CCONJ
aji-166	145	26	immunological	immunological	ADJ
aji-166	145	27	profiles	profile	NOUN
aji-166	145	28	.	.	PUNCT
aji-166	146	1	macrophages	macrophage	NOUN
aji-166	146	2	can	can	AUX
aji-166	146	3	originate	originate	VERB
aji-166	146	4	from	from	ADP
aji-166	146	5	two	two	NUM
aji-166	146	6	distinct	distinct	ADJ
aji-166	146	7	sources	source	NOUN
aji-166	146	8	:	:	PUNCT
aji-166	146	9	from	from	ADP
aji-166	146	10	classical	classical	ADJ
aji-166	146	11	monocytes	monocyte	NOUN
aji-166	146	12	,	,	PUNCT
aji-166	146	13	which	which	PRON
aji-166	146	14	migrate	migrate	VERB
aji-166	146	15	into	into	ADP
aji-166	146	16	tissues	tissue	NOUN
aji-166	146	17	to	to	PART
aji-166	146	18	differentiate	differentiate	VERB
aji-166	146	19	into	into	ADP
aji-166	146	20	macrophages	macrophage	NOUN
aji-166	146	21	or	or	CCONJ
aji-166	146	22	dendritic	dendritic	ADJ
aji-166	146	23	cells	cell	NOUN
aji-166	146	24	(	(	PUNCT
aji-166	146	25	monocytederived	monocytederive	VERB
aji-166	146	26	macrophages	macrophage	NOUN
aji-166	146	27	[	[	X
aji-166	146	28	mdm	mdm	X
aji-166	146	29	]	]	X
aji-166	146	30	)	)	PUNCT
aji-166	146	31	,	,	PUNCT
aji-166	146	32	and	and	CCONJ
aji-166	146	33	from	from	ADP
aji-166	146	34	selfrenewing	selfrenewe	VERB
aji-166	146	35	tissue	tissue	NOUN
aji-166	146	36	-	-	PUNCT
aji-166	146	37	resident	resident	NOUN
aji-166	146	38	macrophages	macrophage	NOUN
aji-166	146	39	that	that	PRON
aji-166	146	40	arise	arise	VERB
aji-166	146	41	from	from	ADP
aji-166	146	42	primitive	primitive	ADJ
aji-166	146	43	embryonic	embryonic	ADJ
aji-166	146	44	precursors	precursor	NOUN
aji-166	146	45	(	(	PUNCT
aji-166	146	46	sattentau	sattentau	PROPN
aji-166	146	47	&	&	CCONJ
aji-166	146	48	stevenson	stevenson	PROPN
aji-166	146	49	,	,	PUNCT
aji-166	146	50	2016	2016	NUM
aji-166	146	51	)	)	PUNCT
aji-166	146	52	.	.	PUNCT
aji-166	147	1	this	this	DET
aji-166	147	2	article	article	NOUN
aji-166	147	3	explores	explore	VERB
aji-166	147	4	the	the	DET
aji-166	147	5	mechanisms	mechanism	NOUN
aji-166	147	6	by	by	ADP
aji-166	147	7	which	which	PRON
aji-166	147	8	monocytes	monocyte	VERB
aji-166	147	9	and	and	CCONJ
aji-166	147	10	macrophages	macrophage	NOUN
aji-166	147	11	contribute	contribute	VERB
aji-166	147	12	to	to	ADP
aji-166	147	13	the	the	DET
aji-166	147	14	pathogenesis	pathogenesis	NOUN
aji-166	147	15	of	of	ADP
aji-166	147	16	hiv	hiv	PROPN
aji-166	147	17	and	and	CCONJ
aji-166	147	18	the	the	DET
aji-166	147	19	development	development	NOUN
aji-166	147	20	of	of	ADP
aji-166	147	21	nades	nade	NOUN
aji-166	147	22	,	,	PUNCT
aji-166	147	23	with	with	ADP
aji-166	147	24	a	a	DET
aji-166	147	25	focus	focus	NOUN
aji-166	147	26	on	on	ADP
aji-166	147	27	their	their	PRON
aji-166	147	28	roles	role	NOUN
aji-166	147	29	as	as	ADP
aji-166	147	30	viral	viral	ADJ
aji-166	147	31	reservoirs	reservoir	NOUN
aji-166	147	32	,	,	PUNCT
aji-166	147	33	mediators	mediator	NOUN
aji-166	147	34	of	of	ADP
aji-166	147	35	inflammation	inflammation	NOUN
aji-166	147	36	,	,	PUNCT
aji-166	147	37	and	and	CCONJ
aji-166	147	38	drivers	driver	NOUN
aji-166	147	39	of	of	ADP
aji-166	147	40	tissue	tissue	NOUN
aji-166	147	41	damage	damage	NOUN
aji-166	147	42	.	.	PUNCT
aji-166	148	1	2	2	X
aji-166	148	2	.	.	X
aji-166	148	3	hiv	hiv	PROPN
aji-166	148	4	infection	infection	NOUN
aji-166	148	5	of	of	ADP
aji-166	148	6	monocytes	monocyte	NOUN
aji-166	148	7	and	and	CCONJ
aji-166	148	8	macrophages	macrophage	NOUN
aji-166	148	9	:	:	PUNCT
aji-166	148	10	key	key	ADJ
aji-166	148	11	factors	factor	NOUN
aji-166	148	12	in	in	ADP
aji-166	148	13	the	the	DET
aji-166	148	14	pathogenesis	pathogenesis	NOUN
aji-166	148	15	of	of	ADP
aji-166	148	16	hiv	hiv	PROPN
aji-166	148	17	monocytes	monocyte	NOUN
aji-166	148	18	and	and	CCONJ
aji-166	148	19	macrophages	macrophage	NOUN
aji-166	148	20	are	be	AUX
aji-166	148	21	significant	significant	ADJ
aji-166	148	22	targets	target	NOUN
aji-166	148	23	for	for	ADP
aji-166	148	24	hiv-1	hiv-1	ADJ
aji-166	148	25	infection	infection	NOUN
aji-166	148	26	and	and	CCONJ
aji-166	148	27	play	play	VERB
aji-166	148	28	crucial	crucial	ADJ
aji-166	148	29	roles	role	NOUN
aji-166	148	30	in	in	ADP
aji-166	148	31	viral	viral	ADJ
aji-166	148	32	transmission	transmission	NOUN
aji-166	148	33	,	,	PUNCT
aji-166	148	34	dissemination	dissemination	NOUN
aji-166	148	35	,	,	PUNCT
aji-166	148	36	and	and	CCONJ
aji-166	148	37	persistence	persistence	NOUN
aji-166	148	38	.	.	PUNCT
aji-166	149	1	while	while	SCONJ
aji-166	149	2	monocytes	monocyte	NOUN
aji-166	149	3	can	can	AUX
aji-166	149	4	be	be	AUX
aji-166	149	5	infected	infect	VERB
aji-166	149	6	by	by	ADP
aji-166	149	7	hiv-1	hiv-1	NOUN
aji-166	149	8	,	,	PUNCT
aji-166	149	9	their	their	PRON
aji-166	149	10	susceptibility	susceptibility	NOUN
aji-166	149	11	to	to	ADP
aji-166	149	12	the	the	DET
aji-166	149	13	virus	virus	NOUN
aji-166	149	14	varies	vary	VERB
aji-166	149	15	depending	depend	VERB
aji-166	149	16	on	on	ADP
aji-166	149	17	their	their	PRON
aji-166	149	18	differentiation	differentiation	NOUN
aji-166	149	19	status	status	NOUN
aji-166	149	20	.	.	PUNCT
aji-166	150	1	as	as	SCONJ
aji-166	150	2	monocytes	monocyte	NOUN
aji-166	150	3	differentiate	differentiate	VERB
aji-166	150	4	into	into	ADP
aji-166	150	5	macrophages	macrophage	NOUN
aji-166	150	6	,	,	PUNCT
aji-166	150	7	they	they	PRON
aji-166	150	8	become	become	VERB
aji-166	150	9	more	more	ADV
aji-166	150	10	receptive	receptive	ADJ
aji-166	150	11	to	to	ADP
aji-166	150	12	infection	infection	NOUN
aji-166	150	13	,	,	PUNCT
aji-166	150	14	acting	act	VERB
aji-166	150	15	as	as	ADP
aji-166	150	16	important	important	ADJ
aji-166	150	17	reservoirs	reservoir	NOUN
aji-166	150	18	for	for	ADP
aji-166	150	19	the	the	DET
aji-166	150	20	virus	virus	NOUN
aji-166	150	21	.	.	PUNCT
aji-166	151	1	these	these	DET
aji-166	151	2	macrophages	macrophage	NOUN
aji-166	151	3	can	can	AUX
aji-166	151	4	productively	productively	ADV
aji-166	151	5	replicate	replicate	VERB
aji-166	151	6	hiv-1	hiv-1	PUNCT
aji-166	151	7	even	even	ADV
aji-166	151	8	in	in	ADP
aji-166	151	9	the	the	DET
aji-166	151	10	presence	presence	NOUN
aji-166	151	11	of	of	ADP
aji-166	151	12	antiretroviral	antiretroviral	ADJ
aji-166	151	13	therapy	therapy	NOUN
aji-166	151	14	(	(	PUNCT
aji-166	151	15	art	art	NOUN
aji-166	151	16	)	)	PUNCT
aji-166	151	17	(	(	PUNCT
aji-166	151	18	parihar	parihar	PROPN
aji-166	151	19	et	et	PROPN
aji-166	151	20	al	al	PROPN
aji-166	151	21	.	.	PROPN
aji-166	151	22	,	,	PUNCT
aji-166	151	23	2010	2010	NUM
aji-166	151	24	)	)	PUNCT
aji-166	151	25	.	.	PUNCT
aji-166	152	1	in	in	ADP
aji-166	152	2	contrast	contrast	NOUN
aji-166	152	3	to	to	ADP
aji-166	152	4	cd4	cd4	PROPN
aji-166	152	5	+	+	PROPN
aji-166	152	6	t	t	NOUN
aji-166	152	7	cells	cell	NOUN
aji-166	152	8	,	,	PUNCT
aji-166	152	9	which	which	PRON
aji-166	152	10	are	be	AUX
aji-166	152	11	rapidly	rapidly	ADV
aji-166	152	12	depleted	deplete	VERB
aji-166	152	13	during	during	ADP
aji-166	152	14	acute	acute	ADJ
aji-166	152	15	infections	infection	NOUN
aji-166	152	16	,	,	PUNCT
aji-166	152	17	hiv	hiv	PROPN
aji-166	152	18	-	-	PUNCT
aji-166	152	19	infected	infect	VERB
aji-166	152	20	monocytes	monocyte	NOUN
aji-166	152	21	and	and	CCONJ
aji-166	152	22	macrophages	macrophage	NOUN
aji-166	152	23	exhibit	exhibit	VERB
aji-166	152	24	greater	great	ADJ
aji-166	152	25	resistance	resistance	NOUN
aji-166	152	26	to	to	ADP
aji-166	152	27	the	the	DET
aji-166	152	28	cytopathic	cytopathic	ADJ
aji-166	152	29	effects	effect	NOUN
aji-166	152	30	of	of	ADP
aji-166	152	31	the	the	DET
aji-166	152	32	virus	virus	NOUN
aji-166	152	33	.	.	PUNCT
aji-166	153	1	this	this	DET
aji-166	153	2	resilience	resilience	NOUN
aji-166	153	3	allows	allow	VERB
aji-166	153	4	them	they	PRON
aji-166	153	5	to	to	PART
aji-166	153	6	harbor	harbor	VERB
aji-166	153	7	hiv	hiv	PROPN
aji-166	153	8	for	for	ADP
aji-166	153	9	extended	extended	ADJ
aji-166	153	10	periods	period	NOUN
aji-166	153	11	,	,	PUNCT
aji-166	153	12	contributing	contribute	VERB
aji-166	153	13	to	to	ADP
aji-166	153	14	viral	viral	ADJ
aji-166	153	15	persistence	persistence	NOUN
aji-166	153	16	(	(	PUNCT
aji-166	153	17	miguel	miguel	PROPN
aji-166	153	18	et	et	PROPN
aji-166	153	19	al	al	PROPN
aji-166	153	20	.	.	PROPN
aji-166	153	21	,	,	PUNCT
aji-166	153	22	2023	2023	NUM
aji-166	153	23	)	)	PUNCT
aji-166	153	24	.	.	PUNCT
aji-166	154	1	this	this	PRON
aji-166	154	2	,	,	PUNCT
aji-166	154	3	in	in	ADP
aji-166	154	4	turn	turn	NOUN
aji-166	154	5	,	,	PUNCT
aji-166	154	6	hinders	hinder	VERB
aji-166	154	7	efforts	effort	NOUN
aji-166	154	8	to	to	PART
aji-166	154	9	achieve	achieve	VERB
aji-166	154	10	a	a	DET
aji-166	154	11	cure	cure	NOUN
aji-166	154	12	and	and	CCONJ
aji-166	154	13	drives	drive	VERB
aji-166	154	14	chronic	chronic	ADJ
aji-166	154	15	immune	immune	ADJ
aji-166	154	16	activation	activation	NOUN
aji-166	154	17	and	and	CCONJ
aji-166	154	18	inflammation	inflammation	NOUN
aji-166	154	19	,	,	PUNCT
aji-166	154	20	leading	lead	VERB
aji-166	154	21	to	to	ADP
aji-166	154	22	various	various	ADJ
aji-166	154	23	consequences	consequence	NOUN
aji-166	154	24	(	(	PUNCT
aji-166	154	25	campbell	campbell	PROPN
aji-166	154	26	et	et	PROPN
aji-166	154	27	al	al	PROPN
aji-166	154	28	.	.	PROPN
aji-166	154	29	,	,	PUNCT
aji-166	154	30	2014	2014	NUM
aji-166	154	31	)	)	PUNCT
aji-166	154	32	.	.	PUNCT
aji-166	155	1	the	the	DET
aji-166	155	2	causes	cause	NOUN
aji-166	155	3	of	of	ADP
aji-166	155	4	chronic	chronic	ADJ
aji-166	155	5	immune	immune	ADJ
aji-166	155	6	activation	activation	NOUN
aji-166	155	7	in	in	ADP
aji-166	155	8	hiv	hiv	PROPN
aji-166	155	9	infection	infection	NOUN
aji-166	155	10	are	be	AUX
aji-166	155	11	complex	complex	ADJ
aji-166	155	12	and	and	CCONJ
aji-166	155	13	not	not	PART
aji-166	155	14	yet	yet	ADV
aji-166	155	15	completely	completely	ADV
aji-166	155	16	understood	understand	VERB
aji-166	155	17	,	,	PUNCT
aji-166	155	18	encompassing	encompass	VERB
aji-166	155	19	both	both	CCONJ
aji-166	155	20	direct	direct	ADJ
aji-166	155	21	factors	factor	NOUN
aji-166	155	22	(	(	PUNCT
aji-166	155	23	such	such	ADJ
aji-166	155	24	as	as	ADP
aji-166	155	25	the	the	DET
aji-166	155	26	enduring	endure	VERB
aji-166	155	27	presence	presence	NOUN
aji-166	155	28	of	of	ADP
aji-166	155	29	hiv	hiv	PROPN
aji-166	155	30	rna	rna	PROPN
aji-166	155	31	)	)	PUNCT
aji-166	155	32	and	and	CCONJ
aji-166	155	33	indirect	indirect	ADJ
aji-166	155	34	triggers	trigger	NOUN
aji-166	155	35	(	(	PUNCT
aji-166	155	36	microbial	microbial	ADJ
aji-166	155	37	translocation	translocation	NOUN
aji-166	155	38	and	and	CCONJ
aji-166	155	39	coinfections	coinfection	NOUN
aji-166	155	40	)	)	PUNCT
aji-166	155	41	(	(	PUNCT
aji-166	155	42	mazzuti	mazzuti	NOUN
aji-166	155	43	et	et	PROPN
aji-166	155	44	al	al	PROPN
aji-166	155	45	.	.	PROPN
aji-166	155	46	,	,	PUNCT
aji-166	155	47	2022	2022	NUM
aji-166	155	48	)	)	PUNCT
aji-166	155	49	.	.	PUNCT
aji-166	156	1	but	but	CCONJ
aji-166	156	2	ultimately	ultimately	ADV
aji-166	156	3	,	,	PUNCT
aji-166	156	4	the	the	DET
aji-166	156	5	persistent	persistent	ADJ
aji-166	156	6	antigenic	antigenic	ADJ
aji-166	156	7	stimulation	stimulation	NOUN
aji-166	156	8	leads	lead	VERB
aji-166	156	9	to	to	ADP
aji-166	156	10	sustained	sustained	ADJ
aji-166	156	11	elevations	elevation	NOUN
aji-166	156	12	of	of	ADP
aji-166	156	13	pro	pro	ADJ
aji-166	156	14	-	-	ADJ
aji-166	156	15	inflammatory	inflammatory	ADJ
aji-166	156	16	cytokines	cytokine	NOUN
aji-166	156	17	,	,	PUNCT
aji-166	156	18	such	such	ADJ
aji-166	156	19	as	as	ADP
aji-166	156	20	il-6	il-6	NUM
aji-166	156	21	and	and	CCONJ
aji-166	156	22	tnf	tnf	PROPN
aji-166	156	23	-	-	PUNCT
aji-166	156	24	α	α	PROPN
aji-166	156	25	,	,	PUNCT
aji-166	156	26	along	along	ADP
aji-166	156	27	with	with	ADP
aji-166	156	28	immune	immune	ADJ
aji-166	156	29	activation	activation	NOUN
aji-166	156	30	markers	marker	NOUN
aji-166	156	31	like	like	ADP
aji-166	156	32	cd38	cd38	PROPN
aji-166	156	33	and	and	CCONJ
aji-166	156	34	hladr	hladr	NOUN
aji-166	156	35	(	(	PUNCT
aji-166	156	36	paiardini	paiardini	PROPN
aji-166	156	37	&	&	CCONJ
aji-166	156	38	müller	müller	PROPN
aji-166	156	39	-	-	PUNCT
aji-166	156	40	trutwin	trutwin	PROPN
aji-166	156	41	,	,	PUNCT
aji-166	156	42	2013	2013	NUM
aji-166	156	43	;	;	PUNCT
aji-166	156	44	lederman	lederman	PROPN
aji-166	156	45	et	et	PROPN
aji-166	156	46	al	al	PROPN
aji-166	156	47	.	.	PROPN
aji-166	156	48	,	,	PUNCT
aji-166	156	49	2013	2013	NUM
aji-166	156	50	)	)	PUNCT
aji-166	156	51	.	.	PUNCT
aji-166	157	1	monocytes	monocyte	NOUN
aji-166	157	2	,	,	PUNCT
aji-166	157	3	particularly	particularly	ADV
aji-166	157	4	the	the	DET
aji-166	157	5	cd16	cd16	PROPN
aji-166	157	6	+	+	CCONJ
aji-166	157	7	intermediate	intermediate	ADJ
aji-166	157	8	and	and	CCONJ
aji-166	157	9	non	non	ADJ
aji-166	157	10	-	-	ADJ
aji-166	157	11	classical	classical	ADJ
aji-166	157	12	subsets	subset	NOUN
aji-166	157	13	,	,	PUNCT
aji-166	157	14	play	play	VERB
aji-166	157	15	a	a	DET
aji-166	157	16	vital	vital	ADJ
aji-166	157	17	role	role	NOUN
aji-166	157	18	in	in	ADP
aji-166	157	19	this	this	DET
aji-166	157	20	inflammatory	inflammatory	ADJ
aji-166	157	21	environment	environment	NOUN
aji-166	157	22	,	,	PUNCT
aji-166	157	23	exhibiting	exhibit	VERB
aji-166	157	24	an	an	DET
aji-166	157	25	activated	activated	ADJ
aji-166	157	26	phenotype	phenotype	NOUN
aji-166	157	27	characterized	characterize	VERB
aji-166	157	28	by	by	ADP
aji-166	157	29	increased	increase	VERB
aji-166	157	30	expression	expression	NOUN
aji-166	157	31	of	of	ADP
aji-166	157	32	adhesion	adhesion	NOUN
aji-166	157	33	molecules	molecule	NOUN
aji-166	157	34	,	,	PUNCT
aji-166	157	35	chemokine	chemokine	ADJ
aji-166	157	36	receptors	receptor	NOUN
aji-166	157	37	,	,	PUNCT
aji-166	157	38	and	and	CCONJ
aji-166	157	39	toll	toll	NOUN
aji-166	157	40	-	-	PUNCT
aji-166	157	41	like	like	ADJ
aji-166	157	42	receptors	receptor	NOUN
aji-166	157	43	(	(	PUNCT
aji-166	157	44	tlrs	tlrs	NOUN
aji-166	157	45	)	)	PUNCT
aji-166	157	46	,	,	PUNCT
aji-166	157	47	which	which	PRON
aji-166	157	48	enhances	enhance	VERB
aji-166	157	49	their	their	PRON
aji-166	157	50	migration	migration	NOUN
aji-166	157	51	into	into	ADP
aji-166	157	52	tissues	tissue	NOUN
aji-166	157	53	and	and	CCONJ
aji-166	157	54	responsiveness	responsiveness	NOUN
aji-166	157	55	to	to	ADP
aji-166	157	56	microbial	microbial	ADJ
aji-166	157	57	products	product	NOUN
aji-166	157	58	(	(	PUNCT
aji-166	157	59	ancuta	ancuta	ADV
aji-166	157	60	et	et	PROPN
aji-166	157	61	al	al	PROPN
aji-166	157	62	.	.	PROPN
aji-166	157	63	,	,	PUNCT
aji-166	157	64	2008	2008	NUM
aji-166	157	65	)	)	PUNCT
aji-166	157	66	.	.	PUNCT
aji-166	158	1	the	the	DET
aji-166	158	2	ongoing	ongoing	ADJ
aji-166	158	3	inflammation	inflammation	NOUN
aji-166	158	4	contributes	contribute	VERB
aji-166	158	5	to	to	ADP
aji-166	158	6	tissue	tissue	NOUN
aji-166	158	7	damage	damage	NOUN
aji-166	158	8	and	and	CCONJ
aji-166	158	9	plays	play	VERB
aji-166	158	10	a	a	DET
aji-166	158	11	role	role	NOUN
aji-166	158	12	in	in	ADP
aji-166	158	13	the	the	DET
aji-166	158	14	development	development	NOUN
aji-166	158	15	of	of	ADP
aji-166	158	16	non	non	ADJ
aji-166	158	17	-	-	ADJ
aji-166	158	18	aids	aids	ADJ
aji-166	158	19	events	event	NOUN
aji-166	158	20	(	(	PUNCT
aji-166	158	21	nades	nade	NOUN
aji-166	158	22	)	)	PUNCT
aji-166	158	23	(	(	PUNCT
aji-166	158	24	burdo	burdo	NOUN
aji-166	158	25	et	et	PROPN
aji-166	158	26	al	al	PROPN
aji-166	158	27	.	.	PROPN
aji-166	158	28	,	,	PUNCT
aji-166	158	29	2011	2011	NUM
aji-166	158	30	)	)	PUNCT
aji-166	158	31	.	.	PUNCT
aji-166	159	1	moreover	moreover	ADV
aji-166	159	2	,	,	PUNCT
aji-166	159	3	hiv	hiv	PROPN
aji-166	159	4	infection	infection	NOUN
aji-166	159	5	alters	alter	VERB
aji-166	159	6	the	the	DET
aji-166	159	7	functional	functional	ADJ
aji-166	159	8	properties	property	NOUN
aji-166	159	9	of	of	ADP
aji-166	159	10	monocytes	monocyte	NOUN
aji-166	159	11	and	and	CCONJ
aji-166	159	12	macrophages	macrophage	NOUN
aji-166	159	13	,	,	PUNCT
aji-166	159	14	diminishing	diminish	VERB
aji-166	159	15	their	their	PRON
aji-166	159	16	ability	ability	NOUN
aji-166	159	17	to	to	PART
aji-166	159	18	eliminate	eliminate	VERB
aji-166	159	19	pathogens	pathogen	NOUN
aji-166	159	20	and	and	CCONJ
aji-166	159	21	regulate	regulate	VERB
aji-166	159	22	immune	immune	ADJ
aji-166	159	23	responses	response	NOUN
aji-166	159	24	.	.	PUNCT
aji-166	160	1	for	for	ADP
aji-166	160	2	instance	instance	NOUN
aji-166	160	3	,	,	PUNCT
aji-166	160	4	hiv	hiv	PROPN
aji-166	160	5	-	-	PUNCT
aji-166	160	6	infected	infect	VERB
aji-166	160	7	macrophages	macrophage	NOUN
aji-166	160	8	demonstrate	demonstrate	VERB
aji-166	160	9	reduced	reduce	VERB
aji-166	160	10	phagocytosis	phagocytosis	NOUN
aji-166	160	11	and	and	CCONJ
aji-166	160	12	impaired	impair	VERB
aji-166	160	13	antigen	antigen	ADJ
aji-166	160	14	presentation	presentation	NOUN
aji-166	160	15	capabilities	capability	NOUN
aji-166	160	16	,	,	PUNCT
aji-166	160	17	while	while	SCONJ
aji-166	160	18	monocytes	monocyte	NOUN
aji-166	160	19	exhibit	exhibit	VERB
aji-166	160	20	downregulated	downregulate	VERB
aji-166	160	21	mhc	mhc	PROPN
aji-166	160	22	ii	ii	PROPN
aji-166	160	23	expression	expression	NOUN
aji-166	160	24	.	.	PUNCT
aji-166	161	1	this	this	DET
aji-166	161	2	downregulation	downregulation	NOUN
aji-166	161	3	inhibits	inhibit	VERB
aji-166	161	4	the	the	DET
aji-166	161	5	formation	formation	NOUN
aji-166	161	6	of	of	ADP
aji-166	161	7	mhc	mhc	PROPN
aji-166	161	8	iiantigen	iiantigen	NOUN
aji-166	161	9	complexes	complexe	VERB
aji-166	161	10	and	and	CCONJ
aji-166	161	11	diminishes	diminish	VERB
aji-166	161	12	the	the	DET
aji-166	161	13	ability	ability	NOUN
aji-166	161	14	of	of	ADP
aji-166	161	15	monocytes	monocyte	NOUN
aji-166	161	16	to	to	PART
aji-166	161	17	uptake	uptake	VERB
aji-166	161	18	antigens	antigen	NOUN
aji-166	161	19	for	for	ADP
aji-166	161	20	processing	processing	NOUN
aji-166	161	21	and	and	CCONJ
aji-166	161	22	presentation	presentation	NOUN
aji-166	161	23	to	to	ADP
aji-166	161	24	t	t	NOUN
aji-166	161	25	cells	cell	NOUN
aji-166	161	26	(	(	PUNCT
aji-166	161	27	nabatanzi	nabatanzi	PROPN
aji-166	161	28	et	et	PROPN
aji-166	161	29	al	al	PROPN
aji-166	161	30	.	.	PROPN
aji-166	161	31	,	,	PUNCT
aji-166	161	32	2018	2018	NUM
aji-166	161	33	)	)	PUNCT
aji-166	161	34	.	.	PUNCT
aji-166	162	1	such	such	ADJ
aji-166	162	2	impairments	impairment	NOUN
aji-166	162	3	contribute	contribute	VERB
aji-166	162	4	to	to	ADP
aji-166	162	5	immune	immune	ADJ
aji-166	162	6	exhaustion	exhaustion	NOUN
aji-166	162	7	,	,	PUNCT
aji-166	162	8	increasing	increase	VERB
aji-166	162	9	susceptibility	susceptibility	NOUN
aji-166	162	10	to	to	ADP
aji-166	162	11	opportunistic	opportunistic	ADJ
aji-166	162	12	infections	infection	NOUN
aji-166	162	13	(	(	PUNCT
aji-166	162	14	kedzierska	kedzierska	PROPN
aji-166	162	15	&	&	CCONJ
aji-166	162	16	crowe	crowe	PROPN
aji-166	162	17	,	,	PUNCT
aji-166	162	18	2001	2001	NUM
aji-166	162	19	)	)	PUNCT
aji-166	162	20	.	.	PUNCT
aji-166	163	1	additionally	additionally	ADV
aji-166	163	2	,	,	PUNCT
aji-166	163	3	hiv	hiv	PROPN
aji-166	163	4	can	can	AUX
aji-166	163	5	induce	induce	VERB
aji-166	163	6	a	a	DET
aji-166	163	7	pro	pro	ADJ
aji-166	163	8	-	-	ADJ
aji-166	163	9	fibrotic	fibrotic	ADJ
aji-166	163	10	phenotype	phenotype	NOUN
aji-166	163	11	in	in	ADP
aji-166	163	12	macrophages	macrophage	NOUN
aji-166	163	13	,	,	PUNCT
aji-166	163	14	potentially	potentially	ADV
aji-166	163	15	leading	lead	VERB
aji-166	163	16	to	to	ADP
aji-166	163	17	organ	organ	NOUN
aji-166	163	18	fibrosis	fibrosis	NOUN
aji-166	163	19	and	and	CCONJ
aji-166	163	20	dysfunction	dysfunction	NOUN
aji-166	163	21	in	in	ADP
aji-166	163	22	conditions	condition	NOUN
aji-166	163	23	such	such	ADJ
aji-166	163	24	as	as	ADP
aji-166	163	25	liver	liver	NOUN
aji-166	163	26	cirrhosis	cirrhosis	NOUN
aji-166	163	27	and	and	CCONJ
aji-166	163	28	chronic	chronic	ADJ
aji-166	163	29	kidney	kidney	NOUN
aji-166	163	30	disease	disease	NOUN
aji-166	163	31	(	(	PUNCT
aji-166	163	32	kaspar	kaspar	NOUN
aji-166	163	33	&	&	CCONJ
aji-166	163	34	sterling	sterling	NOUN
aji-166	163	35	,	,	PUNCT
aji-166	163	36	2017	2017	NUM
aji-166	163	37	)	)	PUNCT
aji-166	163	38	.	.	PUNCT
aji-166	164	1	in	in	ADP
aji-166	164	2	hiv	hiv	PROPN
aji-166	164	3	infection	infection	NOUN
aji-166	164	4	,	,	PUNCT
aji-166	164	5	excessive	excessive	ADJ
aji-166	164	6	production	production	NOUN
aji-166	164	7	of	of	ADP
aji-166	164	8	reactive	reactive	ADJ
aji-166	164	9	oxygen	oxygen	NOUN
aji-166	164	10	species	specie	NOUN
aji-166	164	11	(	(	PUNCT
aji-166	164	12	ros	ros	PROPN
aji-166	164	13	)	)	PUNCT
aji-166	164	14	and	and	CCONJ
aji-166	164	15	impaired	impaired	ADJ
aji-166	164	16	antioxidant	antioxidant	ADJ
aji-166	164	17	defenses	defense	NOUN
aji-166	164	18	in	in	ADP
aji-166	164	19	macrophages	macrophage	NOUN
aji-166	164	20	and	and	CCONJ
aji-166	164	21	monocytes	monocyte	VERB
aji-166	164	22	lead	lead	VERB
aji-166	164	23	to	to	ADP
aji-166	164	24	oxidative	oxidative	ADJ
aji-166	164	25	stress	stress	NOUN
aji-166	164	26	,	,	PUNCT
aji-166	164	27	which	which	PRON
aji-166	164	28	exacerbates	exacerbate	VERB
aji-166	164	29	chronic	chronic	ADJ
aji-166	164	30	inflammation	inflammation	NOUN
aji-166	164	31	,	,	PUNCT
aji-166	164	32	immune	immune	ADJ
aji-166	164	33	dysfunction	dysfunction	NOUN
aji-166	164	34	,	,	PUNCT
aji-166	164	35	and	and	CCONJ
aji-166	164	36	organspecific	organspecific	PROPN
aji-166	164	37	injury	injury	NOUN
aji-166	164	38	,	,	PUNCT
aji-166	164	39	even	even	ADV
aji-166	164	40	in	in	ADP
aji-166	164	41	individuals	individual	NOUN
aji-166	164	42	receiving	receive	VERB
aji-166	164	43	antiretroviral	antiretroviral	ADJ
aji-166	164	44	therapy	therapy	NOUN
aji-166	164	45	(	(	PUNCT
aji-166	164	46	art	art	NOUN
aji-166	164	47	)	)	PUNCT
aji-166	164	48	(	(	PUNCT
aji-166	164	49	ivanov	ivanov	PROPN
aji-166	164	50	et	et	PROPN
aji-166	164	51	al	al	PROPN
aji-166	164	52	.	.	PROPN
aji-166	164	53	,	,	PUNCT
aji-166	164	54	2016	2016	NUM
aji-166	164	55	)	)	PUNCT
aji-166	164	56	.	.	PUNCT
aji-166	165	1	several	several	ADJ
aji-166	165	2	mechanisms	mechanism	NOUN
aji-166	165	3	contribute	contribute	VERB
aji-166	165	4	to	to	ADP
aji-166	165	5	this	this	DET
aji-166	165	6	issue	issue	NOUN
aji-166	165	7	.	.	PUNCT
aji-166	166	1	one	one	NUM
aji-166	166	2	key	key	ADJ
aji-166	166	3	mechanism	mechanism	NOUN
aji-166	166	4	is	be	AUX
aji-166	166	5	the	the	DET
aji-166	166	6	upregulation	upregulation	NOUN
aji-166	166	7	of	of	ADP
aji-166	166	8	nadph	nadph	ADJ
aji-166	166	9	oxidase	oxidase	NOUN
aji-166	166	10	,	,	PUNCT
aji-166	166	11	a	a	DET
aji-166	166	12	significant	significant	ADJ
aji-166	166	13	ros	ros	PROPN
aji-166	166	14	-	-	PUNCT
aji-166	166	15	producing	produce	VERB
aji-166	166	16	enzyme	enzyme	NOUN
aji-166	166	17	in	in	ADP
aji-166	166	18	macrophages	macrophage	NOUN
aji-166	166	19	,	,	PUNCT
aji-166	166	20	induced	induce	VERB
aji-166	166	21	by	by	ADP
aji-166	166	22	hiv	hiv	PROPN
aji-166	166	23	proteins	protein	NOUN
aji-166	166	24	such	such	ADJ
aji-166	166	25	as	as	ADP
aji-166	166	26	tat	tat	NOUN
aji-166	166	27	and	and	CCONJ
aji-166	166	28	gp120	gp120	NOUN
aji-166	166	29	.	.	PUNCT
aji-166	167	1	this	this	DET
aji-166	167	2	results	result	VERB
aji-166	167	3	in	in	ADP
aji-166	167	4	the	the	DET
aji-166	167	5	overproduction	overproduction	NOUN
aji-166	167	6	of	of	ADP
aji-166	167	7	superoxide	superoxide	NOUN
aji-166	167	8	and	and	CCONJ
aji-166	167	9	hydrogen	hydrogen	NOUN
aji-166	167	10	adavba	adavba	NOUN
aji-166	167	11	;	;	PUNCT
aji-166	167	12	asian	asian	PROPN
aji-166	167	13	j.	j.	PROPN
aji-166	167	14	immunol	immunol	PROPN
aji-166	167	15	.	.	PROPN
aji-166	167	16	,	,	PUNCT
aji-166	167	17	vol	vol	NOUN
aji-166	167	18	.	.	PROPN
aji-166	167	19	8	8	NUM
aji-166	167	20	,	,	PUNCT
aji-166	167	21	no	no	INTJ
aji-166	167	22	.	.	NOUN
aji-166	167	23	1	1	NUM
aji-166	167	24	,	,	PUNCT
aji-166	167	25	pp	pp	ADJ
aji-166	167	26	.	.	PUNCT
aji-166	168	1	120	120	NUM
aji-166	168	2	-	-	SYM
aji-166	168	3	133	133	NUM
aji-166	168	4	,	,	PUNCT
aji-166	168	5	2025	2025	NUM
aji-166	168	6	;	;	PUNCT
aji-166	168	7	article	article	NOUN
aji-166	168	8	no.aji.136909	no.aji.136909	NOUN
aji-166	168	9	123	123	NUM
aji-166	168	10	peroxide	peroxide	NOUN
aji-166	168	11	,	,	PUNCT
aji-166	168	12	which	which	PRON
aji-166	168	13	can	can	AUX
aji-166	168	14	damage	damage	VERB
aji-166	168	15	lipids	lipid	NOUN
aji-166	168	16	,	,	PUNCT
aji-166	168	17	proteins	protein	NOUN
aji-166	168	18	,	,	PUNCT
aji-166	168	19	and	and	CCONJ
aji-166	168	20	dna	dna	PROPN
aji-166	168	21	.	.	PUNCT
aji-166	169	1	additionally	additionally	ADV
aji-166	169	2	,	,	PUNCT
aji-166	169	3	hiv	hiv	PROPN
aji-166	169	4	disrupts	disrupt	VERB
aji-166	169	5	mitochondrial	mitochondrial	ADJ
aji-166	169	6	electron	electron	NOUN
aji-166	169	7	transport	transport	NOUN
aji-166	169	8	,	,	PUNCT
aji-166	169	9	causing	cause	VERB
aji-166	169	10	an	an	DET
aji-166	169	11	increase	increase	NOUN
aji-166	169	12	in	in	ADP
aji-166	169	13	mitochondrial	mitochondrial	ADJ
aji-166	169	14	ros	ro	NOUN
aji-166	169	15	(	(	PUNCT
aji-166	169	16	harshithkumar	harshithkumar	VERB
aji-166	169	17	et	et	PROPN
aji-166	169	18	al	al	PROPN
aji-166	169	19	.	.	PROPN
aji-166	169	20	,	,	PUNCT
aji-166	169	21	2024	2024	NUM
aji-166	169	22	)	)	PUNCT
aji-166	169	23	.	.	PUNCT
aji-166	170	1	it	it	PRON
aji-166	170	2	also	also	ADV
aji-166	170	3	depletes	deplete	VERB
aji-166	170	4	glutathione	glutathione	NOUN
aji-166	170	5	,	,	PUNCT
aji-166	170	6	the	the	DET
aji-166	170	7	primary	primary	ADJ
aji-166	170	8	cellular	cellular	ADJ
aji-166	170	9	antioxidant	antioxidant	NOUN
aji-166	170	10	,	,	PUNCT
aji-166	170	11	by	by	ADP
aji-166	170	12	reducing	reduce	VERB
aji-166	170	13	the	the	DET
aji-166	170	14	expression	expression	NOUN
aji-166	170	15	of	of	ADP
aji-166	170	16	glutamate	glutamate	NOUN
aji-166	170	17	-	-	PUNCT
aji-166	170	18	cysteine	cysteine	NOUN
aji-166	170	19	ligase	ligase	NOUN
aji-166	170	20	in	in	ADP
aji-166	170	21	macrophages	macrophage	NOUN
aji-166	170	22	(	(	PUNCT
aji-166	170	23	lin	lin	PROPN
aji-166	170	24	et	et	PROPN
aji-166	170	25	al	al	PROPN
aji-166	170	26	.	.	PROPN
aji-166	170	27	,	,	PUNCT
aji-166	170	28	2023	2023	NUM
aji-166	170	29	)	)	PUNCT
aji-166	170	30	.	.	PUNCT
aji-166	171	1	these	these	DET
aji-166	171	2	mechanisms	mechanism	NOUN
aji-166	171	3	vary	vary	VERB
aji-166	171	4	in	in	ADP
aji-166	171	5	intensity	intensity	NOUN
aji-166	171	6	across	across	ADP
aji-166	171	7	different	different	ADJ
aji-166	171	8	organs	organ	NOUN
aji-166	171	9	and	and	CCONJ
aji-166	171	10	contribute	contribute	VERB
aji-166	171	11	to	to	ADP
aji-166	171	12	the	the	DET
aji-166	171	13	organspecific	organspecific	ADJ
aji-166	171	14	damage	damage	NOUN
aji-166	171	15	observed	observe	VERB
aji-166	171	16	in	in	ADP
aji-166	171	17	people	people	NOUN
aji-166	171	18	living	live	VERB
aji-166	171	19	with	with	ADP
aji-166	171	20	hiv	hiv	PROPN
aji-166	171	21	(	(	PUNCT
aji-166	171	22	plwh	plwh	NOUN
aji-166	171	23	)	)	PUNCT
aji-166	171	24	,	,	PUNCT
aji-166	171	25	forming	form	VERB
aji-166	171	26	the	the	DET
aji-166	171	27	basis	basis	NOUN
aji-166	171	28	for	for	ADP
aji-166	171	29	the	the	DET
aji-166	171	30	development	development	NOUN
aji-166	171	31	of	of	ADP
aji-166	171	32	non	non	ADJ
aji-166	171	33	-	-	ADJ
aji-166	171	34	aids	aids	ADJ
aji-166	171	35	-	-	PUNCT
aji-166	171	36	related	relate	VERB
aji-166	171	37	events	event	NOUN
aji-166	171	38	(	(	PUNCT
aji-166	171	39	nades	nade	NOUN
aji-166	171	40	)	)	PUNCT
aji-166	171	41	.	.	PUNCT
aji-166	172	1	3	3	X
aji-166	172	2	.	.	X
aji-166	172	3	organ	organ	NOUN
aji-166	172	4	-	-	PUNCT
aji-166	172	5	specific	specific	ADJ
aji-166	172	6	effects	effect	NOUN
aji-166	172	7	of	of	ADP
aji-166	172	8	monocytes	monocyte	NOUN
aji-166	172	9	and	and	CCONJ
aji-166	172	10	macrophages	macrophage	NOUN
aji-166	172	11	in	in	ADP
aji-166	172	12	hiv	hiv	PROPN
aji-166	172	13	disease	disease	NOUN
aji-166	172	14	:	:	PUNCT
aji-166	172	15	mechanisms	mechanism	NOUN
aji-166	172	16	of	of	ADP
aji-166	172	17	tissue	tissue	NOUN
aji-166	172	18	damage	damage	NOUN
aji-166	172	19	3.1	3.1	NUM
aji-166	172	20	cardiovascular	cardiovascular	ADJ
aji-166	172	21	disease	disease	NOUN
aji-166	172	22	(	(	PUNCT
aji-166	172	23	cvd	cvd	PROPN
aji-166	172	24	)	)	PUNCT
aji-166	172	25	hiv	hiv	PROPN
aji-166	172	26	is	be	AUX
aji-166	172	27	the	the	DET
aji-166	172	28	main	main	ADJ
aji-166	172	29	contributing	contribute	VERB
aji-166	172	30	factor	factor	NOUN
aji-166	172	31	to	to	ADP
aji-166	172	32	cvd	cvd	PROPN
aji-166	172	33	in	in	ADP
aji-166	172	34	plwh	plwh	NOUN
aji-166	172	35	,	,	PUNCT
aji-166	172	36	accounting	account	VERB
aji-166	172	37	for	for	ADP
aji-166	172	38	approximately	approximately	ADV
aji-166	172	39	a	a	DET
aji-166	172	40	two	two	NUM
aji-166	172	41	-	-	ADJ
aji-166	172	42	fold	fold	ADJ
aji-166	172	43	increase	increase	NOUN
aji-166	172	44	in	in	ADP
aji-166	172	45	the	the	DET
aji-166	172	46	relative	relative	ADJ
aji-166	172	47	risk	risk	NOUN
aji-166	172	48	of	of	ADP
aji-166	172	49	this	this	DET
aji-166	172	50	disease	disease	NOUN
aji-166	172	51	(	(	PUNCT
aji-166	172	52	ancuta	ancuta	ADV
aji-166	172	53	et	et	PROPN
aji-166	172	54	al	al	PROPN
aji-166	172	55	.	.	PROPN
aji-166	172	56	,	,	PUNCT
aji-166	172	57	2008	2008	NUM
aji-166	172	58	)	)	PUNCT
aji-166	172	59	.	.	PUNCT
aji-166	173	1	cvd	cvd	PROPN
aji-166	173	2	is	be	AUX
aji-166	173	3	the	the	DET
aji-166	173	4	leading	lead	VERB
aji-166	173	5	cause	cause	NOUN
aji-166	173	6	of	of	ADP
aji-166	173	7	death	death	NOUN
aji-166	173	8	worldwide	worldwide	ADV
aji-166	173	9	,	,	PUNCT
aji-166	173	10	and	and	CCONJ
aji-166	173	11	has	have	VERB
aji-166	173	12	atherosclerosis	atherosclerosis	NOUN
aji-166	173	13	as	as	ADP
aji-166	173	14	the	the	DET
aji-166	173	15	main	main	ADJ
aji-166	173	16	underlying	underlying	ADJ
aji-166	173	17	pathology	pathology	NOUN
aji-166	173	18	(	(	PUNCT
aji-166	173	19	jebaribenslaiman	jebaribenslaiman	NOUN
aji-166	173	20	et	et	PROPN
aji-166	173	21	al	al	PROPN
aji-166	173	22	.	.	PROPN
aji-166	173	23	,	,	PUNCT
aji-166	173	24	2022	2022	NUM
aji-166	173	25	)	)	PUNCT
aji-166	173	26	.	.	PUNCT
aji-166	174	1	atherosclerosis	atherosclerosis	NOUN
aji-166	174	2	is	be	AUX
aji-166	174	3	a	a	DET
aji-166	174	4	condition	condition	NOUN
aji-166	174	5	in	in	ADP
aji-166	174	6	which	which	DET
aji-166	174	7	plaque	plaque	NOUN
aji-166	174	8	,	,	PUNCT
aji-166	174	9	made	make	VERB
aji-166	174	10	up	up	ADP
aji-166	174	11	of	of	ADP
aji-166	174	12	fat	fat	ADJ
aji-166	174	13	,	,	PUNCT
aji-166	174	14	cholesterol	cholesterol	NOUN
aji-166	174	15	,	,	PUNCT
aji-166	174	16	and	and	CCONJ
aji-166	174	17	other	other	ADJ
aji-166	174	18	substances	substance	NOUN
aji-166	174	19	,	,	PUNCT
aji-166	174	20	accumulates	accumulate	VERB
aji-166	174	21	in	in	ADP
aji-166	174	22	the	the	DET
aji-166	174	23	intima	intima	NOUN
aji-166	174	24	of	of	ADP
aji-166	174	25	arteries	artery	NOUN
aji-166	174	26	,	,	PUNCT
aji-166	174	27	causing	cause	VERB
aji-166	174	28	them	they	PRON
aji-166	174	29	to	to	PART
aji-166	174	30	narrow	narrow	VERB
aji-166	174	31	and	and	CCONJ
aji-166	174	32	stiffen	stiffen	VERB
aji-166	174	33	.	.	PUNCT
aji-166	175	1	this	this	DET
aji-166	175	2	process	process	NOUN
aji-166	175	3	begins	begin	VERB
aji-166	175	4	with	with	ADP
aji-166	175	5	damage	damage	NOUN
aji-166	175	6	to	to	ADP
aji-166	175	7	the	the	DET
aji-166	175	8	endothelium	endothelium	NOUN
aji-166	175	9	,	,	PUNCT
aji-166	175	10	accompanied	accompany	VERB
aji-166	175	11	by	by	ADP
aji-166	175	12	the	the	DET
aji-166	175	13	retention	retention	NOUN
aji-166	175	14	and	and	CCONJ
aji-166	175	15	modification	modification	NOUN
aji-166	175	16	of	of	ADP
aji-166	175	17	low	low	ADJ
aji-166	175	18	-	-	PUNCT
aji-166	175	19	density	density	NOUN
aji-166	175	20	lipoprotein	lipoprotein	ADJ
aji-166	175	21	(	(	PUNCT
aji-166	175	22	ldl	ldl	NOUN
aji-166	175	23	)	)	PUNCT
aji-166	175	24	in	in	ADP
aji-166	175	25	the	the	DET
aji-166	175	26	intima	intima	NOUN
aji-166	175	27	(	(	PUNCT
aji-166	175	28	mundi	mundi	PROPN
aji-166	175	29	et	et	PROPN
aji-166	175	30	al	al	PROPN
aji-166	175	31	.	.	PROPN
aji-166	175	32	,	,	PUNCT
aji-166	175	33	2017	2017	NUM
aji-166	175	34	)	)	PUNCT
aji-166	175	35	.	.	PUNCT
aji-166	176	1	the	the	DET
aji-166	176	2	recruitment	recruitment	NOUN
aji-166	176	3	of	of	ADP
aji-166	176	4	monocytes	monocyte	NOUN
aji-166	176	5	into	into	ADP
aji-166	176	6	the	the	DET
aji-166	176	7	intima	intima	ADJ
aji-166	176	8	triggers	trigger	NOUN
aji-166	176	9	an	an	DET
aji-166	176	10	inflammatory	inflammatory	ADJ
aji-166	176	11	state	state	NOUN
aji-166	176	12	critical	critical	ADJ
aji-166	176	13	to	to	ADP
aji-166	176	14	the	the	DET
aji-166	176	15	development	development	NOUN
aji-166	176	16	of	of	ADP
aji-166	176	17	atherosclerosis	atherosclerosis	NOUN
aji-166	176	18	.	.	PUNCT
aji-166	177	1	monocytes	monocyte	NOUN
aji-166	177	2	recruited	recruit	VERB
aji-166	177	3	into	into	ADP
aji-166	177	4	the	the	DET
aji-166	177	5	arterial	arterial	NOUN
aji-166	177	6	wall	wall	NOUN
aji-166	177	7	differentiate	differentiate	VERB
aji-166	177	8	into	into	ADP
aji-166	177	9	macrophages	macrophage	NOUN
aji-166	177	10	and	and	CCONJ
aji-166	177	11	foam	foam	NOUN
aji-166	177	12	cells	cell	NOUN
aji-166	177	13	,	,	PUNCT
aji-166	177	14	facilitating	facilitate	VERB
aji-166	177	15	plaque	plaque	NOUN
aji-166	177	16	formation	formation	NOUN
aji-166	177	17	(	(	PUNCT
aji-166	177	18	subramanian	subramanian	PROPN
aji-166	177	19	et	et	PROPN
aji-166	177	20	al	al	PROPN
aji-166	177	21	.	.	PROPN
aji-166	177	22	,	,	PUNCT
aji-166	177	23	2012	2012	NUM
aji-166	177	24	)	)	PUNCT
aji-166	177	25	.	.	PUNCT
aji-166	178	1	moreover	moreover	ADV
aji-166	178	2	,	,	PUNCT
aji-166	178	3	the	the	DET
aji-166	178	4	increased	increase	VERB
aji-166	178	5	elaboration	elaboration	NOUN
aji-166	178	6	of	of	ADP
aji-166	178	7	proinflammatory	proinflammatory	ADJ
aji-166	178	8	cytokines	cytokine	NOUN
aji-166	178	9	by	by	ADP
aji-166	178	10	hiv	hiv	PROPN
aji-166	178	11	-	-	PUNCT
aji-166	178	12	infected	infect	VERB
aji-166	178	13	monocytes	monocyte	NOUN
aji-166	178	14	and	and	CCONJ
aji-166	178	15	macrophages	macrophage	NOUN
aji-166	178	16	maintains	maintain	VERB
aji-166	178	17	a	a	DET
aji-166	178	18	systemic	systemic	ADJ
aji-166	178	19	inflammatory	inflammatory	ADJ
aji-166	178	20	state	state	NOUN
aji-166	178	21	,	,	PUNCT
aji-166	178	22	accelerating	accelerate	VERB
aji-166	178	23	atherosclerosis	atherosclerosis	NOUN
aji-166	178	24	and	and	CCONJ
aji-166	178	25	endothelial	endothelial	ADJ
aji-166	178	26	dysfunction	dysfunction	NOUN
aji-166	178	27	(	(	PUNCT
aji-166	178	28	deeks	deek	NOUN
aji-166	178	29	et	et	PROPN
aji-166	178	30	al	al	PROPN
aji-166	178	31	.	.	PROPN
aji-166	178	32	,	,	PUNCT
aji-166	178	33	2013	2013	NUM
aji-166	178	34	)	)	PUNCT
aji-166	178	35	.	.	PUNCT
aji-166	179	1	elevated	elevated	ADJ
aji-166	179	2	levels	level	NOUN
aji-166	179	3	of	of	ADP
aji-166	179	4	markers	marker	NOUN
aji-166	179	5	of	of	ADP
aji-166	179	6	macrophage	macrophage	ADJ
aji-166	179	7	activation	activation	NOUN
aji-166	179	8	,	,	PUNCT
aji-166	179	9	soluble	soluble	ADJ
aji-166	179	10	cd163	cd163	PROPN
aji-166	179	11	and	and	CCONJ
aji-166	179	12	soluble	soluble	ADJ
aji-166	179	13	cd14	cd14	PROPN
aji-166	179	14	,	,	PUNCT
aji-166	179	15	are	be	AUX
aji-166	179	16	strongly	strongly	ADV
aji-166	179	17	associated	associate	VERB
aji-166	179	18	with	with	ADP
aji-166	179	19	subclinical	subclinical	ADJ
aji-166	179	20	atherosclerosis	atherosclerosis	NOUN
aji-166	179	21	and	and	CCONJ
aji-166	179	22	cardiovascular	cardiovascular	ADJ
aji-166	179	23	events	event	NOUN
aji-166	179	24	in	in	ADP
aji-166	179	25	plwh	plwh	NOUN
aji-166	179	26	(	(	PUNCT
aji-166	179	27	serrano	serrano	PROPN
aji-166	179	28	-	-	PUNCT
aji-166	179	29	villar	villar	PROPN
aji-166	179	30	et	et	PROPN
aji-166	179	31	al	al	PROPN
aji-166	179	32	.	.	PROPN
aji-166	179	33	,	,	PUNCT
aji-166	179	34	2014	2014	NUM
aji-166	179	35	)	)	PUNCT
aji-166	179	36	.	.	PUNCT
aji-166	180	1	furthermore	furthermore	ADV
aji-166	180	2	,	,	PUNCT
aji-166	180	3	the	the	DET
aji-166	180	4	increased	increase	VERB
aji-166	180	5	expression	expression	NOUN
aji-166	180	6	of	of	ADP
aji-166	180	7	adhesion	adhesion	NOUN
aji-166	180	8	molecules	molecule	NOUN
aji-166	180	9	(	(	PUNCT
aji-166	180	10	icam-1	icam-1	NOUN
aji-166	180	11	,	,	PUNCT
aji-166	180	12	vcam-1	vcam-1	NOUN
aji-166	180	13	)	)	PUNCT
aji-166	180	14	and	and	CCONJ
aji-166	180	15	chemokine	chemokine	ADJ
aji-166	180	16	receptors	receptor	NOUN
aji-166	180	17	(	(	PUNCT
aji-166	180	18	ccr2	ccr2	PROPN
aji-166	180	19	,	,	PUNCT
aji-166	180	20	cx3cr1	cx3cr1	PROPN
aji-166	180	21	)	)	PUNCT
aji-166	180	22	by	by	ADP
aji-166	180	23	hivinfected	hivinfecte	VERB
aji-166	180	24	monocytes	monocyte	NOUN
aji-166	180	25	enhances	enhance	VERB
aji-166	180	26	their	their	PRON
aji-166	180	27	adhesion	adhesion	NOUN
aji-166	180	28	to	to	ADP
aji-166	180	29	and	and	CCONJ
aji-166	180	30	infiltration	infiltration	NOUN
aji-166	180	31	into	into	ADP
aji-166	180	32	the	the	DET
aji-166	180	33	vascular	vascular	ADJ
aji-166	180	34	endothelium	endothelium	NOUN
aji-166	180	35	.	.	PUNCT
aji-166	181	1	this	this	DET
aji-166	181	2	endothelial	endothelial	ADJ
aji-166	181	3	barrier	barrier	NOUN
aji-166	181	4	disruption	disruption	NOUN
aji-166	181	5	promotes	promote	VERB
aji-166	181	6	vascular	vascular	ADJ
aji-166	181	7	inflammation	inflammation	NOUN
aji-166	181	8	,	,	PUNCT
aji-166	181	9	exacerbates	exacerbate	VERB
aji-166	181	10	endothelial	endothelial	ADJ
aji-166	181	11	dysfunction	dysfunction	NOUN
aji-166	181	12	,	,	PUNCT
aji-166	181	13	and	and	CCONJ
aji-166	181	14	vascular	vascular	ADJ
aji-166	181	15	remodeling	remodeling	NOUN
aji-166	181	16	,	,	PUNCT
aji-166	181	17	thereby	thereby	ADV
aji-166	181	18	increasing	increase	VERB
aji-166	181	19	cardiovascular	cardiovascular	ADJ
aji-166	181	20	risk	risk	NOUN
aji-166	181	21	(	(	PUNCT
aji-166	181	22	hsue	hsue	NOUN
aji-166	181	23	et	et	PROPN
aji-166	181	24	al	al	PROPN
aji-166	181	25	.	.	PROPN
aji-166	181	26	,	,	PUNCT
aji-166	181	27	2012	2012	NUM
aji-166	181	28	)	)	PUNCT
aji-166	181	29	.	.	PUNCT
aji-166	182	1	additionally	additionally	ADV
aji-166	182	2	,	,	PUNCT
aji-166	182	3	cytokines	cytokine	NOUN
aji-166	182	4	derived	derive	VERB
aji-166	182	5	from	from	ADP
aji-166	182	6	macrophages	macrophage	NOUN
aji-166	182	7	(	(	PUNCT
aji-166	182	8	tnf	tnf	PROPN
aji-166	182	9	-	-	PUNCT
aji-166	182	10	α	α	PROPN
aji-166	182	11	,	,	PUNCT
aji-166	182	12	il-6	il-6	NUM
aji-166	182	13	)	)	PUNCT
aji-166	182	14	and	and	CCONJ
aji-166	182	15	hiv	hiv	PROPN
aji-166	182	16	proteins	protein	NOUN
aji-166	182	17	(	(	PUNCT
aji-166	182	18	tat	tat	NOUN
aji-166	182	19	,	,	PUNCT
aji-166	182	20	nef	nef	PROPN
aji-166	182	21	)	)	PUNCT
aji-166	182	22	directly	directly	ADV
aji-166	182	23	activate	activate	VERB
aji-166	182	24	endothelial	endothelial	ADJ
aji-166	182	25	cells	cell	NOUN
aji-166	182	26	,	,	PUNCT
aji-166	182	27	resulting	result	VERB
aji-166	182	28	in	in	ADP
aji-166	182	29	increased	increase	VERB
aji-166	182	30	permeability	permeability	NOUN
aji-166	182	31	that	that	PRON
aji-166	182	32	accelerates	accelerate	VERB
aji-166	182	33	leukocyte	leukocyte	ADJ
aji-166	182	34	recruitment	recruitment	NOUN
aji-166	182	35	(	(	PUNCT
aji-166	182	36	ganor	ganor	NOUN
aji-166	182	37	et	et	NOUN
aji-166	182	38	al	al	PROPN
aji-166	182	39	.	.	PROPN
aji-166	182	40	,	,	PUNCT
aji-166	182	41	2019	2019	NUM
aji-166	182	42	)	)	PUNCT
aji-166	182	43	.	.	PUNCT
aji-166	183	1	in	in	ADP
aji-166	183	2	addition	addition	NOUN
aji-166	183	3	,	,	PUNCT
aji-166	183	4	hiv	hiv	PROPN
aji-166	183	5	infection	infection	NOUN
aji-166	183	6	and	and	CCONJ
aji-166	183	7	art	art	NOUN
aji-166	183	8	disrupt	disrupt	NOUN
aji-166	183	9	lipid	lipid	NOUN
aji-166	183	10	metabolism	metabolism	NOUN
aji-166	183	11	,	,	PUNCT
aji-166	183	12	leading	lead	VERB
aji-166	183	13	to	to	ADP
aji-166	183	14	elevated	elevated	ADJ
aji-166	183	15	levels	level	NOUN
aji-166	183	16	of	of	ADP
aji-166	183	17	triglycerides	triglyceride	NOUN
aji-166	183	18	and	and	CCONJ
aji-166	183	19	ldl	ldl	VERB
aji-166	183	20	cholesterol	cholesterol	NOUN
aji-166	183	21	.	.	PUNCT
aji-166	184	1	macrophages	macrophage	NOUN
aji-166	184	2	in	in	ADP
aji-166	184	3	plwh	plwh	NOUN
aji-166	184	4	accumulate	accumulate	VERB
aji-166	184	5	lipids	lipid	NOUN
aji-166	184	6	and	and	CCONJ
aji-166	184	7	exhibit	exhibit	VERB
aji-166	184	8	impaired	impaired	ADJ
aji-166	184	9	cholesterol	cholesterol	NOUN
aji-166	184	10	efflux	efflux	VERB
aji-166	184	11	due	due	ADP
aji-166	184	12	to	to	ADP
aji-166	184	13	downregulation	downregulation	NOUN
aji-166	184	14	of	of	ADP
aji-166	184	15	abca1	abca1	NOUN
aji-166	184	16	and	and	CCONJ
aji-166	184	17	abcg1	abcg1	ADJ
aji-166	184	18	transporters	transporter	NOUN
aji-166	184	19	(	(	PUNCT
aji-166	184	20	clayton	clayton	PROPN
aji-166	184	21	et	et	PROPN
aji-166	184	22	al	al	PROPN
aji-166	184	23	.	.	PROPN
aji-166	184	24	,	,	PUNCT
aji-166	184	25	2018	2018	NUM
aji-166	184	26	)	)	PUNCT
aji-166	184	27	.	.	PUNCT
aji-166	185	1	these	these	DET
aji-166	185	2	proteins	protein	NOUN
aji-166	185	3	are	be	AUX
aji-166	185	4	crucial	crucial	ADJ
aji-166	185	5	atp	atp	NOUN
aji-166	185	6	-	-	PUNCT
aji-166	185	7	binding	bind	VERB
aji-166	185	8	cassette	cassette	NOUN
aji-166	185	9	transporters	transporter	NOUN
aji-166	185	10	in	in	ADP
aji-166	185	11	macrophages	macrophage	NOUN
aji-166	185	12	that	that	SCONJ
aji-166	185	13	facilitate	facilitate	VERB
aji-166	185	14	cholesterol	cholesterol	NOUN
aji-166	185	15	efflux	efflux	NOUN
aji-166	185	16	and	and	CCONJ
aji-166	185	17	play	play	VERB
aji-166	185	18	a	a	DET
aji-166	185	19	role	role	NOUN
aji-166	185	20	in	in	ADP
aji-166	185	21	reverse	reverse	ADJ
aji-166	185	22	cholesterol	cholesterol	NOUN
aji-166	185	23	transport	transport	NOUN
aji-166	185	24	.	.	PUNCT
aji-166	186	1	deficiency	deficiency	NOUN
aji-166	186	2	or	or	CCONJ
aji-166	186	3	downregulation	downregulation	NOUN
aji-166	186	4	of	of	ADP
aji-166	186	5	these	these	DET
aji-166	186	6	transporters	transporter	NOUN
aji-166	186	7	can	can	AUX
aji-166	186	8	lead	lead	VERB
aji-166	186	9	to	to	ADP
aji-166	186	10	increased	increase	VERB
aji-166	186	11	cholesterol	cholesterol	NOUN
aji-166	186	12	accumulation	accumulation	NOUN
aji-166	186	13	in	in	ADP
aji-166	186	14	macrophages	macrophage	NOUN
aji-166	186	15	,	,	PUNCT
aji-166	186	16	contributing	contribute	VERB
aji-166	186	17	to	to	ADP
aji-166	186	18	foam	foam	NOUN
aji-166	186	19	cell	cell	NOUN
aji-166	186	20	formation	formation	NOUN
aji-166	186	21	and	and	CCONJ
aji-166	186	22	potentially	potentially	ADV
aji-166	186	23	accelerating	accelerate	VERB
aji-166	186	24	atherosclerosis	atherosclerosis	NOUN
aji-166	186	25	(	(	PUNCT
aji-166	186	26	yvan	yvan	PROPN
aji-166	186	27	-	-	PUNCT
aji-166	186	28	charvet	charvet	PROPN
aji-166	186	29	et	et	PROPN
aji-166	186	30	al	al	PROPN
aji-166	186	31	.	.	PROPN
aji-166	186	32	,	,	PUNCT
aji-166	186	33	2007	2007	NUM
aji-166	186	34	)	)	PUNCT
aji-166	186	35	.	.	PUNCT
aji-166	187	1	hiv	hiv	PROPN
aji-166	187	2	is	be	AUX
aji-166	187	3	a	a	DET
aji-166	187	4	major	major	ADJ
aji-166	187	5	contributing	contribute	VERB
aji-166	187	6	factor	factor	NOUN
aji-166	187	7	to	to	ADP
aji-166	187	8	cardiovascular	cardiovascular	ADJ
aji-166	187	9	disease	disease	NOUN
aji-166	187	10	(	(	PUNCT
aji-166	187	11	cvd	cvd	PROPN
aji-166	187	12	)	)	PUNCT
aji-166	187	13	in	in	ADP
aji-166	187	14	plwh	plwh	NOUN
aji-166	187	15	,	,	PUNCT
aji-166	187	16	resulting	result	VERB
aji-166	187	17	in	in	ADP
aji-166	187	18	approximately	approximately	ADV
aji-166	187	19	a	a	DET
aji-166	187	20	two	two	NUM
aji-166	187	21	-	-	ADJ
aji-166	187	22	fold	fold	ADJ
aji-166	187	23	increase	increase	NOUN
aji-166	187	24	in	in	ADP
aji-166	187	25	the	the	DET
aji-166	187	26	relative	relative	ADJ
aji-166	187	27	risk	risk	NOUN
aji-166	187	28	of	of	ADP
aji-166	187	29	this	this	DET
aji-166	187	30	condition	condition	NOUN
aji-166	187	31	(	(	PUNCT
aji-166	187	32	ancuta	ancuta	ADV
aji-166	187	33	et	et	PROPN
aji-166	187	34	al	al	PROPN
aji-166	187	35	.	.	PROPN
aji-166	187	36	,	,	PUNCT
aji-166	187	37	2008	2008	NUM
aji-166	187	38	)	)	PUNCT
aji-166	187	39	.	.	PUNCT
aji-166	188	1	cvd	cvd	PROPN
aji-166	188	2	is	be	AUX
aji-166	188	3	the	the	DET
aji-166	188	4	leading	lead	VERB
aji-166	188	5	cause	cause	NOUN
aji-166	188	6	of	of	ADP
aji-166	188	7	death	death	NOUN
aji-166	188	8	worldwide	worldwide	ADV
aji-166	188	9	,	,	PUNCT
aji-166	188	10	with	with	ADP
aji-166	188	11	atherosclerosis	atherosclerosis	NOUN
aji-166	188	12	being	be	AUX
aji-166	188	13	the	the	DET
aji-166	188	14	primary	primary	ADJ
aji-166	188	15	underlying	underlie	VERB
aji-166	188	16	pathology	pathology	NOUN
aji-166	188	17	(	(	PUNCT
aji-166	188	18	jebari	jebari	NOUN
aji-166	188	19	-	-	PUNCT
aji-166	188	20	benslaiman	benslaiman	PROPN
aji-166	188	21	et	et	PROPN
aji-166	188	22	al	al	PROPN
aji-166	188	23	.	.	PROPN
aji-166	188	24	,	,	PUNCT
aji-166	188	25	2022	2022	NUM
aji-166	188	26	)	)	PUNCT
aji-166	188	27	.	.	PUNCT
aji-166	189	1	atherosclerosis	atherosclerosis	NOUN
aji-166	189	2	occurs	occur	VERB
aji-166	189	3	when	when	SCONJ
aji-166	189	4	plaque	plaque	NOUN
aji-166	189	5	,	,	PUNCT
aji-166	189	6	composed	compose	VERB
aji-166	189	7	of	of	ADP
aji-166	189	8	fat	fat	ADJ
aji-166	189	9	,	,	PUNCT
aji-166	189	10	cholesterol	cholesterol	NOUN
aji-166	189	11	,	,	PUNCT
aji-166	189	12	and	and	CCONJ
aji-166	189	13	other	other	ADJ
aji-166	189	14	substances	substance	NOUN
aji-166	189	15	,	,	PUNCT
aji-166	189	16	accumulates	accumulate	VERB
aji-166	189	17	in	in	ADP
aji-166	189	18	the	the	DET
aji-166	189	19	intima	intima	NOUN
aji-166	189	20	of	of	ADP
aji-166	189	21	arteries	artery	NOUN
aji-166	189	22	,	,	PUNCT
aji-166	189	23	causing	cause	VERB
aji-166	189	24	them	they	PRON
aji-166	189	25	to	to	PART
aji-166	189	26	narrow	narrow	VERB
aji-166	189	27	and	and	CCONJ
aji-166	189	28	stiffen	stiffen	VERB
aji-166	189	29	.	.	PUNCT
aji-166	190	1	this	this	DET
aji-166	190	2	process	process	NOUN
aji-166	190	3	begins	begin	VERB
aji-166	190	4	with	with	ADP
aji-166	190	5	damage	damage	NOUN
aji-166	190	6	to	to	ADP
aji-166	190	7	the	the	DET
aji-166	190	8	endothelium	endothelium	NOUN
aji-166	190	9	,	,	PUNCT
aji-166	190	10	leading	lead	VERB
aji-166	190	11	to	to	ADP
aji-166	190	12	the	the	DET
aji-166	190	13	retention	retention	NOUN
aji-166	190	14	and	and	CCONJ
aji-166	190	15	modification	modification	NOUN
aji-166	190	16	of	of	ADP
aji-166	190	17	low	low	ADJ
aji-166	190	18	-	-	PUNCT
aji-166	190	19	density	density	NOUN
aji-166	190	20	lipoprotein	lipoprotein	ADJ
aji-166	190	21	(	(	PUNCT
aji-166	190	22	ldl	ldl	NOUN
aji-166	190	23	)	)	PUNCT
aji-166	190	24	in	in	ADP
aji-166	190	25	the	the	DET
aji-166	190	26	intima	intima	NOUN
aji-166	190	27	(	(	PUNCT
aji-166	190	28	mundi	mundi	PROPN
aji-166	190	29	et	et	PROPN
aji-166	190	30	al	al	PROPN
aji-166	190	31	.	.	PROPN
aji-166	190	32	,	,	PUNCT
aji-166	190	33	2017	2017	NUM
aji-166	190	34	)	)	PUNCT
aji-166	190	35	.	.	PUNCT
aji-166	191	1	the	the	DET
aji-166	191	2	recruitment	recruitment	NOUN
aji-166	191	3	of	of	ADP
aji-166	191	4	monocytes	monocyte	NOUN
aji-166	191	5	into	into	ADP
aji-166	191	6	the	the	DET
aji-166	191	7	intima	intima	ADJ
aji-166	191	8	triggers	trigger	NOUN
aji-166	191	9	a	a	DET
aji-166	191	10	critical	critical	ADJ
aji-166	191	11	inflammatory	inflammatory	ADJ
aji-166	191	12	response	response	NOUN
aji-166	191	13	that	that	PRON
aji-166	191	14	is	be	AUX
aji-166	191	15	essential	essential	ADJ
aji-166	191	16	for	for	ADP
aji-166	191	17	the	the	DET
aji-166	191	18	development	development	NOUN
aji-166	191	19	of	of	ADP
aji-166	191	20	atherosclerosis	atherosclerosis	NOUN
aji-166	191	21	.	.	PUNCT
aji-166	192	1	once	once	ADV
aji-166	192	2	in	in	ADP
aji-166	192	3	the	the	DET
aji-166	192	4	arterial	arterial	NOUN
aji-166	192	5	wall	wall	NOUN
aji-166	192	6	,	,	PUNCT
aji-166	192	7	these	these	PRON
aji-166	192	8	monocytes	monocyte	VERB
aji-166	192	9	differentiate	differentiate	VERB
aji-166	192	10	into	into	ADP
aji-166	192	11	macrophages	macrophage	NOUN
aji-166	192	12	and	and	CCONJ
aji-166	192	13	foam	foam	NOUN
aji-166	192	14	cells	cell	NOUN
aji-166	192	15	,	,	PUNCT
aji-166	192	16	which	which	PRON
aji-166	192	17	aid	aid	VERB
aji-166	192	18	in	in	ADP
aji-166	192	19	plaque	plaque	NOUN
aji-166	192	20	formation	formation	NOUN
aji-166	192	21	(	(	PUNCT
aji-166	192	22	subramanian	subramanian	PROPN
aji-166	192	23	et	et	PROPN
aji-166	192	24	al	al	PROPN
aji-166	192	25	.	.	PROPN
aji-166	192	26	,	,	PUNCT
aji-166	192	27	2012	2012	NUM
aji-166	192	28	)	)	PUNCT
aji-166	192	29	.	.	PUNCT
aji-166	193	1	additionally	additionally	ADV
aji-166	193	2	,	,	PUNCT
aji-166	193	3	hiv	hiv	PROPN
aji-166	193	4	-	-	PUNCT
aji-166	193	5	infected	infect	VERB
aji-166	193	6	monocytes	monocyte	NOUN
aji-166	193	7	and	and	CCONJ
aji-166	193	8	macrophages	macrophage	NOUN
aji-166	193	9	produce	produce	VERB
aji-166	193	10	increased	increase	VERB
aji-166	193	11	levels	level	NOUN
aji-166	193	12	of	of	ADP
aji-166	193	13	pro	pro	X
aji-166	193	14	adavba	adavba	PROPN
aji-166	193	15	;	;	PUNCT
aji-166	193	16	asian	asian	PROPN
aji-166	193	17	j.	j.	PROPN
aji-166	193	18	immunol	immunol	PROPN
aji-166	193	19	.	.	PROPN
aji-166	193	20	,	,	PUNCT
aji-166	193	21	vol	vol	NOUN
aji-166	193	22	.	.	PROPN
aji-166	193	23	8	8	NUM
aji-166	193	24	,	,	PUNCT
aji-166	193	25	no	no	INTJ
aji-166	193	26	.	.	NOUN
aji-166	193	27	1	1	NUM
aji-166	193	28	,	,	PUNCT
aji-166	193	29	pp	pp	ADJ
aji-166	193	30	.	.	PUNCT
aji-166	194	1	120	120	NUM
aji-166	194	2	-	-	SYM
aji-166	194	3	133	133	NUM
aji-166	194	4	,	,	PUNCT
aji-166	194	5	2025	2025	NUM
aji-166	194	6	;	;	PUNCT
aji-166	194	7	article	article	NOUN
aji-166	194	8	no.aji.136909	no.aji.136909	NOUN
aji-166	194	9	124	124	NUM
aji-166	194	10	inflammatory	inflammatory	ADJ
aji-166	194	11	cytokines	cytokine	NOUN
aji-166	194	12	,	,	PUNCT
aji-166	194	13	maintaining	maintain	VERB
aji-166	194	14	a	a	DET
aji-166	194	15	systemic	systemic	ADJ
aji-166	194	16	inflammatory	inflammatory	ADJ
aji-166	194	17	state	state	NOUN
aji-166	194	18	that	that	PRON
aji-166	194	19	accelerates	accelerate	VERB
aji-166	194	20	atherosclerosis	atherosclerosis	NOUN
aji-166	194	21	and	and	CCONJ
aji-166	194	22	endothelial	endothelial	ADJ
aji-166	194	23	dysfunction	dysfunction	NOUN
aji-166	194	24	(	(	PUNCT
aji-166	194	25	deeks	deek	NOUN
aji-166	194	26	et	et	PROPN
aji-166	194	27	al	al	PROPN
aji-166	194	28	.	.	PROPN
aji-166	194	29	,	,	PUNCT
aji-166	194	30	2013	2013	NUM
aji-166	194	31	)	)	PUNCT
aji-166	194	32	.	.	PUNCT
aji-166	195	1	elevated	elevated	ADJ
aji-166	195	2	levels	level	NOUN
aji-166	195	3	of	of	ADP
aji-166	195	4	markers	marker	NOUN
aji-166	195	5	for	for	ADP
aji-166	195	6	macrophage	macrophage	ADJ
aji-166	195	7	activation	activation	NOUN
aji-166	195	8	,	,	PUNCT
aji-166	195	9	such	such	ADJ
aji-166	195	10	as	as	ADP
aji-166	195	11	soluble	soluble	ADJ
aji-166	195	12	cd163	cd163	PROPN
aji-166	195	13	and	and	CCONJ
aji-166	195	14	soluble	soluble	ADJ
aji-166	195	15	cd14	cd14	PROPN
aji-166	195	16	,	,	PUNCT
aji-166	195	17	have	have	VERB
aji-166	195	18	a	a	DET
aji-166	195	19	strong	strong	ADJ
aji-166	195	20	association	association	NOUN
aji-166	195	21	with	with	ADP
aji-166	195	22	subclinical	subclinical	ADJ
aji-166	195	23	atherosclerosis	atherosclerosis	NOUN
aji-166	195	24	and	and	CCONJ
aji-166	195	25	cardiovascular	cardiovascular	ADJ
aji-166	195	26	events	event	NOUN
aji-166	195	27	in	in	ADP
aji-166	195	28	plwh	plwh	NOUN
aji-166	195	29	(	(	PUNCT
aji-166	195	30	serrano	serrano	PROPN
aji-166	195	31	-	-	PUNCT
aji-166	195	32	villar	villar	PROPN
aji-166	195	33	et	et	PROPN
aji-166	195	34	al	al	PROPN
aji-166	195	35	.	.	PROPN
aji-166	195	36	,	,	PUNCT
aji-166	195	37	2014	2014	NUM
aji-166	195	38	)	)	PUNCT
aji-166	195	39	.	.	PUNCT
aji-166	196	1	furthermore	furthermore	ADV
aji-166	196	2	,	,	PUNCT
aji-166	196	3	the	the	DET
aji-166	196	4	increased	increase	VERB
aji-166	196	5	expression	expression	NOUN
aji-166	196	6	of	of	ADP
aji-166	196	7	adhesion	adhesion	NOUN
aji-166	196	8	molecules	molecule	NOUN
aji-166	196	9	(	(	PUNCT
aji-166	196	10	like	like	ADP
aji-166	196	11	icam-1	icam-1	NUM
aji-166	196	12	and	and	CCONJ
aji-166	196	13	vcam-1	vcam-1	NUM
aji-166	196	14	)	)	PUNCT
aji-166	196	15	and	and	CCONJ
aji-166	196	16	chemokine	chemokine	ADJ
aji-166	196	17	receptors	receptor	NOUN
aji-166	196	18	(	(	PUNCT
aji-166	196	19	such	such	ADJ
aji-166	196	20	as	as	ADP
aji-166	196	21	ccr2	ccr2	NOUN
aji-166	196	22	and	and	CCONJ
aji-166	196	23	cx3cr1	cx3cr1	NOUN
aji-166	196	24	)	)	PUNCT
aji-166	196	25	on	on	ADP
aji-166	196	26	hiv	hiv	PROPN
aji-166	196	27	-	-	PUNCT
aji-166	196	28	infected	infect	VERB
aji-166	196	29	monocytes	monocyte	NOUN
aji-166	196	30	enhances	enhance	VERB
aji-166	196	31	their	their	PRON
aji-166	196	32	ability	ability	NOUN
aji-166	196	33	to	to	PART
aji-166	196	34	adhere	adhere	VERB
aji-166	196	35	to	to	ADP
aji-166	196	36	and	and	CCONJ
aji-166	196	37	infiltrate	infiltrate	VERB
aji-166	196	38	the	the	DET
aji-166	196	39	vascular	vascular	ADJ
aji-166	196	40	endothelium	endothelium	NOUN
aji-166	196	41	.	.	PUNCT
aji-166	197	1	this	this	DET
aji-166	197	2	disruption	disruption	NOUN
aji-166	197	3	of	of	ADP
aji-166	197	4	the	the	DET
aji-166	197	5	endothelial	endothelial	ADJ
aji-166	197	6	barrier	barrier	NOUN
aji-166	197	7	promotes	promote	VERB
aji-166	197	8	vascular	vascular	ADJ
aji-166	197	9	inflammation	inflammation	NOUN
aji-166	197	10	,	,	PUNCT
aji-166	197	11	worsens	worsen	VERB
aji-166	197	12	endothelial	endothelial	ADJ
aji-166	197	13	dysfunction	dysfunction	NOUN
aji-166	197	14	,	,	PUNCT
aji-166	197	15	and	and	CCONJ
aji-166	197	16	contributes	contribute	VERB
aji-166	197	17	to	to	PART
aji-166	197	18	vascular	vascular	VERB
aji-166	197	19	remodeling	remodeling	NOUN
aji-166	197	20	,	,	PUNCT
aji-166	197	21	all	all	PRON
aji-166	197	22	of	of	ADP
aji-166	197	23	which	which	PRON
aji-166	197	24	increase	increase	VERB
aji-166	197	25	cardiovascular	cardiovascular	ADJ
aji-166	197	26	risk	risk	NOUN
aji-166	197	27	(	(	PUNCT
aji-166	197	28	hsue	hsue	NOUN
aji-166	197	29	et	et	PROPN
aji-166	197	30	al	al	PROPN
aji-166	197	31	.	.	PROPN
aji-166	197	32	,	,	PUNCT
aji-166	197	33	2012	2012	NUM
aji-166	197	34	)	)	PUNCT
aji-166	197	35	.	.	PUNCT
aji-166	198	1	cytokines	cytokine	NOUN
aji-166	198	2	released	release	VERB
aji-166	198	3	from	from	ADP
aji-166	198	4	macrophages	macrophage	NOUN
aji-166	198	5	(	(	PUNCT
aji-166	198	6	like	like	ADP
aji-166	198	7	tnf	tnf	PROPN
aji-166	198	8	-	-	PUNCT
aji-166	198	9	α	α	PROPN
aji-166	198	10	and	and	CCONJ
aji-166	198	11	il6	il6	NOUN
aji-166	198	12	)	)	PUNCT
aji-166	198	13	and	and	CCONJ
aji-166	198	14	hiv	hiv	PROPN
aji-166	198	15	proteins	protein	NOUN
aji-166	198	16	(	(	PUNCT
aji-166	198	17	such	such	ADJ
aji-166	198	18	as	as	ADP
aji-166	198	19	tat	tat	NOUN
aji-166	198	20	and	and	CCONJ
aji-166	198	21	nef	nef	PROPN
aji-166	198	22	)	)	PUNCT
aji-166	198	23	directly	directly	ADV
aji-166	198	24	activate	activate	VERB
aji-166	198	25	endothelial	endothelial	ADJ
aji-166	198	26	cells	cell	NOUN
aji-166	198	27	,	,	PUNCT
aji-166	198	28	resulting	result	VERB
aji-166	198	29	in	in	ADP
aji-166	198	30	increased	increase	VERB
aji-166	198	31	permeability	permeability	NOUN
aji-166	198	32	and	and	CCONJ
aji-166	198	33	accelerated	accelerate	VERB
aji-166	198	34	recruitment	recruitment	NOUN
aji-166	198	35	of	of	ADP
aji-166	198	36	leukocytes	leukocyte	NOUN
aji-166	198	37	(	(	PUNCT
aji-166	198	38	hsue	hsue	NOUN
aji-166	198	39	et	et	PROPN
aji-166	198	40	al	al	PROPN
aji-166	198	41	.	.	PROPN
aji-166	198	42	,	,	PUNCT
aji-166	198	43	2012	2012	NUM
aji-166	198	44	)	)	PUNCT
aji-166	198	45	.	.	PUNCT
aji-166	199	1	lastly	lastly	ADV
aji-166	199	2	,	,	PUNCT
aji-166	199	3	hiv	hiv	PROPN
aji-166	199	4	infection	infection	NOUN
aji-166	199	5	and	and	CCONJ
aji-166	199	6	art	art	NOUN
aji-166	199	7	can	can	AUX
aji-166	199	8	disrupt	disrupt	VERB
aji-166	199	9	lipid	lipid	ADJ
aji-166	199	10	metabolism	metabolism	NOUN
aji-166	199	11	,	,	PUNCT
aji-166	199	12	leading	lead	VERB
aji-166	199	13	to	to	ADP
aji-166	199	14	elevated	elevated	ADJ
aji-166	199	15	levels	level	NOUN
aji-166	199	16	of	of	ADP
aji-166	199	17	triglycerides	triglyceride	NOUN
aji-166	199	18	and	and	CCONJ
aji-166	199	19	ldl	ldl	VERB
aji-166	199	20	cholesterol	cholesterol	NOUN
aji-166	199	21	.	.	PUNCT
aji-166	200	1	in	in	ADP
aji-166	200	2	plwh	plwh	NOUN
aji-166	200	3	,	,	PUNCT
aji-166	200	4	macrophages	macrophage	NOUN
aji-166	200	5	accumulate	accumulate	VERB
aji-166	200	6	lipids	lipid	NOUN
aji-166	200	7	and	and	CCONJ
aji-166	200	8	demonstrate	demonstrate	VERB
aji-166	200	9	impaired	impaired	ADJ
aji-166	200	10	cholesterol	cholesterol	NOUN
aji-166	200	11	efflux	efflux	NOUN
aji-166	200	12	,	,	PUNCT
aji-166	200	13	largely	largely	ADV
aji-166	200	14	due	due	ADP
aji-166	200	15	to	to	ADP
aji-166	200	16	the	the	DET
aji-166	200	17	downregulation	downregulation	NOUN
aji-166	200	18	of	of	ADP
aji-166	200	19	critical	critical	ADJ
aji-166	200	20	atp	atp	NOUN
aji-166	200	21	-	-	PUNCT
aji-166	200	22	binding	bind	VERB
aji-166	200	23	cassette	cassette	NOUN
aji-166	200	24	transporters	transporter	NOUN
aji-166	200	25	,	,	PUNCT
aji-166	200	26	abca1	abca1	NOUN
aji-166	200	27	and	and	CCONJ
aji-166	200	28	abcg1	abcg1	PROPN
aji-166	200	29	(	(	PUNCT
aji-166	200	30	yvan	yvan	PROPN
aji-166	200	31	-	-	PUNCT
aji-166	200	32	charvet	charvet	PROPN
aji-166	200	33	et	et	PROPN
aji-166	200	34	al	al	PROPN
aji-166	200	35	.	.	PROPN
aji-166	200	36	,	,	PUNCT
aji-166	200	37	2007	2007	NUM
aji-166	200	38	)	)	PUNCT
aji-166	200	39	.	.	PUNCT
aji-166	201	1	these	these	DET
aji-166	201	2	transporters	transporter	NOUN
aji-166	201	3	play	play	VERB
aji-166	201	4	a	a	DET
aji-166	201	5	vital	vital	ADJ
aji-166	201	6	role	role	NOUN
aji-166	201	7	in	in	ADP
aji-166	201	8	cholesterol	cholesterol	NOUN
aji-166	201	9	efflux	efflux	NOUN
aji-166	201	10	and	and	CCONJ
aji-166	201	11	reverse	reverse	VERB
aji-166	201	12	cholesterol	cholesterol	NOUN
aji-166	201	13	transport	transport	NOUN
aji-166	201	14	.	.	PUNCT
aji-166	202	1	their	their	PRON
aji-166	202	2	deficiency	deficiency	NOUN
aji-166	202	3	or	or	CCONJ
aji-166	202	4	downregulation	downregulation	NOUN
aji-166	202	5	can	can	AUX
aji-166	202	6	lead	lead	VERB
aji-166	202	7	to	to	ADP
aji-166	202	8	increased	increase	VERB
aji-166	202	9	cholesterol	cholesterol	NOUN
aji-166	202	10	accumulation	accumulation	NOUN
aji-166	202	11	in	in	ADP
aji-166	202	12	macrophages	macrophage	NOUN
aji-166	202	13	,	,	PUNCT
aji-166	202	14	promoting	promote	VERB
aji-166	202	15	foam	foam	NOUN
aji-166	202	16	cell	cell	NOUN
aji-166	202	17	formation	formation	NOUN
aji-166	202	18	and	and	CCONJ
aji-166	202	19	potentially	potentially	ADV
aji-166	202	20	accelerating	accelerate	VERB
aji-166	202	21	atherosclerosis	atherosclerosis	NOUN
aji-166	202	22	(	(	PUNCT
aji-166	202	23	yvancharvet	yvancharvet	NOUN
aji-166	202	24	et	et	PROPN
aji-166	202	25	al	al	PROPN
aji-166	202	26	.	.	PROPN
aji-166	202	27	,	,	PUNCT
aji-166	202	28	2007	2007	NUM
aji-166	202	29	)	)	PUNCT
aji-166	202	30	.	.	PUNCT
aji-166	203	1	3.2	3.2	NUM
aji-166	203	2	neurocognitive	neurocognitive	ADJ
aji-166	203	3	disorders	disorder	NOUN
aji-166	203	4	hiv	hiv	NOUN
aji-166	203	5	-	-	PUNCT
aji-166	203	6	associated	associate	VERB
aji-166	203	7	neurocognitive	neurocognitive	ADJ
aji-166	203	8	disorders	disorder	NOUN
aji-166	203	9	(	(	PUNCT
aji-166	203	10	hand	hand	NOUN
aji-166	203	11	)	)	PUNCT
aji-166	203	12	refer	refer	VERB
aji-166	203	13	to	to	ADP
aji-166	203	14	a	a	DET
aji-166	203	15	range	range	NOUN
aji-166	203	16	of	of	ADP
aji-166	203	17	neurological	neurological	ADJ
aji-166	203	18	and	and	CCONJ
aji-166	203	19	cognitive	cognitive	ADJ
aji-166	203	20	impairments	impairment	NOUN
aji-166	203	21	linked	link	VERB
aji-166	203	22	to	to	ADP
aji-166	203	23	hiv	hiv	PROPN
aji-166	203	24	infection	infection	NOUN
aji-166	203	25	and	and	CCONJ
aji-166	203	26	aids	aid	NOUN
aji-166	203	27	.	.	PUNCT
aji-166	204	1	these	these	DET
aji-166	204	2	disorders	disorder	NOUN
aji-166	204	3	remain	remain	VERB
aji-166	204	4	common	common	ADJ
aji-166	204	5	despite	despite	SCONJ
aji-166	204	6	art	art	NOUN
aji-166	204	7	and	and	CCONJ
aji-166	204	8	can	can	AUX
aji-166	204	9	affect	affect	VERB
aji-166	204	10	up	up	ADP
aji-166	204	11	to	to	PART
aji-166	204	12	50	50	NUM
aji-166	204	13	%	%	NOUN
aji-166	204	14	of	of	ADP
aji-166	204	15	plwh	plwh	NOUN
aji-166	204	16	.	.	PUNCT
aji-166	205	1	hand	hand	NOUN
aji-166	205	2	ranges	range	VERB
aji-166	205	3	from	from	ADP
aji-166	205	4	mild	mild	ADJ
aji-166	205	5	cognitive	cognitive	ADJ
aji-166	205	6	deficits	deficit	NOUN
aji-166	205	7	to	to	ADP
aji-166	205	8	severe	severe	ADJ
aji-166	205	9	dementia	dementia	NOUN
aji-166	205	10	and	and	CCONJ
aji-166	205	11	can	can	AUX
aji-166	205	12	significantly	significantly	ADV
aji-166	205	13	impact	impact	VERB
aji-166	205	14	daily	daily	ADV
aji-166	205	15	functioning	function	VERB
aji-166	205	16	(	(	PUNCT
aji-166	205	17	adhikary	adhikary	NOUN
aji-166	205	18	et	et	PROPN
aji-166	205	19	al	al	PROPN
aji-166	205	20	.	.	PROPN
aji-166	205	21	,	,	PUNCT
aji-166	205	22	2025	2025	NUM
aji-166	205	23	)	)	PUNCT
aji-166	205	24	.	.	PUNCT
aji-166	206	1	the	the	DET
aji-166	206	2	blood	blood	NOUN
aji-166	206	3	-	-	PUNCT
aji-166	206	4	brain	brain	NOUN
aji-166	206	5	barrier	barrier	NOUN
aji-166	206	6	(	(	PUNCT
aji-166	206	7	bbb	bbb	NOUN
aji-166	206	8	)	)	PUNCT
aji-166	206	9	is	be	AUX
aji-166	206	10	compromised	compromise	VERB
aji-166	206	11	in	in	ADP
aji-166	206	12	hiv	hiv	PROPN
aji-166	206	13	infection	infection	NOUN
aji-166	206	14	,	,	PUNCT
aji-166	206	15	allowing	allow	VERB
aji-166	206	16	for	for	ADP
aji-166	206	17	the	the	DET
aji-166	206	18	establishment	establishment	NOUN
aji-166	206	19	of	of	ADP
aji-166	206	20	viral	viral	ADJ
aji-166	206	21	reservoirs	reservoir	NOUN
aji-166	206	22	in	in	ADP
aji-166	206	23	the	the	DET
aji-166	206	24	brain	brain	NOUN
aji-166	206	25	.	.	PUNCT
aji-166	207	1	the	the	DET
aji-166	207	2	hiv-1	hiv-1	X
aji-166	207	3	envelope	envelope	NOUN
aji-166	207	4	glycoprotein	glycoprotein	NOUN
aji-166	207	5	,	,	PUNCT
aji-166	207	6	gp120	gp120	PROPN
aji-166	207	7	,	,	PUNCT
aji-166	207	8	plays	play	VERB
aji-166	207	9	a	a	DET
aji-166	207	10	key	key	ADJ
aji-166	207	11	role	role	NOUN
aji-166	207	12	in	in	ADP
aji-166	207	13	damaging	damage	VERB
aji-166	207	14	the	the	DET
aji-166	207	15	integrity	integrity	NOUN
aji-166	207	16	of	of	ADP
aji-166	207	17	the	the	DET
aji-166	207	18	bbb	bbb	NOUN
aji-166	207	19	by	by	ADP
aji-166	207	20	altering	alter	VERB
aji-166	207	21	tight	tight	ADJ
aji-166	207	22	junction	junction	NOUN
aji-166	207	23	proteins	protein	NOUN
aji-166	207	24	in	in	ADP
aji-166	207	25	human	human	ADJ
aji-166	207	26	brain	brain	NOUN
aji-166	207	27	microvascular	microvascular	NOUN
aji-166	207	28	endothelial	endothelial	ADJ
aji-166	207	29	cells	cell	NOUN
aji-166	207	30	(	(	PUNCT
aji-166	207	31	said	say	VERB
aji-166	207	32	&	&	CCONJ
aji-166	207	33	venketaraman	venketaraman	NOUN
aji-166	207	34	,	,	PUNCT
aji-166	207	35	2025	2025	NUM
aji-166	207	36	)	)	PUNCT
aji-166	207	37	.	.	PUNCT
aji-166	208	1	however	however	ADV
aji-166	208	2	,	,	PUNCT
aji-166	208	3	the	the	DET
aji-166	208	4	initial	initial	ADJ
aji-166	208	5	trigger	trigger	NOUN
aji-166	208	6	for	for	ADP
aji-166	208	7	hand	hand	NOUN
aji-166	208	8	is	be	AUX
aji-166	208	9	the	the	DET
aji-166	208	10	movement	movement	NOUN
aji-166	208	11	of	of	ADP
aji-166	208	12	hiv	hiv	PROPN
aji-166	208	13	-	-	PUNCT
aji-166	208	14	infected	infect	VERB
aji-166	208	15	monocytes	monocyte	VERB
aji-166	208	16	across	across	ADP
aji-166	208	17	the	the	DET
aji-166	208	18	bbb	bbb	NOUN
aji-166	208	19	into	into	ADP
aji-166	208	20	the	the	DET
aji-166	208	21	central	central	ADJ
aji-166	208	22	nervous	nervous	ADJ
aji-166	208	23	system	system	NOUN
aji-166	208	24	(	(	PUNCT
aji-166	208	25	cns	cns	NOUN
aji-166	208	26	)	)	PUNCT
aji-166	208	27	,	,	PUNCT
aji-166	208	28	where	where	SCONJ
aji-166	208	29	they	they	PRON
aji-166	208	30	differentiate	differentiate	VERB
aji-166	208	31	into	into	ADP
aji-166	208	32	perivascular	perivascular	ADJ
aji-166	208	33	macrophages	macrophage	NOUN
aji-166	208	34	(	(	PUNCT
aji-166	208	35	león	león	PROPN
aji-166	208	36	-	-	PUNCT
aji-166	208	37	rivera	rivera	PROPN
aji-166	208	38	et	et	PROPN
aji-166	208	39	al	al	PROPN
aji-166	208	40	.	.	PROPN
aji-166	208	41	,	,	PUNCT
aji-166	208	42	2021	2021	NUM
aji-166	208	43	)	)	PUNCT
aji-166	208	44	.	.	PUNCT
aji-166	209	1	perivascular	perivascular	ADJ
aji-166	209	2	macrophages	macrophage	NOUN
aji-166	209	3	are	be	AUX
aji-166	209	4	long	long	ADV
aji-166	209	5	-	-	PUNCT
aji-166	209	6	lived	lived	ADJ
aji-166	209	7	,	,	PUNCT
aji-166	209	8	tissueresident	tissueresident	NOUN
aji-166	209	9	cells	cell	NOUN
aji-166	209	10	that	that	PRON
aji-166	209	11	occupy	occupy	VERB
aji-166	209	12	the	the	DET
aji-166	209	13	spaces	space	NOUN
aji-166	209	14	around	around	ADP
aji-166	209	15	blood	blood	NOUN
aji-166	209	16	vessels	vessel	NOUN
aji-166	209	17	.	.	PUNCT
aji-166	210	1	they	they	PRON
aji-166	210	2	express	express	VERB
aji-166	210	3	cd14	cd14	PROPN
aji-166	210	4	,	,	PUNCT
aji-166	210	5	cd16	cd16	PROPN
aji-166	210	6	,	,	PUNCT
aji-166	210	7	and	and	CCONJ
aji-166	210	8	cd163	cd163	PROPN
aji-166	210	9	,	,	PUNCT
aji-166	210	10	and	and	CCONJ
aji-166	210	11	,	,	PUNCT
aji-166	210	12	together	together	ADV
aji-166	210	13	with	with	ADP
aji-166	210	14	microglia	microglia	NOUN
aji-166	210	15	,	,	PUNCT
aji-166	210	16	contain	contain	VERB
aji-166	210	17	hiv	hiv	NOUN
aji-166	210	18	even	even	ADV
aji-166	210	19	in	in	ADP
aji-166	210	20	individuals	individual	NOUN
aji-166	210	21	receiving	receive	VERB
aji-166	210	22	art	art	NOUN
aji-166	210	23	,	,	PUNCT
aji-166	210	24	contributing	contribute	VERB
aji-166	210	25	to	to	AUX
aji-166	210	26	chronic	chronic	ADJ
aji-166	210	27	low	low	ADJ
aji-166	210	28	-	-	PUNCT
aji-166	210	29	level	level	NOUN
aji-166	210	30	viral	viral	ADJ
aji-166	210	31	replication	replication	NOUN
aji-166	210	32	(	(	PUNCT
aji-166	210	33	kruize	kruize	NOUN
aji-166	210	34	&	&	CCONJ
aji-166	210	35	kootstra	kootstra	PROPN
aji-166	210	36	,	,	PUNCT
aji-166	210	37	2019	2019	NUM
aji-166	210	38	)	)	PUNCT
aji-166	210	39	.	.	PUNCT
aji-166	211	1	additionally	additionally	ADV
aji-166	211	2	,	,	PUNCT
aji-166	211	3	hiv	hiv	PROPN
aji-166	211	4	-	-	PUNCT
aji-166	211	5	infected	infect	VERB
aji-166	211	6	monocytes	monocyte	VERB
aji-166	211	7	secrete	secrete	NOUN
aji-166	211	8	matrix	matrix	NOUN
aji-166	211	9	metalloproteinases	metalloproteinase	NOUN
aji-166	211	10	(	(	PUNCT
aji-166	211	11	mmp-9	mmp-9	NUM
aji-166	211	12	)	)	PUNCT
aji-166	211	13	,	,	PUNCT
aji-166	211	14	which	which	PRON
aji-166	211	15	degrade	degrade	VERB
aji-166	211	16	tight	tight	ADJ
aji-166	211	17	junction	junction	NOUN
aji-166	211	18	proteins	protein	NOUN
aji-166	211	19	(	(	PUNCT
aji-166	211	20	such	such	ADJ
aji-166	211	21	as	as	ADP
aji-166	211	22	claudin-5	claudin-5	PROPN
aji-166	211	23	and	and	CCONJ
aji-166	211	24	occludin	occludin	NOUN
aji-166	211	25	)	)	PUNCT
aji-166	211	26	,	,	PUNCT
aji-166	211	27	thereby	thereby	ADV
aji-166	211	28	increasing	increase	VERB
aji-166	211	29	bbb	bbb	NOUN
aji-166	211	30	permeability	permeability	NOUN
aji-166	211	31	.	.	PUNCT
aji-166	212	1	similar	similar	ADJ
aji-166	212	2	to	to	ADP
aji-166	212	3	the	the	DET
aji-166	212	4	pathogenesis	pathogenesis	NOUN
aji-166	212	5	of	of	ADP
aji-166	212	6	cardiovascular	cardiovascular	ADJ
aji-166	212	7	disease	disease	NOUN
aji-166	212	8	,	,	PUNCT
aji-166	212	9	the	the	DET
aji-166	212	10	increased	increase	VERB
aji-166	212	11	expression	expression	NOUN
aji-166	212	12	of	of	ADP
aji-166	212	13	adhesion	adhesion	NOUN
aji-166	212	14	molecules	molecule	NOUN
aji-166	212	15	and	and	CCONJ
aji-166	212	16	chemokine	chemokine	ADJ
aji-166	212	17	receptors	receptor	NOUN
aji-166	212	18	(	(	PUNCT
aji-166	212	19	such	such	ADJ
aji-166	212	20	as	as	ADP
aji-166	212	21	ccr2	ccr2	NOUN
aji-166	212	22	and	and	CCONJ
aji-166	212	23	cx3cr1	cx3cr1	NOUN
aji-166	212	24	)	)	PUNCT
aji-166	212	25	in	in	ADP
aji-166	212	26	hiv	hiv	PROPN
aji-166	212	27	-	-	PUNCT
aji-166	212	28	infected	infect	VERB
aji-166	212	29	monocytes	monocyte	NOUN
aji-166	212	30	enables	enable	VERB
aji-166	212	31	their	their	PRON
aji-166	212	32	adhesion	adhesion	NOUN
aji-166	212	33	to	to	ADP
aji-166	212	34	and	and	CCONJ
aji-166	212	35	crossing	crossing	NOUN
aji-166	212	36	of	of	ADP
aji-166	212	37	the	the	DET
aji-166	212	38	bbb	bbb	PROPN
aji-166	212	39	.	.	PUNCT
aji-166	213	1	activated	activate	VERB
aji-166	213	2	astrocytes	astrocyte	NOUN
aji-166	213	3	and	and	CCONJ
aji-166	213	4	endothelial	endothelial	NOUN
aji-166	213	5	cells	cell	NOUN
aji-166	213	6	produce	produce	VERB
aji-166	213	7	chemokines	chemokine	NOUN
aji-166	213	8	like	like	ADP
aji-166	213	9	ccl2	ccl2	NOUN
aji-166	213	10	,	,	PUNCT
aji-166	213	11	also	also	ADV
aji-166	213	12	known	know	VERB
aji-166	213	13	as	as	ADP
aji-166	213	14	monocyte	monocyte	PROPN
aji-166	213	15	chemoattractant	chemoattractant	PROPN
aji-166	213	16	protein-1	protein-1	PROPN
aji-166	213	17	(	(	PUNCT
aji-166	213	18	mcp-1	mcp-1	NOUN
aji-166	213	19	)	)	PUNCT
aji-166	213	20	,	,	PUNCT
aji-166	213	21	which	which	PRON
aji-166	213	22	help	help	VERB
aji-166	213	23	recruit	recruit	NOUN
aji-166	213	24	monocytes	monocyte	VERB
aji-166	213	25	into	into	ADP
aji-166	213	26	the	the	DET
aji-166	213	27	cns	cns	NOUN
aji-166	213	28	(	(	PUNCT
aji-166	213	29	hernandez	hernandez	PROPN
aji-166	213	30	et	et	PROPN
aji-166	213	31	al	al	PROPN
aji-166	213	32	.	.	PROPN
aji-166	213	33	,	,	PUNCT
aji-166	213	34	2024	2024	NUM
aji-166	213	35	)	)	PUNCT
aji-166	213	36	.	.	PUNCT
aji-166	214	1	the	the	DET
aji-166	214	2	degradation	degradation	NOUN
aji-166	214	3	of	of	ADP
aji-166	214	4	tight	tight	ADJ
aji-166	214	5	junctions	junction	NOUN
aji-166	214	6	,	,	PUNCT
aji-166	214	7	the	the	DET
aji-166	214	8	apoptosis	apoptosis	NOUN
aji-166	214	9	of	of	ADP
aji-166	214	10	endothelial	endothelial	ADJ
aji-166	214	11	cells	cell	NOUN
aji-166	214	12	,	,	PUNCT
aji-166	214	13	and	and	CCONJ
aji-166	214	14	the	the	DET
aji-166	214	15	consequent	consequent	ADJ
aji-166	214	16	bbb	bbb	PROPN
aji-166	214	17	leakage	leakage	NOUN
aji-166	214	18	allow	allow	VERB
aji-166	214	19	plasma	plasma	NOUN
aji-166	214	20	proteins	protein	NOUN
aji-166	214	21	(	(	PUNCT
aji-166	214	22	e.g.	e.g.	ADV
aji-166	214	23	,	,	PUNCT
aji-166	214	24	fibrinogen	fibrinogen	NOUN
aji-166	214	25	)	)	PUNCT
aji-166	214	26	and	and	CCONJ
aji-166	214	27	peripheral	peripheral	ADJ
aji-166	214	28	immune	immune	ADJ
aji-166	214	29	cells	cell	NOUN
aji-166	214	30	to	to	PART
aji-166	214	31	infiltrate	infiltrate	VERB
aji-166	214	32	the	the	DET
aji-166	214	33	cns	cns	NOUN
aji-166	214	34	,	,	PUNCT
aji-166	214	35	exacerbating	exacerbate	VERB
aji-166	214	36	neuroinflammation	neuroinflammation	NOUN
aji-166	214	37	and	and	CCONJ
aji-166	214	38	white	white	ADJ
aji-166	214	39	matter	matter	NOUN
aji-166	214	40	damage	damage	NOUN
aji-166	214	41	(	(	PUNCT
aji-166	214	42	salimi	salimi	PROPN
aji-166	214	43	&	&	CCONJ
aji-166	214	44	klein	klein	PROPN
aji-166	214	45	,	,	PUNCT
aji-166	214	46	2019	2019	NUM
aji-166	214	47	)	)	PUNCT
aji-166	214	48	.	.	PUNCT
aji-166	215	1	moreover	moreover	ADV
aji-166	215	2	,	,	PUNCT
aji-166	215	3	activated	activated	ADJ
aji-166	215	4	microglia	microglia	NOUN
aji-166	215	5	can	can	AUX
aji-166	215	6	engage	engage	VERB
aji-166	215	7	in	in	ADP
aji-166	215	8	"	"	PUNCT
aji-166	215	9	synaptic	synaptic	ADJ
aji-166	215	10	stripping	stripping	NOUN
aji-166	215	11	,	,	PUNCT
aji-166	215	12	"	"	PUNCT
aji-166	215	13	phagocytizing	phagocytize	VERB
aji-166	215	14	dendritic	dendritic	ADJ
aji-166	215	15	spines	spine	NOUN
aji-166	215	16	and	and	CCONJ
aji-166	215	17	synapses	synapsis	NOUN
aji-166	215	18	,	,	PUNCT
aji-166	215	19	causing	cause	VERB
aji-166	215	20	synaptic	synaptic	ADJ
aji-166	215	21	loss	loss	NOUN
aji-166	215	22	,	,	PUNCT
aji-166	215	23	especially	especially	ADV
aji-166	215	24	in	in	ADP
aji-166	215	25	the	the	DET
aji-166	215	26	hippocampus	hippocampus	NOUN
aji-166	215	27	and	and	CCONJ
aji-166	215	28	prefrontal	prefrontal	ADJ
aji-166	215	29	cortex	cortex	NOUN
aji-166	215	30	areas	area	NOUN
aji-166	215	31	critical	critical	ADJ
aji-166	215	32	for	for	ADP
aji-166	215	33	memory	memory	NOUN
aji-166	215	34	and	and	CCONJ
aji-166	215	35	executive	executive	ADJ
aji-166	215	36	function	function	NOUN
aji-166	215	37	(	(	PUNCT
aji-166	215	38	schlachetzki	schlachetzki	ADV
aji-166	215	39	et	et	PROPN
aji-166	215	40	al	al	PROPN
aji-166	215	41	.	.	PROPN
aji-166	215	42	,	,	PUNCT
aji-166	215	43	2022	2022	NUM
aji-166	215	44	)	)	PUNCT
aji-166	215	45	.	.	PUNCT
aji-166	216	1	soluble	soluble	ADJ
aji-166	216	2	viral	viral	ADJ
aji-166	216	3	proteins	protein	NOUN
aji-166	216	4	(	(	PUNCT
aji-166	216	5	such	such	ADJ
aji-166	216	6	as	as	ADP
aji-166	216	7	gp120	gp120	ADJ
aji-166	216	8	,	,	PUNCT
aji-166	216	9	tat	tat	ADJ
aji-166	216	10	,	,	PUNCT
aji-166	216	11	and	and	CCONJ
aji-166	216	12	nef	nef	PROPN
aji-166	216	13	)	)	PUNCT
aji-166	216	14	secreted	secrete	VERB
aji-166	216	15	by	by	ADP
aji-166	216	16	infected	infect	VERB
aji-166	216	17	macrophages	macrophage	NOUN
aji-166	216	18	contribute	contribute	VERB
aji-166	216	19	to	to	ADP
aji-166	216	20	excitotoxicity	excitotoxicity	NOUN
aji-166	216	21	,	,	PUNCT
aji-166	216	22	oxidative	oxidative	ADJ
aji-166	216	23	stress	stress	NOUN
aji-166	216	24	,	,	PUNCT
aji-166	216	25	and	and	CCONJ
aji-166	216	26	synaptic	synaptic	ADJ
aji-166	216	27	damage	damage	NOUN
aji-166	216	28	(	(	PUNCT
aji-166	216	29	marino	marino	PROPN
aji-166	216	30	et	et	PROPN
aji-166	216	31	al	al	PROPN
aji-166	216	32	.	.	PROPN
aji-166	216	33	,	,	PUNCT
aji-166	216	34	2020	2020	NUM
aji-166	216	35	)	)	PUNCT
aji-166	216	36	.	.	PUNCT
aji-166	217	1	the	the	DET
aji-166	217	2	cd16	cd16	PROPN
aji-166	217	3	+	+	CCONJ
aji-166	217	4	monocyte	monocyte	NOUN
aji-166	217	5	subset	subset	NOUN
aji-166	217	6	,	,	PUNCT
aji-166	217	7	which	which	PRON
aji-166	217	8	has	have	VERB
aji-166	217	9	a	a	DET
aji-166	217	10	pro	pro	ADJ
aji-166	217	11	-	-	ADJ
aji-166	217	12	inflammatory	inflammatory	ADJ
aji-166	217	13	profile	profile	NOUN
aji-166	217	14	(	(	PUNCT
aji-166	217	15	ong	ong	INTJ
aji-166	217	16	et	et	PROPN
aji-166	217	17	al	al	PROPN
aji-166	217	18	.	.	PROPN
aji-166	217	19	,	,	PUNCT
aji-166	217	20	2018	2018	NUM
aji-166	217	21	)	)	PUNCT
aji-166	217	22	,	,	PUNCT
aji-166	217	23	plays	play	VERB
aji-166	217	24	a	a	DET
aji-166	217	25	critical	critical	ADJ
aji-166	217	26	role	role	NOUN
aji-166	217	27	in	in	ADP
aji-166	217	28	hiv	hiv	PROPN
aji-166	217	29	neuroinvasion	neuroinvasion	NOUN
aji-166	217	30	due	due	ADP
aji-166	217	31	to	to	ADP
aji-166	217	32	its	its	PRON
aji-166	217	33	high	high	ADJ
aji-166	217	34	mmp-9	mmp-9	NOUN
aji-166	217	35	secretion	secretion	NOUN
aji-166	217	36	(	(	PUNCT
aji-166	217	37	which	which	PRON
aji-166	217	38	leads	lead	VERB
aji-166	217	39	to	to	ADP
aji-166	217	40	bbb	bbb	PROPN
aji-166	217	41	breakdown	breakdown	NOUN
aji-166	217	42	)	)	PUNCT
aji-166	217	43	(	(	PUNCT
aji-166	217	44	campos	campos	PROPN
aji-166	217	45	et	et	PROPN
aji-166	217	46	al	al	PROPN
aji-166	217	47	.	.	PROPN
aji-166	217	48	,	,	PUNCT
aji-166	217	49	2014	2014	NUM
aji-166	217	50	)	)	PUNCT
aji-166	217	51	and	and	CCONJ
aji-166	217	52	enhanced	enhance	VERB
aji-166	217	53	chemotaxis	chemotaxis	ADJ
aji-166	217	54	(	(	PUNCT
aji-166	217	55	kruize	kruize	NOUN
aji-166	217	56	&	&	CCONJ
aji-166	217	57	kootstra	kootstra	PROPN
aji-166	217	58	,	,	PUNCT
aji-166	217	59	2019	2019	NUM
aji-166	217	60	)	)	PUNCT
aji-166	217	61	.	.	PUNCT
aji-166	218	1	however	however	ADV
aji-166	218	2	,	,	PUNCT
aji-166	218	3	inflammation	inflammation	NOUN
aji-166	218	4	and	and	CCONJ
aji-166	218	5	immune	immune	ADJ
aji-166	218	6	activation	activation	NOUN
aji-166	218	7	are	be	AUX
aji-166	218	8	central	central	ADJ
aji-166	218	9	mechanisms	mechanism	NOUN
aji-166	218	10	driving	drive	VERB
aji-166	218	11	the	the	DET
aji-166	218	12	development	development	NOUN
aji-166	218	13	of	of	ADP
aji-166	218	14	hand	hand	NOUN
aji-166	218	15	,	,	PUNCT
aji-166	218	16	with	with	ADP
aji-166	218	17	various	various	ADJ
aji-166	218	18	contributing	contribute	VERB
aji-166	218	19	factors	factor	NOUN
aji-166	218	20	.	.	PUNCT
aji-166	219	1	hiv	hiv	PROPN
aji-166	219	2	adavba	adavba	PROPN
aji-166	219	3	;	;	PUNCT
aji-166	219	4	asian	asian	PROPN
aji-166	219	5	j.	j.	PROPN
aji-166	219	6	immunol	immunol	PROPN
aji-166	219	7	.	.	PROPN
aji-166	219	8	,	,	PUNCT
aji-166	219	9	vol	vol	NOUN
aji-166	219	10	.	.	PROPN
aji-166	219	11	8	8	NUM
aji-166	219	12	,	,	PUNCT
aji-166	219	13	no	no	INTJ
aji-166	219	14	.	.	NOUN
aji-166	219	15	1	1	NUM
aji-166	219	16	,	,	PUNCT
aji-166	219	17	pp	pp	ADJ
aji-166	219	18	.	.	PUNCT
aji-166	220	1	120	120	NUM
aji-166	220	2	-	-	SYM
aji-166	220	3	133	133	NUM
aji-166	220	4	,	,	PUNCT
aji-166	220	5	2025	2025	NUM
aji-166	220	6	;	;	PUNCT
aji-166	220	7	article	article	NOUN
aji-166	220	8	no.aji.136909	no.aji.136909	NOUN
aji-166	220	9	125	125	NUM
aji-166	220	10	infected	infect	VERB
aji-166	220	11	macrophages	macrophage	NOUN
aji-166	220	12	release	release	VERB
aji-166	220	13	pro	pro	ADJ
aji-166	220	14	-	-	ADJ
aji-166	220	15	inflammatory	inflammatory	ADJ
aji-166	220	16	cytokines	cytokine	NOUN
aji-166	220	17	(	(	PUNCT
aji-166	220	18	such	such	ADJ
aji-166	220	19	as	as	ADP
aji-166	220	20	tnf	tnf	PROPN
aji-166	220	21	-	-	PUNCT
aji-166	220	22	α	α	PROPN
aji-166	220	23	,	,	PUNCT
aji-166	220	24	il-1β	il-1β	PROPN
aji-166	220	25	,	,	PUNCT
aji-166	220	26	and	and	CCONJ
aji-166	220	27	il-6	il-6	NUM
aji-166	220	28	)	)	PUNCT
aji-166	220	29	and	and	CCONJ
aji-166	220	30	chemokines	chemokine	NOUN
aji-166	220	31	(	(	PUNCT
aji-166	220	32	like	like	ADP
aji-166	220	33	mcp-1	mcp-1	NOUN
aji-166	220	34	/	/	SYM
aji-166	220	35	ccl2	ccl2	NOUN
aji-166	220	36	)	)	PUNCT
aji-166	220	37	,	,	PUNCT
aji-166	220	38	activating	activate	VERB
aji-166	220	39	astrocytes	astrocyte	NOUN
aji-166	220	40	and	and	CCONJ
aji-166	220	41	microglia	microglia	ADJ
aji-166	220	42	while	while	SCONJ
aji-166	220	43	recruiting	recruit	VERB
aji-166	220	44	additional	additional	ADJ
aji-166	220	45	monocytes	monocyte	NOUN
aji-166	220	46	into	into	ADP
aji-166	220	47	the	the	DET
aji-166	220	48	cns	cns	NOUN
aji-166	220	49	,	,	PUNCT
aji-166	220	50	sustaining	sustain	VERB
aji-166	220	51	chronic	chronic	ADJ
aji-166	220	52	neuroinflammation	neuroinflammation	NOUN
aji-166	220	53	(	(	PUNCT
aji-166	220	54	saylor	saylor	PROPN
aji-166	220	55	et	et	PROPN
aji-166	220	56	al	al	PROPN
aji-166	220	57	.	.	PROPN
aji-166	220	58	,	,	PUNCT
aji-166	220	59	2016	2016	NUM
aji-166	220	60	)	)	PUNCT
aji-166	220	61	.	.	PUNCT
aji-166	221	1	additionally	additionally	ADV
aji-166	221	2	,	,	PUNCT
aji-166	221	3	hiv	hiv	PROPN
aji-166	221	4	rna	rna	NOUN
aji-166	221	5	and	and	CCONJ
aji-166	221	6	proteins	protein	NOUN
aji-166	221	7	activate	activate	VERB
aji-166	221	8	the	the	DET
aji-166	221	9	nlrp3	nlrp3	NOUN
aji-166	221	10	inflammasome	inflammasome	NOUN
aji-166	221	11	in	in	ADP
aji-166	221	12	macrophages	macrophage	NOUN
aji-166	221	13	,	,	PUNCT
aji-166	221	14	increasing	increase	VERB
aji-166	221	15	the	the	DET
aji-166	221	16	release	release	NOUN
aji-166	221	17	of	of	ADP
aji-166	221	18	il-1β	il-1β	PROPN
aji-166	221	19	and	and	CCONJ
aji-166	221	20	il-18	il-18	PRON
aji-166	221	21	.	.	PUNCT
aji-166	222	1	nlrp3	nlrp3	PROPN
aji-166	222	2	is	be	AUX
aji-166	222	3	primarily	primarily	ADV
aji-166	222	4	found	find	VERB
aji-166	222	5	in	in	ADP
aji-166	222	6	myeloid	myeloid	ADJ
aji-166	222	7	cells	cell	NOUN
aji-166	222	8	(	(	PUNCT
aji-166	222	9	monocytes	monocyte	NOUN
aji-166	222	10	,	,	PUNCT
aji-166	222	11	macrophages	macrophage	NOUN
aji-166	222	12	,	,	PUNCT
aji-166	222	13	and	and	CCONJ
aji-166	222	14	neutrophils	neutrophil	NOUN
aji-166	222	15	)	)	PUNCT
aji-166	222	16	and	and	CCONJ
aji-166	222	17	acts	act	VERB
aji-166	222	18	as	as	ADP
aji-166	222	19	a	a	DET
aji-166	222	20	sensor	sensor	NOUN
aji-166	222	21	for	for	ADP
aji-166	222	22	pathogen	pathogen	NOUN
aji-166	222	23	-	-	PUNCT
aji-166	222	24	associated	associate	VERB
aji-166	222	25	molecular	molecular	ADJ
aji-166	222	26	patterns	pattern	NOUN
aji-166	222	27	(	(	PUNCT
aji-166	222	28	pamps	pamp	NOUN
aji-166	222	29	)	)	PUNCT
aji-166	222	30	and	and	CCONJ
aji-166	222	31	damage	damage	NOUN
aji-166	222	32	-	-	PUNCT
aji-166	222	33	associated	associate	VERB
aji-166	222	34	molecular	molecular	ADJ
aji-166	222	35	patterns	pattern	NOUN
aji-166	222	36	(	(	PUNCT
aji-166	222	37	damps	damps	VERB
aji-166	222	38	)	)	PUNCT
aji-166	222	39	,	,	PUNCT
aji-166	222	40	initiating	initiate	VERB
aji-166	222	41	an	an	DET
aji-166	222	42	inflammatory	inflammatory	ADJ
aji-166	222	43	response	response	NOUN
aji-166	222	44	(	(	PUNCT
aji-166	222	45	swanson	swanson	PROPN
aji-166	222	46	et	et	PROPN
aji-166	222	47	al	al	PROPN
aji-166	222	48	.	.	PROPN
aji-166	222	49	,	,	PUNCT
aji-166	222	50	2019	2019	NUM
aji-166	222	51	)	)	PUNCT
aji-166	222	52	.	.	PUNCT
aji-166	223	1	this	this	DET
aji-166	223	2	activation	activation	NOUN
aji-166	223	3	occurs	occur	VERB
aji-166	223	4	in	in	ADP
aji-166	223	5	two	two	NUM
aji-166	223	6	steps	step	NOUN
aji-166	223	7	:	:	PUNCT
aji-166	223	8	first	first	ADV
aji-166	223	9	,	,	PUNCT
aji-166	223	10	hiv	hiv	PROPN
aji-166	223	11	infection	infection	NOUN
aji-166	223	12	primes	prime	VERB
aji-166	223	13	macrophages	macrophage	NOUN
aji-166	223	14	by	by	ADP
aji-166	223	15	increasing	increase	VERB
aji-166	223	16	nlrp3	nlrp3	ADJ
aji-166	223	17	expression	expression	NOUN
aji-166	223	18	,	,	PUNCT
aji-166	223	19	and	and	CCONJ
aji-166	223	20	then	then	ADV
aji-166	223	21	specific	specific	ADJ
aji-166	223	22	viral	viral	ADJ
aji-166	223	23	components	component	NOUN
aji-166	223	24	activate	activate	VERB
aji-166	223	25	the	the	DET
aji-166	223	26	inflammasome	inflammasome	NOUN
aji-166	223	27	,	,	PUNCT
aji-166	223	28	resulting	result	VERB
aji-166	223	29	in	in	ADP
aji-166	223	30	the	the	DET
aji-166	223	31	maturation	maturation	NOUN
aji-166	223	32	and	and	CCONJ
aji-166	223	33	release	release	NOUN
aji-166	223	34	of	of	ADP
aji-166	223	35	il-1β	il-1β	PROPN
aji-166	223	36	and	and	CCONJ
aji-166	223	37	il-18	il-18	ADP
aji-166	223	38	(	(	PUNCT
aji-166	223	39	chivero	chivero	NOUN
aji-166	223	40	et	et	PROPN
aji-166	223	41	al	al	PROPN
aji-166	223	42	.	.	PROPN
aji-166	223	43	,	,	PUNCT
aji-166	223	44	2017	2017	NUM
aji-166	223	45	)	)	PUNCT
aji-166	223	46	.	.	PUNCT
aji-166	224	1	activated	activate	VERB
aji-166	224	2	macrophages	macrophage	NOUN
aji-166	224	3	and	and	CCONJ
aji-166	224	4	microglia	microglia	NOUN
aji-166	224	5	produce	produce	VERB
aji-166	224	6	quinolinic	quinolinic	ADJ
aji-166	224	7	acid	acid	NOUN
aji-166	224	8	,	,	PUNCT
aji-166	224	9	an	an	DET
aji-166	224	10	n	n	CCONJ
aji-166	224	11	-	-	PUNCT
aji-166	224	12	methyl	methyl	NOUN
aji-166	224	13	-	-	PUNCT
aji-166	224	14	d	d	NOUN
aji-166	224	15	-	-	NOUN
aji-166	224	16	aspartate	aspartate	ADJ
aji-166	224	17	(	(	PUNCT
aji-166	224	18	nmda	nmda	ADJ
aji-166	224	19	)	)	PUNCT
aji-166	224	20	receptor	receptor	NOUN
aji-166	224	21	agonist	agonist	NOUN
aji-166	224	22	that	that	PRON
aji-166	224	23	induces	induce	VERB
aji-166	224	24	excitotoxicity	excitotoxicity	NOUN
aji-166	224	25	by	by	ADP
aji-166	224	26	overstimulating	overstimulate	VERB
aji-166	224	27	neurons	neuron	NOUN
aji-166	224	28	.	.	PUNCT
aji-166	225	1	nmda	nmda	ADJ
aji-166	225	2	receptors	receptor	NOUN
aji-166	225	3	,	,	PUNCT
aji-166	225	4	which	which	PRON
aji-166	225	5	are	be	AUX
aji-166	225	6	the	the	DET
aji-166	225	7	primary	primary	ADJ
aji-166	225	8	excitatory	excitatory	NOUN
aji-166	225	9	neurotransmitter	neurotransmitter	NOUN
aji-166	225	10	receptors	receptor	NOUN
aji-166	225	11	in	in	ADP
aji-166	225	12	the	the	DET
aji-166	225	13	human	human	ADJ
aji-166	225	14	brain	brain	NOUN
aji-166	225	15	,	,	PUNCT
aji-166	225	16	play	play	VERB
aji-166	225	17	a	a	DET
aji-166	225	18	crucial	crucial	ADJ
aji-166	225	19	role	role	NOUN
aji-166	225	20	in	in	ADP
aji-166	225	21	synaptic	synaptic	ADJ
aji-166	225	22	plasticity	plasticity	NOUN
aji-166	225	23	,	,	PUNCT
aji-166	225	24	a	a	DET
aji-166	225	25	neuronal	neuronal	ADJ
aji-166	225	26	mechanism	mechanism	NOUN
aji-166	225	27	thought	think	VERB
aji-166	225	28	to	to	PART
aji-166	225	29	be	be	AUX
aji-166	225	30	fundamental	fundamental	ADJ
aji-166	225	31	for	for	ADP
aji-166	225	32	memory	memory	NOUN
aji-166	225	33	formation	formation	NOUN
aji-166	225	34	.	.	PUNCT
aji-166	226	1	quinolinic	quinolinic	ADJ
aji-166	226	2	acid	acid	NOUN
aji-166	226	3	also	also	ADV
aji-166	226	4	generates	generate	VERB
aji-166	226	5	ros	ros	PROPN
aji-166	226	6	,	,	PUNCT
aji-166	226	7	leading	lead	VERB
aji-166	226	8	to	to	ADP
aji-166	226	9	mitochondrial	mitochondrial	ADJ
aji-166	226	10	dysfunction	dysfunction	NOUN
aji-166	226	11	and	and	CCONJ
aji-166	226	12	neuronal	neuronal	ADJ
aji-166	226	13	apoptosis	apoptosis	NOUN
aji-166	226	14	(	(	PUNCT
aji-166	226	15	lugohuitrón	lugohuitrón	PROPN
aji-166	226	16	et	et	PROPN
aji-166	226	17	al	al	PROPN
aji-166	226	18	.	.	PROPN
aji-166	226	19	,	,	PUNCT
aji-166	226	20	2013	2013	NUM
aji-166	226	21	)	)	PUNCT
aji-166	226	22	.	.	PUNCT
aji-166	227	1	these	these	DET
aji-166	227	2	pathological	pathological	ADJ
aji-166	227	3	processes	process	NOUN
aji-166	227	4	ultimately	ultimately	ADV
aji-166	227	5	result	result	VERB
aji-166	227	6	in	in	ADP
aji-166	227	7	a	a	DET
aji-166	227	8	range	range	NOUN
aji-166	227	9	of	of	ADP
aji-166	227	10	cognitive	cognitive	ADJ
aji-166	227	11	deficits	deficit	NOUN
aji-166	227	12	,	,	PUNCT
aji-166	227	13	including	include	VERB
aji-166	227	14	asymptomatic	asymptomatic	ADJ
aji-166	227	15	neurocognitive	neurocognitive	ADJ
aji-166	227	16	impairment	impairment	NOUN
aji-166	227	17	(	(	PUNCT
aji-166	227	18	subtle	subtle	ADJ
aji-166	227	19	deficits	deficit	NOUN
aji-166	227	20	detectable	detectable	ADJ
aji-166	227	21	only	only	ADV
aji-166	227	22	through	through	ADP
aji-166	227	23	neuropsychological	neuropsychological	ADJ
aji-166	227	24	testing	testing	NOUN
aji-166	227	25	)	)	PUNCT
aji-166	227	26	,	,	PUNCT
aji-166	227	27	mild	mild	ADJ
aji-166	227	28	neurocognitive	neurocognitive	ADJ
aji-166	227	29	disorder	disorder	NOUN
aji-166	227	30	(	(	PUNCT
aji-166	227	31	functional	functional	ADJ
aji-166	227	32	impairment	impairment	NOUN
aji-166	227	33	in	in	ADP
aji-166	227	34	daily	daily	ADJ
aji-166	227	35	activities	activity	NOUN
aji-166	227	36	)	)	PUNCT
aji-166	227	37	,	,	PUNCT
aji-166	227	38	and	and	CCONJ
aji-166	227	39	hiv	hiv	PROPN
aji-166	227	40	-	-	PUNCT
aji-166	227	41	associated	associate	VERB
aji-166	227	42	dementia	dementia	NOUN
aji-166	227	43	(	(	PUNCT
aji-166	227	44	severe	severe	ADJ
aji-166	227	45	cognitive	cognitive	ADJ
aji-166	227	46	and	and	CCONJ
aji-166	227	47	motor	motor	NOUN
aji-166	227	48	decline	decline	NOUN
aji-166	227	49	,	,	PUNCT
aji-166	227	50	which	which	PRON
aji-166	227	51	is	be	AUX
aji-166	227	52	now	now	ADV
aji-166	227	53	rare	rare	ADJ
aji-166	227	54	in	in	ADP
aji-166	227	55	the	the	DET
aji-166	227	56	art	art	NOUN
aji-166	227	57	era	era	NOUN
aji-166	227	58	)	)	PUNCT
aji-166	227	59	(	(	PUNCT
aji-166	227	60	adhikary	adhikary	NOUN
aji-166	227	61	et	et	PROPN
aji-166	227	62	al	al	PROPN
aji-166	227	63	.	.	PROPN
aji-166	227	64	,	,	PUNCT
aji-166	227	65	2025	2025	NUM
aji-166	227	66	)	)	PUNCT
aji-166	227	67	.	.	PUNCT
aji-166	228	1	3.3	3.3	NUM
aji-166	228	2	liver	liver	NOUN
aji-166	228	3	and	and	CCONJ
aji-166	228	4	kidney	kidney	NOUN
aji-166	228	5	disease	disease	NOUN
aji-166	228	6	common	common	ADJ
aji-166	228	7	to	to	ADP
aji-166	228	8	the	the	DET
aji-166	228	9	mechanism	mechanism	NOUN
aji-166	228	10	of	of	ADP
aji-166	228	11	tissue	tissue	NOUN
aji-166	228	12	damage	damage	NOUN
aji-166	228	13	in	in	ADP
aji-166	228	14	other	other	ADJ
aji-166	228	15	organs	organ	NOUN
aji-166	228	16	,	,	PUNCT
aji-166	228	17	chronic	chronic	ADJ
aji-166	228	18	inflammation	inflammation	NOUN
aji-166	228	19	and	and	CCONJ
aji-166	228	20	immune	immune	ADJ
aji-166	228	21	activation	activation	NOUN
aji-166	228	22	driven	drive	VERB
aji-166	228	23	by	by	ADP
aji-166	228	24	hiv	hiv	PROPN
aji-166	228	25	-	-	PUNCT
aji-166	228	26	infected	infect	VERB
aji-166	228	27	monocytes	monocyte	NOUN
aji-166	228	28	and	and	CCONJ
aji-166	228	29	macrophages	macrophage	NOUN
aji-166	228	30	play	play	VERB
aji-166	228	31	a	a	DET
aji-166	228	32	central	central	ADJ
aji-166	228	33	role	role	NOUN
aji-166	228	34	in	in	ADP
aji-166	228	35	liver	liver	NOUN
aji-166	228	36	and	and	CCONJ
aji-166	228	37	kidney	kidney	NOUN
aji-166	228	38	pathology	pathology	NOUN
aji-166	228	39	among	among	ADP
aji-166	228	40	plwh	plwh	NOUN
aji-166	228	41	.	.	PUNCT
aji-166	229	1	however	however	ADV
aji-166	229	2	,	,	PUNCT
aji-166	229	3	the	the	DET
aji-166	229	4	dynamics	dynamic	NOUN
aji-166	229	5	underlying	underlie	VERB
aji-166	229	6	the	the	DET
aji-166	229	7	damage	damage	NOUN
aji-166	229	8	differ	differ	VERB
aji-166	229	9	between	between	ADP
aji-166	229	10	the	the	DET
aji-166	229	11	two	two	NUM
aji-166	229	12	organs	organ	NOUN
aji-166	229	13	.	.	PUNCT
aji-166	229	14	fig	fig	NOUN
aji-166	229	15	.	.	PUNCT
aji-166	230	1	1	1	X
aji-166	230	2	.	.	NUM
aji-166	230	3	mechanisms	mechanism	NOUN
aji-166	230	4	of	of	ADP
aji-166	230	5	hand	hand	NOUN
aji-166	230	6	.	.	PUNCT
aji-166	231	1	hiv	hiv	PROPN
aji-166	231	2	-	-	PUNCT
aji-166	231	3	infected	infect	VERB
aji-166	231	4	cd16	cd16	PROPN
aji-166	231	5	+	+	PROPN
aji-166	231	6	monocytes	monocyte	NOUN
aji-166	231	7	migrate	migrate	VERB
aji-166	231	8	across	across	ADP
aji-166	231	9	the	the	DET
aji-166	231	10	bbb	bbb	NOUN
aji-166	231	11	enabled	enable	VERB
aji-166	231	12	by	by	ADP
aji-166	231	13	ccr2	ccr2	PROPN
aji-166	231	14	/	/	SYM
aji-166	231	15	mmp-9	mmp-9	NOUN
aji-166	231	16	expression	expression	NOUN
aji-166	231	17	,	,	PUNCT
aji-166	231	18	seeding	seed	VERB
aji-166	231	19	cns	cns	NOUN
aji-166	231	20	reservoirs	reservoir	NOUN
aji-166	231	21	.	.	PUNCT
aji-166	232	1	persistent	persistent	ADJ
aji-166	232	2	viral	viral	ADJ
aji-166	232	3	proteins	protein	NOUN
aji-166	232	4	(	(	PUNCT
aji-166	232	5	tat	tat	NOUN
aji-166	232	6	/	/	SYM
aji-166	232	7	gp120	gp120	NOUN
aji-166	232	8	)	)	PUNCT
aji-166	232	9	and	and	CCONJ
aji-166	232	10	cytokines	cytokine	NOUN
aji-166	232	11	(	(	PUNCT
aji-166	232	12	tnf	tnf	PROPN
aji-166	232	13	-	-	PUNCT
aji-166	232	14	α	α	PROPN
aji-166	232	15	/	/	SYM
aji-166	232	16	il-1β	il-1β	PROPN
aji-166	232	17	)	)	PUNCT
aji-166	232	18	drive	drive	NOUN
aji-166	232	19	neuroinflammation	neuroinflammation	NOUN
aji-166	232	20	,	,	PUNCT
aji-166	232	21	oxidative	oxidative	ADJ
aji-166	232	22	stress	stress	NOUN
aji-166	232	23	,	,	PUNCT
aji-166	232	24	and	and	CCONJ
aji-166	232	25	synaptic	synaptic	ADJ
aji-166	232	26	damage	damage	NOUN
aji-166	232	27	,	,	PUNCT
aji-166	232	28	culminating	culminate	VERB
aji-166	232	29	in	in	ADP
aji-166	232	30	cognitive	cognitive	ADJ
aji-166	232	31	decline	decline	NOUN
aji-166	232	32	adavba	adavba	NOUN
aji-166	232	33	;	;	PUNCT
aji-166	232	34	asian	asian	PROPN
aji-166	232	35	j.	j.	PROPN
aji-166	232	36	immunol	immunol	PROPN
aji-166	232	37	.	.	PROPN
aji-166	232	38	,	,	PUNCT
aji-166	232	39	vol	vol	NOUN
aji-166	232	40	.	.	PROPN
aji-166	232	41	8	8	NUM
aji-166	232	42	,	,	PUNCT
aji-166	232	43	no	no	INTJ
aji-166	232	44	.	.	NOUN
aji-166	232	45	1	1	NUM
aji-166	232	46	,	,	PUNCT
aji-166	232	47	pp	pp	ADJ
aji-166	232	48	.	.	PUNCT
aji-166	233	1	120	120	NUM
aji-166	233	2	-	-	SYM
aji-166	233	3	133	133	NUM
aji-166	233	4	,	,	PUNCT
aji-166	233	5	2025	2025	NUM
aji-166	233	6	;	;	PUNCT
aji-166	233	7	article	article	NOUN
aji-166	233	8	no.aji.136909	no.aji.136909	NOUN
aji-166	233	9	126	126	NUM
aji-166	233	10	most	most	ADJ
aji-166	233	11	of	of	ADP
aji-166	233	12	the	the	DET
aji-166	233	13	focus	focus	NOUN
aji-166	233	14	on	on	ADP
aji-166	233	15	liver	liver	NOUN
aji-166	233	16	disease	disease	NOUN
aji-166	233	17	has	have	AUX
aji-166	233	18	been	be	AUX
aji-166	233	19	on	on	ADP
aji-166	233	20	individuals	individual	NOUN
aji-166	233	21	co	co	VERB
aji-166	233	22	-	-	VERB
aji-166	233	23	infected	infect	VERB
aji-166	233	24	with	with	ADP
aji-166	233	25	hcv	hcv	NOUN
aji-166	233	26	or	or	CCONJ
aji-166	233	27	hbv	hbv	NOUN
aji-166	233	28	.	.	PUNCT
aji-166	234	1	however	however	ADV
aji-166	234	2	,	,	PUNCT
aji-166	234	3	even	even	ADV
aji-166	234	4	though	though	SCONJ
aji-166	234	5	the	the	DET
aji-166	234	6	apparent	apparent	ADJ
aji-166	234	7	net	net	ADJ
aji-166	234	8	effect	effect	NOUN
aji-166	234	9	of	of	ADP
aji-166	234	10	hiv	hiv	PROPN
aji-166	234	11	on	on	ADP
aji-166	234	12	liver	liver	NOUN
aji-166	234	13	fibrosis	fibrosis	NOUN
aji-166	234	14	is	be	AUX
aji-166	234	15	most	most	ADV
aji-166	234	16	evident	evident	ADJ
aji-166	234	17	in	in	ADP
aji-166	234	18	the	the	DET
aji-166	234	19	presence	presence	NOUN
aji-166	234	20	of	of	ADP
aji-166	234	21	a	a	DET
aji-166	234	22	second	second	ADJ
aji-166	234	23	contributor	contributor	NOUN
aji-166	234	24	,	,	PUNCT
aji-166	234	25	such	such	ADJ
aji-166	234	26	as	as	ADP
aji-166	234	27	hcv	hcv	NOUN
aji-166	234	28	infection	infection	NOUN
aji-166	234	29	,	,	PUNCT
aji-166	234	30	hbv	hbv	NOUN
aji-166	234	31	infection	infection	NOUN
aji-166	234	32	,	,	PUNCT
aji-166	234	33	excessive	excessive	ADJ
aji-166	234	34	alcohol	alcohol	NOUN
aji-166	234	35	use	use	NOUN
aji-166	234	36	,	,	PUNCT
aji-166	234	37	or	or	CCONJ
aji-166	234	38	metabolic	metabolic	NOUN
aji-166	234	39	liver	liver	NOUN
aji-166	234	40	disease	disease	NOUN
aji-166	234	41	,	,	PUNCT
aji-166	234	42	hiv	hiv	PROPN
aji-166	234	43	infection	infection	NOUN
aji-166	234	44	itself	itself	PRON
aji-166	234	45	biases	bias	VERB
aji-166	234	46	the	the	DET
aji-166	234	47	liver	liver	NOUN
aji-166	234	48	toward	toward	ADP
aji-166	234	49	fibrosis	fibrosis	NOUN
aji-166	234	50	and	and	CCONJ
aji-166	234	51	synergistically	synergistically	ADV
aji-166	234	52	promotes	promote	VERB
aji-166	234	53	these	these	DET
aji-166	234	54	other	other	ADJ
aji-166	234	55	processes	process	NOUN
aji-166	234	56	.	.	PUNCT
aji-166	235	1	there	there	PRON
aji-166	235	2	is	be	VERB
aji-166	235	3	also	also	ADV
aji-166	235	4	significant	significant	ADJ
aji-166	235	5	evidence	evidence	NOUN
aji-166	235	6	suggesting	suggest	VERB
aji-166	235	7	that	that	SCONJ
aji-166	235	8	even	even	ADV
aji-166	235	9	without	without	ADP
aji-166	235	10	primary	primary	ADJ
aji-166	235	11	liver	liver	NOUN
aji-166	235	12	disease	disease	NOUN
aji-166	235	13	,	,	PUNCT
aji-166	235	14	hiv	hiv	PROPN
aji-166	235	15	itself	itself	PRON
aji-166	235	16	may	may	AUX
aji-166	235	17	cause	cause	VERB
aji-166	235	18	liver	liver	NOUN
aji-166	235	19	steatosis	steatosis	NOUN
aji-166	235	20	and	and	CCONJ
aji-166	235	21	fibrosis	fibrosis	NOUN
aji-166	235	22	(	(	PUNCT
aji-166	235	23	sherman	sherman	PROPN
aji-166	235	24	&	&	CCONJ
aji-166	235	25	thomas	thomas	PROPN
aji-166	235	26	,	,	PUNCT
aji-166	235	27	2022	2022	NUM
aji-166	235	28	)	)	PUNCT
aji-166	235	29	.	.	PUNCT
aji-166	236	1	various	various	ADJ
aji-166	236	2	seemingly	seemingly	ADV
aji-166	236	3	overlapping	overlap	VERB
aji-166	236	4	mechanisms	mechanism	NOUN
aji-166	236	5	have	have	AUX
aji-166	236	6	been	be	AUX
aji-166	236	7	proposed	propose	VERB
aji-166	236	8	to	to	PART
aji-166	236	9	explain	explain	VERB
aji-166	236	10	how	how	SCONJ
aji-166	236	11	hiv	hiv	PROPN
aji-166	236	12	may	may	AUX
aji-166	236	13	potentiate	potentiate	VERB
aji-166	236	14	or	or	CCONJ
aji-166	236	15	cause	cause	VERB
aji-166	236	16	liver	liver	NOUN
aji-166	236	17	fibrosis	fibrosis	NOUN
aji-166	236	18	,	,	PUNCT
aji-166	236	19	but	but	CCONJ
aji-166	236	20	they	they	PRON
aji-166	236	21	all	all	PRON
aji-166	236	22	converge	converge	VERB
aji-166	236	23	on	on	ADP
aji-166	236	24	the	the	DET
aji-166	236	25	central	central	ADJ
aji-166	236	26	role	role	NOUN
aji-166	236	27	of	of	ADP
aji-166	236	28	the	the	DET
aji-166	236	29	hepatic	hepatic	ADJ
aji-166	236	30	stellate	stellate	ADJ
aji-166	236	31	cell	cell	NOUN
aji-166	236	32	(	(	PUNCT
aji-166	236	33	hsc	hsc	PROPN
aji-166	236	34	)	)	PUNCT
aji-166	236	35	.	.	PUNCT
aji-166	237	1	hscs	hsc	NOUN
aji-166	237	2	are	be	AUX
aji-166	237	3	pivotal	pivotal	ADJ
aji-166	237	4	in	in	ADP
aji-166	237	5	liver	liver	NOUN
aji-166	237	6	fibrosis	fibrosis	NOUN
aji-166	237	7	,	,	PUNCT
aji-166	237	8	where	where	SCONJ
aji-166	237	9	the	the	DET
aji-166	237	10	liver	liver	NOUN
aji-166	237	11	develops	develop	VERB
aji-166	237	12	scar	scar	ADJ
aji-166	237	13	tissue	tissue	NOUN
aji-166	237	14	secondary	secondary	ADJ
aji-166	237	15	to	to	ADP
aji-166	237	16	chronic	chronic	ADJ
aji-166	237	17	injury	injury	NOUN
aji-166	237	18	.	.	PUNCT
aji-166	238	1	when	when	SCONJ
aji-166	238	2	hscs	hsc	NOUN
aji-166	238	3	are	be	AUX
aji-166	238	4	activated	activate	VERB
aji-166	238	5	,	,	PUNCT
aji-166	238	6	they	they	PRON
aji-166	238	7	can	can	AUX
aji-166	238	8	transdifferentiate	transdifferentiate	VERB
aji-166	238	9	from	from	ADP
aji-166	238	10	a	a	DET
aji-166	238	11	quiescent	quiescent	NOUN
aji-166	238	12	to	to	ADP
aji-166	238	13	an	an	DET
aji-166	238	14	activated	activated	ADJ
aji-166	238	15	phenotype	phenotype	NOUN
aji-166	238	16	,	,	PUNCT
aji-166	238	17	producing	produce	VERB
aji-166	238	18	excess	excess	ADJ
aji-166	238	19	extracellular	extracellular	ADJ
aji-166	238	20	matrix	matrix	NOUN
aji-166	238	21	(	(	PUNCT
aji-166	238	22	ecm	ecm	PROPN
aji-166	238	23	)	)	PUNCT
aji-166	238	24	,	,	PUNCT
aji-166	238	25	which	which	PRON
aji-166	238	26	contributes	contribute	VERB
aji-166	238	27	to	to	ADP
aji-166	238	28	the	the	DET
aji-166	238	29	development	development	NOUN
aji-166	238	30	of	of	ADP
aji-166	238	31	fibrosis	fibrosis	NOUN
aji-166	238	32	,	,	PUNCT
aji-166	238	33	cirrhosis	cirrhosis	NOUN
aji-166	238	34	,	,	PUNCT
aji-166	238	35	and	and	CCONJ
aji-166	238	36	other	other	ADJ
aji-166	238	37	liver	liver	NOUN
aji-166	238	38	diseases	disease	NOUN
aji-166	238	39	(	(	PUNCT
aji-166	238	40	hoffmann	hoffmann	PROPN
aji-166	238	41	et	et	PROPN
aji-166	238	42	al	al	PROPN
aji-166	238	43	.	.	PROPN
aji-166	238	44	,	,	PUNCT
aji-166	238	45	2020	2020	NUM
aji-166	238	46	)	)	PUNCT
aji-166	238	47	.	.	PUNCT
aji-166	239	1	hiv	hiv	PROPN
aji-166	239	2	-	-	PUNCT
aji-166	239	3	infected	infect	VERB
aji-166	239	4	kupffer	kupffer	NOUN
aji-166	239	5	cells	cell	NOUN
aji-166	239	6	(	(	PUNCT
aji-166	239	7	resident	resident	ADJ
aji-166	239	8	liver	liver	NOUN
aji-166	239	9	macrophages	macrophage	NOUN
aji-166	239	10	)	)	PUNCT
aji-166	239	11	and	and	CCONJ
aji-166	239	12	circulating	circulate	VERB
aji-166	239	13	monocytes	monocyte	NOUN
aji-166	239	14	that	that	PRON
aji-166	239	15	migrate	migrate	VERB
aji-166	239	16	to	to	ADP
aji-166	239	17	the	the	DET
aji-166	239	18	liver	liver	NOUN
aji-166	239	19	become	become	VERB
aji-166	239	20	chronically	chronically	ADV
aji-166	239	21	activated	activate	VERB
aji-166	239	22	due	due	ADP
aji-166	239	23	to	to	ADP
aji-166	239	24	viral	viral	ADJ
aji-166	239	25	persistence	persistence	NOUN
aji-166	239	26	.	.	PUNCT
aji-166	240	1	they	they	PRON
aji-166	240	2	create	create	VERB
aji-166	240	3	a	a	DET
aji-166	240	4	proinflammatory	proinflammatory	ADJ
aji-166	240	5	microenvironment	microenvironment	NOUN
aji-166	240	6	in	in	ADP
aji-166	240	7	the	the	DET
aji-166	240	8	liver	liver	NOUN
aji-166	240	9	by	by	ADP
aji-166	240	10	releasing	release	VERB
aji-166	240	11	tnf	tnf	PROPN
aji-166	240	12	-	-	PUNCT
aji-166	240	13	α	α	PROPN
aji-166	240	14	,	,	PUNCT
aji-166	240	15	il-6	il-6	NUM
aji-166	240	16	,	,	PUNCT
aji-166	240	17	il-1β	il-1β	PROPN
aji-166	240	18	,	,	PUNCT
aji-166	240	19	and	and	CCONJ
aji-166	240	20	ccl2	ccl2	PROPN
aji-166	240	21	.	.	PUNCT
aji-166	241	1	(	(	PUNCT
aji-166	241	2	mosoian	mosoian	PROPN
aji-166	241	3	et	et	PROPN
aji-166	241	4	al	al	PROPN
aji-166	241	5	.	.	PROPN
aji-166	241	6	,	,	PUNCT
aji-166	241	7	2016	2016	NUM
aji-166	241	8	)	)	PUNCT
aji-166	241	9	,	,	PUNCT
aji-166	241	10	while	while	SCONJ
aji-166	241	11	hiv	hiv	PROPN
aji-166	241	12	proteins	protein	NOUN
aji-166	241	13	(	(	PUNCT
aji-166	241	14	tat	tat	NOUN
aji-166	241	15	,	,	PUNCT
aji-166	241	16	nef	nef	PROPN
aji-166	241	17	)	)	PUNCT
aji-166	241	18	,	,	PUNCT
aji-166	241	19	which	which	PRON
aji-166	241	20	directly	directly	ADV
aji-166	241	21	enhance	enhance	VERB
aji-166	241	22	macrophage	macrophage	ADJ
aji-166	241	23	activation	activation	NOUN
aji-166	241	24	,	,	PUNCT
aji-166	241	25	may	may	AUX
aji-166	241	26	stimulate	stimulate	VERB
aji-166	241	27	signaling	signal	VERB
aji-166	241	28	pathways	pathway	NOUN
aji-166	241	29	such	such	ADJ
aji-166	241	30	as	as	ADP
aji-166	241	31	nf	nf	NOUN
aji-166	241	32	-	-	PUNCT
aji-166	241	33	κb	κb	NOUN
aji-166	241	34	,	,	PUNCT
aji-166	241	35	amplifying	amplifying	ADJ
aji-166	241	36	cytokine	cytokine	NOUN
aji-166	241	37	production	production	NOUN
aji-166	241	38	.	.	PUNCT
aji-166	242	1	additionally	additionally	ADV
aji-166	242	2	,	,	PUNCT
aji-166	242	3	activated	activate	VERB
aji-166	242	4	macrophages	macrophage	NOUN
aji-166	242	5	secrete	secrete	NOUN
aji-166	242	6	tgf	tgf	PROPN
aji-166	242	7	-	-	PUNCT
aji-166	242	8	β	β	PROPN
aji-166	242	9	,	,	PUNCT
aji-166	242	10	a	a	DET
aji-166	242	11	key	key	ADJ
aji-166	242	12	fibrogenic	fibrogenic	ADJ
aji-166	242	13	cytokine	cytokine	NOUN
aji-166	242	14	,	,	PUNCT
aji-166	242	15	and	and	CCONJ
aji-166	242	16	plateletderived	plateletderive	VERB
aji-166	242	17	growth	growth	NOUN
aji-166	242	18	factor	factor	NOUN
aji-166	242	19	(	(	PUNCT
aji-166	242	20	pdgf	pdgf	NOUN
aji-166	242	21	)	)	PUNCT
aji-166	242	22	,	,	PUNCT
aji-166	242	23	a	a	DET
aji-166	242	24	potent	potent	ADJ
aji-166	242	25	mitogen	mitogen	NOUN
aji-166	242	26	(	(	PUNCT
aji-166	242	27	mosoian	mosoian	PROPN
aji-166	242	28	et	et	PROPN
aji-166	242	29	al	al	PROPN
aji-166	242	30	.	.	PROPN
aji-166	242	31	,	,	PUNCT
aji-166	242	32	2016	2016	NUM
aji-166	242	33	)	)	PUNCT
aji-166	242	34	.	.	PUNCT
aji-166	243	1	these	these	DET
aji-166	243	2	factors	factor	NOUN
aji-166	243	3	are	be	AUX
aji-166	243	4	crucial	crucial	ADJ
aji-166	243	5	in	in	ADP
aji-166	243	6	transitioning	transition	VERB
aji-166	243	7	hscs	hsc	NOUN
aji-166	243	8	from	from	ADP
aji-166	243	9	a	a	DET
aji-166	243	10	quiescent	quiescent	NOUN
aji-166	243	11	to	to	ADP
aji-166	243	12	an	an	DET
aji-166	243	13	activated	activated	ADJ
aji-166	243	14	state	state	NOUN
aji-166	243	15	.	.	PUNCT
aji-166	244	1	furthermore	furthermore	ADV
aji-166	244	2	,	,	PUNCT
aji-166	244	3	hiv	hiv	PROPN
aji-166	244	4	-	-	PUNCT
aji-166	244	5	infected	infect	VERB
aji-166	244	6	macrophages	macrophage	NOUN
aji-166	244	7	generate	generate	VERB
aji-166	244	8	ros	ros	PROPN
aji-166	244	9	,	,	PUNCT
aji-166	244	10	which	which	PRON
aji-166	244	11	directly	directly	ADV
aji-166	244	12	activate	activate	VERB
aji-166	244	13	hscs	hsc	NOUN
aji-166	244	14	and	and	CCONJ
aji-166	244	15	enhance	enhance	VERB
aji-166	244	16	tgf	tgf	PROPN
aji-166	244	17	-	-	PUNCT
aji-166	244	18	β	β	NOUN
aji-166	244	19	signaling	signal	VERB
aji-166	244	20	,	,	PUNCT
aji-166	244	21	exacerbating	exacerbate	VERB
aji-166	244	22	the	the	DET
aji-166	244	23	process	process	NOUN
aji-166	244	24	of	of	ADP
aji-166	244	25	tissue	tissue	NOUN
aji-166	244	26	damage	damage	NOUN
aji-166	244	27	.	.	PUNCT
aji-166	245	1	in	in	ADP
aji-166	245	2	addition	addition	NOUN
aji-166	245	3	,	,	PUNCT
aji-166	245	4	hivinduced	hivinduce	VERB
aji-166	245	5	gut	gut	NOUN
aji-166	245	6	barrier	barrier	NOUN
aji-166	245	7	dysfunction	dysfunction	NOUN
aji-166	245	8	allows	allow	VERB
aji-166	245	9	translocation	translocation	NOUN
aji-166	245	10	of	of	ADP
aji-166	245	11	microbial	microbial	ADJ
aji-166	245	12	components	component	NOUN
aji-166	245	13	,	,	PUNCT
aji-166	245	14	especially	especially	ADV
aji-166	245	15	lipopolysaccharides	lipopolysaccharide	NOUN
aji-166	245	16	(	(	PUNCT
aji-166	245	17	lps	lps	PROPN
aji-166	245	18	)	)	PUNCT
aji-166	245	19	,	,	PUNCT
aji-166	245	20	to	to	ADP
aji-166	245	21	the	the	DET
aji-166	245	22	liver	liver	NOUN
aji-166	245	23	.	.	PUNCT
aji-166	246	1	these	these	PRON
aji-166	246	2	bind	bind	VERB
aji-166	246	3	to	to	ADP
aji-166	246	4	tlr4	tlr4	NOUN
aji-166	246	5	on	on	ADP
aji-166	246	6	kupffer	kupffer	NOUN
aji-166	246	7	cells	cell	NOUN
aji-166	246	8	,	,	PUNCT
aji-166	246	9	further	far	ADV
aji-166	246	10	amplifying	amplify	VERB
aji-166	246	11	cytokine	cytokine	ADJ
aji-166	246	12	production	production	NOUN
aji-166	246	13	(	(	PUNCT
aji-166	246	14	e.g.	e.g.	ADV
aji-166	246	15	,	,	PUNCT
aji-166	246	16	il-1β	il-1β	PROPN
aji-166	246	17	via	via	ADP
aji-166	246	18	nlrp3	nlrp3	NOUN
aji-166	246	19	inflammasome	inflammasome	NOUN
aji-166	246	20	activation	activation	NOUN
aji-166	246	21	)	)	PUNCT
aji-166	246	22	(	(	PUNCT
aji-166	246	23	hoffmann	hoffmann	PROPN
aji-166	246	24	et	et	PROPN
aji-166	246	25	al	al	PROPN
aji-166	246	26	.	.	PROPN
aji-166	246	27	,	,	PUNCT
aji-166	246	28	2020	2020	NUM
aji-166	246	29	)	)	PUNCT
aji-166	246	30	.	.	PUNCT
aji-166	247	1	ultimately	ultimately	ADV
aji-166	247	2	,	,	PUNCT
aji-166	247	3	the	the	DET
aji-166	247	4	resulting	result	VERB
aji-166	247	5	accumulation	accumulation	NOUN
aji-166	247	6	of	of	ADP
aji-166	247	7	ecm	ecm	NOUN
aji-166	247	8	disrupts	disrupt	VERB
aji-166	247	9	liver	liver	NOUN
aji-166	247	10	architecture	architecture	NOUN
aji-166	247	11	,	,	PUNCT
aji-166	247	12	leading	lead	VERB
aji-166	247	13	to	to	ADP
aji-166	247	14	cirrhosis	cirrhosis	NOUN
aji-166	247	15	and	and	CCONJ
aji-166	247	16	impaired	impaired	ADJ
aji-166	247	17	hepatic	hepatic	ADJ
aji-166	247	18	function	function	NOUN
aji-166	247	19	.	.	PUNCT
aji-166	248	1	hiv	hiv	PROPN
aji-166	248	2	-	-	PUNCT
aji-166	248	3	infected	infect	VERB
aji-166	248	4	monocytes	monocyte	NOUN
aji-166	248	5	and	and	CCONJ
aji-166	248	6	macrophages	macrophage	NOUN
aji-166	248	7	significantly	significantly	ADV
aji-166	248	8	contribute	contribute	VERB
aji-166	248	9	to	to	ADP
aji-166	248	10	hiv	hiv	PROPN
aji-166	248	11	-	-	PUNCT
aji-166	248	12	associated	associate	VERB
aji-166	248	13	kidney	kidney	NOUN
aji-166	248	14	disease	disease	NOUN
aji-166	248	15	,	,	PUNCT
aji-166	248	16	particularly	particularly	ADV
aji-166	248	17	hiv	hiv	NOUN
aji-166	248	18	-	-	PUNCT
aji-166	248	19	associated	associate	VERB
aji-166	248	20	nephropathy	nephropathy	NOUN
aji-166	248	21	(	(	PUNCT
aji-166	248	22	hivan	hivan	NOUN
aji-166	248	23	)	)	PUNCT
aji-166	248	24	and	and	CCONJ
aji-166	248	25	immune	immune	ADJ
aji-166	248	26	complex	complex	NOUN
aji-166	248	27	-	-	PUNCT
aji-166	248	28	mediated	mediate	VERB
aji-166	248	29	glomerulonephritis	glomerulonephritis	NOUN
aji-166	248	30	,	,	PUNCT
aji-166	248	31	through	through	ADP
aji-166	248	32	direct	direct	ADJ
aji-166	248	33	viral	viral	ADJ
aji-166	248	34	infection	infection	NOUN
aji-166	248	35	,	,	PUNCT
aji-166	248	36	chronic	chronic	ADJ
aji-166	248	37	inflammation	inflammation	NOUN
aji-166	248	38	,	,	PUNCT
aji-166	248	39	and	and	CCONJ
aji-166	248	40	podocyte	podocyte	NOUN
aji-166	248	41	injury	injury	NOUN
aji-166	248	42	.	.	PUNCT
aji-166	249	1	hivan	hivan	NOUN
aji-166	249	2	,	,	PUNCT
aji-166	249	3	characterized	characterize	VERB
aji-166	249	4	by	by	ADP
aji-166	249	5	focal	focal	ADJ
aji-166	249	6	segmental	segmental	ADJ
aji-166	249	7	glomerulosclerosis	glomerulosclerosis	NOUN
aji-166	249	8	with	with	ADP
aji-166	249	9	collapsing	collapse	VERB
aji-166	249	10	glomerulopathy	glomerulopathy	ADJ
aji-166	249	11	and	and	CCONJ
aji-166	249	12	tubulointerstitial	tubulointerstitial	ADJ
aji-166	249	13	inflammation	inflammation	NOUN
aji-166	249	14	,	,	PUNCT
aji-166	249	15	is	be	AUX
aji-166	249	16	underpinned	underpin	VERB
aji-166	249	17	by	by	ADP
aji-166	249	18	various	various	ADJ
aji-166	249	19	pathological	pathological	ADJ
aji-166	249	20	processes	process	NOUN
aji-166	249	21	.	.	PUNCT
aji-166	250	1	hiv	hiv	PROPN
aji-166	250	2	-	-	PUNCT
aji-166	250	3	infected	infect	VERB
aji-166	250	4	macrophages	macrophage	NOUN
aji-166	250	5	expressing	express	VERB
aji-166	250	6	pro	pro	ADJ
aji-166	250	7	-	-	ADJ
aji-166	250	8	inflammatory	inflammatory	ADJ
aji-166	250	9	cytokines	cytokine	NOUN
aji-166	250	10	(	(	PUNCT
aji-166	250	11	tnf	tnf	PROPN
aji-166	250	12	-	-	PUNCT
aji-166	250	13	α	α	PROPN
aji-166	250	14	,	,	PUNCT
aji-166	250	15	il-6	il-6	NOUN
aji-166	250	16	,	,	PUNCT
aji-166	250	17	and	and	CCONJ
aji-166	250	18	tgf	tgf	PROPN
aji-166	250	19	-	-	PUNCT
aji-166	250	20	β	β	NOUN
aji-166	250	21	)	)	PUNCT
aji-166	250	22	promote	promote	VERB
aji-166	250	23	fibrosis	fibrosis	NOUN
aji-166	250	24	and	and	CCONJ
aji-166	250	25	glomerular	glomerular	ADJ
aji-166	250	26	scarring	scarring	NOUN
aji-166	250	27	(	(	PUNCT
aji-166	250	28	medapalli	medapalli	PROPN
aji-166	250	29	,	,	PUNCT
aji-166	250	30	he	he	PRON
aji-166	250	31	&	&	CCONJ
aji-166	250	32	klotman	klotman	PROPN
aji-166	250	33	,	,	PUNCT
aji-166	250	34	2011	2011	NUM
aji-166	250	35	)	)	PUNCT
aji-166	250	36	.	.	PUNCT
aji-166	251	1	additionally	additionally	ADV
aji-166	251	2	,	,	PUNCT
aji-166	251	3	infected	infect	VERB
aji-166	251	4	macrophages	macrophage	NOUN
aji-166	251	5	release	release	VERB
aji-166	251	6	il-1β	il-1β	ADJ
aji-166	251	7	via	via	ADP
aji-166	251	8	nlrp3	nlrp3	ADJ
aji-166	251	9	inflammasomes	inflammasome	NOUN
aji-166	251	10	,	,	PUNCT
aji-166	251	11	amplifying	amplifying	ADJ
aji-166	251	12	glomerular	glomerular	ADJ
aji-166	251	13	damage	damage	NOUN
aji-166	251	14	(	(	PUNCT
aji-166	251	15	ekabe	ekabe	NOUN
aji-166	251	16	et	et	PROPN
aji-166	251	17	al	al	PROPN
aji-166	251	18	.	.	PROPN
aji-166	251	19	,	,	PUNCT
aji-166	251	20	2021	2021	NUM
aji-166	251	21	)	)	PUNCT
aji-166	251	22	.	.	PUNCT
aji-166	252	1	podocytes	podocyte	NOUN
aji-166	252	2	can	can	AUX
aji-166	252	3	also	also	ADV
aji-166	252	4	be	be	AUX
aji-166	252	5	infected	infect	VERB
aji-166	252	6	,	,	PUNCT
aji-166	252	7	but	but	CCONJ
aji-166	252	8	through	through	ADP
aji-166	252	9	non	non	ADJ
aji-166	252	10	-	-	ADJ
aji-166	252	11	conventional	conventional	ADJ
aji-166	252	12	mechanisms	mechanism	NOUN
aji-166	252	13	(	(	PUNCT
aji-166	252	14	hiv	hiv	NOUN
aji-166	252	15	-	-	PUNCT
aji-166	252	16	receptor	receptor	NOUN
aji-166	252	17	-	-	PUNCT
aji-166	252	18	independent	independent	NOUN
aji-166	252	19	)	)	PUNCT
aji-166	252	20	.	.	PUNCT
aji-166	253	1	one	one	NUM
aji-166	253	2	such	such	ADJ
aji-166	253	3	mechanism	mechanism	NOUN
aji-166	253	4	is	be	AUX
aji-166	253	5	through	through	ADP
aji-166	253	6	virological	virological	ADJ
aji-166	253	7	synapses	synapsis	NOUN
aji-166	253	8	and	and	CCONJ
aji-166	253	9	tunneling	tunneling	NOUN
aji-166	253	10	nanotubes	nanotube	NOUN
aji-166	253	11	between	between	ADP
aji-166	253	12	cd4	cd4	PROPN
aji-166	253	13	+	+	PROPN
aji-166	253	14	t	t	NOUN
aji-166	253	15	cells	cell	NOUN
aji-166	253	16	,	,	PUNCT
aji-166	253	17	macrophages	macrophage	NOUN
aji-166	253	18	,	,	PUNCT
aji-166	253	19	and	and	CCONJ
aji-166	253	20	renal	renal	ADJ
aji-166	253	21	cells	cell	NOUN
aji-166	253	22	.	.	PUNCT
aji-166	254	1	these	these	DET
aji-166	254	2	facilitate	facilitate	NOUN
aji-166	254	3	hiv	hiv	PROPN
aji-166	254	4	spread	spread	VERB
aji-166	254	5	among	among	ADP
aji-166	254	6	these	these	DET
aji-166	254	7	different	different	ADJ
aji-166	254	8	cell	cell	NOUN
aji-166	254	9	types	type	NOUN
aji-166	254	10	(	(	PUNCT
aji-166	254	11	hughes	hughe	NOUN
aji-166	254	12	et	et	PROPN
aji-166	254	13	al	al	PROPN
aji-166	254	14	.	.	PROPN
aji-166	254	15	,	,	PUNCT
aji-166	254	16	2021	2021	NUM
aji-166	254	17	)	)	PUNCT
aji-166	254	18	.	.	PUNCT
aji-166	255	1	infection	infection	NOUN
aji-166	255	2	of	of	ADP
aji-166	255	3	podocytes	podocyte	NOUN
aji-166	255	4	triggers	trigger	VERB
aji-166	255	5	apoptosis	apoptosis	NOUN
aji-166	255	6	,	,	PUNCT
aji-166	255	7	loss	loss	NOUN
aji-166	255	8	of	of	ADP
aji-166	255	9	function	function	NOUN
aji-166	255	10	,	,	PUNCT
aji-166	255	11	and	and	CCONJ
aji-166	255	12	dedifferentiation	dedifferentiation	NOUN
aji-166	255	13	,	,	PUNCT
aji-166	255	14	all	all	PRON
aji-166	255	15	contributing	contribute	VERB
aji-166	255	16	to	to	ADP
aji-166	255	17	glomerular	glomerular	ADJ
aji-166	255	18	damage	damage	NOUN
aji-166	255	19	(	(	PUNCT
aji-166	255	20	hughes	hughe	NOUN
aji-166	255	21	et	et	PROPN
aji-166	255	22	al	al	PROPN
aji-166	255	23	.	.	PROPN
aji-166	255	24	,	,	PUNCT
aji-166	255	25	2021	2021	NUM
aji-166	255	26	)	)	PUNCT
aji-166	255	27	.	.	PUNCT
aji-166	256	1	3.4	3.4	NUM
aji-166	256	2	cancer	cancer	NOUN
aji-166	256	3	while	while	SCONJ
aji-166	256	4	art	art	NOUN
aji-166	256	5	has	have	AUX
aji-166	256	6	reduced	reduce	VERB
aji-166	256	7	the	the	DET
aji-166	256	8	incidence	incidence	NOUN
aji-166	256	9	of	of	ADP
aji-166	256	10	aidsdefining	aidsdefine	VERB
aji-166	256	11	cancers	cancer	NOUN
aji-166	256	12	,	,	PUNCT
aji-166	256	13	plwh	plwh	AUX
aji-166	256	14	still	still	ADV
aji-166	256	15	experience	experience	VERB
aji-166	256	16	an	an	DET
aji-166	256	17	elevated	elevated	ADJ
aji-166	256	18	risk	risk	NOUN
aji-166	256	19	for	for	ADP
aji-166	256	20	certain	certain	ADJ
aji-166	256	21	non	non	ADJ
aji-166	256	22	-	-	ADJ
aji-166	256	23	aids	aids	ADJ
aji-166	256	24	-	-	PUNCT
aji-166	256	25	defining	define	VERB
aji-166	256	26	cancers	cancer	NOUN
aji-166	256	27	due	due	ADJ
aji-166	256	28	to	to	ADP
aji-166	256	29	multiple	multiple	ADJ
aji-166	256	30	mechanisms	mechanism	NOUN
aji-166	256	31	,	,	PUNCT
aji-166	256	32	including	include	VERB
aji-166	256	33	improvements	improvement	NOUN
aji-166	256	34	in	in	ADP
aji-166	256	35	life	life	NOUN
aji-166	256	36	expectancy	expectancy	NOUN
aji-166	256	37	with	with	ADP
aji-166	256	38	art	art	NOUN
aji-166	256	39	,	,	PUNCT
aji-166	256	40	immunosenescence	immunosenescence	NOUN
aji-166	256	41	,	,	PUNCT
aji-166	256	42	and	and	CCONJ
aji-166	256	43	the	the	DET
aji-166	256	44	loss	loss	NOUN
aji-166	256	45	of	of	ADP
aji-166	256	46	control	control	NOUN
aji-166	256	47	over	over	ADP
aji-166	256	48	oncogenic	oncogenic	ADJ
aji-166	256	49	infections	infection	NOUN
aji-166	256	50	due	due	ADP
aji-166	256	51	to	to	ADP
aji-166	256	52	hiv	hiv	PROPN
aji-166	256	53	-	-	PUNCT
aji-166	256	54	related	relate	VERB
aji-166	256	55	immune	immune	ADJ
aji-166	256	56	suppression	suppression	NOUN
aji-166	256	57	.	.	PUNCT
aji-166	257	1	but	but	CCONJ
aji-166	257	2	additionally	additionally	ADV
aji-166	257	3	,	,	PUNCT
aji-166	257	4	macrophagederived	macrophagederive	VERB
aji-166	257	5	chronic	chronic	ADJ
aji-166	257	6	inflammation	inflammation	NOUN
aji-166	257	7	and	and	CCONJ
aji-166	257	8	immune	immune	ADJ
aji-166	257	9	activation	activation	NOUN
aji-166	257	10	create	create	VERB
aji-166	257	11	a	a	DET
aji-166	257	12	microenvironment	microenvironment	NOUN
aji-166	257	13	conducive	conducive	ADJ
aji-166	257	14	to	to	ADP
aji-166	257	15	carcinogenesis	carcinogenesis	NOUN
aji-166	257	16	(	(	PUNCT
aji-166	257	17	grulich	grulich	NOUN
aji-166	257	18	et	et	PROPN
aji-166	257	19	al	al	PROPN
aji-166	257	20	.	.	PROPN
aji-166	257	21	,	,	PUNCT
aji-166	257	22	2007	2007	NUM
aji-166	257	23	)	)	PUNCT
aji-166	257	24	.	.	PUNCT
aji-166	258	1	hodgkin	hodgkin	PROPN
aji-166	258	2	lymphoma	lymphoma	NOUN
aji-166	258	3	and	and	CCONJ
aji-166	258	4	cancers	cancer	NOUN
aji-166	258	5	of	of	ADP
aji-166	258	6	the	the	DET
aji-166	258	7	lung	lung	NOUN
aji-166	258	8	,	,	PUNCT
aji-166	258	9	anus	anus	ADJ
aji-166	258	10	,	,	PUNCT
aji-166	258	11	liver	liver	NOUN
aji-166	258	12	,	,	PUNCT
aji-166	258	13	which	which	PRON
aji-166	258	14	are	be	AUX
aji-166	258	15	non	non	ADJ
aji-166	258	16	-	-	ADJ
aji-166	258	17	aids	aids	ADJ
aji-166	258	18	malignancies	malignancy	NOUN
aji-166	258	19	have	have	AUX
aji-166	258	20	become	become	VERB
aji-166	258	21	more	more	ADV
aji-166	258	22	prevalent	prevalent	ADJ
aji-166	258	23	in	in	ADP
aji-166	258	24	plwh	plwh	PROPN
aji-166	258	25	(	(	PUNCT
aji-166	258	26	wang	wang	PROPN
aji-166	258	27	,	,	PUNCT
aji-166	258	28	silverberg	silverberg	PROPN
aji-166	258	29	&	&	CCONJ
aji-166	258	30	abrams	abrams	PROPN
aji-166	258	31	,	,	PUNCT
aji-166	258	32	2014	2014	NUM
aji-166	258	33	)	)	PUNCT
aji-166	258	34	.	.	PUNCT
aji-166	259	1	while	while	SCONJ
aji-166	259	2	art	art	NOUN
aji-166	259	3	has	have	AUX
aji-166	259	4	significantly	significantly	ADV
aji-166	259	5	reduced	reduce	VERB
aji-166	259	6	the	the	DET
aji-166	259	7	incidence	incidence	NOUN
aji-166	259	8	of	of	ADP
aji-166	259	9	aids	aid	NOUN
aji-166	259	10	-	-	PUNCT
aji-166	259	11	defining	define	VERB
aji-166	259	12	cancers	cancer	NOUN
aji-166	259	13	,	,	PUNCT
aji-166	259	14	plwh	plwh	ADP
aji-166	259	15	still	still	ADV
aji-166	259	16	face	face	VERB
aji-166	259	17	an	an	DET
aji-166	259	18	increased	increase	VERB
aji-166	259	19	risk	risk	NOUN
aji-166	259	20	for	for	ADP
aji-166	259	21	certain	certain	ADJ
aji-166	259	22	non	non	ADJ
aji-166	259	23	-	-	ADJ
aji-166	259	24	aidsdefining	aidsdefine	VERB
aji-166	259	25	cancers	cancer	NOUN
aji-166	259	26	.	.	PUNCT
aji-166	260	1	this	this	DET
aji-166	260	2	heightened	heighten	VERB
aji-166	260	3	risk	risk	NOUN
aji-166	260	4	arises	arise	VERB
aji-166	260	5	from	from	ADP
aji-166	260	6	various	various	ADJ
aji-166	260	7	factors	factor	NOUN
aji-166	260	8	,	,	PUNCT
aji-166	260	9	including	include	VERB
aji-166	260	10	the	the	DET
aji-166	260	11	prolonged	prolong	VERB
aji-166	260	12	life	life	NOUN
aji-166	260	13	expectancy	expectancy	NOUN
aji-166	260	14	associated	associate	VERB
aji-166	260	15	with	with	ADP
aji-166	260	16	art	art	NOUN
aji-166	260	17	,	,	PUNCT
aji-166	260	18	immunosenescence	immunosenescence	NOUN
aji-166	260	19	,	,	PUNCT
aji-166	260	20	and	and	CCONJ
aji-166	260	21	diminished	diminish	VERB
aji-166	260	22	control	control	NOUN
aji-166	260	23	over	over	ADP
aji-166	260	24	oncogenic	oncogenic	ADJ
aji-166	260	25	infections	infection	NOUN
aji-166	260	26	due	due	ADP
aji-166	260	27	to	to	ADP
aji-166	260	28	hiv	hiv	PROPN
aji-166	260	29	-	-	PUNCT
aji-166	260	30	related	relate	VERB
aji-166	260	31	immune	immune	ADJ
aji-166	260	32	suppression	suppression	NOUN
aji-166	260	33	(	(	PUNCT
aji-166	260	34	wang	wang	PROPN
aji-166	260	35	,	,	PUNCT
aji-166	260	36	silverberg	silverberg	PROPN
aji-166	260	37	&	&	CCONJ
aji-166	260	38	abrams	abrams	PROPN
aji-166	260	39	,	,	PUNCT
aji-166	260	40	2014	2014	NUM
aji-166	260	41	)	)	PUNCT
aji-166	260	42	.	.	PUNCT
aji-166	261	1	furthermore	furthermore	ADV
aji-166	261	2	,	,	PUNCT
aji-166	261	3	macrophage	macrophage	NOUN
aji-166	261	4	-	-	PUNCT
aji-166	261	5	driven	drive	VERB
aji-166	261	6	immune	immune	ADJ
aji-166	261	7	dysregulation	dysregulation	NOUN
aji-166	261	8	contributes	contribute	VERB
aji-166	261	9	to	to	ADP
aji-166	261	10	a	a	DET
aji-166	261	11	microenvironment	microenvironment	NOUN
aji-166	261	12	adavba	adavba	NOUN
aji-166	261	13	;	;	PUNCT
aji-166	261	14	asian	asian	PROPN
aji-166	261	15	j.	j.	PROPN
aji-166	261	16	immunol	immunol	PROPN
aji-166	261	17	.	.	PROPN
aji-166	261	18	,	,	PUNCT
aji-166	261	19	vol	vol	NOUN
aji-166	261	20	.	.	PROPN
aji-166	261	21	8	8	NUM
aji-166	261	22	,	,	PUNCT
aji-166	261	23	no	no	INTJ
aji-166	261	24	.	.	NOUN
aji-166	261	25	1	1	NUM
aji-166	261	26	,	,	PUNCT
aji-166	261	27	pp	pp	ADJ
aji-166	261	28	.	.	PUNCT
aji-166	262	1	120	120	NUM
aji-166	262	2	-	-	SYM
aji-166	262	3	133	133	NUM
aji-166	262	4	,	,	PUNCT
aji-166	262	5	2025	2025	NUM
aji-166	262	6	;	;	PUNCT
aji-166	262	7	article	article	NOUN
aji-166	262	8	no.aji.136909	no.aji.136909	PROPN
aji-166	262	9	127	127	NUM
aji-166	262	10	fig	fig	NOUN
aji-166	262	11	.	.	PUNCT
aji-166	263	1	2	2	X
aji-166	263	2	.	.	NUM
aji-166	263	3	mechanisms	mechanism	NOUN
aji-166	263	4	of	of	ADP
aji-166	263	5	hiv	hiv	PROPN
aji-166	263	6	-	-	PUNCT
aji-166	263	7	associated	associate	VERB
aji-166	263	8	nephropathy	nephropathy	NOUN
aji-166	263	9	(	(	PUNCT
aji-166	263	10	hivan	hivan	NOUN
aji-166	263	11	)	)	PUNCT
aji-166	263	12	that	that	PRON
aji-166	263	13	favors	favor	VERB
aji-166	263	14	carcinogenesis	carcinogenesis	NOUN
aji-166	263	15	(	(	PUNCT
aji-166	263	16	grulich	grulich	NOUN
aji-166	263	17	et	et	PROPN
aji-166	263	18	al	al	PROPN
aji-166	263	19	.	.	PROPN
aji-166	263	20	,	,	PUNCT
aji-166	263	21	2007	2007	NUM
aji-166	263	22	)	)	PUNCT
aji-166	263	23	.	.	PUNCT
aji-166	264	1	consequently	consequently	ADV
aji-166	264	2	,	,	PUNCT
aji-166	264	3	non	non	ADJ
aji-166	264	4	-	-	ADJ
aji-166	264	5	aids	aids	ADJ
aji-166	264	6	malignancies	malignancy	NOUN
aji-166	264	7	,	,	PUNCT
aji-166	264	8	such	such	ADJ
aji-166	264	9	as	as	ADP
aji-166	264	10	hodgkin	hodgkin	ADJ
aji-166	264	11	lymphoma	lymphoma	NOUN
aji-166	264	12	and	and	CCONJ
aji-166	264	13	cancers	cancer	NOUN
aji-166	264	14	of	of	ADP
aji-166	264	15	the	the	DET
aji-166	264	16	lung	lung	NOUN
aji-166	264	17	,	,	PUNCT
aji-166	264	18	anus	anus	NOUN
aji-166	264	19	,	,	PUNCT
aji-166	264	20	and	and	CCONJ
aji-166	264	21	liver	liver	NOUN
aji-166	264	22	,	,	PUNCT
aji-166	264	23	have	have	AUX
aji-166	264	24	become	become	VERB
aji-166	264	25	more	more	ADV
aji-166	264	26	prevalent	prevalent	ADJ
aji-166	264	27	among	among	ADP
aji-166	264	28	plwh	plwh	NOUN
aji-166	264	29	(	(	PUNCT
aji-166	264	30	wang	wang	PROPN
aji-166	264	31	,	,	PUNCT
aji-166	264	32	silverberg	silverberg	PROPN
aji-166	264	33	&	&	CCONJ
aji-166	264	34	abrams	abrams	PROPN
aji-166	264	35	,	,	PUNCT
aji-166	264	36	2014	2014	NUM
aji-166	264	37	)	)	PUNCT
aji-166	264	38	.	.	PUNCT
aji-166	265	1	the	the	DET
aji-166	265	2	chronic	chronic	ADJ
aji-166	265	3	inflammatory	inflammatory	ADJ
aji-166	265	4	state	state	NOUN
aji-166	265	5	induced	induce	VERB
aji-166	265	6	by	by	ADP
aji-166	265	7	the	the	DET
aji-166	265	8	increased	increase	VERB
aji-166	265	9	secretion	secretion	NOUN
aji-166	265	10	of	of	ADP
aji-166	265	11	proinflammatory	proinflammatory	ADJ
aji-166	265	12	cytokines	cytokine	NOUN
aji-166	265	13	from	from	ADP
aji-166	265	14	hiv	hiv	PROPN
aji-166	265	15	-	-	PUNCT
aji-166	265	16	infected	infect	VERB
aji-166	265	17	monocytes	monocyte	NOUN
aji-166	265	18	and	and	CCONJ
aji-166	265	19	macrophages	macrophage	NOUN
aji-166	265	20	promotes	promote	VERB
aji-166	265	21	dna	dna	ADJ
aji-166	265	22	damage	damage	NOUN
aji-166	265	23	,	,	PUNCT
aji-166	265	24	inhibits	inhibit	VERB
aji-166	265	25	apoptosis	apoptosis	NOUN
aji-166	265	26	in	in	ADP
aji-166	265	27	malignant	malignant	ADJ
aji-166	265	28	cells	cell	NOUN
aji-166	265	29	,	,	PUNCT
aji-166	265	30	and	and	CCONJ
aji-166	265	31	supports	support	VERB
aji-166	265	32	tumor	tumor	NOUN
aji-166	265	33	cell	cell	NOUN
aji-166	265	34	proliferation	proliferation	NOUN
aji-166	265	35	(	(	PUNCT
aji-166	265	36	grivennikov	grivennikov	PROPN
aji-166	265	37	,	,	PUNCT
aji-166	265	38	greten	greten	PROPN
aji-166	265	39	&	&	CCONJ
aji-166	265	40	karin	karin	PROPN
aji-166	265	41	,	,	PUNCT
aji-166	265	42	2010	2010	NUM
aji-166	265	43	)	)	PUNCT
aji-166	265	44	.	.	PUNCT
aji-166	266	1	for	for	ADP
aji-166	266	2	instance	instance	NOUN
aji-166	266	3	,	,	PUNCT
aji-166	266	4	il-6	il-6	PRON
aji-166	266	5	activates	activate	VERB
aji-166	266	6	jak	jak	PROPN
aji-166	266	7	-	-	PUNCT
aji-166	266	8	stat3	stat3	NOUN
aji-166	266	9	signaling	signal	VERB
aji-166	266	10	in	in	ADP
aji-166	266	11	epithelial	epithelial	ADJ
aji-166	266	12	cells	cell	NOUN
aji-166	266	13	by	by	ADP
aji-166	266	14	binding	bind	VERB
aji-166	266	15	to	to	ADP
aji-166	266	16	its	its	PRON
aji-166	266	17	receptor	receptor	NOUN
aji-166	266	18	(	(	PUNCT
aji-166	266	19	il6r	il6r	NOUN
aji-166	266	20	)	)	PUNCT
aji-166	266	21	.	.	PUNCT
aji-166	267	1	activating	activate	VERB
aji-166	267	2	this	this	DET
aji-166	267	3	signaling	signal	VERB
aji-166	267	4	pathway	pathway	NOUN
aji-166	267	5	leads	lead	VERB
aji-166	267	6	to	to	ADP
aji-166	267	7	downstream	downstream	ADJ
aji-166	267	8	effects	effect	NOUN
aji-166	267	9	on	on	ADP
aji-166	267	10	gene	gene	NOUN
aji-166	267	11	expression	expression	NOUN
aji-166	267	12	and	and	CCONJ
aji-166	267	13	cellular	cellular	ADJ
aji-166	267	14	behavior	behavior	NOUN
aji-166	267	15	,	,	PUNCT
aji-166	267	16	including	include	VERB
aji-166	267	17	driving	drive	VERB
aji-166	267	18	the	the	DET
aji-166	267	19	expression	expression	NOUN
aji-166	267	20	of	of	ADP
aji-166	267	21	genes	gene	NOUN
aji-166	267	22	involved	involve	VERB
aji-166	267	23	in	in	ADP
aji-166	267	24	cell	cell	NOUN
aji-166	267	25	survival	survival	NOUN
aji-166	267	26	,	,	PUNCT
aji-166	267	27	proliferation	proliferation	NOUN
aji-166	267	28	,	,	PUNCT
aji-166	267	29	angiogenesis	angiogenesis	NOUN
aji-166	267	30	,	,	PUNCT
aji-166	267	31	and	and	CCONJ
aji-166	267	32	metastasis	metastasis	NOUN
aji-166	267	33	,	,	PUNCT
aji-166	267	34	ultimately	ultimately	ADV
aji-166	267	35	facilitating	facilitate	VERB
aji-166	267	36	oncogenic	oncogenic	ADJ
aji-166	267	37	transformation	transformation	NOUN
aji-166	267	38	in	in	ADP
aji-166	267	39	certain	certain	ADJ
aji-166	267	40	cells	cell	NOUN
aji-166	267	41	(	(	PUNCT
aji-166	267	42	thuya	thuya	PROPN
aji-166	267	43	et	et	PROPN
aji-166	267	44	al	al	PROPN
aji-166	267	45	.	.	PROPN
aji-166	267	46	,	,	PUNCT
aji-166	267	47	2025	2025	NUM
aji-166	267	48	)	)	PUNCT
aji-166	267	49	.	.	PUNCT
aji-166	268	1	secondly	secondly	ADV
aji-166	268	2	,	,	PUNCT
aji-166	268	3	hiv	hiv	PROPN
aji-166	268	4	alters	alter	VERB
aji-166	268	5	macrophage	macrophage	ADJ
aji-166	268	6	polarization	polarization	NOUN
aji-166	268	7	,	,	PUNCT
aji-166	268	8	steering	steer	VERB
aji-166	268	9	them	they	PRON
aji-166	268	10	toward	toward	ADP
aji-166	268	11	a	a	DET
aji-166	268	12	pro	pro	ADJ
aji-166	268	13	-	-	ADJ
aji-166	268	14	tumor	tumor	ADJ
aji-166	268	15	m2	m2	NOUN
aji-166	268	16	-	-	PUNCT
aji-166	268	17	like	like	ADJ
aji-166	268	18	phenotype	phenotype	NOUN
aji-166	268	19	,	,	PUNCT
aji-166	268	20	characterized	characterize	VERB
aji-166	268	21	by	by	ADP
aji-166	268	22	increased	increase	VERB
aji-166	268	23	pd	pd	PROPN
aji-166	268	24	-	-	PUNCT
aji-166	268	25	l1	l1	PROPN
aji-166	268	26	,	,	PUNCT
aji-166	268	27	il-10	il-10	PRON
aji-166	268	28	,	,	PUNCT
aji-166	268	29	and	and	CCONJ
aji-166	268	30	tgf	tgf	PROPN
aji-166	268	31	-	-	PUNCT
aji-166	268	32	β	β	NOUN
aji-166	268	33	expression	expression	NOUN
aji-166	268	34	.	.	PUNCT
aji-166	269	1	these	these	DET
aji-166	269	2	factors	factor	NOUN
aji-166	269	3	suppress	suppress	VERB
aji-166	269	4	the	the	DET
aji-166	269	5	cytotoxic	cytotoxic	ADJ
aji-166	269	6	t	t	NOUN
aji-166	269	7	-	-	PUNCT
aji-166	269	8	cell	cell	NOUN
aji-166	269	9	responses	response	NOUN
aji-166	269	10	and	and	CCONJ
aji-166	269	11	encourage	encourage	VERB
aji-166	269	12	the	the	DET
aji-166	269	13	expansion	expansion	NOUN
aji-166	269	14	of	of	ADP
aji-166	269	15	regulatory	regulatory	ADJ
aji-166	269	16	t	t	PROPN
aji-166	269	17	-	-	PUNCT
aji-166	269	18	cells	cell	NOUN
aji-166	269	19	(	(	PUNCT
aji-166	269	20	tregs	treg	NOUN
aji-166	269	21	)	)	PUNCT
aji-166	269	22	,	,	PUNCT
aji-166	269	23	which	which	PRON
aji-166	269	24	favors	favor	VERB
aji-166	269	25	immune	immune	ADJ
aji-166	269	26	escape	escape	NOUN
aji-166	269	27	by	by	ADP
aji-166	269	28	tumours	tumours	PROPN
aji-166	269	29	(	(	PUNCT
aji-166	269	30	li	li	PROPN
aji-166	269	31	et	et	PROPN
aji-166	269	32	al	al	PROPN
aji-166	269	33	.	.	PROPN
aji-166	269	34	,	,	PUNCT
aji-166	269	35	2024	2024	NUM
aji-166	269	36	)	)	PUNCT
aji-166	269	37	.	.	PUNCT
aji-166	270	1	furthermore	furthermore	ADV
aji-166	270	2	,	,	PUNCT
aji-166	270	3	chronic	chronic	ADJ
aji-166	270	4	hiv	hiv	PROPN
aji-166	270	5	activation	activation	NOUN
aji-166	270	6	boosts	boost	VERB
aji-166	270	7	the	the	DET
aji-166	270	8	population	population	NOUN
aji-166	270	9	of	of	ADP
aji-166	270	10	monocyte	monocyte	NOUN
aji-166	270	11	-	-	PUNCT
aji-166	270	12	derived	derive	VERB
aji-166	270	13	myeloid	myeloid	NOUN
aji-166	270	14	-	-	PUNCT
aji-166	270	15	derived	derive	VERB
aji-166	270	16	suppressor	suppressor	NOUN
aji-166	270	17	cells	cell	NOUN
aji-166	270	18	(	(	PUNCT
aji-166	270	19	mdscs	mdsc	NOUN
aji-166	270	20	)	)	PUNCT
aji-166	270	21	,	,	PUNCT
aji-166	270	22	which	which	PRON
aji-166	270	23	impede	impede	VERB
aji-166	270	24	the	the	DET
aji-166	270	25	functions	function	NOUN
aji-166	270	26	of	of	ADP
aji-166	270	27	nk	nk	PROPN
aji-166	270	28	and	and	CCONJ
aji-166	270	29	cd8	cd8	PROPN
aji-166	270	30	+	+	PROPN
aji-166	270	31	t	t	PROPN
aji-166	270	32	-	-	PUNCT
aji-166	270	33	cells	cell	NOUN
aji-166	270	34	.	.	PUNCT
aji-166	271	1	mdscs	mdsc	NOUN
aji-166	271	2	are	be	AUX
aji-166	271	3	linked	link	VERB
aji-166	271	4	to	to	ADP
aji-166	271	5	aggressive	aggressive	ADJ
aji-166	271	6	tumor	tumor	NOUN
aji-166	271	7	growth	growth	NOUN
aji-166	271	8	and	and	CCONJ
aji-166	271	9	poorer	poor	ADJ
aji-166	271	10	outcomes	outcome	NOUN
aji-166	271	11	in	in	ADP
aji-166	271	12	hiv	hiv	PROPN
aji-166	271	13	-	-	PUNCT
aji-166	271	14	related	relate	VERB
aji-166	271	15	cancers	cancer	NOUN
aji-166	271	16	(	(	PUNCT
aji-166	271	17	tumino	tumino	PROPN
aji-166	271	18	et	et	PROPN
aji-166	271	19	al	al	PROPN
aji-166	271	20	.	.	PROPN
aji-166	271	21	,	,	PUNCT
aji-166	271	22	2022	2022	NUM
aji-166	271	23	)	)	PUNCT
aji-166	271	24	.	.	PUNCT
aji-166	272	1	moreover	moreover	ADV
aji-166	272	2	,	,	PUNCT
aji-166	272	3	metabolic	metabolic	NOUN
aji-166	272	4	reprogramming	reprogramme	VERB
aji-166	272	5	within	within	ADP
aji-166	272	6	the	the	DET
aji-166	272	7	tumor	tumor	NOUN
aji-166	272	8	microenvironment	microenvironment	NOUN
aji-166	272	9	—	—	PUNCT
aji-166	272	10	exemplified	exemplify	VERB
aji-166	272	11	by	by	ADP
aji-166	272	12	increased	increase	VERB
aji-166	272	13	glycolysis	glycolysis	NOUN
aji-166	272	14	in	in	ADP
aji-166	272	15	hiv	hiv	PROPN
aji-166	272	16	-	-	PUNCT
aji-166	272	17	infected	infect	VERB
aji-166	272	18	monocytes	monocyte	NOUN
aji-166	272	19	and	and	CCONJ
aji-166	272	20	macrophages	macrophage	NOUN
aji-166	272	21	—	—	PUNCT
aji-166	272	22	results	result	NOUN
aji-166	272	23	in	in	ADP
aji-166	272	24	the	the	DET
aji-166	272	25	production	production	NOUN
aji-166	272	26	of	of	ADP
aji-166	272	27	lactate	lactate	NOUN
aji-166	272	28	.	.	PUNCT
aji-166	273	1	the	the	DET
aji-166	273	2	lactate	lactate	NOUN
aji-166	273	3	acidifies	acidify	VERB
aji-166	273	4	the	the	DET
aji-166	273	5	tumor	tumor	NOUN
aji-166	273	6	environment	environment	NOUN
aji-166	273	7	,	,	PUNCT
aji-166	273	8	suppresses	suppress	VERB
aji-166	273	9	antitumor	antitumor	PROPN
aji-166	273	10	immunity	immunity	NOUN
aji-166	273	11	,	,	PUNCT
aji-166	273	12	and	and	CCONJ
aji-166	273	13	promotes	promote	VERB
aji-166	273	14	metastasis	metastasis	NOUN
aji-166	273	15	.	.	PUNCT
aji-166	274	1	additionally	additionally	ADV
aji-166	274	2	,	,	PUNCT
aji-166	274	3	the	the	DET
aji-166	274	4	elevated	elevated	ADJ
aji-166	274	5	production	production	NOUN
aji-166	274	6	of	of	ADP
aji-166	274	7	ros	ros	PROPN
aji-166	274	8	from	from	ADP
aji-166	274	9	dysfunctional	dysfunctional	ADJ
aji-166	274	10	mitochondria	mitochondria	NOUN
aji-166	274	11	in	in	ADP
aji-166	274	12	these	these	DET
aji-166	274	13	hiv	hiv	PROPN
aji-166	274	14	-	-	PUNCT
aji-166	274	15	infected	infect	VERB
aji-166	274	16	cells	cell	NOUN
aji-166	274	17	causes	cause	VERB
aji-166	274	18	dna	dna	ADJ
aji-166	274	19	damage	damage	NOUN
aji-166	274	20	in	in	ADP
aji-166	274	21	adjacent	adjacent	ADJ
aji-166	274	22	cells	cell	NOUN
aji-166	274	23	.	.	PUNCT
aji-166	275	1	this	this	DET
aji-166	275	2	damage	damage	NOUN
aji-166	275	3	affects	affect	VERB
aji-166	275	4	oncogenes	oncogene	NOUN
aji-166	275	5	and	and	CCONJ
aji-166	275	6	tumor	tumor	NOUN
aji-166	275	7	suppressor	suppressor	NOUN
aji-166	275	8	genes	gene	NOUN
aji-166	275	9	,	,	PUNCT
aji-166	275	10	thereby	thereby	ADV
aji-166	275	11	increasing	increase	VERB
aji-166	275	12	the	the	DET
aji-166	275	13	risk	risk	NOUN
aji-166	275	14	of	of	ADP
aji-166	275	15	carcinogenesis	carcinogenesis	NOUN
aji-166	275	16	(	(	PUNCT
aji-166	275	17	zhou	zhou	X
aji-166	275	18	et	et	PROPN
aji-166	275	19	al	al	PROPN
aji-166	275	20	.	.	PROPN
aji-166	275	21	,	,	PUNCT
aji-166	275	22	2022	2022	NUM
aji-166	275	23	)	)	PUNCT
aji-166	275	24	.	.	PUNCT
aji-166	276	1	4	4	X
aji-166	276	2	.	.	X
aji-166	276	3	therapeutic	therapeutic	ADJ
aji-166	276	4	implications	implication	NOUN
aji-166	276	5	given	give	VERB
aji-166	276	6	the	the	DET
aji-166	276	7	substantial	substantial	ADJ
aji-166	276	8	evidence	evidence	NOUN
aji-166	276	9	highlighting	highlight	VERB
aji-166	276	10	the	the	DET
aji-166	276	11	crucial	crucial	ADJ
aji-166	276	12	involvement	involvement	NOUN
aji-166	276	13	of	of	ADP
aji-166	276	14	monocytes	monocyte	NOUN
aji-166	276	15	and	and	CCONJ
aji-166	276	16	macrophages	macrophage	NOUN
aji-166	276	17	in	in	ADP
aji-166	276	18	the	the	DET
aji-166	276	19	development	development	NOUN
aji-166	276	20	of	of	ADP
aji-166	276	21	nades	nade	NOUN
aji-166	276	22	,	,	PUNCT
aji-166	276	23	targeting	target	VERB
aji-166	276	24	the	the	DET
aji-166	276	25	mechanisms	mechanism	NOUN
aji-166	276	26	by	by	ADP
aji-166	276	27	which	which	PRON
aji-166	276	28	these	these	DET
aji-166	276	29	cells	cell	NOUN
aji-166	276	30	contribute	contribute	VERB
aji-166	276	31	to	to	ADP
aji-166	276	32	these	these	DET
aji-166	276	33	pathologies	pathology	NOUN
aji-166	276	34	presents	present	VERB
aji-166	276	35	a	a	DET
aji-166	276	36	promising	promising	ADJ
aji-166	276	37	strategy	strategy	NOUN
aji-166	276	38	for	for	ADP
aji-166	276	39	alleviating	alleviate	VERB
aji-166	276	40	chronic	chronic	ADJ
aji-166	276	41	inflammation	inflammation	NOUN
aji-166	276	42	and	and	CCONJ
aji-166	276	43	enhancing	enhance	VERB
aji-166	276	44	clinical	clinical	ADJ
aji-166	276	45	outcomes	outcome	NOUN
aji-166	276	46	in	in	ADP
aji-166	276	47	plwh	plwh	NOUN
aji-166	276	48	in	in	ADP
aji-166	276	49	the	the	DET
aji-166	276	50	era	era	NOUN
aji-166	276	51	of	of	ADP
aji-166	276	52	viral	viral	ADJ
aji-166	276	53	suppression	suppression	NOUN
aji-166	276	54	.	.	PUNCT
aji-166	277	1	nonspecific	nonspecific	ADJ
aji-166	277	2	,	,	PUNCT
aji-166	277	3	potential	potential	ADJ
aji-166	277	4	therapeutic	therapeutic	ADJ
aji-166	277	5	approaches	approach	NOUN
aji-166	277	6	include	include	VERB
aji-166	277	7	:	:	PUNCT
aji-166	277	8	adavba	adavba	PROPN
aji-166	277	9	;	;	PUNCT
aji-166	277	10	asian	asian	PROPN
aji-166	277	11	j.	j.	PROPN
aji-166	277	12	immunol	immunol	PROPN
aji-166	277	13	.	.	PROPN
aji-166	277	14	,	,	PUNCT
aji-166	277	15	vol	vol	NOUN
aji-166	277	16	.	.	PROPN
aji-166	277	17	8	8	NUM
aji-166	277	18	,	,	PUNCT
aji-166	277	19	no	no	INTJ
aji-166	277	20	.	.	NOUN
aji-166	277	21	1	1	NUM
aji-166	277	22	,	,	PUNCT
aji-166	277	23	pp	pp	ADJ
aji-166	277	24	.	.	PUNCT
aji-166	278	1	120	120	NUM
aji-166	278	2	-	-	SYM
aji-166	278	3	133	133	NUM
aji-166	278	4	,	,	PUNCT
aji-166	278	5	2025	2025	NUM
aji-166	278	6	;	;	PUNCT
aji-166	278	7	article	article	NOUN
aji-166	278	8	no.aji.136909	no.aji.136909	NOUN
aji-166	278	9	128	128	NUM
aji-166	278	10	fig	fig	NOUN
aji-166	278	11	.	.	PUNCT
aji-166	279	1	3	3	X
aji-166	279	2	.	.	X
aji-166	279	3	conceptual	conceptual	ADJ
aji-166	279	4	basis	basis	NOUN
aji-166	279	5	for	for	ADP
aji-166	279	6	employing	employ	VERB
aji-166	279	7	reservoir	reservoir	NOUN
aji-166	279	8	targeting	targeting	NOUN
aji-166	279	9	strategies	strategy	NOUN
aji-166	279	10	table	table	NOUN
aji-166	279	11	1	1	NUM
aji-166	279	12	.	.	PUNCT
aji-166	279	13	plausible	plausible	ADJ
aji-166	279	14	mechanisms	mechanism	NOUN
aji-166	279	15	of	of	ADP
aji-166	279	16	amelioration	amelioration	NOUN
aji-166	279	17	of	of	ADP
aji-166	279	18	nades	nade	NOUN
aji-166	279	19	following	follow	VERB
aji-166	279	20	successful	successful	ADJ
aji-166	279	21	reservoir	reservoir	NOUN
aji-166	279	22	reduction	reduction	NOUN
aji-166	279	23	/	/	SYM
aji-166	279	24	elimination	elimination	NOUN
aji-166	279	25	nade	nade	NOUN
aji-166	279	26	mechanism	mechanism	NOUN
aji-166	279	27	of	of	ADP
aji-166	279	28	amelioration	amelioration	NOUN
aji-166	279	29	neurocognitive	neurocognitive	ADJ
aji-166	279	30	(	(	PUNCT
aji-166	279	31	hand	hand	NOUN
aji-166	279	32	)	)	PUNCT
aji-166	279	33	↓	↓	PROPN
aji-166	279	34	hiv	hiv	PROPN
aji-166	279	35	-	-	PUNCT
aji-166	279	36	infected	infect	VERB
aji-166	279	37	microglia	microglia	NOUN
aji-166	279	38	,	,	PUNCT
aji-166	279	39	↓	↓	PROPN
aji-166	279	40	neuroinflammation	neuroinflammation	NOUN
aji-166	279	41	cardiovascular	cardiovascular	ADJ
aji-166	279	42	↓	↓	PROPN
aji-166	279	43	il-6	il-6	SYM
aji-166	279	44	/	/	SYM
aji-166	279	45	tnf	tnf	PROPN
aji-166	279	46	-	-	PUNCT
aji-166	279	47	α	α	PROPN
aji-166	279	48	→	→	SYM
aji-166	279	49	↓	↓	NOUN
aji-166	279	50	endothelial	endothelial	ADJ
aji-166	279	51	dysfunction	dysfunction	NOUN
aji-166	279	52	liver	liver	NOUN
aji-166	279	53	/	/	SYM
aji-166	279	54	kidney	kidney	NOUN
aji-166	279	55	fibrosis	fibrosis	NOUN
aji-166	279	56	↓	↓	PROPN
aji-166	279	57	tgf	tgf	PROPN
aji-166	279	58	-	-	PUNCT
aji-166	279	59	β	β	PROPN
aji-166	279	60	→	→	SYM
aji-166	279	61	↓	↓	NOUN
aji-166	279	62	collagen	collagen	PROPN
aji-166	279	63	deposition	deposition	NOUN
aji-166	279	64	4.1	4.1	NUM
aji-166	279	65	reservoir	reservoir	NOUN
aji-166	279	66	-	-	PUNCT
aji-166	279	67	targeting	target	VERB
aji-166	279	68	strategies	strategy	NOUN
aji-166	279	69	the	the	DET
aji-166	279	70	persistence	persistence	NOUN
aji-166	279	71	of	of	ADP
aji-166	279	72	latent	latent	NOUN
aji-166	279	73	or	or	CCONJ
aji-166	279	74	transcriptionally	transcriptionally	ADV
aji-166	279	75	active	active	ADJ
aji-166	279	76	viruses	virus	NOUN
aji-166	279	77	in	in	ADP
aji-166	279	78	myeloid	myeloid	ADJ
aji-166	279	79	cells	cell	NOUN
aji-166	279	80	despite	despite	SCONJ
aji-166	279	81	art	art	NOUN
aji-166	279	82	remains	remain	VERB
aji-166	279	83	a	a	DET
aji-166	279	84	major	major	ADJ
aji-166	279	85	barrier	barrier	NOUN
aji-166	279	86	to	to	PART
aji-166	279	87	cure	cure	VERB
aji-166	279	88	efforts	effort	NOUN
aji-166	279	89	and	and	CCONJ
aji-166	279	90	a	a	DET
aji-166	279	91	major	major	ADJ
aji-166	279	92	contributor	contributor	NOUN
aji-166	279	93	to	to	ADP
aji-166	279	94	the	the	DET
aji-166	279	95	chronic	chronic	ADJ
aji-166	279	96	immune	immune	ADJ
aji-166	279	97	dysfunction	dysfunction	NOUN
aji-166	279	98	underlying	underlie	VERB
aji-166	279	99	the	the	DET
aji-166	279	100	development	development	NOUN
aji-166	279	101	of	of	ADP
aji-166	279	102	nades	nade	NOUN
aji-166	279	103	.	.	PUNCT
aji-166	280	1	reservoir	reservoir	NOUN
aji-166	280	2	-	-	PUNCT
aji-166	280	3	targeting	target	VERB
aji-166	280	4	strategies	strategy	NOUN
aji-166	280	5	aim	aim	VERB
aji-166	280	6	to	to	PART
aji-166	280	7	eliminate	eliminate	VERB
aji-166	280	8	persistent	persistent	ADJ
aji-166	280	9	hiv	hiv	NOUN
aji-166	280	10	and	and	CCONJ
aji-166	280	11	reduce	reduce	VERB
aji-166	280	12	chronic	chronic	ADJ
aji-166	280	13	inflammation	inflammation	NOUN
aji-166	280	14	,	,	PUNCT
aji-166	280	15	directly	directly	ADV
aji-166	280	16	addressing	address	VERB
aji-166	280	17	the	the	DET
aji-166	280	18	root	root	NOUN
aji-166	280	19	cause	cause	NOUN
aji-166	280	20	of	of	ADP
aji-166	280	21	nades	nade	NOUN
aji-166	280	22	.	.	PUNCT
aji-166	281	1	while	while	SCONJ
aji-166	281	2	challenges	challenge	NOUN
aji-166	281	3	remain	remain	VERB
aji-166	281	4	(	(	PUNCT
aji-166	281	5	e.g.	e.g.	ADV
aji-166	281	6	,	,	PUNCT
aji-166	281	7	myeloid	myeloid	ADJ
aji-166	281	8	reservoir	reservoir	NOUN
aji-166	281	9	penetration	penetration	NOUN
aji-166	281	10	(	(	PUNCT
aji-166	281	11	chun	chun	PROPN
aji-166	281	12	,	,	PUNCT
aji-166	281	13	moir	moir	PROPN
aji-166	281	14	&	&	CCONJ
aji-166	281	15	fauci	fauci	PROPN
aji-166	281	16	,	,	PUNCT
aji-166	281	17	2015	2015	NUM
aji-166	281	18	)	)	PUNCT
aji-166	281	19	)	)	PUNCT
aji-166	281	20	,	,	PUNCT
aji-166	281	21	combined	combine	VERB
aji-166	281	22	approaches	approach	NOUN
aji-166	281	23	promise	promise	VERB
aji-166	281	24	to	to	PART
aji-166	281	25	improve	improve	VERB
aji-166	281	26	long	long	ADJ
aji-166	281	27	-	-	PUNCT
aji-166	281	28	term	term	NOUN
aji-166	281	29	outcomes	outcome	NOUN
aji-166	281	30	for	for	ADP
aji-166	281	31	plwh	plwh	NOUN
aji-166	281	32	.	.	PUNCT
aji-166	282	1	eliminating	eliminate	VERB
aji-166	282	2	hiv	hiv	PROPN
aji-166	282	3	reservoirs	reservoir	NOUN
aji-166	282	4	in	in	ADP
aji-166	282	5	monocytes	monocyte	NOUN
aji-166	282	6	and	and	CCONJ
aji-166	282	7	macrophages	macrophage	NOUN
aji-166	282	8	is	be	AUX
aji-166	282	9	critical	critical	ADJ
aji-166	282	10	for	for	ADP
aji-166	282	11	achieving	achieve	VERB
aji-166	282	12	a	a	DET
aji-166	282	13	cure	cure	NOUN
aji-166	282	14	and	and	CCONJ
aji-166	282	15	lowering	lower	VERB
aji-166	282	16	the	the	DET
aji-166	282	17	risk	risk	NOUN
aji-166	282	18	of	of	ADP
aji-166	282	19	nades	nade	NOUN
aji-166	282	20	.	.	PUNCT
aji-166	283	1	recent	recent	ADJ
aji-166	283	2	research	research	NOUN
aji-166	283	3	provides	provide	VERB
aji-166	283	4	evidence	evidence	NOUN
aji-166	283	5	supporting	support	VERB
aji-166	283	6	strategies	strategy	NOUN
aji-166	283	7	to	to	PART
aji-166	283	8	target	target	VERB
aji-166	283	9	these	these	DET
aji-166	283	10	reservoirs	reservoir	NOUN
aji-166	283	11	by	by	ADP
aji-166	283	12	employing	employ	VERB
aji-166	283	13	latency	latency	NOUN
aji-166	283	14	-	-	PUNCT
aji-166	283	15	reversing	reverse	VERB
aji-166	283	16	agents	agent	NOUN
aji-166	283	17	such	such	ADJ
aji-166	283	18	as	as	ADP
aji-166	283	19	tlr	tlr	PROPN
aji-166	283	20	agonists	agonist	NOUN
aji-166	283	21	(	(	PUNCT
aji-166	283	22	li	li	PROPN
aji-166	283	23	et	et	PROPN
aji-166	283	24	al	al	PROPN
aji-166	283	25	.	.	PROPN
aji-166	283	26	,	,	PUNCT
aji-166	283	27	2023	2023	NUM
aji-166	283	28	)	)	PUNCT
aji-166	283	29	and	and	CCONJ
aji-166	283	30	gene	gene	NOUN
aji-166	283	31	-	-	PUNCT
aji-166	283	32	editing	edit	VERB
aji-166	283	33	technologies	technology	NOUN
aji-166	283	34	using	use	VERB
aji-166	283	35	crispr	crispr	NOUN
aji-166	283	36	to	to	PART
aji-166	283	37	excise	excise	VERB
aji-166	283	38	hiv	hiv	PROPN
aji-166	283	39	dna	dna	PROPN
aji-166	283	40	from	from	ADP
aji-166	283	41	infected	infect	VERB
aji-166	283	42	macrophages	macrophage	NOUN
aji-166	283	43	(	(	PUNCT
aji-166	283	44	das	das	PROPN
aji-166	283	45	et	et	PROPN
aji-166	283	46	al	al	PROPN
aji-166	283	47	.	.	PROPN
aji-166	283	48	,	,	PUNCT
aji-166	283	49	2019	2019	NUM
aji-166	283	50	)	)	PUNCT
aji-166	283	51	.	.	PUNCT
aji-166	284	1	the	the	DET
aji-166	284	2	ultimate	ultimate	ADJ
aji-166	284	3	aim	aim	NOUN
aji-166	284	4	is	be	AUX
aji-166	284	5	to	to	PART
aji-166	284	6	reduce	reduce	VERB
aji-166	284	7	reservoir	reservoir	NOUN
aji-166	284	8	load	load	NOUN
aji-166	284	9	,	,	PUNCT
aji-166	284	10	lower	low	ADJ
aji-166	284	11	immune	immune	ADJ
aji-166	284	12	activation	activation	NOUN
aji-166	284	13	and	and	CCONJ
aji-166	284	14	inflammation	inflammation	NOUN
aji-166	284	15	,	,	PUNCT
aji-166	284	16	and	and	CCONJ
aji-166	284	17	decrease	decrease	VERB
aji-166	284	18	the	the	DET
aji-166	284	19	incidence	incidence	NOUN
aji-166	284	20	of	of	ADP
aji-166	284	21	nades	nade	NOUN
aji-166	284	22	.	.	PUNCT
aji-166	285	1	4.2	4.2	NUM
aji-166	285	2	anti	anti	ADJ
aji-166	285	3	-	-	ADJ
aji-166	285	4	inflammatory	inflammatory	ADJ
aji-166	285	5	therapies	therapy	NOUN
aji-166	285	6	agents	agent	NOUN
aji-166	285	7	that	that	PRON
aji-166	285	8	modulate	modulate	VERB
aji-166	285	9	the	the	DET
aji-166	285	10	activation	activation	NOUN
aji-166	285	11	of	of	ADP
aji-166	285	12	monocytes	monocyte	NOUN
aji-166	285	13	and	and	CCONJ
aji-166	285	14	macrophages	macrophage	NOUN
aji-166	285	15	,	,	PUNCT
aji-166	285	16	such	such	ADJ
aji-166	285	17	as	as	ADP
aji-166	285	18	statins	statin	NOUN
aji-166	285	19	,	,	PUNCT
aji-166	285	20	aspirin	aspirin	NOUN
aji-166	285	21	,	,	PUNCT
aji-166	285	22	and	and	CCONJ
aji-166	285	23	cytokine	cytokine	VERB
aji-166	285	24	inhibitors	inhibitor	NOUN
aji-166	285	25	(	(	PUNCT
aji-166	285	26	e.g.	e.g.	ADV
aji-166	285	27	,	,	PUNCT
aji-166	285	28	il-6	il-6	NUM
aji-166	285	29	and	and	CCONJ
aji-166	285	30	tnf	tnf	PROPN
aji-166	285	31	-	-	PUNCT
aji-166	285	32	α	α	NUM
aji-166	285	33	blockers	blocker	NOUN
aji-166	285	34	)	)	PUNCT
aji-166	285	35	,	,	PUNCT
aji-166	285	36	may	may	AUX
aji-166	285	37	help	help	VERB
aji-166	285	38	reduce	reduce	VERB
aji-166	285	39	inflammation	inflammation	NOUN
aji-166	285	40	and	and	CCONJ
aji-166	285	41	lower	low	ADJ
aji-166	285	42	the	the	DET
aji-166	285	43	risk	risk	NOUN
aji-166	285	44	of	of	ADP
aji-166	285	45	nades	nade	NOUN
aji-166	285	46	.	.	PUNCT
aji-166	286	1	specifically	specifically	ADV
aji-166	286	2	,	,	PUNCT
aji-166	286	3	statins	statin	NOUN
aji-166	286	4	can	can	AUX
aji-166	286	5	influence	influence	VERB
aji-166	286	6	vascular	vascular	ADJ
aji-166	286	7	atherosclerotic	atherosclerotic	ADJ
aji-166	286	8	inflammation	inflammation	NOUN
aji-166	286	9	by	by	ADP
aji-166	286	10	directly	directly	ADV
aji-166	286	11	enhancing	enhance	VERB
aji-166	286	12	the	the	DET
aji-166	286	13	function	function	NOUN
aji-166	286	14	of	of	ADP
aji-166	286	15	endothelial	endothelial	ADJ
aji-166	286	16	cells	cell	NOUN
aji-166	286	17	,	,	PUNCT
aji-166	286	18	vascular	vascular	ADJ
aji-166	286	19	smooth	smooth	ADJ
aji-166	286	20	muscle	muscle	NOUN
aji-166	286	21	cells	cell	NOUN
aji-166	286	22	,	,	PUNCT
aji-166	286	23	platelets	platelet	NOUN
aji-166	286	24	,	,	PUNCT
aji-166	286	25	and	and	CCONJ
aji-166	286	26	immune	immune	ADJ
aji-166	286	27	cells	cell	NOUN
aji-166	286	28	.	.	PUNCT
aji-166	287	1	additionally	additionally	ADV
aji-166	287	2	,	,	PUNCT
aji-166	287	3	rosiglitazone	rosiglitazone	NOUN
aji-166	287	4	,	,	PUNCT
aji-166	287	5	a	a	DET
aji-166	287	6	ppar	ppar	NOUN
aji-166	287	7	-	-	PUNCT
aji-166	287	8	gamma	gamma	NOUN
aji-166	287	9	agonist	agonist	NOUN
aji-166	287	10	,	,	PUNCT
aji-166	287	11	has	have	AUX
aji-166	287	12	demonstrated	demonstrate	VERB
aji-166	287	13	potential	potential	NOUN
aji-166	287	14	in	in	ADP
aji-166	287	15	halting	halt	VERB
aji-166	287	16	brain	brain	NOUN
aji-166	287	17	inflammation	inflammation	NOUN
aji-166	287	18	and	and	CCONJ
aji-166	287	19	inhibiting	inhibit	VERB
aji-166	287	20	hiv	hiv	PROPN
aji-166	287	21	replication	replication	NOUN
aji-166	287	22	in	in	ADP
aji-166	287	23	murine	murine	ADJ
aji-166	287	24	models	model	NOUN
aji-166	287	25	of	of	ADP
aji-166	287	26	hiv	hiv	PROPN
aji-166	287	27	encephalitis	encephalitis	NOUN
aji-166	287	28	.	.	PUNCT
aji-166	288	1	4.3	4.3	NUM
aji-166	288	2	restoring	restore	VERB
aji-166	288	3	immune	immune	ADJ
aji-166	288	4	homeostasis	homeostasis	NOUN
aji-166	288	5	interventions	intervention	NOUN
aji-166	288	6	designed	design	VERB
aji-166	288	7	to	to	PART
aji-166	288	8	restore	restore	VERB
aji-166	288	9	the	the	DET
aji-166	288	10	functional	functional	ADJ
aji-166	288	11	properties	property	NOUN
aji-166	288	12	of	of	ADP
aji-166	288	13	monocytes	monocyte	NOUN
aji-166	288	14	and	and	CCONJ
aji-166	288	15	macrophages	macrophage	NOUN
aji-166	288	16	,	,	PUNCT
aji-166	288	17	such	such	ADJ
aji-166	288	18	as	as	ADP
aji-166	288	19	enhancing	enhance	VERB
aji-166	288	20	phagocytosis	phagocytosis	NOUN
aji-166	288	21	and	and	CCONJ
aji-166	288	22	promoting	promote	VERB
aji-166	288	23	antiinflammatory	antiinflammatory	NOUN
aji-166	288	24	phenotypes	phenotype	NOUN
aji-166	288	25	,	,	PUNCT
aji-166	288	26	may	may	AUX
aji-166	288	27	contribute	contribute	VERB
aji-166	288	28	to	to	ADP
aji-166	288	29	mitigating	mitigate	VERB
aji-166	288	30	tissue	tissue	NOUN
aji-166	288	31	damage	damage	NOUN
aji-166	288	32	and	and	CCONJ
aji-166	288	33	improving	improve	VERB
aji-166	288	34	overall	overall	ADJ
aji-166	288	35	outcomes	outcome	NOUN
aji-166	288	36	.	.	PUNCT
aji-166	289	1	in	in	ADP
aji-166	289	2	particular	particular	ADJ
aji-166	289	3	,	,	PUNCT
aji-166	289	4	modulating	modulate	VERB
aji-166	289	5	macrophage	macrophage	ADJ
aji-166	289	6	function	function	NOUN
aji-166	289	7	by	by	ADP
aji-166	289	8	shifting	shift	VERB
aji-166	289	9	polarization	polarization	NOUN
aji-166	289	10	from	from	ADP
aji-166	289	11	proinflammatory	proinflammatory	ADJ
aji-166	289	12	m1	m1	NOUN
aji-166	289	13	to	to	ADP
aji-166	289	14	anti	anti	ADJ
aji-166	289	15	-	-	ADJ
aji-166	289	16	inflammatory	inflammatory	ADJ
aji-166	289	17	m2	m2	PROPN
aji-166	289	18	(	(	PUNCT
aji-166	289	19	and	and	CCONJ
aji-166	289	20	vice	vice	ADV
aji-166	289	21	versa	versa	ADV
aji-166	289	22	)	)	PUNCT
aji-166	289	23	could	could	AUX
aji-166	289	24	have	have	VERB
aji-166	289	25	significant	significant	ADJ
aji-166	289	26	implications	implication	NOUN
aji-166	289	27	for	for	ADP
aji-166	289	28	hiv	hiv	PROPN
aji-166	289	29	pathogenesis	pathogenesis	NOUN
aji-166	289	30	and	and	CCONJ
aji-166	289	31	the	the	DET
aji-166	289	32	development	development	NOUN
aji-166	289	33	of	of	ADP
aji-166	289	34	nonantibody	nonantibody	ADJ
aji-166	289	35	-	-	PUNCT
aji-166	289	36	dependent	dependent	ADJ
aji-166	289	37	enhancement	enhancement	NOUN
aji-166	289	38	(	(	PUNCT
aji-166	289	39	nades	nade	NOUN
aji-166	289	40	)	)	PUNCT
aji-166	289	41	(	(	PUNCT
aji-166	289	42	luo	luo	PROPN
aji-166	289	43	et	et	PROPN
aji-166	289	44	al	al	PROPN
aji-166	289	45	.	.	PROPN
aji-166	289	46	,	,	PUNCT
aji-166	289	47	2024	2024	NUM
aji-166	289	48	)	)	PUNCT
aji-166	289	49	.	.	PUNCT
aji-166	290	1	5	5	X
aji-166	290	2	.	.	X
aji-166	290	3	conclusion	conclusion	NOUN
aji-166	290	4	monocytes	monocyte	NOUN
aji-166	290	5	and	and	CCONJ
aji-166	290	6	macrophages	macrophage	NOUN
aji-166	290	7	play	play	VERB
aji-166	290	8	crucial	crucial	ADJ
aji-166	290	9	roles	role	NOUN
aji-166	290	10	in	in	ADP
aji-166	290	11	the	the	DET
aji-166	290	12	pathogenesis	pathogenesis	NOUN
aji-166	290	13	of	of	ADP
aji-166	290	14	hiv	hiv	PROPN
aji-166	290	15	disease	disease	NOUN
aji-166	290	16	and	and	CCONJ
aji-166	290	17	the	the	DET
aji-166	290	18	development	development	NOUN
aji-166	290	19	of	of	ADP
aji-166	290	20	nades	nade	NOUN
aji-166	290	21	.	.	PUNCT
aji-166	291	1	their	their	PRON
aji-166	291	2	functions	function	NOUN
aji-166	291	3	as	as	ADP
aji-166	291	4	viral	viral	ADJ
aji-166	291	5	reservoirs	reservoir	NOUN
aji-166	291	6	,	,	PUNCT
aji-166	291	7	drivers	driver	NOUN
aji-166	291	8	of	of	ADP
aji-166	291	9	chronic	chronic	ADJ
aji-166	291	10	inflammation	inflammation	NOUN
aji-166	291	11	,	,	PUNCT
aji-166	291	12	and	and	CCONJ
aji-166	291	13	mediators	mediator	NOUN
aji-166	291	14	of	of	ADP
aji-166	291	15	tissue	tissue	NOUN
aji-166	291	16	damage	damage	NOUN
aji-166	291	17	underscore	underscore	VERB
aji-166	291	18	the	the	DET
aji-166	291	19	need	need	NOUN
aji-166	291	20	for	for	ADP
aji-166	291	21	targeted	target	VERB
aji-166	291	22	therapeutic	therapeutic	ADJ
aji-166	291	23	strategies	strategy	NOUN
aji-166	291	24	to	to	PART
aji-166	291	25	address	address	VERB
aji-166	291	26	these	these	DET
aji-166	291	27	mechanisms	mechanism	NOUN
aji-166	291	28	.	.	PUNCT
aji-166	292	1	while	while	SCONJ
aji-166	292	2	current	current	ADJ
aji-166	292	3	challenges	challenge	NOUN
aji-166	292	4	such	such	ADJ
aji-166	292	5	as	as	ADP
aji-166	292	6	low	low	ADJ
aji-166	292	7	myeloid	myeloid	ADJ
aji-166	292	8	cell	cell	NOUN
aji-166	292	9	penetration	penetration	NOUN
aji-166	292	10	,	,	PUNCT
aji-166	292	11	reservoir	reservoir	NOUN
aji-166	292	12	heterogeneity	heterogeneity	NOUN
aji-166	292	13	,	,	PUNCT
aji-166	292	14	and	and	CCONJ
aji-166	292	15	limited	limited	ADJ
aji-166	292	16	cns	cns	NOUN
aji-166	292	17	penetration	penetration	NOUN
aji-166	292	18	still	still	ADV
aji-166	292	19	need	need	VERB
aji-166	292	20	to	to	PART
aji-166	292	21	be	be	AUX
aji-166	292	22	overcome	overcome	VERB
aji-166	292	23	,	,	PUNCT
aji-166	292	24	understanding	understanding	NOUN
aji-166	292	25	and	and	CCONJ
aji-166	292	26	modulating	modulate	VERB
aji-166	292	27	the	the	DET
aji-166	292	28	functions	function	NOUN
aji-166	292	29	of	of	ADP
aji-166	292	30	monocytes	monocyte	NOUN
aji-166	292	31	and	and	CCONJ
aji-166	292	32	adavba	adavba	NOUN
aji-166	292	33	;	;	PUNCT
aji-166	292	34	asian	asian	PROPN
aji-166	292	35	j.	j.	PROPN
aji-166	292	36	immunol	immunol	PROPN
aji-166	292	37	.	.	PROPN
aji-166	292	38	,	,	PUNCT
aji-166	292	39	vol	vol	NOUN
aji-166	292	40	.	.	PROPN
aji-166	292	41	8	8	NUM
aji-166	292	42	,	,	PUNCT
aji-166	292	43	no	no	INTJ
aji-166	292	44	.	.	NOUN
aji-166	292	45	1	1	NUM
aji-166	292	46	,	,	PUNCT
aji-166	292	47	pp	pp	ADJ
aji-166	292	48	.	.	PUNCT
aji-166	293	1	120	120	NUM
aji-166	293	2	-	-	SYM
aji-166	293	3	133	133	NUM
aji-166	293	4	,	,	PUNCT
aji-166	293	5	2025	2025	NUM
aji-166	293	6	;	;	PUNCT
aji-166	293	7	article	article	NOUN
aji-166	293	8	no.aji.136909	no.aji.136909	NOUN
aji-166	293	9	129	129	NUM
aji-166	293	10	macrophages	macrophage	NOUN
aji-166	293	11	presents	present	VERB
aji-166	293	12	a	a	DET
aji-166	293	13	promising	promising	ADJ
aji-166	293	14	strategy	strategy	NOUN
aji-166	293	15	for	for	ADP
aji-166	293	16	reducing	reduce	VERB
aji-166	293	17	the	the	DET
aji-166	293	18	burden	burden	NOUN
aji-166	293	19	of	of	ADP
aji-166	293	20	nades	nade	NOUN
aji-166	293	21	and	and	CCONJ
aji-166	293	22	enhancing	enhance	VERB
aji-166	293	23	the	the	DET
aji-166	293	24	long	long	ADJ
aji-166	293	25	-	-	PUNCT
aji-166	293	26	term	term	NOUN
aji-166	293	27	health	health	NOUN
aji-166	293	28	outcomes	outcome	NOUN
aji-166	293	29	of	of	ADP
aji-166	293	30	plwh	plwh	PROPN
aji-166	293	31	.	.	PUNCT
aji-166	294	1	consent	consent	NOUN
aji-166	294	2	and	and	CCONJ
aji-166	294	3	ethical	ethical	ADJ
aji-166	294	4	approval	approval	NOUN
aji-166	294	5	it	it	PRON
aji-166	294	6	is	be	AUX
aji-166	294	7	not	not	PART
aji-166	294	8	applicable	applicable	ADJ
aji-166	294	9	.	.	PUNCT
aji-166	295	1	disclaimer	disclaimer	NOUN
aji-166	295	2	(	(	PUNCT
aji-166	295	3	artificial	artificial	ADJ
aji-166	295	4	intelligence	intelligence	NOUN
aji-166	295	5	)	)	PUNCT
aji-166	295	6	the	the	DET
aji-166	295	7	author	author	NOUN
aji-166	295	8	hereby	hereby	ADV
aji-166	295	9	declares	declare	VERB
aji-166	295	10	that	that	SCONJ
aji-166	295	11	no	no	PRON
aji-166	295	12	generative	generative	NOUN
aji-166	295	13	ai	ai	VERB
aji-166	295	14	technologies	technology	NOUN
aji-166	295	15	such	such	ADJ
aji-166	295	16	as	as	ADP
aji-166	295	17	large	large	ADJ
aji-166	295	18	language	language	NOUN
aji-166	295	19	models	model	NOUN
aji-166	295	20	(	(	PUNCT
aji-166	295	21	chatgpt	chatgpt	NOUN
aji-166	295	22	,	,	PUNCT
aji-166	295	23	copilot	copilot	NOUN
aji-166	295	24	,	,	PUNCT
aji-166	295	25	etc	etc	X
aji-166	295	26	.	.	X
aji-166	295	27	)	)	PUNCT
aji-166	295	28	and	and	CCONJ
aji-166	295	29	text	text	NOUN
aji-166	295	30	-	-	PUNCT
aji-166	295	31	to	to	ADP
aji-166	295	32	-	-	PUNCT
aji-166	295	33	image	image	NOUN
aji-166	295	34	generators	generator	NOUN
aji-166	295	35	have	have	AUX
aji-166	295	36	been	be	AUX
aji-166	295	37	used	use	VERB
aji-166	295	38	during	during	ADP
aji-166	295	39	the	the	DET
aji-166	295	40	writing	writing	NOUN
aji-166	295	41	or	or	CCONJ
aji-166	295	42	editing	editing	NOUN
aji-166	295	43	of	of	ADP
aji-166	295	44	this	this	DET
aji-166	295	45	manuscript	manuscript	NOUN
aji-166	295	46	.	.	PUNCT
aji-166	296	1	competing	compete	VERB
aji-166	296	2	interests	interest	NOUN
aji-166	296	3	author	author	NOUN
aji-166	296	4	has	have	AUX
aji-166	296	5	declared	declare	VERB
aji-166	296	6	that	that	SCONJ
aji-166	296	7	no	no	DET
aji-166	296	8	competing	compete	VERB
aji-166	296	9	interests	interest	NOUN
aji-166	296	10	exist	exist	VERB
aji-166	296	11	.	.	PUNCT
aji-166	297	1	references	reference	NOUN
aji-166	297	2	adhikary	adhikary	PROPN
aji-166	297	3	,	,	PUNCT
aji-166	297	4	k.	k.	PROPN
aji-166	297	5	,	,	PUNCT
aji-166	297	6	banerjee	banerjee	PROPN
aji-166	297	7	,	,	PUNCT
aji-166	297	8	a.	a.	PROPN
aji-166	297	9	,	,	PUNCT
aji-166	297	10	sarkar	sarkar	PROPN
aji-166	297	11	,	,	PUNCT
aji-166	297	12	r.	r.	PROPN
aji-166	297	13	,	,	PUNCT
aji-166	297	14	banerjee	banerjee	PROPN
aji-166	297	15	,	,	PUNCT
aji-166	297	16	r.	r.	PROPN
aji-166	297	17	,	,	PUNCT
aji-166	297	18	chowdhury	chowdhury	PROPN
aji-166	297	19	,	,	PUNCT
aji-166	297	20	s.	s.	PROPN
aji-166	297	21	r.	r.	PROPN
aji-166	297	22	,	,	PUNCT
aji-166	297	23	ganguly	ganguly	PROPN
aji-166	297	24	,	,	PUNCT
aji-166	297	25	k.	k.	PROPN
aji-166	297	26	,	,	PUNCT
aji-166	297	27	&	&	CCONJ
aji-166	297	28	karak	karak	PROPN
aji-166	297	29	,	,	PUNCT
aji-166	297	30	p.	p.	NOUN
aji-166	297	31	(	(	PUNCT
aji-166	297	32	2025	2025	NUM
aji-166	297	33	)	)	PUNCT
aji-166	297	34	.	.	PUNCT
aji-166	298	1	hiv	hiv	PROPN
aji-166	298	2	-	-	PUNCT
aji-166	298	3	associated	associate	VERB
aji-166	298	4	neurocognitive	neurocognitive	ADJ
aji-166	298	5	disorders	disorder	NOUN
aji-166	298	6	(	(	PUNCT
aji-166	298	7	hand	hand	NOUN
aji-166	298	8	):	):	PUNCT
aji-166	298	9	optimal	optimal	ADJ
aji-166	298	10	diagnosis	diagnosis	NOUN
aji-166	298	11	,	,	PUNCT
aji-166	298	12	antiviral	antiviral	ADJ
aji-166	298	13	therapy	therapy	NOUN
aji-166	298	14	,	,	PUNCT
aji-166	298	15	pharmacological	pharmacological	ADJ
aji-166	298	16	treatment	treatment	NOUN
aji-166	298	17	,	,	PUNCT
aji-166	298	18	management	management	NOUN
aji-166	298	19	,	,	PUNCT
aji-166	298	20	and	and	CCONJ
aji-166	298	21	future	future	ADJ
aji-166	298	22	scopes	scope	NOUN
aji-166	298	23	.	.	PUNCT
aji-166	299	1	journal	journal	NOUN
aji-166	299	2	of	of	ADP
aji-166	299	3	the	the	DET
aji-166	299	4	neurological	neurological	ADJ
aji-166	299	5	sciences	science	NOUN
aji-166	299	6	,	,	PUNCT
aji-166	299	7	470	470	NUM
aji-166	299	8	,	,	PUNCT
aji-166	299	9	123410	123410	NUM
aji-166	299	10	.	.	PUNCT
aji-166	300	1	https://doi.org/10.1016/j.jns.2025.123410	https://doi.org/10.1016/j.jns.2025.123410	PROPN
aji-166	300	2	adhikary	adhikary	NOUN
aji-166	300	3	,	,	PUNCT
aji-166	300	4	k.	k.	PROPN
aji-166	300	5	,	,	PUNCT
aji-166	300	6	banerjee	banerjee	PROPN
aji-166	300	7	,	,	PUNCT
aji-166	300	8	a.	a.	PROPN
aji-166	300	9	,	,	PUNCT
aji-166	300	10	sarkar	sarkar	PROPN
aji-166	300	11	,	,	PUNCT
aji-166	300	12	r.	r.	PROPN
aji-166	300	13	,	,	PUNCT
aji-166	300	14	banerjee	banerjee	PROPN
aji-166	300	15	,	,	PUNCT
aji-166	300	16	r.	r.	PROPN
aji-166	300	17	,	,	PUNCT
aji-166	300	18	chowdhury	chowdhury	PROPN
aji-166	300	19	,	,	PUNCT
aji-166	300	20	s.	s.	PROPN
aji-166	300	21	r.	r.	PROPN
aji-166	300	22	,	,	PUNCT
aji-166	300	23	ganguly	ganguly	PROPN
aji-166	300	24	,	,	PUNCT
aji-166	300	25	k.	k.	PROPN
aji-166	300	26	,	,	PUNCT
aji-166	300	27	&	&	CCONJ
aji-166	300	28	karak	karak	PROPN
aji-166	300	29	,	,	PUNCT
aji-166	300	30	p.	p.	NOUN
aji-166	300	31	(	(	PUNCT
aji-166	300	32	2025	2025	NUM
aji-166	300	33	)	)	PUNCT
aji-166	300	34	.	.	PUNCT
aji-166	301	1	hiv	hiv	PROPN
aji-166	301	2	-	-	PUNCT
aji-166	301	3	associated	associate	VERB
aji-166	301	4	neurocognitive	neurocognitive	ADJ
aji-166	301	5	disorders	disorder	NOUN
aji-166	301	6	(	(	PUNCT
aji-166	301	7	hand	hand	NOUN
aji-166	301	8	):	):	PUNCT
aji-166	301	9	optimal	optimal	ADJ
aji-166	301	10	diagnosis	diagnosis	NOUN
aji-166	301	11	,	,	PUNCT
aji-166	301	12	antiviral	antiviral	ADJ
aji-166	301	13	therapy	therapy	NOUN
aji-166	301	14	,	,	PUNCT
aji-166	301	15	pharmacological	pharmacological	ADJ
aji-166	301	16	treatment	treatment	NOUN
aji-166	301	17	,	,	PUNCT
aji-166	301	18	management	management	NOUN
aji-166	301	19	,	,	PUNCT
aji-166	301	20	and	and	CCONJ
aji-166	301	21	future	future	ADJ
aji-166	301	22	scopes	scope	NOUN
aji-166	301	23	.	.	PUNCT
aji-166	302	1	journal	journal	NOUN
aji-166	302	2	of	of	ADP
aji-166	302	3	the	the	DET
aji-166	302	4	neurological	neurological	ADJ
aji-166	302	5	sciences	science	NOUN
aji-166	302	6	,	,	PUNCT
aji-166	302	7	470	470	NUM
aji-166	302	8	,	,	PUNCT
aji-166	302	9	123410	123410	NUM
aji-166	302	10	.	.	PUNCT
aji-166	303	1	https://doi.org/10.1016/j.jns.2025.123410	https://doi.org/10.1016/j.jns.2025.123410	PROPN
aji-166	303	2	ancuta	ancuta	ADV
aji-166	303	3	,	,	PUNCT
aji-166	303	4	p.	p.	PROPN
aji-166	303	5	,	,	PUNCT
aji-166	303	6	kamat	kamat	PROPN
aji-166	303	7	,	,	PUNCT
aji-166	303	8	a.	a.	PROPN
aji-166	303	9	,	,	PUNCT
aji-166	303	10	kunstman	kunstman	PROPN
aji-166	303	11	,	,	PUNCT
aji-166	303	12	k.	k.	PROPN
aji-166	303	13	j.	j.	PROPN
aji-166	303	14	,	,	PUNCT
aji-166	303	15	kim	kim	PROPN
aji-166	303	16	,	,	PUNCT
aji-166	303	17	e.	e.	PROPN
aji-166	303	18	y.	y.	PROPN
aji-166	303	19	,	,	PUNCT
aji-166	303	20	autissier	autissier	ADV
aji-166	303	21	,	,	PUNCT
aji-166	303	22	p.	p.	NOUN
aji-166	303	23	,	,	PUNCT
aji-166	303	24	wurcel	wurcel	NOUN
aji-166	303	25	,	,	PUNCT
aji-166	303	26	a.	a.	NOUN
aji-166	303	27	,	,	PUNCT
aji-166	303	28	zaman	zaman	NOUN
aji-166	303	29	,	,	PUNCT
aji-166	303	30	t.	t.	PROPN
aji-166	303	31	,	,	PUNCT
aji-166	303	32	stone	stone	NOUN
aji-166	303	33	,	,	PUNCT
aji-166	303	34	d.	d.	PROPN
aji-166	303	35	,	,	PUNCT
aji-166	303	36	et	et	PROPN
aji-166	303	37	al	al	PROPN
aji-166	303	38	.	.	PUNCT
aji-166	304	1	(	(	PUNCT
aji-166	304	2	2008	2008	NUM
aji-166	304	3	)	)	PUNCT
aji-166	304	4	.	.	PUNCT
aji-166	305	1	microbial	microbial	ADJ
aji-166	305	2	translocation	translocation	NOUN
aji-166	305	3	is	be	AUX
aji-166	305	4	associated	associate	VERB
aji-166	305	5	with	with	ADP
aji-166	305	6	increased	increase	VERB
aji-166	305	7	monocyte	monocyte	NOUN
aji-166	305	8	activation	activation	NOUN
aji-166	305	9	and	and	CCONJ
aji-166	305	10	dementia	dementia	NOUN
aji-166	305	11	in	in	ADP
aji-166	305	12	aids	aids	PROPN
aji-166	305	13	patients	patient	NOUN
aji-166	305	14	.	.	PUNCT
aji-166	306	1	plos	plos	PROPN
aji-166	306	2	one	one	NUM
aji-166	306	3	,	,	PUNCT
aji-166	306	4	3(6	3(6	NUM
aji-166	306	5	)	)	PUNCT
aji-166	306	6	,	,	PUNCT
aji-166	306	7	e2516	e2516	PROPN
aji-166	306	8	.	.	PUNCT
aji-166	306	9	https://doi.org/10.1371/journal.pone.00025	https://doi.org/10.1371/journal.pone.00025	PROPN
aji-166	306	10	16	16	NUM
aji-166	306	11	ancuta	ancuta	ADJ
aji-166	306	12	,	,	PUNCT
aji-166	306	13	p.	p.	PROPN
aji-166	306	14	,	,	PUNCT
aji-166	306	15	kamat	kamat	PROPN
aji-166	306	16	,	,	PUNCT
aji-166	306	17	a.	a.	PROPN
aji-166	306	18	,	,	PUNCT
aji-166	306	19	kunstman	kunstman	PROPN
aji-166	306	20	,	,	PUNCT
aji-166	306	21	k.	k.	PROPN
aji-166	306	22	j.	j.	PROPN
aji-166	306	23	,	,	PUNCT
aji-166	306	24	kim	kim	PROPN
aji-166	306	25	,	,	PUNCT
aji-166	306	26	e.	e.	PROPN
aji-166	306	27	y.	y.	PROPN
aji-166	306	28	,	,	PUNCT
aji-166	306	29	autissier	autissier	ADV
aji-166	306	30	,	,	PUNCT
aji-166	306	31	p.	p.	NOUN
aji-166	306	32	,	,	PUNCT
aji-166	306	33	wurcel	wurcel	NOUN
aji-166	306	34	,	,	PUNCT
aji-166	306	35	a.	a.	NOUN
aji-166	306	36	,	,	PUNCT
aji-166	306	37	zaman	zaman	NOUN
aji-166	306	38	,	,	PUNCT
aji-166	306	39	t.	t.	PROPN
aji-166	306	40	,	,	PUNCT
aji-166	306	41	stone	stone	NOUN
aji-166	306	42	,	,	PUNCT
aji-166	306	43	d.	d.	PROPN
aji-166	306	44	,	,	PUNCT
aji-166	306	45	mefford	mefford	NOUN
aji-166	306	46	,	,	PUNCT
aji-166	306	47	m.	m.	NOUN
aji-166	306	48	,	,	PUNCT
aji-166	306	49	et	et	PROPN
aji-166	306	50	al	al	PROPN
aji-166	306	51	.	.	PUNCT
aji-166	307	1	(	(	PUNCT
aji-166	307	2	2008	2008	NUM
aji-166	307	3	)	)	PUNCT
aji-166	307	4	.	.	PUNCT
aji-166	308	1	microbial	microbial	ADJ
aji-166	308	2	translocation	translocation	NOUN
aji-166	308	3	is	be	AUX
aji-166	308	4	associated	associate	VERB
aji-166	308	5	with	with	ADP
aji-166	308	6	increased	increase	VERB
aji-166	308	7	monocyte	monocyte	NOUN
aji-166	308	8	activation	activation	NOUN
aji-166	308	9	and	and	CCONJ
aji-166	308	10	dementia	dementia	NOUN
aji-166	308	11	in	in	ADP
aji-166	308	12	aids	aids	PROPN
aji-166	308	13	patients	patient	NOUN
aji-166	308	14	.	.	PUNCT
aji-166	309	1	plos	plos	PROPN
aji-166	309	2	one	one	NUM
aji-166	309	3	,	,	PUNCT
aji-166	309	4	3(6	3(6	NUM
aji-166	309	5	)	)	PUNCT
aji-166	309	6	,	,	PUNCT
aji-166	309	7	e2516	e2516	PROPN
aji-166	309	8	.	.	PUNCT
aji-166	310	1	https://doi.org/10.1371/journal.pone.00025	https://doi.org/10.1371/journal.pone.00025	PROPN
aji-166	310	2	16	16	NUM
aji-166	310	3	borkham	borkham	NOUN
aji-166	310	4	-	-	PUNCT
aji-166	310	5	kamphorst	kamphorst	NOUN
aji-166	310	6	,	,	PUNCT
aji-166	310	7	e.	e.	PROPN
aji-166	310	8	,	,	PUNCT
aji-166	310	9	&	&	CCONJ
aji-166	310	10	weiskirchen	weiskirchen	PROPN
aji-166	310	11	,	,	PUNCT
aji-166	310	12	r.	r.	PROPN
aji-166	310	13	(	(	PUNCT
aji-166	310	14	2016	2016	NUM
aji-166	310	15	)	)	PUNCT
aji-166	310	16	.	.	PUNCT
aji-166	311	1	the	the	DET
aji-166	311	2	pdgf	pdgf	ADJ
aji-166	311	3	system	system	NOUN
aji-166	311	4	and	and	CCONJ
aji-166	311	5	its	its	PRON
aji-166	311	6	antagonists	antagonist	NOUN
aji-166	311	7	in	in	ADP
aji-166	311	8	liver	liver	NOUN
aji-166	311	9	fibrosis	fibrosis	NOUN
aji-166	311	10	.	.	PUNCT
aji-166	312	1	cytokine	cytokine	VERB
aji-166	312	2	&	&	CCONJ
aji-166	312	3	growth	growth	NOUN
aji-166	312	4	factor	factor	NOUN
aji-166	312	5	reviews	review	NOUN
aji-166	312	6	,	,	PUNCT
aji-166	312	7	28	28	NUM
aji-166	312	8	,	,	PUNCT
aji-166	312	9	53	53	NUM
aji-166	312	10	-	-	SYM
aji-166	312	11	61	61	NUM
aji-166	312	12	.	.	PUNCT
aji-166	313	1	https://doi.org/10.1016/j.cytogfr.2015.10.00	https://doi.org/10.1016/j.cytogfr.2015.10.00	PROPN
aji-166	313	2	2	2	NUM
aji-166	313	3	burdo	burdo	NOUN
aji-166	313	4	,	,	PUNCT
aji-166	313	5	t.	t.	PROPN
aji-166	313	6	h.	h.	PROPN
aji-166	313	7	,	,	PUNCT
aji-166	313	8	lentz	lentz	PROPN
aji-166	313	9	,	,	PUNCT
aji-166	313	10	m.	m.	PROPN
aji-166	313	11	r.	r.	PROPN
aji-166	313	12	,	,	PUNCT
aji-166	313	13	autissier	autissier	ADV
aji-166	313	14	,	,	PUNCT
aji-166	313	15	p.	p.	PROPN
aji-166	313	16	,	,	PUNCT
aji-166	313	17	krishnan	krishnan	PROPN
aji-166	313	18	,	,	PUNCT
aji-166	313	19	a.	a.	PROPN
aji-166	313	20	,	,	PUNCT
aji-166	313	21	halpern	halpern	PROPN
aji-166	313	22	,	,	PUNCT
aji-166	313	23	e.	e.	PROPN
aji-166	313	24	,	,	PUNCT
aji-166	313	25	letendre	letendre	PROPN
aji-166	313	26	,	,	PUNCT
aji-166	313	27	s.	s.	PROPN
aji-166	313	28	,	,	PUNCT
aji-166	313	29	rosenberg	rosenberg	PROPN
aji-166	313	30	,	,	PUNCT
aji-166	313	31	e.	e.	PROPN
aji-166	313	32	s.	s.	PROPN
aji-166	313	33	,	,	PUNCT
aji-166	313	34	ellis	ellis	PROPN
aji-166	313	35	,	,	PUNCT
aji-166	313	36	r.	r.	PROPN
aji-166	313	37	j.	j.	PROPN
aji-166	313	38	,	,	PUNCT
aji-166	313	39	&	&	CCONJ
aji-166	313	40	williams	williams	PROPN
aji-166	313	41	,	,	PUNCT
aji-166	313	42	k.	k.	PROPN
aji-166	313	43	c.	c.	PROPN
aji-166	313	44	(	(	PUNCT
aji-166	313	45	2011	2011	NUM
aji-166	313	46	)	)	PUNCT
aji-166	313	47	.	.	PUNCT
aji-166	314	1	soluble	soluble	ADJ
aji-166	314	2	cd163	cd163	PROPN
aji-166	314	3	made	make	VERB
aji-166	314	4	by	by	ADP
aji-166	314	5	monocyte	monocyte	NOUN
aji-166	314	6	/	/	SYM
aji-166	314	7	macrophages	macrophage	NOUN
aji-166	314	8	is	be	AUX
aji-166	314	9	a	a	DET
aji-166	314	10	novel	novel	ADJ
aji-166	314	11	marker	marker	NOUN
aji-166	314	12	of	of	ADP
aji-166	314	13	hiv	hiv	PROPN
aji-166	314	14	activity	activity	NOUN
aji-166	314	15	in	in	ADP
aji-166	314	16	early	early	ADJ
aji-166	314	17	and	and	CCONJ
aji-166	314	18	chronic	chronic	ADJ
aji-166	314	19	infection	infection	NOUN
aji-166	314	20	prior	prior	ADV
aji-166	314	21	to	to	ADP
aji-166	314	22	and	and	CCONJ
aji-166	314	23	after	after	ADP
aji-166	314	24	anti	anti	ADJ
aji-166	314	25	-	-	ADJ
aji-166	314	26	retroviral	retroviral	ADJ
aji-166	314	27	therapy	therapy	NOUN
aji-166	314	28	.	.	PUNCT
aji-166	315	1	the	the	DET
aji-166	315	2	journal	journal	NOUN
aji-166	315	3	of	of	ADP
aji-166	315	4	infectious	infectious	ADJ
aji-166	315	5	diseases	disease	NOUN
aji-166	315	6	,	,	PUNCT
aji-166	315	7	204(1	204(1	NUM
aji-166	315	8	)	)	PUNCT
aji-166	315	9	,	,	PUNCT
aji-166	315	10	154–163	154–163	NUM
aji-166	315	11	.	.	PUNCT
aji-166	316	1	https://doi.org/10.1093/infdis/jir214	https://doi.org/10.1093/infdis/jir214	PROPN
aji-166	316	2	campbell	campbell	PROPN
aji-166	316	3	,	,	PUNCT
aji-166	316	4	j.	j.	PROPN
aji-166	316	5	h.	h.	PROPN
aji-166	316	6	,	,	PUNCT
aji-166	316	7	hearps	hearps	PROPN
aji-166	316	8	,	,	PUNCT
aji-166	316	9	a.	a.	PROPN
aji-166	316	10	c.	c.	PROPN
aji-166	316	11	,	,	PUNCT
aji-166	316	12	martin	martin	PROPN
aji-166	316	13	,	,	PUNCT
aji-166	316	14	g.	g.	PROPN
aji-166	316	15	e.	e.	PROPN
aji-166	316	16	,	,	PUNCT
aji-166	316	17	williams	williams	PROPN
aji-166	316	18	,	,	PUNCT
aji-166	316	19	k.	k.	PROPN
aji-166	316	20	c.	c.	PROPN
aji-166	316	21	,	,	PUNCT
aji-166	316	22	&	&	CCONJ
aji-166	316	23	crowe	crowe	PROPN
aji-166	316	24	,	,	PUNCT
aji-166	316	25	s.	s.	PROPN
aji-166	316	26	m.	m.	PROPN
aji-166	316	27	(	(	PUNCT
aji-166	316	28	2014	2014	NUM
aji-166	316	29	)	)	PUNCT
aji-166	316	30	.	.	PUNCT
aji-166	317	1	the	the	DET
aji-166	317	2	importance	importance	NOUN
aji-166	317	3	of	of	ADP
aji-166	317	4	monocytes	monocyte	NOUN
aji-166	317	5	and	and	CCONJ
aji-166	317	6	macrophages	macrophage	NOUN
aji-166	317	7	in	in	ADP
aji-166	317	8	hiv	hiv	PROPN
aji-166	317	9	pathogenesis	pathogenesis	NOUN
aji-166	317	10	,	,	PUNCT
aji-166	317	11	treatment	treatment	NOUN
aji-166	317	12	,	,	PUNCT
aji-166	317	13	and	and	CCONJ
aji-166	317	14	cure	cure	NOUN
aji-166	317	15	.	.	PUNCT
aji-166	318	1	aids	aids	PROPN
aji-166	318	2	(	(	PUNCT
aji-166	318	3	london	london	PROPN
aji-166	318	4	,	,	PUNCT
aji-166	318	5	england	england	PROPN
aji-166	318	6	)	)	PUNCT
aji-166	318	7	,	,	PUNCT
aji-166	318	8	28(15	28(15	NUM
aji-166	318	9	)	)	PUNCT
aji-166	318	10	,	,	PUNCT
aji-166	318	11	2175–2187	2175–2187	NUM
aji-166	318	12	.	.	PUNCT
aji-166	319	1	https://doi.org/10.1097/qad.00000000000	https://doi.org/10.1097/qad.00000000000	PROPN
aji-166	319	2	00408	00408	NUM
aji-166	319	3	campos	campos	PROPN
aji-166	319	4	,	,	PUNCT
aji-166	319	5	t.m	t.m	PROPN
aji-166	319	6	.	.	PROPN
aji-166	319	7	,	,	PUNCT
aji-166	319	8	passos	passos	PROPN
aji-166	319	9	,	,	PUNCT
aji-166	319	10	s.t	s.t	PROPN
aji-166	319	11	.	.	PROPN
aji-166	319	12	,	,	PUNCT
aji-166	319	13	novais	novais	PROPN
aji-166	319	14	,	,	PUNCT
aji-166	319	15	f.o	f.o	PROPN
aji-166	319	16	.	.	PROPN
aji-166	319	17	,	,	PUNCT
aji-166	319	18	beiting	beite	VERB
aji-166	319	19	,	,	PUNCT
aji-166	319	20	d.p	d.p	PROPN
aji-166	319	21	.	.	PROPN
aji-166	319	22	,	,	PUNCT
aji-166	319	23	costa	costa	PROPN
aji-166	319	24	,	,	PUNCT
aji-166	319	25	r.s	r.s	PROPN
aji-166	319	26	.	.	PROPN
aji-166	319	27	,	,	PUNCT
aji-166	319	28	et	et	PROPN
aji-166	319	29	al	al	PROPN
aji-166	319	30	.	.	PUNCT
aji-166	320	1	(	(	PUNCT
aji-166	320	2	2014	2014	NUM
aji-166	320	3	)	)	PUNCT
aji-166	320	4	matrix	matrix	NOUN
aji-166	320	5	metalloproteinase	metalloproteinase	NOUN
aji-166	320	6	9	9	NUM
aji-166	320	7	production	production	NOUN
aji-166	320	8	by	by	ADP
aji-166	320	9	monocytes	monocyte	NOUN
aji-166	320	10	is	be	AUX
aji-166	320	11	enhanced	enhance	VERB
aji-166	320	12	by	by	ADP
aji-166	320	13	tnf	tnf	PROPN
aji-166	320	14	and	and	CCONJ
aji-166	320	15	participates	participate	VERB
aji-166	320	16	in	in	ADP
aji-166	320	17	the	the	DET
aji-166	320	18	pathology	pathology	NOUN
aji-166	320	19	of	of	ADP
aji-166	320	20	human	human	ADJ
aji-166	320	21	cutaneous	cutaneous	ADJ
aji-166	320	22	leishmaniasis	leishmaniasis	NOUN
aji-166	320	23	.	.	PUNCT
aji-166	321	1	plos	plos	PROPN
aji-166	321	2	neglected	neglect	VERB
aji-166	321	3	tropical	tropical	ADJ
aji-166	321	4	diseases	disease	NOUN
aji-166	321	5	8	8	NUM
aji-166	321	6	(	(	PUNCT
aji-166	321	7	11	11	NUM
aji-166	321	8	):	):	PUNCT
aji-166	321	9	e3282	e3282	NOUN
aji-166	321	10	.	.	PUNCT
aji-166	322	1	https://doi.org/10.1371/journal.pntd.000328	https://doi.org/10.1371/journal.pntd.000328	ADJ
aji-166	322	2	2	2	NUM
aji-166	322	3	chivero	chivero	NOUN
aji-166	322	4	,	,	PUNCT
aji-166	322	5	e.	e.	PROPN
aji-166	322	6	t.	t.	PROPN
aji-166	322	7	,	,	PUNCT
aji-166	322	8	guo	guo	PROPN
aji-166	322	9	,	,	PUNCT
aji-166	322	10	l.	l.	PROPN
aji-166	322	11	,	,	PUNCT
aji-166	322	12	periyasamy	periyasamy	NOUN
aji-166	322	13	,	,	PUNCT
aji-166	322	14	p.	p.	PROPN
aji-166	322	15	,	,	PUNCT
aji-166	322	16	liao	liao	PROPN
aji-166	322	17	,	,	PUNCT
aji-166	322	18	k.	k.	PROPN
aji-166	322	19	,	,	PUNCT
aji-166	322	20	callen	callen	PROPN
aji-166	322	21	,	,	PUNCT
aji-166	322	22	s.	s.	PROPN
aji-166	322	23	e.	e.	PROPN
aji-166	322	24	,	,	PUNCT
aji-166	322	25	&	&	CCONJ
aji-166	322	26	buch	buch	PROPN
aji-166	322	27	,	,	PUNCT
aji-166	322	28	s.	s.	PROPN
aji-166	322	29	(	(	PUNCT
aji-166	322	30	2017	2017	NUM
aji-166	322	31	)	)	PUNCT
aji-166	322	32	.	.	PUNCT
aji-166	323	1	hiv-1	hiv-1	X
aji-166	323	2	tat	tat	ADJ
aji-166	323	3	primes	prime	NOUN
aji-166	323	4	and	and	CCONJ
aji-166	323	5	activates	activate	VERB
aji-166	323	6	microglial	microglial	ADJ
aji-166	323	7	nlrp3	nlrp3	NOUN
aji-166	323	8	inflammasome	inflammasome	NOUN
aji-166	323	9	-	-	PUNCT
aji-166	323	10	mediated	mediate	VERB
aji-166	323	11	neuroinflammation	neuroinflammation	NOUN
aji-166	323	12	.	.	PUNCT
aji-166	324	1	the	the	DET
aji-166	324	2	journal	journal	NOUN
aji-166	324	3	of	of	ADP
aji-166	324	4	neuroscience	neuroscience	NOUN
aji-166	324	5	,	,	PUNCT
aji-166	324	6	37(13	37(13	NUM
aji-166	324	7	)	)	PUNCT
aji-166	324	8	,	,	PUNCT
aji-166	324	9	3599	3599	NUM
aji-166	324	10	.	.	PUNCT
aji-166	325	1	https://doi.org/10.1523/jneurosci.304516.2017	https://doi.org/10.1523/jneurosci.304516.2017	PROPN
aji-166	325	2	chun	chun	PROPN
aji-166	325	3	,	,	PUNCT
aji-166	325	4	t.	t.	PROPN
aji-166	325	5	,	,	PUNCT
aji-166	325	6	moir	moir	PROPN
aji-166	325	7	,	,	PUNCT
aji-166	325	8	s.	s.	PROPN
aji-166	325	9	,	,	PUNCT
aji-166	325	10	&	&	CCONJ
aji-166	325	11	fauci	fauci	PROPN
aji-166	325	12	,	,	PUNCT
aji-166	325	13	a.	a.	PROPN
aji-166	325	14	s.	s.	PROPN
aji-166	325	15	(	(	PUNCT
aji-166	325	16	2015	2015	NUM
aji-166	325	17	)	)	PUNCT
aji-166	325	18	.	.	PUNCT
aji-166	326	1	hiv	hiv	PROPN
aji-166	326	2	reservoirs	reservoir	NOUN
aji-166	326	3	as	as	ADP
aji-166	326	4	obstacles	obstacle	NOUN
aji-166	326	5	and	and	CCONJ
aji-166	326	6	opportunities	opportunity	NOUN
aji-166	326	7	for	for	ADP
aji-166	326	8	an	an	DET
aji-166	326	9	hiv	hiv	PROPN
aji-166	326	10	cure	cure	NOUN
aji-166	326	11	.	.	PUNCT
aji-166	327	1	nature	nature	NOUN
aji-166	327	2	immunology	immunology	NOUN
aji-166	327	3	,	,	PUNCT
aji-166	327	4	16(6	16(6	NUM
aji-166	327	5	)	)	PUNCT
aji-166	327	6	,	,	PUNCT
aji-166	327	7	584	584	NUM
aji-166	327	8	-	-	SYM
aji-166	327	9	589	589	NUM
aji-166	327	10	.	.	PUNCT
aji-166	328	1	https://doi.org/10.1038/ni.3152	https://doi.org/10.1038/ni.3152	PROPN
aji-166	328	2	clayton	clayton	PROPN
aji-166	328	3	k.	k.	PROPN
aji-166	328	4	l.	l.	PROPN
aji-166	328	5	,	,	PUNCT
aji-166	328	6	collins	collins	PROPN
aji-166	328	7	d.	d.	PROPN
aji-166	328	8	r.	r.	PROPN
aji-166	328	9	,	,	PUNCT
aji-166	328	10	lengieza	lengieza	PROPN
aji-166	328	11	j.	j.	PROPN
aji-166	328	12	,	,	PUNCT
aji-166	328	13	ghebremichael	ghebremichael	PROPN
aji-166	328	14	m.	m.	PROPN
aji-166	328	15	,	,	PUNCT
aji-166	328	16	dotiwala	dotiwala	PROPN
aji-166	328	17	f.	f.	PROPN
aji-166	328	18	,	,	PUNCT
aji-166	328	19	lieberman	lieberman	PROPN
aji-166	328	20	j.	j.	PROPN
aji-166	328	21	,	,	PUNCT
aji-166	328	22	et	et	PROPN
aji-166	328	23	al	al	PROPN
aji-166	328	24	.	.	PUNCT
aji-166	329	1	(	(	PUNCT
aji-166	329	2	2018	2018	NUM
aji-166	329	3	)	)	PUNCT
aji-166	329	4	.	.	PUNCT
aji-166	330	1	resistance	resistance	NOUN
aji-166	330	2	of	of	ADP
aji-166	330	3	hiv	hiv	PROPN
aji-166	330	4	-	-	PUNCT
aji-166	330	5	infected	infect	VERB
aji-166	330	6	macrophages	macrophage	NOUN
aji-166	330	7	to	to	PART
aji-166	330	8	cd8(+	cd8(+	VERB
aji-166	330	9	)	)	PUNCT
aji-166	330	10	t	t	PROPN
aji-166	330	11	lymphocytemediated	lymphocytemediate	VERB
aji-166	330	12	killing	kill	VERB
aji-166	330	13	drives	drive	NOUN
aji-166	330	14	activation	activation	NOUN
aji-166	330	15	of	of	ADP
aji-166	330	16	the	the	DET
aji-166	330	17	immune	immune	ADJ
aji-166	330	18	system	system	NOUN
aji-166	330	19	.	.	PUNCT
aji-166	331	1	nat	nat	NOUN
aji-166	331	2	.	.	PUNCT
aji-166	332	1	immunol	immunol	PROPN
aji-166	332	2	.	.	PUNCT
aji-166	333	1	19	19	NUM
aji-166	333	2	475	475	NUM
aji-166	333	3	–	–	PUNCT
aji-166	333	4	486	486	NUM
aji-166	333	5	.	.	PUNCT
aji-166	333	6	10.1038	10.1038	NUM
aji-166	333	7	/	/	SYM
aji-166	333	8	s41590	s41590	NUM
aji-166	333	9	-	-	PUNCT
aji-166	333	10	018	018	NUM
aji-166	333	11	-	-	PUNCT
aji-166	333	12	0085	0085	NUM
aji-166	333	13	-	-	SYM
aji-166	333	14	3	3	NUM
aji-166	333	15	adavba	adavba	NOUN
aji-166	333	16	;	;	PUNCT
aji-166	333	17	asian	asian	PROPN
aji-166	333	18	j.	j.	PROPN
aji-166	333	19	immunol	immunol	PROPN
aji-166	333	20	.	.	PROPN
aji-166	333	21	,	,	PUNCT
aji-166	333	22	vol	vol	NOUN
aji-166	333	23	.	.	PROPN
aji-166	333	24	8	8	NUM
aji-166	333	25	,	,	PUNCT
aji-166	333	26	no	no	INTJ
aji-166	333	27	.	.	NOUN
aji-166	333	28	1	1	NUM
aji-166	333	29	,	,	PUNCT
aji-166	333	30	pp	pp	ADJ
aji-166	333	31	.	.	PUNCT
aji-166	334	1	120	120	NUM
aji-166	334	2	-	-	SYM
aji-166	334	3	133	133	NUM
aji-166	334	4	,	,	PUNCT
aji-166	334	5	2025	2025	NUM
aji-166	334	6	;	;	PUNCT
aji-166	334	7	article	article	NOUN
aji-166	334	8	no.aji.136909	no.aji.136909	PROPN
aji-166	334	9	130	130	NUM
aji-166	334	10	das	das	PROPN
aji-166	334	11	,	,	PUNCT
aji-166	334	12	a.	a.	NOUN
aji-166	334	13	t.	t.	PROPN
aji-166	334	14	,	,	PUNCT
aji-166	334	15	binda	binda	PROPN
aji-166	334	16	,	,	PUNCT
aji-166	334	17	c.	c.	PROPN
aji-166	334	18	s.	s.	PROPN
aji-166	334	19	,	,	PUNCT
aji-166	334	20	&	&	CCONJ
aji-166	334	21	berkhout	berkhout	PROPN
aji-166	334	22	,	,	PUNCT
aji-166	334	23	b.	b.	PROPN
aji-166	334	24	(	(	PUNCT
aji-166	334	25	2019	2019	NUM
aji-166	334	26	)	)	PUNCT
aji-166	334	27	.	.	PUNCT
aji-166	335	1	elimination	elimination	NOUN
aji-166	335	2	of	of	ADP
aji-166	335	3	infectious	infectious	ADJ
aji-166	335	4	hiv	hiv	PROPN
aji-166	335	5	dna	dna	PROPN
aji-166	335	6	by	by	ADP
aji-166	335	7	crispr	crispr	ADJ
aji-166	335	8	–	–	PUNCT
aji-166	335	9	cas9	cas9	NOUN
aji-166	335	10	.	.	PUNCT
aji-166	336	1	current	current	ADJ
aji-166	336	2	opinion	opinion	NOUN
aji-166	336	3	in	in	ADP
aji-166	336	4	virology	virology	NOUN
aji-166	336	5	,	,	PUNCT
aji-166	336	6	38	38	NUM
aji-166	336	7	,	,	PUNCT
aji-166	336	8	81	81	NUM
aji-166	336	9	-	-	SYM
aji-166	336	10	88	88	NUM
aji-166	336	11	.	.	PUNCT
aji-166	337	1	https://doi.org/10.1016/j.coviro.2019.07.00	https://doi.org/10.1016/j.coviro.2019.07.00	PROPN
aji-166	337	2	1	1	NUM
aji-166	337	3	deeks	deek	NOUN
aji-166	337	4	,	,	PUNCT
aji-166	337	5	s.	s.	PROPN
aji-166	337	6	g.	g.	PROPN
aji-166	337	7	,	,	PUNCT
aji-166	337	8	lewin	lewin	PROPN
aji-166	337	9	,	,	PUNCT
aji-166	337	10	s.	s.	PROPN
aji-166	337	11	r.	r.	PROPN
aji-166	337	12	,	,	PUNCT
aji-166	337	13	&	&	CCONJ
aji-166	337	14	havlir	havlir	PROPN
aji-166	337	15	,	,	PUNCT
aji-166	337	16	d.	d.	PROPN
aji-166	337	17	v.	v.	PROPN
aji-166	337	18	(	(	PUNCT
aji-166	337	19	2013	2013	NUM
aji-166	337	20	)	)	PUNCT
aji-166	337	21	.	.	PUNCT
aji-166	338	1	the	the	DET
aji-166	338	2	end	end	NOUN
aji-166	338	3	of	of	ADP
aji-166	338	4	aids	aids	PROPN
aji-166	338	5	:	:	PUNCT
aji-166	338	6	hiv	hiv	PROPN
aji-166	338	7	infection	infection	NOUN
aji-166	338	8	as	as	ADP
aji-166	338	9	a	a	DET
aji-166	338	10	chronic	chronic	ADJ
aji-166	338	11	disease	disease	NOUN
aji-166	338	12	.	.	PUNCT
aji-166	339	1	lancet	lancet	PROPN
aji-166	339	2	(	(	PUNCT
aji-166	339	3	london	london	PROPN
aji-166	339	4	,	,	PUNCT
aji-166	339	5	england	england	PROPN
aji-166	339	6	)	)	PUNCT
aji-166	339	7	,	,	PUNCT
aji-166	339	8	382(9903	382(9903	NUM
aji-166	339	9	)	)	PUNCT
aji-166	339	10	,	,	PUNCT
aji-166	339	11	1525–1533	1525–1533	NUM
aji-166	339	12	.	.	PUNCT
aji-166	339	13	https://doi.org/10.1016/s01406736(13)61809-7	https://doi.org/10.1016/s01406736(13)61809-7	NOUN
aji-166	339	14	ekabe	ekabe	NOUN
aji-166	339	15	,	,	PUNCT
aji-166	339	16	c.	c.	PROPN
aji-166	339	17	j.	j.	PROPN
aji-166	339	18	,	,	PUNCT
aji-166	339	19	clinton	clinton	PROPN
aji-166	339	20	,	,	PUNCT
aji-166	339	21	n.	n.	PROPN
aji-166	339	22	a.	a.	PROPN
aji-166	339	23	,	,	PUNCT
aji-166	339	24	kehbila	kehbila	PROPN
aji-166	339	25	,	,	PUNCT
aji-166	339	26	j.	j.	PROPN
aji-166	339	27	,	,	PUNCT
aji-166	339	28	&	&	CCONJ
aji-166	339	29	franck	franck	PROPN
aji-166	339	30	,	,	PUNCT
aji-166	339	31	n.	n.	PROPN
aji-166	339	32	c.	c.	PROPN
aji-166	339	33	(	(	PUNCT
aji-166	339	34	2021	2021	NUM
aji-166	339	35	)	)	PUNCT
aji-166	339	36	.	.	PUNCT
aji-166	340	1	the	the	DET
aji-166	340	2	role	role	NOUN
aji-166	340	3	of	of	ADP
aji-166	340	4	inflammasome	inflammasome	NOUN
aji-166	340	5	activation	activation	NOUN
aji-166	340	6	in	in	ADP
aji-166	340	7	early	early	ADJ
aji-166	340	8	hiv	hiv	PROPN
aji-166	340	9	infection	infection	NOUN
aji-166	340	10	.	.	PUNCT
aji-166	341	1	journal	journal	NOUN
aji-166	341	2	of	of	ADP
aji-166	341	3	immunology	immunology	NOUN
aji-166	341	4	research	research	NOUN
aji-166	341	5	,	,	PUNCT
aji-166	341	6	2021	2021	NUM
aji-166	341	7	,	,	PUNCT
aji-166	341	8	1487287	1487287	NUM
aji-166	341	9	.	.	PUNCT
aji-166	342	1	https://doi.org/10.1155/2021/1487287	https://doi.org/10.1155/2021/1487287	PROPN
aji-166	342	2	ganor	ganor	NOUN
aji-166	342	3	,	,	PUNCT
aji-166	342	4	y.	y.	NOUN
aji-166	342	5	,	,	PUNCT
aji-166	342	6	real	real	ADJ
aji-166	342	7	,	,	PUNCT
aji-166	342	8	f.	f.	PROPN
aji-166	342	9	,	,	PUNCT
aji-166	342	10	sennepin	sennepin	NOUN
aji-166	342	11	,	,	PUNCT
aji-166	342	12	a.	a.	NOUN
aji-166	342	13	,	,	PUNCT
aji-166	342	14	dutertre	dutertre	NOUN
aji-166	342	15	,	,	PUNCT
aji-166	342	16	c.	c.	PROPN
aji-166	342	17	a.	a.	PROPN
aji-166	342	18	,	,	PUNCT
aji-166	342	19	prevedel	prevedel	PROPN
aji-166	342	20	,	,	PUNCT
aji-166	342	21	l.	l.	PROPN
aji-166	342	22	,	,	PUNCT
aji-166	342	23	xu	xu	PROPN
aji-166	342	24	,	,	PUNCT
aji-166	342	25	l.	l.	PROPN
aji-166	342	26	,	,	PUNCT
aji-166	342	27	tudor	tudor	PROPN
aji-166	342	28	,	,	PUNCT
aji-166	342	29	d.	d.	PROPN
aji-166	342	30	,	,	PUNCT
aji-166	342	31	charmeteau	charmeteau	PROPN
aji-166	342	32	,	,	PUNCT
aji-166	342	33	b.	b.	PROPN
aji-166	342	34	,	,	PUNCT
aji-166	342	35	et	et	PROPN
aji-166	342	36	al	al	PROPN
aji-166	342	37	.	.	PROPN
aji-166	342	38	(	(	PUNCT
aji-166	342	39	2019	2019	NUM
aji-166	342	40	)	)	PUNCT
aji-166	342	41	.	.	PUNCT
aji-166	343	1	hiv-1	hiv-1	X
aji-166	343	2	reservoirs	reservoir	NOUN
aji-166	343	3	in	in	ADP
aji-166	343	4	urethral	urethral	ADJ
aji-166	343	5	macrophages	macrophage	NOUN
aji-166	343	6	of	of	ADP
aji-166	343	7	patients	patient	NOUN
aji-166	343	8	under	under	ADP
aji-166	343	9	suppressive	suppressive	ADJ
aji-166	343	10	antiretroviral	antiretroviral	ADJ
aji-166	343	11	therapy	therapy	NOUN
aji-166	343	12	.	.	PUNCT
aji-166	344	1	nature	nature	NOUN
aji-166	344	2	microbiology	microbiology	NOUN
aji-166	344	3	,	,	PUNCT
aji-166	344	4	4(4	4(4	NUM
aji-166	344	5	)	)	PUNCT
aji-166	344	6	,	,	PUNCT
aji-166	344	7	633	633	NUM
aji-166	344	8	–	–	PUNCT
aji-166	344	9	644	644	NUM
aji-166	344	10	.	.	PUNCT
aji-166	345	1	https://doi.org/10.1038/s41564-0180335-z	https://doi.org/10.1038/s41564-0180335-z	PRON
aji-166	345	2	gramegna	gramegna	PROPN
aji-166	345	3	,	,	PUNCT
aji-166	345	4	p.	p.	NOUN
aji-166	345	5	,	,	PUNCT
aji-166	345	6	latronico	latronico	NOUN
aji-166	345	7	,	,	PUNCT
aji-166	345	8	t.	t.	PROPN
aji-166	345	9	,	,	PUNCT
aji-166	345	10	branà	branà	PROPN
aji-166	345	11	,	,	PUNCT
aji-166	345	12	m.	m.	NOUN
aji-166	345	13	t.	t.	PROPN
aji-166	345	14	,	,	PUNCT
aji-166	345	15	bari	bari	NOUN
aji-166	345	16	,	,	PUNCT
aji-166	345	17	g.	g.	PROPN
aji-166	345	18	d.	d.	PROPN
aji-166	345	19	,	,	PUNCT
aji-166	345	20	mengoni	mengoni	NOUN
aji-166	345	21	,	,	PUNCT
aji-166	345	22	f.	f.	PROPN
aji-166	345	23	,	,	PUNCT
aji-166	345	24	belvisi	belvisi	ADJ
aji-166	345	25	,	,	PUNCT
aji-166	345	26	v.	v.	PROPN
aji-166	345	27	,	,	PUNCT
aji-166	345	28	mascellino	mascellino	PROPN
aji-166	345	29	,	,	PUNCT
aji-166	345	30	m.	m.	NOUN
aji-166	345	31	t.	t.	PROPN
aji-166	345	32	,	,	PUNCT
aji-166	345	33	lichtner	lichtner	ADJ
aji-166	345	34	,	,	PUNCT
aji-166	345	35	m.	m.	NOUN
aji-166	345	36	,	,	PUNCT
aji-166	345	37	et	et	PROPN
aji-166	345	38	al	al	PROPN
aji-166	345	39	.	.	PUNCT
aji-166	345	40	(	(	PUNCT
aji-166	345	41	2011	2011	NUM
aji-166	345	42	)	)	PUNCT
aji-166	345	43	.	.	PUNCT
aji-166	346	1	in	in	ADP
aji-166	346	2	vitro	vitro	X
aji-166	346	3	downregulation	downregulation	NOUN
aji-166	346	4	of	of	ADP
aji-166	346	5	matrix	matrix	NOUN
aji-166	346	6	metalloproteinase-9	metalloproteinase-9	NUM
aji-166	346	7	in	in	ADP
aji-166	346	8	rat	rat	NOUN
aji-166	346	9	glial	glial	ADJ
aji-166	346	10	cells	cell	NOUN
aji-166	346	11	by	by	ADP
aji-166	346	12	ccr5	ccr5	NOUN
aji-166	346	13	antagonist	antagonist	NOUN
aji-166	346	14	maraviroc	maraviroc	NOUN
aji-166	346	15	:	:	PUNCT
aji-166	346	16	therapeutic	therapeutic	ADJ
aji-166	346	17	implication	implication	NOUN
aji-166	346	18	for	for	ADP
aji-166	346	19	hiv	hiv	PROPN
aji-166	346	20	brain	brain	NOUN
aji-166	346	21	infection	infection	NOUN
aji-166	346	22	.	.	PUNCT
aji-166	347	1	plos	plos	PROPN
aji-166	347	2	one	one	NUM
aji-166	347	3	,	,	PUNCT
aji-166	347	4	6(12	6(12	NUM
aji-166	347	5	)	)	PUNCT
aji-166	347	6	,	,	PUNCT
aji-166	348	1	e28499	e28499	PROPN
aji-166	348	2	.	.	PUNCT
aji-166	349	1	https://doi.org/10.1371/journal.pone.00284	https://doi.org/10.1371/journal.pone.00284	PROPN
aji-166	349	2	99	99	NUM
aji-166	349	3	grivennikov	grivennikov	NOUN
aji-166	349	4	,	,	PUNCT
aji-166	349	5	s.	s.	PROPN
aji-166	349	6	i.	i.	PROPN
aji-166	349	7	,	,	PUNCT
aji-166	349	8	greten	greten	PROPN
aji-166	349	9	,	,	PUNCT
aji-166	349	10	f.	f.	PROPN
aji-166	349	11	r.	r.	PROPN
aji-166	349	12	,	,	PUNCT
aji-166	349	13	&	&	CCONJ
aji-166	349	14	karin	karin	PROPN
aji-166	349	15	,	,	PUNCT
aji-166	349	16	m.	m.	NOUN
aji-166	349	17	(	(	PUNCT
aji-166	349	18	2010	2010	NUM
aji-166	349	19	)	)	PUNCT
aji-166	349	20	.	.	PUNCT
aji-166	350	1	immunity	immunity	NOUN
aji-166	350	2	,	,	PUNCT
aji-166	350	3	inflammation	inflammation	NOUN
aji-166	350	4	,	,	PUNCT
aji-166	350	5	and	and	CCONJ
aji-166	350	6	cancer	cancer	NOUN
aji-166	350	7	.	.	PUNCT
aji-166	351	1	cell	cell	NOUN
aji-166	351	2	,	,	PUNCT
aji-166	351	3	140(6	140(6	NUM
aji-166	351	4	)	)	PUNCT
aji-166	351	5	,	,	PUNCT
aji-166	351	6	883	883	NUM
aji-166	351	7	.	.	PUNCT
aji-166	352	1	https://doi.org/10.1016/j.cell.2010.01.025	https://doi.org/10.1016/j.cell.2010.01.025	NUM
aji-166	352	2	grulich	grulich	NOUN
aji-166	352	3	,	,	PUNCT
aji-166	352	4	a.	a.	PROPN
aji-166	352	5	e.	e.	PROPN
aji-166	352	6	,	,	PUNCT
aji-166	352	7	van	van	PROPN
aji-166	352	8	leeuwen	leeuwen	PROPN
aji-166	352	9	,	,	PUNCT
aji-166	352	10	m.	m.	NOUN
aji-166	352	11	t.	t.	PROPN
aji-166	352	12	,	,	PUNCT
aji-166	352	13	falster	falster	NOUN
aji-166	352	14	,	,	PUNCT
aji-166	352	15	m.	m.	NOUN
aji-166	352	16	o.	o.	PROPN
aji-166	352	17	,	,	PUNCT
aji-166	352	18	&	&	CCONJ
aji-166	352	19	vajdic	vajdic	ADJ
aji-166	352	20	,	,	PUNCT
aji-166	352	21	c.	c.	PROPN
aji-166	352	22	m.	m.	NOUN
aji-166	352	23	(	(	PUNCT
aji-166	352	24	2007	2007	NUM
aji-166	352	25	)	)	PUNCT
aji-166	352	26	.	.	PUNCT
aji-166	353	1	incidence	incidence	NOUN
aji-166	353	2	of	of	ADP
aji-166	353	3	cancers	cancer	NOUN
aji-166	353	4	in	in	ADP
aji-166	353	5	people	people	NOUN
aji-166	353	6	with	with	ADP
aji-166	353	7	hiv	hiv	PROPN
aji-166	353	8	/	/	SYM
aji-166	353	9	aids	aid	NOUN
aji-166	353	10	compared	compare	VERB
aji-166	353	11	with	with	ADP
aji-166	353	12	immunosuppressed	immunosuppressed	ADJ
aji-166	353	13	transplant	transplant	NOUN
aji-166	353	14	recipients	recipient	NOUN
aji-166	353	15	:	:	PUNCT
aji-166	353	16	a	a	DET
aji-166	353	17	meta	meta	ADJ
aji-166	353	18	-	-	PUNCT
aji-166	353	19	analysis	analysis	NOUN
aji-166	353	20	.	.	PUNCT
aji-166	354	1	lancet	lancet	PROPN
aji-166	354	2	(	(	PUNCT
aji-166	354	3	london	london	PROPN
aji-166	354	4	,	,	PUNCT
aji-166	354	5	england	england	PROPN
aji-166	354	6	)	)	PUNCT
aji-166	354	7	,	,	PUNCT
aji-166	354	8	370(9581	370(9581	NUM
aji-166	354	9	)	)	PUNCT
aji-166	354	10	,	,	PUNCT
aji-166	354	11	59	59	NUM
aji-166	354	12	–	–	SYM
aji-166	354	13	67	67	NUM
aji-166	354	14	.	.	PUNCT
aji-166	354	15	https://doi.org/10.1016/s01406736(07)61050-2	https://doi.org/10.1016/s01406736(07)61050-2	PROPN
aji-166	354	16	harshithkumar	harshithkumar	PROPN
aji-166	354	17	,	,	PUNCT
aji-166	354	18	r.	r.	PROPN
aji-166	354	19	,	,	PUNCT
aji-166	354	20	shah	shah	NOUN
aji-166	354	21	,	,	PUNCT
aji-166	354	22	p.	p.	PROPN
aji-166	354	23	,	,	PUNCT
aji-166	354	24	jadaun	jadaun	ADJ
aji-166	354	25	,	,	PUNCT
aji-166	354	26	p.	p.	NOUN
aji-166	354	27	,	,	PUNCT
aji-166	354	28	&	&	CCONJ
aji-166	354	29	mukherjee	mukherjee	PROPN
aji-166	354	30	,	,	PUNCT
aji-166	354	31	a.	a.	NOUN
aji-166	354	32	(	(	PUNCT
aji-166	354	33	2024	2024	NUM
aji-166	354	34	)	)	PUNCT
aji-166	354	35	.	.	PUNCT
aji-166	355	1	ros	ros	PROPN
aji-166	355	2	chronicles	chronicle	NOUN
aji-166	355	3	in	in	ADP
aji-166	355	4	hiv	hiv	PROPN
aji-166	355	5	infection	infection	NOUN
aji-166	355	6	:	:	PUNCT
aji-166	355	7	genesis	genesis	NOUN
aji-166	355	8	of	of	ADP
aji-166	355	9	oxidative	oxidative	ADJ
aji-166	355	10	stress	stress	NOUN
aji-166	355	11	,	,	PUNCT
aji-166	355	12	associated	associated	ADJ
aji-166	355	13	pathologies	pathology	NOUN
aji-166	355	14	,	,	PUNCT
aji-166	355	15	and	and	CCONJ
aji-166	355	16	therapeutic	therapeutic	ADJ
aji-166	355	17	strategies	strategy	NOUN
aji-166	355	18	.	.	PUNCT
aji-166	356	1	current	current	ADJ
aji-166	356	2	issues	issue	NOUN
aji-166	356	3	in	in	ADP
aji-166	356	4	molecular	molecular	ADJ
aji-166	356	5	biology	biology	NOUN
aji-166	356	6	,	,	PUNCT
aji-166	356	7	46(8	46(8	NOUN
aji-166	356	8	)	)	PUNCT
aji-166	356	9	,	,	PUNCT
aji-166	356	10	8852	8852	NUM
aji-166	356	11	-	-	SYM
aji-166	356	12	8873	8873	NUM
aji-166	356	13	.	.	PUNCT
aji-166	357	1	https://doi.org/10.3390/cimb46080523	https://doi.org/10.3390/cimb46080523	PROPN
aji-166	357	2	hernandez	hernandez	PROPN
aji-166	357	3	,	,	PUNCT
aji-166	357	4	c.	c.	PROPN
aji-166	357	5	,	,	PUNCT
aji-166	357	6	gorska	gorska	PROPN
aji-166	357	7	,	,	PUNCT
aji-166	357	8	a.	a.	NOUN
aji-166	357	9	m.	m.	NOUN
aji-166	357	10	,	,	PUNCT
aji-166	357	11	&	&	CCONJ
aji-166	357	12	eugenin	eugenin	PROPN
aji-166	357	13	,	,	PUNCT
aji-166	357	14	e.	e.	PROPN
aji-166	357	15	(	(	PUNCT
aji-166	357	16	2024	2024	NUM
aji-166	357	17	)	)	PUNCT
aji-166	357	18	.	.	PUNCT
aji-166	358	1	mechanisms	mechanism	NOUN
aji-166	358	2	of	of	ADP
aji-166	358	3	hiv	hiv	PROPN
aji-166	358	4	-	-	PUNCT
aji-166	358	5	mediated	mediate	VERB
aji-166	358	6	blood	blood	NOUN
aji-166	358	7	-	-	PUNCT
aji-166	358	8	brain	brain	NOUN
aji-166	358	9	barrier	barrier	NOUN
aji-166	358	10	compromise	compromise	NOUN
aji-166	358	11	and	and	CCONJ
aji-166	358	12	leukocyte	leukocyte	ADJ
aji-166	358	13	transmigration	transmigration	NOUN
aji-166	358	14	under	under	ADP
aji-166	358	15	the	the	DET
aji-166	358	16	current	current	ADJ
aji-166	358	17	antiretroviral	antiretroviral	ADJ
aji-166	358	18	era	era	NOUN
aji-166	358	19	.	.	PUNCT
aji-166	359	1	iscience	iscience	NOUN
aji-166	359	2	,	,	PUNCT
aji-166	359	3	27(3	27(3	NUM
aji-166	359	4	)	)	PUNCT
aji-166	359	5	,	,	PUNCT
aji-166	359	6	109236	109236	NUM
aji-166	359	7	.	.	PUNCT
aji-166	360	1	https://doi.org/10.1016/j.isci.2024.109236	https://doi.org/10.1016/j.isci.2024.109236	ADJ
aji-166	360	2	hoffmann	hoffmann	PROPN
aji-166	360	3	,	,	PUNCT
aji-166	360	4	c.	c.	PROPN
aji-166	360	5	,	,	PUNCT
aji-166	360	6	djerir	djerir	NOUN
aji-166	360	7	,	,	PUNCT
aji-166	360	8	n.	n.	PROPN
aji-166	360	9	e.	e.	PROPN
aji-166	360	10	,	,	PUNCT
aji-166	360	11	danckaert	danckaert	PROPN
aji-166	360	12	,	,	PUNCT
aji-166	360	13	a.	a.	PROPN
aji-166	360	14	,	,	PUNCT
aji-166	360	15	fernandes	fernandes	PROPN
aji-166	360	16	,	,	PUNCT
aji-166	360	17	j.	j.	PROPN
aji-166	360	18	,	,	PUNCT
aji-166	360	19	roux	roux	NOUN
aji-166	360	20	,	,	PUNCT
aji-166	360	21	p.	p.	NOUN
aji-166	360	22	,	,	PUNCT
aji-166	360	23	charrueau	charrueau	PROPN
aji-166	360	24	,	,	PUNCT
aji-166	360	25	c.	c.	PROPN
aji-166	360	26	,	,	PUNCT
aji-166	360	27	lachagès	lachagès	PROPN
aji-166	360	28	,	,	PUNCT
aji-166	360	29	a.	a.	PROPN
aji-166	360	30	,	,	PUNCT
aji-166	360	31	charlotte	charlotte	PROPN
aji-166	360	32	,	,	PUNCT
aji-166	360	33	f.	f.	PROPN
aji-166	360	34	,	,	PUNCT
aji-166	360	35	brocheriou	brocheriou	NOUN
aji-166	360	36	,	,	PUNCT
aji-166	360	37	i.	i.	NOUN
aji-166	360	38	,	,	PUNCT
aji-166	360	39	clément	clément	PROPN
aji-166	360	40	,	,	PUNCT
aji-166	360	41	k.	k.	PROPN
aji-166	360	42	,	,	PUNCT
aji-166	360	43	foufelle	foufelle	PROPN
aji-166	360	44	,	,	PUNCT
aji-166	360	45	f.	f.	PROPN
aji-166	360	46	,	,	PUNCT
aji-166	360	47	ratziu	ratziu	NOUN
aji-166	360	48	,	,	PUNCT
aji-166	360	49	v.	v.	ADV
aji-166	360	50	,	,	PUNCT
aji-166	360	51	hainque	hainque	NOUN
aji-166	360	52	,	,	PUNCT
aji-166	360	53	b.	b.	PROPN
aji-166	360	54	,	,	PUNCT
aji-166	360	55	bigey	bigey	PROPN
aji-166	360	56	,	,	PUNCT
aji-166	360	57	p.	p.	PROPN
aji-166	360	58	,	,	PUNCT
aji-166	360	59	&	&	CCONJ
aji-166	360	60	escriou	escriou	PROPN
aji-166	360	61	,	,	PUNCT
aji-166	360	62	v.	v.	PROPN
aji-166	360	63	(	(	PUNCT
aji-166	360	64	2020	2020	NUM
aji-166	360	65	)	)	PUNCT
aji-166	360	66	.	.	PUNCT
aji-166	361	1	hepatic	hepatic	ADJ
aji-166	361	2	stellate	stellate	ADJ
aji-166	361	3	cell	cell	NOUN
aji-166	361	4	hypertrophy	hypertrophy	NOUN
aji-166	361	5	is	be	AUX
aji-166	361	6	associated	associate	VERB
aji-166	361	7	with	with	ADP
aji-166	361	8	metabolic	metabolic	NOUN
aji-166	361	9	liver	liver	NOUN
aji-166	361	10	fibrosis	fibrosis	NOUN
aji-166	361	11	.	.	PUNCT
aji-166	362	1	scientific	scientific	ADJ
aji-166	362	2	reports	report	NOUN
aji-166	362	3	,	,	PUNCT
aji-166	362	4	10(1	10(1	NUM
aji-166	362	5	)	)	PUNCT
aji-166	362	6	,	,	PUNCT
aji-166	362	7	1	1	NUM
aji-166	362	8	-	-	SYM
aji-166	362	9	13	13	NUM
aji-166	362	10	.	.	PUNCT
aji-166	363	1	https://doi.org/10.1038/s41598-020-606150	https://doi.org/10.1038/s41598-020-606150	AUX
aji-166	363	2	hsue	hsue	NOUN
aji-166	363	3	,	,	PUNCT
aji-166	363	4	p.	p.	PROPN
aji-166	363	5	y.	y.	PROPN
aji-166	363	6	,	,	PUNCT
aji-166	363	7	deeks	deek	NOUN
aji-166	363	8	,	,	PUNCT
aji-166	363	9	s.	s.	PROPN
aji-166	363	10	g.	g.	PROPN
aji-166	363	11	,	,	PUNCT
aji-166	363	12	&	&	CCONJ
aji-166	363	13	hunt	hunt	PROPN
aji-166	363	14	,	,	PUNCT
aji-166	363	15	p.	p.	PROPN
aji-166	363	16	w.	w.	PROPN
aji-166	363	17	(	(	PUNCT
aji-166	363	18	2012	2012	NUM
aji-166	363	19	)	)	PUNCT
aji-166	363	20	.	.	PUNCT
aji-166	364	1	immunologic	immunologic	ADJ
aji-166	364	2	basis	basis	NOUN
aji-166	364	3	of	of	ADP
aji-166	364	4	cardiovascular	cardiovascular	ADJ
aji-166	364	5	disease	disease	NOUN
aji-166	364	6	in	in	ADP
aji-166	364	7	hiv	hiv	PROPN
aji-166	364	8	-	-	PUNCT
aji-166	364	9	infected	infect	VERB
aji-166	364	10	adults	adult	NOUN
aji-166	364	11	.	.	PUNCT
aji-166	365	1	the	the	DET
aji-166	365	2	journal	journal	NOUN
aji-166	365	3	of	of	ADP
aji-166	365	4	infectious	infectious	ADJ
aji-166	365	5	diseases	disease	NOUN
aji-166	365	6	,	,	PUNCT
aji-166	365	7	205	205	NUM
aji-166	365	8	suppl	suppl	ADJ
aji-166	365	9	3(suppl	3(suppl	PROPN
aji-166	365	10	3	3	NUM
aji-166	365	11	)	)	PUNCT
aji-166	365	12	,	,	PUNCT
aji-166	365	13	s375	s375	PROPN
aji-166	365	14	–	–	PUNCT
aji-166	365	15	s382	s382	PROPN
aji-166	365	16	.	.	PUNCT
aji-166	366	1	https://doi.org/10.1093/infdis/jis200	https://doi.org/10.1093/infdis/jis200	NOUN
aji-166	366	2	hughes	hughes	PROPN
aji-166	366	3	,	,	PUNCT
aji-166	366	4	k.	k.	PROPN
aji-166	366	5	,	,	PUNCT
aji-166	366	6	chang	chang	PROPN
aji-166	366	7	,	,	PUNCT
aji-166	366	8	j.	j.	PROPN
aji-166	366	9	,	,	PUNCT
aji-166	366	10	stadtler	stadtler	NOUN
aji-166	366	11	,	,	PUNCT
aji-166	366	12	h.	h.	PROPN
aji-166	366	13	,	,	PUNCT
aji-166	366	14	wyatt	wyatt	PROPN
aji-166	366	15	,	,	PUNCT
aji-166	366	16	c.	c.	PROPN
aji-166	366	17	,	,	PUNCT
aji-166	366	18	klotman	klotman	PROPN
aji-166	366	19	,	,	PUNCT
aji-166	366	20	m.	m.	NOUN
aji-166	366	21	,	,	PUNCT
aji-166	366	22	&	&	CCONJ
aji-166	366	23	blasi	blasi	PROPN
aji-166	366	24	,	,	PUNCT
aji-166	366	25	m.	m.	NOUN
aji-166	366	26	(	(	PUNCT
aji-166	366	27	2021	2021	NUM
aji-166	366	28	)	)	PUNCT
aji-166	366	29	.	.	PUNCT
aji-166	367	1	hiv-1	hiv-1	X
aji-166	367	2	infection	infection	NOUN
aji-166	367	3	of	of	ADP
aji-166	367	4	the	the	DET
aji-166	367	5	kidney	kidney	NOUN
aji-166	367	6	:	:	PUNCT
aji-166	367	7	mechanisms	mechanism	NOUN
aji-166	367	8	and	and	CCONJ
aji-166	367	9	implications	implication	NOUN
aji-166	367	10	.	.	PUNCT
aji-166	368	1	aids	aids	PROPN
aji-166	368	2	(	(	PUNCT
aji-166	368	3	london	london	PROPN
aji-166	368	4	,	,	PUNCT
aji-166	368	5	england	england	PROPN
aji-166	368	6	)	)	PUNCT
aji-166	368	7	,	,	PUNCT
aji-166	368	8	35(3	35(3	NUM
aji-166	368	9	)	)	PUNCT
aji-166	368	10	,	,	PUNCT
aji-166	368	11	359	359	NUM
aji-166	368	12	.	.	PUNCT
aji-166	369	1	https://doi.org/10.1097/qad.00000000000	https://doi.org/10.1097/qad.00000000000	PROPN
aji-166	369	2	02753	02753	NUM
aji-166	369	3	ivanov	ivanov	PROPN
aji-166	369	4	,	,	PUNCT
aji-166	369	5	a.	a.	PROPN
aji-166	369	6	v.	v.	PROPN
aji-166	369	7	,	,	PUNCT
aji-166	369	8	valuev	valuev	PROPN
aji-166	369	9	-	-	PUNCT
aji-166	369	10	elliston	elliston	PROPN
aji-166	369	11	,	,	PUNCT
aji-166	369	12	v.	v.	PROPN
aji-166	369	13	t.	t.	PROPN
aji-166	369	14	,	,	PUNCT
aji-166	369	15	ivanova	ivanova	PROPN
aji-166	369	16	,	,	PUNCT
aji-166	369	17	o.	o.	PROPN
aji-166	369	18	n.	n.	PROPN
aji-166	369	19	,	,	PUNCT
aji-166	369	20	kochetkov	kochetkov	PROPN
aji-166	369	21	,	,	PUNCT
aji-166	369	22	s.	s.	PROPN
aji-166	369	23	n.	n.	PROPN
aji-166	369	24	,	,	PUNCT
aji-166	369	25	starodubova	starodubova	PROPN
aji-166	369	26	,	,	PUNCT
aji-166	369	27	e.	e.	PROPN
aji-166	369	28	s.	s.	PROPN
aji-166	369	29	,	,	PUNCT
aji-166	369	30	bartosch	bartosch	PROPN
aji-166	369	31	,	,	PUNCT
aji-166	369	32	b.	b.	PROPN
aji-166	369	33	,	,	PUNCT
aji-166	369	34	&	&	CCONJ
aji-166	369	35	isaguliants	isaguliant	NOUN
aji-166	369	36	,	,	PUNCT
aji-166	369	37	m.	m.	NOUN
aji-166	369	38	g.	g.	PROPN
aji-166	369	39	(	(	PUNCT
aji-166	369	40	2016	2016	NUM
aji-166	369	41	)	)	PUNCT
aji-166	369	42	.	.	PUNCT
aji-166	370	1	oxidative	oxidative	ADJ
aji-166	370	2	stress	stress	NOUN
aji-166	370	3	during	during	ADP
aji-166	370	4	hiv	hiv	PROPN
aji-166	370	5	infection	infection	NOUN
aji-166	370	6	:	:	PUNCT
aji-166	370	7	mechanisms	mechanism	NOUN
aji-166	370	8	and	and	CCONJ
aji-166	370	9	consequences	consequence	NOUN
aji-166	370	10	.	.	PUNCT
aji-166	371	1	oxidative	oxidative	ADJ
aji-166	371	2	medicine	medicine	NOUN
aji-166	371	3	and	and	CCONJ
aji-166	371	4	cellular	cellular	ADJ
aji-166	371	5	longevity	longevity	NOUN
aji-166	371	6	,	,	PUNCT
aji-166	371	7	2016	2016	NUM
aji-166	371	8	,	,	PUNCT
aji-166	371	9	8910396	8910396	NUM
aji-166	371	10	.	.	PUNCT
aji-166	372	1	https://doi.org/10.1155/2016/8910396	https://doi.org/10.1155/2016/8910396	PROPN
aji-166	372	2	jebari	jebari	PROPN
aji-166	372	3	-	-	PUNCT
aji-166	372	4	benslaiman	benslaiman	NOUN
aji-166	372	5	,	,	PUNCT
aji-166	372	6	s.	s.	PROPN
aji-166	372	7	,	,	PUNCT
aji-166	372	8	galicia	galicia	PROPN
aji-166	372	9	-	-	PUNCT
aji-166	372	10	garcía	garcía	ADJ
aji-166	372	11	,	,	PUNCT
aji-166	372	12	u.	u.	PROPN
aji-166	372	13	,	,	PUNCT
aji-166	372	14	larrea	larrea	NOUN
aji-166	372	15	-	-	PUNCT
aji-166	372	16	sebal	sebal	PROPN
aji-166	372	17	,	,	PUNCT
aji-166	372	18	a.	a.	NOUN
aji-166	372	19	,	,	PUNCT
aji-166	372	20	olaetxea	olaetxea	NOUN
aji-166	372	21	,	,	PUNCT
aji-166	372	22	j.	j.	PROPN
aji-166	372	23	r.	r.	PROPN
aji-166	372	24	,	,	PUNCT
aji-166	372	25	alloza	alloza	PROPN
aji-166	372	26	,	,	PUNCT
aji-166	372	27	i.	i.	PROPN
aji-166	372	28	,	,	PUNCT
aji-166	372	29	vandenbroeck	vandenbroeck	PROPN
aji-166	372	30	,	,	PUNCT
aji-166	372	31	k.	k.	PROPN
aji-166	372	32	,	,	PUNCT
aji-166	372	33	benito	benito	PROPN
aji-166	372	34	-	-	PROPN
aji-166	372	35	vicente	vicente	PROPN
aji-166	372	36	,	,	PUNCT
aji-166	372	37	a.	a.	PROPN
aji-166	372	38	,	,	PUNCT
aji-166	372	39	&	&	CCONJ
aji-166	372	40	martín	martín	PROPN
aji-166	372	41	,	,	PUNCT
aji-166	372	42	c.	c.	PROPN
aji-166	372	43	(	(	PUNCT
aji-166	372	44	2022	2022	NUM
aji-166	372	45	)	)	PUNCT
aji-166	372	46	.	.	PUNCT
aji-166	373	1	pathophysiology	pathophysiology	NOUN
aji-166	373	2	of	of	ADP
aji-166	373	3	atherosclerosis	atherosclerosis	NOUN
aji-166	373	4	.	.	PUNCT
aji-166	374	1	international	international	ADJ
aji-166	374	2	journal	journal	NOUN
aji-166	374	3	of	of	ADP
aji-166	374	4	molecular	molecular	ADJ
aji-166	374	5	sciences	science	NOUN
aji-166	374	6	,	,	PUNCT
aji-166	374	7	23(6	23(6	NUM
aji-166	374	8	)	)	PUNCT
aji-166	374	9	,	,	PUNCT
aji-166	374	10	3346	3346	NUM
aji-166	374	11	.	.	PUNCT
aji-166	375	1	https://doi.org/10.3390/ijms23063346	https://doi.org/10.3390/ijms23063346	PROPN
aji-166	375	2	joseph	joseph	PROPN
aji-166	375	3	,	,	PUNCT
aji-166	375	4	j.	j.	PROPN
aji-166	375	5	,	,	PUNCT
aji-166	375	6	daley	daley	PROPN
aji-166	375	7	,	,	PUNCT
aji-166	375	8	w.	w.	PROPN
aji-166	375	9	,	,	PUNCT
aji-166	375	10	lawrence	lawrence	PROPN
aji-166	375	11	,	,	PUNCT
aji-166	375	12	d.	d.	PROPN
aji-166	375	13	,	,	PUNCT
aji-166	375	14	lorenzo	lorenzo	PROPN
aji-166	375	15	,	,	PUNCT
aji-166	375	16	e.	e.	PROPN
aji-166	375	17	,	,	PUNCT
aji-166	375	18	perrin	perrin	NOUN
aji-166	375	19	,	,	PUNCT
aji-166	375	20	p.	p.	PROPN
aji-166	375	21	,	,	PUNCT
aji-166	375	22	rao	rao	PROPN
aji-166	375	23	,	,	PUNCT
aji-166	375	24	v.	v.	PROPN
aji-166	375	25	r.	r.	PROPN
aji-166	375	26	,	,	PUNCT
aji-166	375	27	tsai	tsai	PROPN
aji-166	375	28	,	,	PUNCT
aji-166	375	29	y.	y.	PROPN
aji-166	375	30	,	,	PUNCT
aji-166	375	31	&	&	CCONJ
aji-166	375	32	varthakavi	varthakavi	PROPN
aji-166	375	33	,	,	PUNCT
aji-166	375	34	v.	v.	PROPN
aji-166	375	35	(	(	PUNCT
aji-166	375	36	2022	2022	NUM
aji-166	375	37	)	)	PUNCT
aji-166	375	38	.	.	PUNCT
aji-166	376	1	role	role	NOUN
aji-166	376	2	of	of	ADP
aji-166	376	3	macrophages	macrophage	NOUN
aji-166	376	4	in	in	ADP
aji-166	376	5	hiv	hiv	PROPN
aji-166	376	6	pathogenesis	pathogenesis	NOUN
aji-166	376	7	and	and	CCONJ
aji-166	376	8	cure	cure	NOUN
aji-166	376	9	:	:	PUNCT
aji-166	376	10	nih	nih	PROPN
aji-166	376	11	perspectives	perspective	NOUN
aji-166	376	12	.	.	PUNCT
aji-166	377	1	journal	journal	NOUN
aji-166	377	2	of	of	ADP
aji-166	377	3	leukocyte	leukocyte	NOUN
aji-166	377	4	biology	biology	NOUN
aji-166	377	5	,	,	PUNCT
aji-166	377	6	112(5	112(5	NUM
aji-166	377	7	)	)	PUNCT
aji-166	377	8	,	,	PUNCT
aji-166	377	9	1233	1233	NUM
aji-166	377	10	-	-	SYM
aji-166	377	11	1243	1243	NUM
aji-166	377	12	.	.	PUNCT
aji-166	378	1	https://doi.org/10.1002/jlb.4mr0722619r	https://doi.org/10.1002/jlb.4mr0722619r	ADJ
aji-166	378	2	kapellos	kapello	NOUN
aji-166	378	3	,	,	PUNCT
aji-166	378	4	t.	t.	PROPN
aji-166	378	5	s.	s.	PROPN
aji-166	378	6	,	,	PUNCT
aji-166	378	7	bonaguro	bonaguro	PROPN
aji-166	378	8	,	,	PUNCT
aji-166	378	9	l.	l.	PROPN
aji-166	378	10	,	,	PUNCT
aji-166	378	11	gemünd	gemünd	PROPN
aji-166	378	12	,	,	PUNCT
aji-166	378	13	i.	i.	PROPN
aji-166	378	14	,	,	PUNCT
aji-166	378	15	reusch	reusch	PROPN
aji-166	378	16	,	,	PUNCT
aji-166	378	17	n.	n.	NOUN
aji-166	378	18	,	,	PUNCT
aji-166	378	19	saglam	saglam	PROPN
aji-166	378	20	,	,	PUNCT
aji-166	378	21	a.	a.	PROPN
aji-166	378	22	,	,	PUNCT
aji-166	378	23	hinkley	hinkley	PROPN
aji-166	378	24	,	,	PUNCT
aji-166	378	25	e.	e.	PROPN
aji-166	378	26	r.	r.	PROPN
aji-166	378	27	,	,	PUNCT
aji-166	378	28	&	&	CCONJ
aji-166	378	29	schultze	schultze	PROPN
aji-166	378	30	,	,	PUNCT
aji-166	378	31	j.	j.	PROPN
aji-166	378	32	l.	l.	PROPN
aji-166	378	33	(	(	PUNCT
aji-166	378	34	2019	2019	NUM
aji-166	378	35	)	)	PUNCT
aji-166	378	36	.	.	PUNCT
aji-166	379	1	human	human	ADJ
aji-166	379	2	monocyte	monocyte	NOUN
aji-166	379	3	subsets	subset	NOUN
aji-166	379	4	and	and	CCONJ
aji-166	379	5	phenotypes	phenotype	NOUN
aji-166	379	6	in	in	ADP
aji-166	379	7	major	major	ADJ
aji-166	379	8	chronic	chronic	ADJ
aji-166	379	9	inflammatory	inflammatory	ADJ
aji-166	379	10	diseases	disease	NOUN
aji-166	379	11	.	.	PUNCT
aji-166	380	1	frontiers	frontier	NOUN
aji-166	380	2	in	in	ADP
aji-166	380	3	immunology	immunology	NOUN
aji-166	380	4	,	,	PUNCT
aji-166	380	5	10	10	NUM
aji-166	380	6	,	,	PUNCT
aji-166	380	7	2035	2035	NUM
aji-166	380	8	.	.	PUNCT
aji-166	381	1	https://doi.org/10.3389/fimmu.2019.02035	https://doi.org/10.3389/fimmu.2019.02035	PROPN
aji-166	381	2	adavba	adavba	NOUN
aji-166	381	3	;	;	PUNCT
aji-166	381	4	asian	asian	PROPN
aji-166	381	5	j.	j.	PROPN
aji-166	381	6	immunol	immunol	PROPN
aji-166	381	7	.	.	PROPN
aji-166	381	8	,	,	PUNCT
aji-166	381	9	vol	vol	NOUN
aji-166	381	10	.	.	PROPN
aji-166	381	11	8	8	NUM
aji-166	381	12	,	,	PUNCT
aji-166	381	13	no	no	INTJ
aji-166	381	14	.	.	NOUN
aji-166	381	15	1	1	NUM
aji-166	381	16	,	,	PUNCT
aji-166	381	17	pp	pp	ADJ
aji-166	381	18	.	.	PUNCT
aji-166	382	1	120	120	NUM
aji-166	382	2	-	-	SYM
aji-166	382	3	133	133	NUM
aji-166	382	4	,	,	PUNCT
aji-166	382	5	2025	2025	NUM
aji-166	382	6	;	;	PUNCT
aji-166	382	7	article	article	NOUN
aji-166	382	8	no.aji.136909	no.aji.136909	PROPN
aji-166	382	9	131	131	NUM
aji-166	382	10	kaspar	kaspar	NOUN
aji-166	382	11	,	,	PUNCT
aji-166	382	12	m.	m.	PROPN
aji-166	382	13	b.	b.	PROPN
aji-166	382	14	,	,	PUNCT
aji-166	382	15	&	&	CCONJ
aji-166	382	16	sterling	sterling	PROPN
aji-166	382	17	,	,	PUNCT
aji-166	382	18	r.	r.	PROPN
aji-166	382	19	k.	k.	PROPN
aji-166	382	20	(	(	PUNCT
aji-166	382	21	2017	2017	NUM
aji-166	382	22	)	)	PUNCT
aji-166	382	23	.	.	PUNCT
aji-166	383	1	mechanisms	mechanism	NOUN
aji-166	383	2	of	of	ADP
aji-166	383	3	liver	liver	NOUN
aji-166	383	4	disease	disease	NOUN
aji-166	383	5	in	in	ADP
aji-166	383	6	patients	patient	NOUN
aji-166	383	7	infected	infect	VERB
aji-166	383	8	with	with	ADP
aji-166	383	9	hiv	hiv	PROPN
aji-166	383	10	.	.	PUNCT
aji-166	384	1	bmj	bmj	PROPN
aji-166	384	2	open	open	ADJ
aji-166	384	3	gastroenterology	gastroenterology	NOUN
aji-166	384	4	,	,	PUNCT
aji-166	384	5	4(1	4(1	NUM
aji-166	384	6	)	)	PUNCT
aji-166	384	7	,	,	PUNCT
aji-166	384	8	e000166	e000166	PROPN
aji-166	384	9	.	.	PUNCT
aji-166	385	1	https://doi.org/10.1136/bmjgast-2017000166	https://doi.org/10.1136/bmjgast-2017000166	PROPN
aji-166	385	2	kedzierska	kedzierska	PROPN
aji-166	385	3	,	,	PUNCT
aji-166	385	4	k.	k.	PROPN
aji-166	385	5	,	,	PUNCT
aji-166	385	6	&	&	CCONJ
aji-166	385	7	crowe	crowe	PROPN
aji-166	385	8	,	,	PUNCT
aji-166	385	9	s.	s.	PROPN
aji-166	385	10	m.	m.	PROPN
aji-166	385	11	(	(	PUNCT
aji-166	385	12	2001	2001	NUM
aji-166	385	13	)	)	PUNCT
aji-166	385	14	.	.	PUNCT
aji-166	386	1	cytokines	cytokine	NOUN
aji-166	386	2	and	and	CCONJ
aji-166	386	3	hiv-1	hiv-1	X
aji-166	386	4	:	:	PUNCT
aji-166	386	5	interactions	interaction	NOUN
aji-166	386	6	and	and	CCONJ
aji-166	386	7	clinical	clinical	ADJ
aji-166	386	8	implications	implication	NOUN
aji-166	386	9	.	.	PUNCT
aji-166	387	1	antiviral	antiviral	ADJ
aji-166	387	2	chemistry	chemistry	PROPN
aji-166	387	3	&	&	CCONJ
aji-166	387	4	chemotherapy	chemotherapy	PROPN
aji-166	387	5	,	,	PUNCT
aji-166	387	6	12(3	12(3	NUM
aji-166	387	7	)	)	PUNCT
aji-166	387	8	,	,	PUNCT
aji-166	387	9	133–150	133–150	NUM
aji-166	387	10	.	.	PUNCT
aji-166	388	1	https://doi.org/10.1177/0956320201012003	https://doi.org/10.1177/0956320201012003	PROPN
aji-166	388	2	01	01	NUM
aji-166	388	3	kruize	kruize	PROPN
aji-166	388	4	,	,	PUNCT
aji-166	388	5	z.	z.	PROPN
aji-166	388	6	,	,	PUNCT
aji-166	388	7	&	&	CCONJ
aji-166	388	8	kootstra	kootstra	PROPN
aji-166	388	9	,	,	PUNCT
aji-166	388	10	n.	n.	NOUN
aji-166	388	11	a.	a.	NOUN
aji-166	388	12	(	(	PUNCT
aji-166	388	13	2019	2019	NUM
aji-166	388	14	)	)	PUNCT
aji-166	388	15	.	.	PUNCT
aji-166	389	1	the	the	DET
aji-166	389	2	role	role	NOUN
aji-166	389	3	of	of	ADP
aji-166	389	4	macrophages	macrophage	NOUN
aji-166	389	5	in	in	ADP
aji-166	389	6	hiv-1	hiv-1	ADJ
aji-166	389	7	persistence	persistence	NOUN
aji-166	389	8	and	and	CCONJ
aji-166	389	9	pathogenesis	pathogenesis	NOUN
aji-166	389	10	.	.	PUNCT
aji-166	390	1	frontiers	frontier	NOUN
aji-166	390	2	in	in	ADP
aji-166	390	3	microbiology	microbiology	NOUN
aji-166	390	4	,	,	PUNCT
aji-166	390	5	10	10	NUM
aji-166	390	6	,	,	PUNCT
aji-166	390	7	2828	2828	NUM
aji-166	390	8	.	.	PUNCT
aji-166	391	1	https://doi.org/10.3389/fmicb.2019.02828	https://doi.org/10.3389/fmicb.2019.02828	PROPN
aji-166	391	2	lederman	lederman	PROPN
aji-166	391	3	,	,	PUNCT
aji-166	391	4	m.	m.	NOUN
aji-166	391	5	m.	m.	NOUN
aji-166	391	6	,	,	PUNCT
aji-166	391	7	funderburg	funderburg	PROPN
aji-166	391	8	,	,	PUNCT
aji-166	391	9	n.	n.	PROPN
aji-166	391	10	t.	t.	PROPN
aji-166	391	11	,	,	PUNCT
aji-166	391	12	sekaly	sekaly	PROPN
aji-166	391	13	,	,	PUNCT
aji-166	391	14	r.	r.	PROPN
aji-166	391	15	p.	p.	PROPN
aji-166	391	16	,	,	PUNCT
aji-166	391	17	klatt	klatt	PROPN
aji-166	391	18	,	,	PUNCT
aji-166	391	19	n.	n.	PROPN
aji-166	391	20	r.	r.	PROPN
aji-166	391	21	,	,	PUNCT
aji-166	391	22	&	&	CCONJ
aji-166	391	23	hunt	hunt	PROPN
aji-166	391	24	,	,	PUNCT
aji-166	391	25	p.	p.	PROPN
aji-166	391	26	w.	w.	PROPN
aji-166	391	27	(	(	PUNCT
aji-166	391	28	2013	2013	NUM
aji-166	391	29	)	)	PUNCT
aji-166	391	30	.	.	PUNCT
aji-166	392	1	residual	residual	ADJ
aji-166	392	2	immune	immune	ADJ
aji-166	392	3	dysregulation	dysregulation	NOUN
aji-166	392	4	syndrome	syndrome	NOUN
aji-166	392	5	in	in	ADP
aji-166	392	6	treated	treat	VERB
aji-166	392	7	hiv	hiv	PROPN
aji-166	392	8	infection	infection	NOUN
aji-166	392	9	.	.	PUNCT
aji-166	393	1	advances	advance	NOUN
aji-166	393	2	in	in	ADP
aji-166	393	3	immunology	immunology	NOUN
aji-166	393	4	,	,	PUNCT
aji-166	393	5	119	119	NUM
aji-166	393	6	,	,	PUNCT
aji-166	393	7	51–83	51–83	NUM
aji-166	393	8	.	.	PUNCT
aji-166	393	9	https://doi.org/10.1016/b978-0-12-4077072.00002-3	https://doi.org/10.1016/b978-0-12-4077072.00002-3	X
aji-166	394	1	león	león	PROPN
aji-166	394	2	-	-	PUNCT
aji-166	394	3	rivera	rivera	PROPN
aji-166	394	4	,	,	PUNCT
aji-166	394	5	r.	r.	PROPN
aji-166	394	6	,	,	PUNCT
aji-166	394	7	veenstra	veenstra	ADJ
aji-166	394	8	,	,	PUNCT
aji-166	394	9	m.	m.	NOUN
aji-166	394	10	,	,	PUNCT
aji-166	394	11	donoso	donoso	PROPN
aji-166	394	12	,	,	PUNCT
aji-166	394	13	m.	m.	NOUN
aji-166	394	14	,	,	PUNCT
aji-166	394	15	tell	tell	VERB
aji-166	394	16	,	,	PUNCT
aji-166	394	17	e.	e.	PROPN
aji-166	394	18	,	,	PUNCT
aji-166	394	19	eugenin	eugenin	PROPN
aji-166	394	20	,	,	PUNCT
aji-166	394	21	e.a	e.a	PROPN
aji-166	394	22	.	.	PROPN
aji-166	394	23	,	,	PUNCT
aji-166	394	24	morgello	morgello	PROPN
aji-166	394	25	,	,	PUNCT
aji-166	394	26	s.	s.	PROPN
aji-166	394	27	,	,	PUNCT
aji-166	394	28	berman	berman	PROPN
aji-166	394	29	,	,	PUNCT
aji-166	394	30	j.w	j.w	PROPN
aji-166	394	31	.	.	PROPN
aji-166	395	1	(	(	PUNCT
aji-166	395	2	2021	2021	NUM
aji-166	395	3	)	)	PUNCT
aji-166	395	4	.	.	PUNCT
aji-166	396	1	central	central	ADJ
aji-166	396	2	nervous	nervous	ADJ
aji-166	396	3	system	system	NOUN
aji-166	396	4	(	(	PUNCT
aji-166	396	5	cns	cns	NOUN
aji-166	396	6	)	)	PUNCT
aji-166	396	7	viral	viral	ADJ
aji-166	396	8	seeding	seeding	NOUN
aji-166	396	9	by	by	ADP
aji-166	396	10	mature	mature	ADJ
aji-166	396	11	monocytes	monocyte	NOUN
aji-166	396	12	and	and	CCONJ
aji-166	396	13	potential	potential	ADJ
aji-166	396	14	therapies	therapy	NOUN
aji-166	396	15	to	to	PART
aji-166	396	16	reduce	reduce	VERB
aji-166	396	17	cns	cns	NOUN
aji-166	396	18	viral	viral	ADJ
aji-166	396	19	reservoirs	reservoir	NOUN
aji-166	396	20	in	in	ADP
aji-166	396	21	the	the	DET
aji-166	396	22	cart	cart	NOUN
aji-166	396	23	era	era	NOUN
aji-166	396	24	.	.	PUNCT
aji-166	397	1	mbio12:10.1128	mbio12:10.1128	ADP
aji-166	397	2	/	/	SYM
aji-166	397	3	mbio.0363320.https://doi.org/10.1128	mbio.0363320.https://doi.org/10.1128	NOUN
aji-166	397	4	/	/	SYM
aji-166	397	5	mbio.03633	mbio.03633	PROPN
aji-166	397	6	-	-	PUNCT
aji-166	397	7	20	20	NUM
aji-166	397	8	li	li	PROPN
aji-166	397	9	,	,	PUNCT
aji-166	397	10	y.	y.	PROPN
aji-166	397	11	,	,	PUNCT
aji-166	397	12	wang	wang	PROPN
aji-166	397	13	,	,	PUNCT
aji-166	397	14	z.	z.	PROPN
aji-166	397	15	,	,	PUNCT
aji-166	397	16	hou	hou	PROPN
aji-166	397	17	,	,	PUNCT
aji-166	397	18	y.	y.	PROPN
aji-166	397	19	,	,	PUNCT
aji-166	397	20	liu	liu	PROPN
aji-166	397	21	,	,	PUNCT
aji-166	397	22	x.	x.	PROPN
aji-166	397	23	,	,	PUNCT
aji-166	397	24	hong	hong	PROPN
aji-166	397	25	,	,	PUNCT
aji-166	397	26	j.	j.	PROPN
aji-166	397	27	,	,	PUNCT
aji-166	397	28	shi	shi	PROPN
aji-166	397	29	,	,	PUNCT
aji-166	397	30	x.	x.	PROPN
aji-166	397	31	,	,	PUNCT
aji-166	397	32	huang	huang	PROPN
aji-166	397	33	,	,	PUNCT
aji-166	397	34	x.	x.	PROPN
aji-166	397	35	,	,	PUNCT
aji-166	397	36	zhang	zhang	PROPN
aji-166	397	37	,	,	PUNCT
aji-166	397	38	t.	t.	PROPN
aji-166	397	39	,	,	PUNCT
aji-166	397	40	et	et	PROPN
aji-166	397	41	al	al	PROPN
aji-166	397	42	.	.	PROPN
aji-166	398	1	(	(	PUNCT
aji-166	398	2	2023	2023	NUM
aji-166	398	3	)	)	PUNCT
aji-166	398	4	.	.	PUNCT
aji-166	399	1	novel	novel	NOUN
aji-166	399	2	tlr7/8	tlr7/8	NUM
aji-166	399	3	agonists	agonist	NOUN
aji-166	399	4	promote	promote	VERB
aji-166	399	5	activation	activation	NOUN
aji-166	399	6	of	of	ADP
aji-166	399	7	hiv-1	hiv-1	X
aji-166	399	8	latent	latent	NOUN
aji-166	399	9	reservoirs	reservoir	NOUN
aji-166	399	10	and	and	CCONJ
aji-166	399	11	human	human	PROPN
aji-166	399	12	t	t	PROPN
aji-166	399	13	and	and	CCONJ
aji-166	399	14	nk	nk	PROPN
aji-166	399	15	cells	cell	NOUN
aji-166	399	16	.	.	PUNCT
aji-166	400	1	frontiers	frontier	NOUN
aji-166	400	2	in	in	ADP
aji-166	400	3	microbiology	microbiology	NOUN
aji-166	400	4	,	,	PUNCT
aji-166	400	5	14	14	NUM
aji-166	400	6	,	,	PUNCT
aji-166	400	7	1033448	1033448	NUM
aji-166	400	8	.	.	PUNCT
aji-166	401	1	https://doi.org/10.3389/fmicb.2023.103344	https://doi.org/10.3389/fmicb.2023.103344	PROPN
aji-166	401	2	8	8	NUM
aji-166	401	3	li	li	PROPN
aji-166	401	4	,	,	PUNCT
aji-166	401	5	z.	z.	PROPN
aji-166	401	6	,	,	PUNCT
aji-166	401	7	duan	duan	PROPN
aji-166	401	8	,	,	PUNCT
aji-166	401	9	d.	d.	PROPN
aji-166	401	10	,	,	PUNCT
aji-166	401	11	li	li	PROPN
aji-166	401	12	,	,	PUNCT
aji-166	401	13	l.	l.	PROPN
aji-166	401	14	,	,	PUNCT
aji-166	401	15	peng	peng	PROPN
aji-166	401	16	,	,	PUNCT
aji-166	401	17	d.	d.	PROPN
aji-166	401	18	,	,	PUNCT
aji-166	401	19	ming	ming	PROPN
aji-166	401	20	,	,	PUNCT
aji-166	401	21	y.	y.	PROPN
aji-166	401	22	,	,	PUNCT
aji-166	401	23	ni	ni	PROPN
aji-166	401	24	,	,	PUNCT
aji-166	401	25	r.	r.	PROPN
aji-166	401	26	,	,	PUNCT
aji-166	401	27	&	&	CCONJ
aji-166	401	28	liu	liu	PROPN
aji-166	401	29	,	,	PUNCT
aji-166	401	30	y.	y.	PROPN
aji-166	401	31	(	(	PUNCT
aji-166	401	32	2024	2024	NUM
aji-166	401	33	)	)	PUNCT
aji-166	401	34	.	.	PUNCT
aji-166	402	1	tumor	tumor	NOUN
aji-166	402	2	-	-	PUNCT
aji-166	402	3	associated	associate	VERB
aji-166	402	4	macrophages	macrophage	NOUN
aji-166	402	5	in	in	ADP
aji-166	402	6	anti	anti	ADJ
aji-166	402	7	-	-	ADJ
aji-166	402	8	pd-1	pd-1	ADJ
aji-166	402	9	/	/	SYM
aji-166	402	10	pd	pd	NOUN
aji-166	402	11	-	-	PROPN
aji-166	402	12	l1	l1	PROPN
aji-166	402	13	immunotherapy	immunotherapy	NOUN
aji-166	402	14	for	for	ADP
aji-166	402	15	hepatocellular	hepatocellular	ADJ
aji-166	402	16	carcinoma	carcinoma	NOUN
aji-166	402	17	:	:	PUNCT
aji-166	402	18	recent	recent	ADJ
aji-166	402	19	research	research	NOUN
aji-166	402	20	progress	progress	NOUN
aji-166	402	21	.	.	PUNCT
aji-166	403	1	frontiers	frontier	NOUN
aji-166	403	2	in	in	ADP
aji-166	403	3	pharmacology	pharmacology	NOUN
aji-166	403	4	,	,	PUNCT
aji-166	403	5	15	15	NUM
aji-166	403	6	,	,	PUNCT
aji-166	403	7	1382256	1382256	NUM
aji-166	403	8	.	.	PUNCT
aji-166	404	1	https://doi.org/10.3389/fphar.2024.138225	https://doi.org/10.3389/fphar.2024.138225	PROPN
aji-166	404	2	6	6	NUM
aji-166	404	3	liberale	liberale	PROPN
aji-166	404	4	,	,	PUNCT
aji-166	404	5	l.	l.	PROPN
aji-166	404	6	,	,	PUNCT
aji-166	404	7	carbone	carbone	PROPN
aji-166	404	8	,	,	PUNCT
aji-166	404	9	f.	f.	PROPN
aji-166	404	10	,	,	PUNCT
aji-166	404	11	montecucco	montecucco	PROPN
aji-166	404	12	,	,	PUNCT
aji-166	404	13	f.	f.	PROPN
aji-166	404	14	,	,	PUNCT
aji-166	404	15	&	&	CCONJ
aji-166	404	16	sahebkar	sahebkar	PROPN
aji-166	404	17	,	,	PUNCT
aji-166	404	18	a.	a.	PROPN
aji-166	404	19	(	(	PUNCT
aji-166	404	20	2020	2020	NUM
aji-166	404	21	)	)	PUNCT
aji-166	404	22	.	.	PUNCT
aji-166	405	1	statins	statin	NOUN
aji-166	405	2	reduce	reduce	VERB
aji-166	405	3	vascular	vascular	ADJ
aji-166	405	4	inflammation	inflammation	NOUN
aji-166	405	5	in	in	ADP
aji-166	405	6	atherogenesis	atherogenesis	NOUN
aji-166	405	7	:	:	PUNCT
aji-166	405	8	a	a	DET
aji-166	405	9	review	review	NOUN
aji-166	405	10	of	of	ADP
aji-166	405	11	underlying	underlie	VERB
aji-166	405	12	molecular	molecular	ADJ
aji-166	405	13	mechanisms	mechanism	NOUN
aji-166	405	14	.	.	PUNCT
aji-166	406	1	the	the	DET
aji-166	406	2	international	international	ADJ
aji-166	406	3	journal	journal	NOUN
aji-166	406	4	of	of	ADP
aji-166	406	5	biochemistry	biochemistry	PROPN
aji-166	406	6	&	&	CCONJ
aji-166	406	7	cell	cell	NOUN
aji-166	406	8	biology	biology	NOUN
aji-166	406	9	,	,	PUNCT
aji-166	406	10	122	122	NUM
aji-166	406	11	,	,	PUNCT
aji-166	406	12	105735	105735	NUM
aji-166	406	13	.	.	PUNCT
aji-166	407	1	https://doi.org/10.1016/j.biocel.2020.10573	https://doi.org/10.1016/j.biocel.2020.10573	NOUN
aji-166	407	2	5	5	NUM
aji-166	407	3	lin	lin	PROPN
aji-166	407	4	,	,	PUNCT
aji-166	407	5	n.	n.	NOUN
aji-166	407	6	,	,	PUNCT
aji-166	407	7	erdos	erdo	NOUN
aji-166	407	8	,	,	PUNCT
aji-166	407	9	t.	t.	PROPN
aji-166	407	10	,	,	PUNCT
aji-166	407	11	louie	louie	PROPN
aji-166	407	12	,	,	PUNCT
aji-166	407	13	c.	c.	PROPN
aji-166	407	14	,	,	PUNCT
aji-166	407	15	desai	desai	PROPN
aji-166	407	16	,	,	PUNCT
aji-166	407	17	r.	r.	PROPN
aji-166	407	18	,	,	PUNCT
aji-166	407	19	lin	lin	PROPN
aji-166	407	20	,	,	PUNCT
aji-166	407	21	n.	n.	PROPN
aji-166	407	22	,	,	PUNCT
aji-166	407	23	ayzenberg	ayzenberg	PROPN
aji-166	407	24	,	,	PUNCT
aji-166	407	25	g.	g.	PROPN
aji-166	407	26	,	,	PUNCT
aji-166	407	27	&	&	CCONJ
aji-166	407	28	venketaraman	venketaraman	PROPN
aji-166	407	29	,	,	PUNCT
aji-166	407	30	v.	v.	CCONJ
aji-166	407	31	(	(	PUNCT
aji-166	407	32	2023	2023	NUM
aji-166	407	33	)	)	PUNCT
aji-166	407	34	.	.	PUNCT
aji-166	408	1	the	the	DET
aji-166	408	2	role	role	NOUN
aji-166	408	3	of	of	ADP
aji-166	408	4	glutathione	glutathione	NOUN
aji-166	408	5	in	in	ADP
aji-166	408	6	the	the	DET
aji-166	408	7	management	management	NOUN
aji-166	408	8	of	of	ADP
aji-166	408	9	cell	cell	NOUN
aji-166	408	10	-	-	PUNCT
aji-166	408	11	mediated	mediate	VERB
aji-166	408	12	immune	immune	ADJ
aji-166	408	13	responses	response	NOUN
aji-166	408	14	in	in	ADP
aji-166	408	15	individuals	individual	NOUN
aji-166	408	16	with	with	ADP
aji-166	408	17	hiv	hiv	PROPN
aji-166	408	18	.	.	PUNCT
aji-166	409	1	international	international	ADJ
aji-166	409	2	journal	journal	NOUN
aji-166	409	3	of	of	ADP
aji-166	409	4	molecular	molecular	ADJ
aji-166	409	5	sciences	science	NOUN
aji-166	409	6	,	,	PUNCT
aji-166	409	7	25(5	25(5	NUM
aji-166	409	8	)	)	PUNCT
aji-166	409	9	,	,	PUNCT
aji-166	409	10	2952	2952	NUM
aji-166	409	11	.	.	PUNCT
aji-166	410	1	https://doi.org/10.3390/ijms25052952	https://doi.org/10.3390/ijms25052952	NOUN
aji-166	410	2	lugo	lugo	PROPN
aji-166	410	3	-	-	PUNCT
aji-166	410	4	huitrón	huitrón	PROPN
aji-166	410	5	,	,	PUNCT
aji-166	410	6	r.	r.	PROPN
aji-166	410	7	,	,	PUNCT
aji-166	410	8	muñiz	muñiz	NOUN
aji-166	410	9	,	,	PUNCT
aji-166	410	10	p.	p.	PROPN
aji-166	410	11	u.	u.	PROPN
aji-166	410	12	,	,	PUNCT
aji-166	410	13	pineda	pineda	PROPN
aji-166	410	14	,	,	PUNCT
aji-166	410	15	b.	b.	PROPN
aji-166	410	16	,	,	PUNCT
aji-166	410	17	pedraza	pedraza	PROPN
aji-166	410	18	-	-	PUNCT
aji-166	410	19	chaverrí	chaverrí	PROPN
aji-166	410	20	,	,	PUNCT
aji-166	410	21	j.	j.	PROPN
aji-166	410	22	,	,	PUNCT
aji-166	410	23	&	&	CCONJ
aji-166	410	24	ríos	ríos	PROPN
aji-166	410	25	,	,	PUNCT
aji-166	410	26	c.	c.	PROPN
aji-166	410	27	(	(	PUNCT
aji-166	410	28	2013	2013	NUM
aji-166	410	29	)	)	PUNCT
aji-166	410	30	.	.	PUNCT
aji-166	411	1	quinolinic	quinolinic	ADJ
aji-166	411	2	acid	acid	NOUN
aji-166	411	3	:	:	PUNCT
aji-166	411	4	an	an	DET
aji-166	411	5	endogenous	endogenous	ADJ
aji-166	411	6	neurotoxin	neurotoxin	NOUN
aji-166	411	7	with	with	ADP
aji-166	411	8	multiple	multiple	ADJ
aji-166	411	9	targets	target	NOUN
aji-166	411	10	.	.	PUNCT
aji-166	412	1	oxidative	oxidative	ADJ
aji-166	412	2	medicine	medicine	NOUN
aji-166	412	3	and	and	CCONJ
aji-166	412	4	cellular	cellular	ADJ
aji-166	412	5	longevity	longevity	NOUN
aji-166	412	6	,	,	PUNCT
aji-166	412	7	2013	2013	NUM
aji-166	412	8	,	,	PUNCT
aji-166	412	9	104024	104024	NUM
aji-166	412	10	.	.	PUNCT
aji-166	413	1	https://doi.org/10.1155/2013/104024	https://doi.org/10.1155/2013/104024	PROPN
aji-166	413	2	luo	luo	PROPN
aji-166	413	3	,	,	PUNCT
aji-166	413	4	m.	m.	NOUN
aji-166	413	5	,	,	PUNCT
aji-166	413	6	zhao	zhao	PROPN
aji-166	413	7	,	,	PUNCT
aji-166	413	8	f.	f.	PROPN
aji-166	413	9	,	,	PUNCT
aji-166	413	10	cheng	cheng	PROPN
aji-166	413	11	,	,	PUNCT
aji-166	413	12	h.	h.	PROPN
aji-166	413	13	,	,	PUNCT
aji-166	413	14	su	su	PROPN
aji-166	413	15	,	,	PUNCT
aji-166	413	16	m.	m.	NOUN
aji-166	413	17	,	,	PUNCT
aji-166	413	18	&	&	CCONJ
aji-166	413	19	wang	wang	PROPN
aji-166	413	20	,	,	PUNCT
aji-166	413	21	y.	y.	PROPN
aji-166	413	22	(	(	PUNCT
aji-166	413	23	2024	2024	NUM
aji-166	413	24	)	)	PUNCT
aji-166	413	25	.	.	PUNCT
aji-166	414	1	macrophage	macrophage	ADJ
aji-166	414	2	polarization	polarization	NOUN
aji-166	414	3	:	:	PUNCT
aji-166	414	4	an	an	DET
aji-166	414	5	important	important	ADJ
aji-166	414	6	role	role	NOUN
aji-166	414	7	in	in	ADP
aji-166	414	8	inflammatory	inflammatory	ADJ
aji-166	414	9	diseases	disease	NOUN
aji-166	414	10	.	.	PUNCT
aji-166	415	1	frontiers	frontier	NOUN
aji-166	415	2	in	in	ADP
aji-166	415	3	immunology	immunology	NOUN
aji-166	415	4	,	,	PUNCT
aji-166	415	5	15	15	NUM
aji-166	415	6	,	,	PUNCT
aji-166	415	7	1352946	1352946	NUM
aji-166	415	8	.	.	PUNCT
aji-166	416	1	https://doi.org/10.3389/fimmu.2024.135294	https://doi.org/10.3389/fimmu.2024.135294	NOUN
aji-166	416	2	6	6	NUM
aji-166	416	3	marino	marino	NOUN
aji-166	416	4	,	,	PUNCT
aji-166	416	5	j.	j.	PROPN
aji-166	416	6	,	,	PUNCT
aji-166	416	7	maubert	maubert	NOUN
aji-166	416	8	,	,	PUNCT
aji-166	416	9	m.	m.	PROPN
aji-166	416	10	e.	e.	PROPN
aji-166	416	11	,	,	PUNCT
aji-166	416	12	mele	mele	PROPN
aji-166	416	13	,	,	PUNCT
aji-166	416	14	a.	a.	PROPN
aji-166	416	15	r.	r.	PROPN
aji-166	416	16	,	,	PUNCT
aji-166	416	17	spector	spector	PROPN
aji-166	416	18	,	,	PUNCT
aji-166	416	19	c.	c.	PROPN
aji-166	416	20	,	,	PUNCT
aji-166	416	21	wigdahl	wigdahl	ADV
aji-166	416	22	,	,	PUNCT
aji-166	416	23	b.	b.	PROPN
aji-166	416	24	,	,	PUNCT
aji-166	416	25	&	&	CCONJ
aji-166	416	26	nonnemacher	nonnemacher	PROPN
aji-166	416	27	,	,	PUNCT
aji-166	416	28	m.	m.	PROPN
aji-166	416	29	r.	r.	PROPN
aji-166	416	30	(	(	PUNCT
aji-166	416	31	2020	2020	NUM
aji-166	416	32	)	)	PUNCT
aji-166	416	33	.	.	PUNCT
aji-166	417	1	functional	functional	ADJ
aji-166	417	2	impact	impact	NOUN
aji-166	417	3	of	of	ADP
aji-166	417	4	hiv-1	hiv-1	PUNCT
aji-166	417	5	tat	tat	NOUN
aji-166	417	6	on	on	ADP
aji-166	417	7	cells	cell	NOUN
aji-166	417	8	of	of	ADP
aji-166	417	9	the	the	DET
aji-166	417	10	cns	cns	NOUN
aji-166	417	11	and	and	CCONJ
aji-166	417	12	its	its	PRON
aji-166	417	13	role	role	NOUN
aji-166	417	14	in	in	ADP
aji-166	417	15	hand	hand	NOUN
aji-166	417	16	.	.	PUNCT
aji-166	418	1	cellular	cellular	ADJ
aji-166	418	2	and	and	CCONJ
aji-166	418	3	molecular	molecular	ADJ
aji-166	418	4	life	life	NOUN
aji-166	418	5	sciences	science	NOUN
aji-166	418	6	:	:	PUNCT
aji-166	418	7	cmls	cmls	NOUN
aji-166	418	8	,	,	PUNCT
aji-166	418	9	77(24	77(24	NUM
aji-166	418	10	)	)	PUNCT
aji-166	418	11	,	,	PUNCT
aji-166	418	12	5079	5079	NUM
aji-166	418	13	.	.	PUNCT
aji-166	419	1	https://doi.org/10.1007/s00018-020-035614	https://doi.org/10.1007/s00018-020-035614	PROPN
aji-166	419	2	mazzuti	mazzuti	PROPN
aji-166	419	3	,	,	PUNCT
aji-166	419	4	l.	l.	PROPN
aji-166	419	5	,	,	PUNCT
aji-166	419	6	turriziani	turriziani	ADJ
aji-166	419	7	,	,	PUNCT
aji-166	419	8	o.	o.	NOUN
aji-166	419	9	,	,	PUNCT
aji-166	419	10	&	&	CCONJ
aji-166	419	11	mezzaroma	mezzaroma	PROPN
aji-166	419	12	,	,	PUNCT
aji-166	419	13	i.	i.	PROPN
aji-166	419	14	(	(	PUNCT
aji-166	419	15	2022	2022	NUM
aji-166	419	16	)	)	PUNCT
aji-166	419	17	.	.	PUNCT
aji-166	420	1	the	the	DET
aji-166	420	2	many	many	ADJ
aji-166	420	3	faces	face	NOUN
aji-166	420	4	of	of	ADP
aji-166	420	5	immune	immune	ADJ
aji-166	420	6	activation	activation	NOUN
aji-166	420	7	in	in	ADP
aji-166	420	8	hiv-1	hiv-1	ADJ
aji-166	420	9	infection	infection	NOUN
aji-166	420	10	:	:	PUNCT
aji-166	420	11	a	a	DET
aji-166	420	12	multifactorial	multifactorial	ADJ
aji-166	420	13	interconnection	interconnection	NOUN
aji-166	420	14	.	.	PUNCT
aji-166	421	1	biomedicines	biomedicine	NOUN
aji-166	421	2	,	,	PUNCT
aji-166	421	3	11(1	11(1	NUM
aji-166	421	4	)	)	PUNCT
aji-166	421	5	,	,	PUNCT
aji-166	421	6	159	159	NUM
aji-166	421	7	.	.	PUNCT
aji-166	422	1	https://doi.org/10.3390/biomedicines11010	https://doi.org/10.3390/biomedicines11010	PROPN
aji-166	422	2	159	159	NUM
aji-166	422	3	medapalli	medapalli	PROPN
aji-166	422	4	,	,	PUNCT
aji-166	422	5	r.	r.	PROPN
aji-166	422	6	k.	k.	PROPN
aji-166	422	7	,	,	PUNCT
aji-166	422	8	he	he	PRON
aji-166	422	9	,	,	PUNCT
aji-166	422	10	j.	j.	PROPN
aji-166	422	11	c.	c.	PROPN
aji-166	422	12	,	,	PUNCT
aji-166	422	13	&	&	CCONJ
aji-166	422	14	klotman	klotman	PROPN
aji-166	422	15	,	,	PUNCT
aji-166	422	16	p.	p.	PROPN
aji-166	422	17	e.	e.	PROPN
aji-166	423	1	(	(	PUNCT
aji-166	423	2	2011	2011	NUM
aji-166	423	3	)	)	PUNCT
aji-166	423	4	.	.	PUNCT
aji-166	424	1	hivhiv	hivhiv	PROPN
aji-166	424	2	-	-	PUNCT
aji-166	424	3	associated	associate	VERB
aji-166	424	4	nephropathy	nephropathy	NOUN
aji-166	424	5	:	:	PUNCT
aji-166	424	6	pathogenesis	pathogenesis	NOUN
aji-166	424	7	.	.	PUNCT
aji-166	425	1	current	current	ADJ
aji-166	425	2	opinion	opinion	NOUN
aji-166	425	3	in	in	ADP
aji-166	425	4	nephrology	nephrology	NOUN
aji-166	425	5	and	and	CCONJ
aji-166	425	6	hypertension	hypertension	NOUN
aji-166	425	7	,	,	PUNCT
aji-166	425	8	20(3	20(3	NOUN
aji-166	425	9	)	)	PUNCT
aji-166	425	10	,	,	PUNCT
aji-166	425	11	306	306	NUM
aji-166	425	12	.	.	PUNCT
aji-166	426	1	https://doi.org/10.1097/mnh.0b013e32834	https://doi.org/10.1097/mnh.0b013e32834	NOUN
aji-166	426	2	5359a	5359a	PROPN
aji-166	426	3	miguel	miguel	PROPN
aji-166	426	4	,	,	PUNCT
aji-166	426	5	j.	j.	PROPN
aji-166	426	6	,	,	PUNCT
aji-166	426	7	pires	pire	NOUN
aji-166	426	8	,	,	PUNCT
aji-166	426	9	d.	d.	PROPN
aji-166	426	10	,	,	PUNCT
aji-166	426	11	calado	calado	ADJ
aji-166	426	12	,	,	PUNCT
aji-166	426	13	m.	m.	NOUN
aji-166	426	14	,	,	PUNCT
aji-166	426	15	mandal	mandal	PROPN
aji-166	426	16	,	,	PUNCT
aji-166	426	17	m.	m.	NOUN
aji-166	426	18	,	,	PUNCT
aji-166	426	19	&	&	CCONJ
aji-166	426	20	anes	anes	PROPN
aji-166	426	21	,	,	PUNCT
aji-166	426	22	e.	e.	PROPN
aji-166	426	23	(	(	PUNCT
aji-166	426	24	2023	2023	NUM
aji-166	426	25	)	)	PUNCT
aji-166	426	26	.	.	PUNCT
aji-166	427	1	hiv	hiv	PROPN
aji-166	427	2	/	/	SYM
aji-166	427	3	mtb	mtb	X
aji-166	427	4	co	co	NOUN
aji-166	427	5	-	-	NOUN
aji-166	427	6	infection	infection	NOUN
aji-166	427	7	:	:	PUNCT
aji-166	427	8	from	from	ADP
aji-166	427	9	the	the	DET
aji-166	427	10	amplification	amplification	NOUN
aji-166	427	11	of	of	ADP
aji-166	427	12	disease	disease	NOUN
aji-166	427	13	pathogenesis	pathogenesis	NOUN
aji-166	427	14	to	to	ADP
aji-166	427	15	an	an	DET
aji-166	427	16	“	"	PUNCT
aji-166	427	17	emerging	emerge	VERB
aji-166	427	18	syndemic	syndemic	ADJ
aji-166	427	19	”	"	PUNCT
aji-166	427	20	.	.	PUNCT
aji-166	428	1	microorganisms	microorganism	NOUN
aji-166	428	2	,	,	PUNCT
aji-166	428	3	11(4	11(4	NUM
aji-166	428	4	)	)	PUNCT
aji-166	428	5	,	,	PUNCT
aji-166	428	6	853	853	NUM
aji-166	428	7	.	.	PUNCT
aji-166	429	1	https://doi.org/10.3390/microorganisms110	https://doi.org/10.3390/microorganisms110	PROPN
aji-166	429	2	40853	40853	NUM
aji-166	429	3	mosoian	mosoian	PROPN
aji-166	429	4	,	,	PUNCT
aji-166	429	5	a.	a.	PROPN
aji-166	429	6	,	,	PUNCT
aji-166	429	7	zhang	zhang	PROPN
aji-166	429	8	,	,	PUNCT
aji-166	429	9	l.	l.	PROPN
aji-166	429	10	,	,	PUNCT
aji-166	429	11	hong	hong	PROPN
aji-166	429	12	,	,	PUNCT
aji-166	429	13	f.	f.	PROPN
aji-166	429	14	,	,	PUNCT
aji-166	429	15	cunyat	cunyat	PROPN
aji-166	429	16	,	,	PUNCT
aji-166	429	17	f.	f.	PROPN
aji-166	429	18	,	,	PUNCT
aji-166	429	19	rahman	rahman	PROPN
aji-166	429	20	,	,	PUNCT
aji-166	429	21	a.	a.	NOUN
aji-166	429	22	,	,	PUNCT
aji-166	429	23	bhalla	bhalla	PROPN
aji-166	429	24	,	,	PUNCT
aji-166	429	25	r.	r.	PROPN
aji-166	429	26	,	,	PUNCT
aji-166	429	27	panchal	panchal	NOUN
aji-166	429	28	,	,	PUNCT
aji-166	429	29	a.	a.	NOUN
aji-166	429	30	,	,	PUNCT
aji-166	429	31	saiman	saiman	NOUN
aji-166	429	32	,	,	PUNCT
aji-166	429	33	y.	y.	PROPN
aji-166	429	34	,	,	PUNCT
aji-166	429	35	fiel	fiel	PROPN
aji-166	429	36	,	,	PUNCT
aji-166	429	37	m.	m.	NOUN
aji-166	429	38	i.	i.	PROPN
aji-166	429	39	,	,	PUNCT
aji-166	429	40	florman	florman	NOUN
aji-166	429	41	,	,	PUNCT
aji-166	429	42	s.	s.	PROPN
aji-166	429	43	,	,	PUNCT
aji-166	429	44	roayaie	roayaie	PROPN
aji-166	429	45	,	,	PUNCT
aji-166	429	46	s.	s.	PROPN
aji-166	429	47	,	,	PUNCT
aji-166	429	48	schwartz	schwartz	PROPN
aji-166	429	49	,	,	PUNCT
aji-166	429	50	m.	m.	NOUN
aji-166	429	51	,	,	PUNCT
aji-166	429	52	branch	branch	NOUN
aji-166	429	53	,	,	PUNCT
aji-166	429	54	a.	a.	NOUN
aji-166	429	55	,	,	PUNCT
aji-166	429	56	stevenson	stevenson	PROPN
aji-166	429	57	,	,	PUNCT
aji-166	429	58	m.	m.	NOUN
aji-166	429	59	,	,	PUNCT
aji-166	429	60	&	&	CCONJ
aji-166	429	61	bansal	bansal	NOUN
aji-166	429	62	,	,	PUNCT
aji-166	429	63	m.	m.	PROPN
aji-166	429	64	b.	b.	PROPN
aji-166	429	65	(	(	PUNCT
aji-166	429	66	2016	2016	NUM
aji-166	429	67	)	)	PUNCT
aji-166	429	68	.	.	PUNCT
aji-166	430	1	frontline	frontline	NOUN
aji-166	430	2	science	science	NOUN
aji-166	430	3	:	:	PUNCT
aji-166	430	4	hiv	hiv	PROPN
aji-166	430	5	infection	infection	NOUN
aji-166	430	6	of	of	ADP
aji-166	430	7	kupffer	kupffer	NOUN
aji-166	430	8	cells	cell	NOUN
aji-166	430	9	results	result	NOUN
aji-166	430	10	in	in	ADP
aji-166	430	11	an	an	DET
aji-166	430	12	amplified	amplify	VERB
aji-166	430	13	proinflammatory	proinflammatory	ADJ
aji-166	430	14	response	response	NOUN
aji-166	430	15	to	to	ADP
aji-166	430	16	lps	lps	PROPN
aji-166	430	17	.	.	PROPN
aji-166	431	1	journal	journal	PROPN
aji-166	431	2	adavba	adavba	PROPN
aji-166	431	3	;	;	PUNCT
aji-166	431	4	asian	asian	PROPN
aji-166	431	5	j.	j.	PROPN
aji-166	431	6	immunol	immunol	PROPN
aji-166	431	7	.	.	PROPN
aji-166	431	8	,	,	PUNCT
aji-166	431	9	vol	vol	NOUN
aji-166	431	10	.	.	PROPN
aji-166	431	11	8	8	NUM
aji-166	431	12	,	,	PUNCT
aji-166	431	13	no	no	INTJ
aji-166	431	14	.	.	NOUN
aji-166	431	15	1	1	NUM
aji-166	431	16	,	,	PUNCT
aji-166	431	17	pp	pp	ADJ
aji-166	431	18	.	.	PUNCT
aji-166	432	1	120	120	NUM
aji-166	432	2	-	-	SYM
aji-166	432	3	133	133	NUM
aji-166	432	4	,	,	PUNCT
aji-166	432	5	2025	2025	NUM
aji-166	432	6	;	;	PUNCT
aji-166	432	7	article	article	NOUN
aji-166	432	8	no.aji.136909	no.aji.136909	NOUN
aji-166	432	9	132	132	NUM
aji-166	432	10	of	of	ADP
aji-166	432	11	leukocyte	leukocyte	NOUN
aji-166	432	12	biology	biology	NOUN
aji-166	432	13	,	,	PUNCT
aji-166	432	14	101(5	101(5	NUM
aji-166	432	15	)	)	PUNCT
aji-166	432	16	,	,	PUNCT
aji-166	432	17	1083	1083	NUM
aji-166	432	18	.	.	PUNCT
aji-166	433	1	https://doi.org/10.1189/jlb.3hi0516-242r	https://doi.org/10.1189/jlb.3hi0516-242r	PROPN
aji-166	433	2	mundi	mundi	PROPN
aji-166	433	3	,	,	PUNCT
aji-166	433	4	s.	s.	PROPN
aji-166	433	5	,	,	PUNCT
aji-166	433	6	massaro	massaro	PROPN
aji-166	433	7	,	,	PUNCT
aji-166	433	8	m.	m.	NOUN
aji-166	433	9	,	,	PUNCT
aji-166	433	10	scoditti	scoditti	PROPN
aji-166	433	11	,	,	PUNCT
aji-166	433	12	e.	e.	PROPN
aji-166	433	13	,	,	PUNCT
aji-166	433	14	carluccio	carluccio	PROPN
aji-166	433	15	,	,	PUNCT
aji-166	433	16	m.	m.	NOUN
aji-166	433	17	a.	a.	PROPN
aji-166	433	18	,	,	PUNCT
aji-166	433	19	van	van	PROPN
aji-166	433	20	hinsbergh	hinsbergh	PROPN
aji-166	433	21	,	,	PUNCT
aji-166	433	22	v.	v.	ADP
aji-166	433	23	w.	w.	PROPN
aji-166	433	24	,	,	PUNCT
aji-166	433	25	luisa	luisa	PROPN
aji-166	433	26	,	,	PUNCT
aji-166	433	27	m.	m.	NOUN
aji-166	433	28	,	,	PUNCT
aji-166	433	29	&	&	CCONJ
aji-166	433	30	de	de	PROPN
aji-166	433	31	caterina	caterina	PROPN
aji-166	433	32	,	,	PUNCT
aji-166	433	33	r.	r.	PROPN
aji-166	433	34	(	(	PUNCT
aji-166	433	35	2017	2017	NUM
aji-166	433	36	)	)	PUNCT
aji-166	433	37	.	.	PUNCT
aji-166	434	1	endothelial	endothelial	ADJ
aji-166	434	2	permeability	permeability	NOUN
aji-166	434	3	,	,	PUNCT
aji-166	434	4	ldl	ldl	NOUN
aji-166	434	5	deposition	deposition	NOUN
aji-166	434	6	,	,	PUNCT
aji-166	434	7	and	and	CCONJ
aji-166	434	8	cardiovascular	cardiovascular	ADJ
aji-166	434	9	risk	risk	NOUN
aji-166	434	10	factors	factor	NOUN
aji-166	434	11	—	—	PUNCT
aji-166	434	12	a	a	DET
aji-166	434	13	review	review	NOUN
aji-166	434	14	.	.	PUNCT
aji-166	435	1	cardiovascular	cardiovascular	ADJ
aji-166	435	2	research	research	NOUN
aji-166	435	3	,	,	PUNCT
aji-166	435	4	114(1	114(1	NUM
aji-166	435	5	)	)	PUNCT
aji-166	435	6	,	,	PUNCT
aji-166	435	7	35	35	NUM
aji-166	435	8	-	-	SYM
aji-166	435	9	52	52	NUM
aji-166	435	10	.	.	PUNCT
aji-166	436	1	https://doi.org/10.1093/cvr/cvx226	https://doi.org/10.1093/cvr/cvx226	PROPN
aji-166	436	2	nabatanzi	nabatanzi	PROPN
aji-166	436	3	,	,	PUNCT
aji-166	436	4	r.	r.	PROPN
aji-166	436	5	,	,	PUNCT
aji-166	436	6	cose	cose	PROPN
aji-166	436	7	,	,	PUNCT
aji-166	436	8	s.	s.	PROPN
aji-166	436	9	,	,	PUNCT
aji-166	436	10	joloba	joloba	PROPN
aji-166	436	11	,	,	PUNCT
aji-166	436	12	m.	m.	NOUN
aji-166	436	13	et	et	PROPN
aji-166	436	14	al	al	PROPN
aji-166	436	15	.	.	PUNCT
aji-166	436	16	effects	effect	NOUN
aji-166	436	17	of	of	ADP
aji-166	436	18	hiv	hiv	PROPN
aji-166	436	19	infection	infection	NOUN
aji-166	436	20	and	and	CCONJ
aji-166	436	21	art	art	NOUN
aji-166	436	22	on	on	ADP
aji-166	436	23	phenotype	phenotype	NOUN
aji-166	436	24	and	and	CCONJ
aji-166	436	25	function	function	NOUN
aji-166	436	26	of	of	ADP
aji-166	436	27	circulating	circulate	VERB
aji-166	436	28	monocytes	monocyte	NOUN
aji-166	436	29	,	,	PUNCT
aji-166	436	30	natural	natural	ADJ
aji-166	436	31	killer	killer	NOUN
aji-166	436	32	,	,	PUNCT
aji-166	436	33	and	and	CCONJ
aji-166	436	34	innate	innate	ADJ
aji-166	436	35	lymphoid	lymphoid	ADJ
aji-166	436	36	cells	cell	NOUN
aji-166	436	37	.	.	PUNCT
aji-166	437	1	aids	aids	PROPN
aji-166	437	2	res	re	NOUN
aji-166	437	3	ther	ther	ADV
aji-166	437	4	,	,	PUNCT
aji-166	437	5	15	15	NUM
aji-166	437	6	,	,	PUNCT
aji-166	437	7	7	7	NUM
aji-166	437	8	(	(	PUNCT
aji-166	437	9	2018	2018	NUM
aji-166	437	10	)	)	PUNCT
aji-166	437	11	.	.	PUNCT
aji-166	438	1	https://doi.org/10.1186/s12981-018-0194-y	https://doi.org/10.1186/s12981-018-0194-y	PROPN
aji-166	438	2	ong	ong	PROPN
aji-166	438	3	,	,	PUNCT
aji-166	438	4	s.	s.	PROPN
aji-166	438	5	,	,	PUNCT
aji-166	438	6	hadadi	hadadi	PROPN
aji-166	438	7	,	,	PUNCT
aji-166	438	8	e.	e.	PROPN
aji-166	438	9	,	,	PUNCT
aji-166	438	10	dang	dang	PROPN
aji-166	438	11	,	,	PUNCT
aji-166	438	12	t.	t.	PROPN
aji-166	438	13	,	,	PUNCT
aji-166	438	14	yeap	yeap	PROPN
aji-166	438	15	,	,	PUNCT
aji-166	438	16	w.	w.	PROPN
aji-166	438	17	,	,	PUNCT
aji-166	438	18	tan	tan	PROPN
aji-166	438	19	,	,	PUNCT
aji-166	438	20	c.	c.	PROPN
aji-166	438	21	t.	t.	PROPN
aji-166	438	22	,	,	PUNCT
aji-166	438	23	ng	ng	PROPN
aji-166	438	24	,	,	PUNCT
aji-166	438	25	t.	t.	PROPN
aji-166	438	26	,	,	PUNCT
aji-166	438	27	larbi	larbi	PROPN
aji-166	438	28	,	,	PUNCT
aji-166	438	29	a.	a.	NOUN
aji-166	438	30	,	,	PUNCT
aji-166	438	31	&	&	CCONJ
aji-166	438	32	wong	wong	PROPN
aji-166	438	33	,	,	PUNCT
aji-166	438	34	s.	s.	PROPN
aji-166	438	35	(	(	PUNCT
aji-166	438	36	2018	2018	NUM
aji-166	438	37	)	)	PUNCT
aji-166	438	38	.	.	PUNCT
aji-166	439	1	the	the	DET
aji-166	439	2	pro	pro	ADJ
aji-166	439	3	-	-	ADJ
aji-166	439	4	inflammatory	inflammatory	ADJ
aji-166	439	5	phenotype	phenotype	NOUN
aji-166	439	6	of	of	ADP
aji-166	439	7	the	the	DET
aji-166	439	8	human	human	ADJ
aji-166	439	9	non	non	ADJ
aji-166	439	10	-	-	ADJ
aji-166	439	11	classical	classical	ADJ
aji-166	439	12	monocyte	monocyte	NOUN
aji-166	439	13	subset	subset	NOUN
aji-166	439	14	is	be	AUX
aji-166	439	15	attributed	attribute	VERB
aji-166	439	16	to	to	ADP
aji-166	439	17	senescence	senescence	NOUN
aji-166	439	18	.	.	PUNCT
aji-166	440	1	cell	cell	NOUN
aji-166	440	2	death	death	NOUN
aji-166	440	3	&	&	CCONJ
aji-166	440	4	disease	disease	PROPN
aji-166	440	5	,	,	PUNCT
aji-166	440	6	9(3	9(3	NUM
aji-166	440	7	)	)	PUNCT
aji-166	440	8	,	,	PUNCT
aji-166	440	9	1	1	NUM
aji-166	440	10	-	-	SYM
aji-166	440	11	12	12	NUM
aji-166	440	12	.	.	PUNCT
aji-166	441	1	https://doi.org/10.1038/s41419-018-0327-1	https://doi.org/10.1038/s41419-018-0327-1	PROPN
aji-166	441	2	paiardini	paiardini	PROPN
aji-166	441	3	,	,	PUNCT
aji-166	441	4	m.	m.	NOUN
aji-166	441	5	,	,	PUNCT
aji-166	441	6	&	&	CCONJ
aji-166	441	7	müller	müller	PROPN
aji-166	441	8	-	-	PUNCT
aji-166	441	9	trutwin	trutwin	PROPN
aji-166	441	10	,	,	PUNCT
aji-166	441	11	m.	m.	NOUN
aji-166	441	12	(	(	PUNCT
aji-166	441	13	2013	2013	NUM
aji-166	441	14	)	)	PUNCT
aji-166	441	15	.	.	PUNCT
aji-166	442	1	hivassociated	hivassociated	ADJ
aji-166	442	2	chronic	chronic	ADJ
aji-166	442	3	immune	immune	ADJ
aji-166	442	4	activation	activation	NOUN
aji-166	442	5	.	.	PUNCT
aji-166	443	1	immunological	immunological	ADJ
aji-166	443	2	reviews	review	NOUN
aji-166	443	3	,	,	PUNCT
aji-166	443	4	254(1	254(1	NUM
aji-166	443	5	)	)	PUNCT
aji-166	443	6	,	,	PUNCT
aji-166	443	7	78	78	NUM
aji-166	443	8	.	.	PUNCT
aji-166	444	1	https://doi.org/10.1111/imr.12079	https://doi.org/10.1111/imr.12079	PROPN
aji-166	444	2	parihar	parihar	PROPN
aji-166	444	3	,	,	PUNCT
aji-166	444	4	a.	a.	PROPN
aji-166	444	5	,	,	PUNCT
aji-166	444	6	eubank	eubank	PROPN
aji-166	444	7	,	,	PUNCT
aji-166	444	8	t.	t.	PROPN
aji-166	444	9	d.	d.	PROPN
aji-166	444	10	,	,	PUNCT
aji-166	444	11	&	&	CCONJ
aji-166	444	12	doseff	doseff	PROPN
aji-166	444	13	,	,	PUNCT
aji-166	444	14	a.	a.	NOUN
aji-166	444	15	i.	i.	PROPN
aji-166	444	16	(	(	PUNCT
aji-166	444	17	2010	2010	NUM
aji-166	444	18	)	)	PUNCT
aji-166	444	19	.	.	PUNCT
aji-166	445	1	monocytes	monocyte	NOUN
aji-166	445	2	and	and	CCONJ
aji-166	445	3	macrophages	macrophage	NOUN
aji-166	445	4	regulate	regulate	VERB
aji-166	445	5	immunity	immunity	NOUN
aji-166	445	6	through	through	ADP
aji-166	445	7	dynamic	dynamic	ADJ
aji-166	445	8	networks	network	NOUN
aji-166	445	9	of	of	ADP
aji-166	445	10	survival	survival	NOUN
aji-166	445	11	and	and	CCONJ
aji-166	445	12	cell	cell	NOUN
aji-166	445	13	death	death	NOUN
aji-166	445	14	.	.	PUNCT
aji-166	446	1	journal	journal	NOUN
aji-166	446	2	of	of	ADP
aji-166	446	3	innate	innate	ADJ
aji-166	446	4	immunity	immunity	NOUN
aji-166	446	5	,	,	PUNCT
aji-166	446	6	2(3	2(3	NUM
aji-166	446	7	)	)	PUNCT
aji-166	446	8	,	,	PUNCT
aji-166	446	9	204	204	NUM
aji-166	446	10	.	.	PUNCT
aji-166	447	1	https://doi.org/10.1159/000296507	https://doi.org/10.1159/000296507	NOUN
aji-166	447	2	potula	potula	PROPN
aji-166	447	3	,	,	PUNCT
aji-166	447	4	r.	r.	PROPN
aji-166	447	5	,	,	PUNCT
aji-166	447	6	ramirez	ramirez	PROPN
aji-166	447	7	,	,	PUNCT
aji-166	447	8	s.	s.	PROPN
aji-166	447	9	h.	h.	PROPN
aji-166	447	10	,	,	PUNCT
aji-166	447	11	knipe	knipe	PROPN
aji-166	447	12	,	,	PUNCT
aji-166	447	13	b.	b.	PROPN
aji-166	447	14	,	,	PUNCT
aji-166	447	15	leibhart	leibhart	PROPN
aji-166	447	16	,	,	PUNCT
aji-166	447	17	j.	j.	PROPN
aji-166	447	18	,	,	PUNCT
aji-166	447	19	schall	schall	PROPN
aji-166	447	20	,	,	PUNCT
aji-166	447	21	k.	k.	PROPN
aji-166	447	22	,	,	PUNCT
aji-166	447	23	heilman	heilman	PROPN
aji-166	447	24	,	,	PUNCT
aji-166	447	25	d.	d.	PROPN
aji-166	447	26	,	,	PUNCT
aji-166	447	27	morsey	morsey	PROPN
aji-166	447	28	,	,	PUNCT
aji-166	447	29	b.	b.	PROPN
aji-166	447	30	,	,	PUNCT
aji-166	447	31	mercer	mercer	PROPN
aji-166	447	32	,	,	PUNCT
aji-166	447	33	a.	a.	NOUN
aji-166	447	34	,	,	PUNCT
aji-166	447	35	papugani	papugani	PROPN
aji-166	447	36	,	,	PUNCT
aji-166	447	37	a.	a.	NOUN
aji-166	447	38	,	,	PUNCT
aji-166	447	39	dou	dou	PROPN
aji-166	447	40	,	,	PUNCT
aji-166	447	41	h.	h.	PROPN
aji-166	447	42	,	,	PUNCT
aji-166	447	43	&	&	CCONJ
aji-166	447	44	persidsky	persidsky	NOUN
aji-166	447	45	,	,	PUNCT
aji-166	447	46	y.	y.	PROPN
aji-166	447	47	(	(	PUNCT
aji-166	447	48	2008	2008	NUM
aji-166	447	49	)	)	PUNCT
aji-166	447	50	.	.	PUNCT
aji-166	448	1	pparγ	pparγ	ADJ
aji-166	448	2	activation	activation	NOUN
aji-166	448	3	suppresses	suppress	VERB
aji-166	448	4	hiv-1	hiv-1	ADJ
aji-166	448	5	replication	replication	NOUN
aji-166	448	6	in	in	ADP
aji-166	448	7	an	an	DET
aji-166	448	8	animal	animal	NOUN
aji-166	448	9	model	model	NOUN
aji-166	448	10	of	of	ADP
aji-166	448	11	encephalitis	encephalitis	NOUN
aji-166	448	12	.	.	PUNCT
aji-166	449	1	aids	aids	PROPN
aji-166	449	2	(	(	PUNCT
aji-166	449	3	london	london	PROPN
aji-166	449	4	,	,	PUNCT
aji-166	449	5	england	england	PROPN
aji-166	449	6	)	)	PUNCT
aji-166	449	7	,	,	PUNCT
aji-166	449	8	22(13	22(13	NUM
aji-166	449	9	)	)	PUNCT
aji-166	449	10	,	,	PUNCT
aji-166	449	11	1539	1539	NUM
aji-166	449	12	.	.	PUNCT
aji-166	450	1	https://doi.org/10.1097/qad.0b013e32830	https://doi.org/10.1097/qad.0b013e32830	PROPN
aji-166	450	2	81e08	81e08	NUM
aji-166	450	3	rose	rise	VERB
aji-166	450	4	r.	r.	PROPN
aji-166	450	5	,	,	PUNCT
aji-166	450	6	lamers	lamers	PROPN
aji-166	450	7	s.	s.	PROPN
aji-166	450	8	l.	l.	PROPN
aji-166	450	9	,	,	PUNCT
aji-166	450	10	nolan	nolan	PROPN
aji-166	450	11	d.	d.	PROPN
aji-166	450	12	j.	j.	PROPN
aji-166	450	13	,	,	PUNCT
aji-166	450	14	maidji	maidji	PROPN
aji-166	450	15	e.	e.	PROPN
aji-166	450	16	,	,	PUNCT
aji-166	450	17	faria	faria	PROPN
aji-166	450	18	n.	n.	PROPN
aji-166	450	19	r.	r.	PROPN
aji-166	450	20	,	,	PUNCT
aji-166	450	21	pybus	pybus	PROPN
aji-166	450	22	o.	o.	PROPN
aji-166	450	23	g.	g.	PROPN
aji-166	450	24	,	,	PUNCT
aji-166	450	25	et	et	PROPN
aji-166	450	26	al	al	PROPN
aji-166	450	27	.	.	PUNCT
aji-166	451	1	(	(	PUNCT
aji-166	451	2	2016	2016	NUM
aji-166	451	3	)	)	PUNCT
aji-166	451	4	.	.	PUNCT
aji-166	452	1	hiv	hiv	PROPN
aji-166	452	2	maintains	maintain	VERB
aji-166	452	3	an	an	DET
aji-166	452	4	evolving	evolve	VERB
aji-166	452	5	and	and	CCONJ
aji-166	452	6	dispersed	disperse	VERB
aji-166	452	7	population	population	NOUN
aji-166	452	8	in	in	ADP
aji-166	452	9	multiple	multiple	ADJ
aji-166	452	10	tissues	tissue	NOUN
aji-166	452	11	during	during	ADP
aji-166	452	12	suppressive	suppressive	ADJ
aji-166	452	13	combined	combine	VERB
aji-166	452	14	antiretroviral	antiretroviral	ADJ
aji-166	452	15	therapy	therapy	NOUN
aji-166	452	16	in	in	ADP
aji-166	452	17	individuals	individual	NOUN
aji-166	452	18	with	with	ADP
aji-166	452	19	cancer	cancer	NOUN
aji-166	452	20	.	.	PUNCT
aji-166	453	1	j.	j.	PROPN
aji-166	453	2	virol	virol	PROPN
aji-166	453	3	.	.	PUNCT
aji-166	454	1	90	90	NUM
aji-166	454	2	8984–8993	8984–8993	NUM
aji-166	454	3	.	.	PUNCT
aji-166	455	1	10.1128	10.1128	NUM
aji-166	455	2	/	/	SYM
aji-166	455	3	jvi.00684	jvi.00684	NUM
aji-166	455	4	-	-	SYM
aji-166	455	5	16	16	NUM
aji-166	455	6	said	say	VERB
aji-166	455	7	,	,	PUNCT
aji-166	455	8	n.	n.	NOUN
aji-166	455	9	,	,	PUNCT
aji-166	455	10	&	&	CCONJ
aji-166	455	11	venketaraman	venketaraman	PROPN
aji-166	455	12	,	,	PUNCT
aji-166	455	13	v.	v.	CCONJ
aji-166	455	14	(	(	PUNCT
aji-166	455	15	2025	2025	NUM
aji-166	455	16	)	)	PUNCT
aji-166	455	17	.	.	PUNCT
aji-166	456	1	neuroinflammation	neuroinflammation	NOUN
aji-166	456	2	,	,	PUNCT
aji-166	456	3	blood	blood	NOUN
aji-166	456	4	–	–	PUNCT
aji-166	456	5	brain	brain	NOUN
aji-166	456	6	barrier	barrier	NOUN
aji-166	456	7	,	,	PUNCT
aji-166	456	8	and	and	CCONJ
aji-166	456	9	hiv	hiv	PROPN
aji-166	456	10	reservoirs	reservoir	NOUN
aji-166	456	11	in	in	ADP
aji-166	456	12	the	the	DET
aji-166	456	13	cns	cns	NOUN
aji-166	456	14	:	:	PUNCT
aji-166	456	15	an	an	DET
aji-166	456	16	indepth	indepth	ADJ
aji-166	456	17	exploration	exploration	NOUN
aji-166	456	18	of	of	ADP
aji-166	456	19	latency	latency	NOUN
aji-166	456	20	mechanisms	mechanism	NOUN
aji-166	456	21	and	and	CCONJ
aji-166	456	22	emerging	emerge	VERB
aji-166	456	23	therapeutic	therapeutic	ADJ
aji-166	456	24	strategies	strategy	NOUN
aji-166	456	25	.	.	PUNCT
aji-166	457	1	viruses	virus	NOUN
aji-166	457	2	,	,	PUNCT
aji-166	457	3	17(4	17(4	NUM
aji-166	457	4	)	)	PUNCT
aji-166	457	5	,	,	PUNCT
aji-166	457	6	572	572	NUM
aji-166	457	7	.	.	PUNCT
aji-166	458	1	https://doi.org/10.3390/v17040572	https://doi.org/10.3390/v17040572	NUM
aji-166	458	2	salimi	salimi	PROPN
aji-166	458	3	,	,	PUNCT
aji-166	458	4	h.	h.	PROPN
aji-166	458	5	,	,	PUNCT
aji-166	458	6	&	&	CCONJ
aji-166	458	7	klein	klein	PROPN
aji-166	458	8	,	,	PUNCT
aji-166	458	9	r.	r.	PROPN
aji-166	458	10	s.	s.	PROPN
aji-166	458	11	(	(	PUNCT
aji-166	458	12	2019	2019	NUM
aji-166	458	13	)	)	PUNCT
aji-166	458	14	.	.	PUNCT
aji-166	459	1	disruption	disruption	NOUN
aji-166	459	2	of	of	ADP
aji-166	459	3	the	the	DET
aji-166	459	4	blood	blood	NOUN
aji-166	459	5	-	-	PUNCT
aji-166	459	6	brain	brain	NOUN
aji-166	459	7	barrier	barrier	NOUN
aji-166	459	8	during	during	ADP
aji-166	459	9	neuroinflammatory	neuroinflammatory	ADJ
aji-166	459	10	and	and	CCONJ
aji-166	459	11	neuroinfectious	neuroinfectious	ADJ
aji-166	459	12	diseases	disease	NOUN
aji-166	459	13	.	.	PUNCT
aji-166	460	1	neuroimmune	neuroimmune	NOUN
aji-166	460	2	diseases	disease	NOUN
aji-166	460	3	,	,	PUNCT
aji-166	460	4	195	195	NUM
aji-166	460	5	.	.	PUNCT
aji-166	461	1	https://doi.org/10.1007/978-3-030-195151_7	https://doi.org/10.1007/978-3-030-195151_7	X
aji-166	461	2	sattentau	sattentau	ADV
aji-166	461	3	,	,	PUNCT
aji-166	461	4	q.	q.	PROPN
aji-166	461	5	j.	j.	PROPN
aji-166	461	6	,	,	PUNCT
aji-166	461	7	&	&	CCONJ
aji-166	461	8	stevenson	stevenson	PROPN
aji-166	461	9	,	,	PUNCT
aji-166	461	10	m.	m.	NOUN
aji-166	461	11	(	(	PUNCT
aji-166	461	12	2016	2016	NUM
aji-166	461	13	)	)	PUNCT
aji-166	461	14	.	.	PUNCT
aji-166	462	1	macrophages	macrophage	NOUN
aji-166	462	2	and	and	CCONJ
aji-166	462	3	hiv-1	hiv-1	X
aji-166	462	4	:	:	PUNCT
aji-166	462	5	an	an	DET
aji-166	462	6	unhealthy	unhealthy	ADJ
aji-166	462	7	constellation	constellation	NOUN
aji-166	462	8	.	.	PUNCT
aji-166	463	1	cell	cell	NOUN
aji-166	463	2	host	host	NOUN
aji-166	463	3	&	&	CCONJ
aji-166	463	4	microbe	microbe	PROPN
aji-166	463	5	,	,	PUNCT
aji-166	463	6	19(3	19(3	NUM
aji-166	463	7	)	)	PUNCT
aji-166	463	8	,	,	PUNCT
aji-166	463	9	304–310	304–310	NUM
aji-166	463	10	.	.	PUNCT
aji-166	464	1	https://doi.org/10.1016/j.chom.2016.02.013	https://doi.org/10.1016/j.chom.2016.02.013	PROPN
aji-166	464	2	saylor	saylor	PROPN
aji-166	464	3	,	,	PUNCT
aji-166	464	4	d.	d.	PROPN
aji-166	464	5	,	,	PUNCT
aji-166	464	6	dickens	dickens	PROPN
aji-166	464	7	,	,	PUNCT
aji-166	464	8	a.	a.	NOUN
aji-166	464	9	m.	m.	NOUN
aji-166	464	10	,	,	PUNCT
aji-166	464	11	sacktor	sacktor	NOUN
aji-166	464	12	,	,	PUNCT
aji-166	464	13	n.	n.	PROPN
aji-166	464	14	,	,	PUNCT
aji-166	464	15	haughey	haughey	PRON
aji-166	464	16	,	,	PUNCT
aji-166	464	17	n.	n.	NOUN
aji-166	464	18	,	,	PUNCT
aji-166	464	19	slusher	slusher	PROPN
aji-166	464	20	,	,	PUNCT
aji-166	464	21	b.	b.	PROPN
aji-166	464	22	,	,	PUNCT
aji-166	464	23	pletnikov	pletnikov	PROPN
aji-166	464	24	,	,	PUNCT
aji-166	464	25	m.	m.	NOUN
aji-166	464	26	,	,	PUNCT
aji-166	464	27	mankowski	mankowski	PROPN
aji-166	464	28	,	,	PUNCT
aji-166	464	29	j.	j.	PROPN
aji-166	464	30	l.	l.	PROPN
aji-166	464	31	,	,	PUNCT
aji-166	464	32	brown	brown	PROPN
aji-166	464	33	,	,	PUNCT
aji-166	464	34	a.	a.	NOUN
aji-166	464	35	,	,	PUNCT
aji-166	464	36	volsky	volsky	NOUN
aji-166	464	37	,	,	PUNCT
aji-166	464	38	d.	d.	PROPN
aji-166	464	39	j.	j.	PROPN
aji-166	464	40	,	,	PUNCT
aji-166	464	41	&	&	CCONJ
aji-166	464	42	mcarthur	mcarthur	PROPN
aji-166	464	43	,	,	PUNCT
aji-166	464	44	j.	j.	PROPN
aji-166	464	45	c.	c.	PROPN
aji-166	464	46	(	(	PUNCT
aji-166	464	47	2016	2016	NUM
aji-166	464	48	)	)	PUNCT
aji-166	464	49	.	.	PUNCT
aji-166	465	1	hivassociated	hivassociate	VERB
aji-166	465	2	neurocognitive	neurocognitive	ADJ
aji-166	465	3	disorder	disorder	NOUN
aji-166	465	4	-	-	PUNCT
aji-166	465	5	pathogenesis	pathogenesis	NOUN
aji-166	465	6	and	and	CCONJ
aji-166	465	7	prospects	prospect	NOUN
aji-166	465	8	for	for	ADP
aji-166	465	9	treatment	treatment	NOUN
aji-166	465	10	.	.	PUNCT
aji-166	466	1	nature	nature	NOUN
aji-166	466	2	reviews	review	NOUN
aji-166	466	3	.	.	PUNCT
aji-166	467	1	neurology	neurology	NOUN
aji-166	467	2	,	,	PUNCT
aji-166	467	3	12(4	12(4	NUM
aji-166	467	4	)	)	PUNCT
aji-166	467	5	,	,	PUNCT
aji-166	467	6	234	234	NUM
aji-166	467	7	–	–	PUNCT
aji-166	467	8	248	248	NUM
aji-166	467	9	.	.	PUNCT
aji-166	468	1	https://doi.org/10.1038/nrneurol.2016.27	https://doi.org/10.1038/nrneurol.2016.27	PROPN
aji-166	468	2	schlachetzki	schlachetzki	NOUN
aji-166	468	3	,	,	PUNCT
aji-166	468	4	j.	j.	PROPN
aji-166	468	5	c.	c.	PROPN
aji-166	468	6	,	,	PUNCT
aji-166	468	7	zhou	zhou	PROPN
aji-166	468	8	,	,	PUNCT
aji-166	468	9	y.	y.	PROPN
aji-166	468	10	,	,	PUNCT
aji-166	468	11	&	&	CCONJ
aji-166	468	12	glass	glass	NOUN
aji-166	468	13	,	,	PUNCT
aji-166	468	14	c.	c.	PROPN
aji-166	468	15	k.	k.	PROPN
aji-166	468	16	(	(	PUNCT
aji-166	468	17	2022	2022	NUM
aji-166	468	18	)	)	PUNCT
aji-166	468	19	.	.	PUNCT
aji-166	469	1	human	human	ADJ
aji-166	469	2	microglia	microglia	ADJ
aji-166	469	3	phenotypes	phenotype	NOUN
aji-166	469	4	in	in	ADP
aji-166	469	5	the	the	DET
aji-166	469	6	brain	brain	NOUN
aji-166	469	7	associated	associate	VERB
aji-166	469	8	with	with	ADP
aji-166	469	9	hiv	hiv	PROPN
aji-166	469	10	infection	infection	NOUN
aji-166	469	11	.	.	PUNCT
aji-166	470	1	current	current	ADJ
aji-166	470	2	opinion	opinion	NOUN
aji-166	470	3	in	in	ADP
aji-166	470	4	neurobiology	neurobiology	NOUN
aji-166	470	5	,	,	PUNCT
aji-166	470	6	77	77	NUM
aji-166	470	7	,	,	PUNCT
aji-166	470	8	102637	102637	NUM
aji-166	470	9	.	.	PUNCT
aji-166	471	1	https://doi.org/10.1016/j.conb.2022.102637	https://doi.org/10.1016/j.conb.2022.102637	PROPN
aji-166	471	2	serrano	serrano	PROPN
aji-166	471	3	-	-	PUNCT
aji-166	471	4	villar	villar	PROPN
aji-166	471	5	,	,	PUNCT
aji-166	471	6	s.	s.	PROPN
aji-166	471	7	,	,	PUNCT
aji-166	471	8	pérez	pérez	NOUN
aji-166	471	9	-	-	PUNCT
aji-166	471	10	elías	elías	NOUN
aji-166	471	11	,	,	PUNCT
aji-166	471	12	m.	m.	NOUN
aji-166	471	13	j.	j.	PROPN
aji-166	471	14	,	,	PUNCT
aji-166	471	15	dronda	dronda	PROPN
aji-166	471	16	,	,	PUNCT
aji-166	471	17	f.	f.	PROPN
aji-166	471	18	,	,	PUNCT
aji-166	471	19	casado	casado	PROPN
aji-166	471	20	,	,	PUNCT
aji-166	471	21	j.	j.	PROPN
aji-166	471	22	l.	l.	PROPN
aji-166	471	23	,	,	PUNCT
aji-166	471	24	moreno	moreno	PROPN
aji-166	471	25	,	,	PUNCT
aji-166	471	26	a.	a.	PROPN
aji-166	471	27	,	,	PUNCT
aji-166	471	28	royuela	royuela	PROPN
aji-166	471	29	,	,	PUNCT
aji-166	471	30	a.	a.	NOUN
aji-166	471	31	,	,	PUNCT
aji-166	471	32	pérez	pérez	NOUN
aji-166	471	33	-	-	PUNCT
aji-166	471	34	molina	molina	NOUN
aji-166	471	35	,	,	PUNCT
aji-166	471	36	j.	j.	PROPN
aji-166	471	37	a.	a.	PROPN
aji-166	471	38	,	,	PUNCT
aji-166	471	39	sainz	sainz	PROPN
aji-166	471	40	,	,	PUNCT
aji-166	471	41	t.	t.	PROPN
aji-166	471	42	,	,	PUNCT
aji-166	471	43	et	et	PROPN
aji-166	471	44	al	al	PROPN
aji-166	471	45	.	.	PUNCT
aji-166	471	46	(	(	PUNCT
aji-166	471	47	2014	2014	NUM
aji-166	471	48	)	)	PUNCT
aji-166	471	49	.	.	PUNCT
aji-166	472	1	increased	increase	VERB
aji-166	472	2	risk	risk	NOUN
aji-166	472	3	of	of	ADP
aji-166	472	4	serious	serious	ADJ
aji-166	472	5	non	non	ADJ
aji-166	472	6	-	-	ADJ
aji-166	472	7	aidsrelated	aidsrelated	ADJ
aji-166	472	8	events	event	NOUN
aji-166	472	9	in	in	ADP
aji-166	472	10	hiv	hiv	PROPN
aji-166	472	11	-	-	PUNCT
aji-166	472	12	infected	infect	VERB
aji-166	472	13	subjects	subject	NOUN
aji-166	472	14	on	on	ADP
aji-166	472	15	antiretroviral	antiretroviral	ADJ
aji-166	472	16	therapy	therapy	NOUN
aji-166	472	17	associated	associate	VERB
aji-166	472	18	with	with	ADP
aji-166	472	19	a	a	DET
aji-166	472	20	low	low	ADJ
aji-166	472	21	cd4	cd4	PROPN
aji-166	472	22	/	/	SYM
aji-166	472	23	cd8	cd8	PROPN
aji-166	472	24	ratio	ratio	NOUN
aji-166	472	25	.	.	PUNCT
aji-166	473	1	plos	plos	PROPN
aji-166	473	2	one	one	NUM
aji-166	473	3	,	,	PUNCT
aji-166	473	4	9(1	9(1	NUM
aji-166	473	5	)	)	PUNCT
aji-166	473	6	,	,	PUNCT
aji-166	473	7	e85798	e85798	PROPN
aji-166	473	8	.	.	PROPN
aji-166	473	9	https://doi.org/10.1371/journal.pone.00857	https://doi.org/10.1371/journal.pone.00857	PROPN
aji-166	473	10	98	98	NUM
aji-166	473	11	sherman	sherman	PROPN
aji-166	473	12	,	,	PUNCT
aji-166	473	13	k.	k.	PROPN
aji-166	473	14	e.	e.	PROPN
aji-166	473	15	,	,	PUNCT
aji-166	473	16	&	&	CCONJ
aji-166	473	17	thomas	thomas	PROPN
aji-166	473	18	,	,	PUNCT
aji-166	473	19	d.	d.	PROPN
aji-166	473	20	l.	l.	PROPN
aji-166	473	21	(	(	PUNCT
aji-166	473	22	2022	2022	NUM
aji-166	473	23	)	)	PUNCT
aji-166	473	24	.	.	PUNCT
aji-166	474	1	hiv	hiv	PROPN
aji-166	474	2	and	and	CCONJ
aji-166	474	3	liver	liver	NOUN
aji-166	474	4	disease	disease	NOUN
aji-166	474	5	:	:	PUNCT
aji-166	474	6	a	a	DET
aji-166	474	7	comprehensive	comprehensive	ADJ
aji-166	474	8	update	update	NOUN
aji-166	474	9	.	.	PUNCT
aji-166	475	1	topics	topic	NOUN
aji-166	475	2	in	in	ADP
aji-166	475	3	antiviral	antiviral	ADJ
aji-166	475	4	medicine	medicine	NOUN
aji-166	475	5	,	,	PUNCT
aji-166	475	6	30(4	30(4	NUM
aji-166	475	7	)	)	PUNCT
aji-166	475	8	,	,	PUNCT
aji-166	475	9	547	547	NUM
aji-166	475	10	.	.	PUNCT
aji-166	475	11	https://pmc.ncbi.nlm.nih.gov/articles/pmc9	https://pmc.ncbi.nlm.nih.gov/articles/pmc9	PROPN
aji-166	475	12	681142/	681142/	NUM
aji-166	475	13	subramanian	subramanian	PROPN
aji-166	475	14	,	,	PUNCT
aji-166	475	15	s.	s.	PROPN
aji-166	475	16	,	,	PUNCT
aji-166	475	17	tawakol	tawakol	PROPN
aji-166	475	18	,	,	PUNCT
aji-166	475	19	a.	a.	NOUN
aji-166	475	20	,	,	PUNCT
aji-166	475	21	burdo	burdo	NOUN
aji-166	475	22	,	,	PUNCT
aji-166	475	23	t.	t.	PROPN
aji-166	475	24	h.	h.	PROPN
aji-166	475	25	,	,	PUNCT
aji-166	475	26	abbara	abbara	PROPN
aji-166	475	27	,	,	PUNCT
aji-166	475	28	s.	s.	PROPN
aji-166	475	29	,	,	PUNCT
aji-166	475	30	wei	wei	PROPN
aji-166	475	31	,	,	PUNCT
aji-166	475	32	j.	j.	PROPN
aji-166	475	33	,	,	PUNCT
aji-166	475	34	vijayakumar	vijayakumar	PROPN
aji-166	475	35	,	,	PUNCT
aji-166	475	36	j.	j.	PROPN
aji-166	475	37	,	,	PUNCT
aji-166	475	38	corsini	corsini	PROPN
aji-166	475	39	,	,	PUNCT
aji-166	475	40	e.	e.	PROPN
aji-166	475	41	,	,	PUNCT
aji-166	475	42	abdelbaky	abdelbaky	PROPN
aji-166	475	43	,	,	PUNCT
aji-166	475	44	a.	a.	PROPN
aji-166	475	45	,	,	PUNCT
aji-166	475	46	et	et	PROPN
aji-166	475	47	al	al	PROPN
aji-166	475	48	.	.	PUNCT
aji-166	476	1	(	(	PUNCT
aji-166	476	2	2012	2012	NUM
aji-166	476	3	)	)	PUNCT
aji-166	476	4	.	.	PUNCT
aji-166	477	1	arterial	arterial	ADJ
aji-166	477	2	inflammation	inflammation	NOUN
aji-166	477	3	in	in	ADP
aji-166	477	4	patients	patient	NOUN
aji-166	477	5	with	with	ADP
aji-166	477	6	hiv	hiv	PROPN
aji-166	477	7	.	.	PUNCT
aji-166	478	1	jama	jama	PROPN
aji-166	478	2	,	,	PUNCT
aji-166	478	3	308(4	308(4	NUM
aji-166	478	4	)	)	PUNCT
aji-166	478	5	,	,	PUNCT
aji-166	478	6	379–386	379–386	NUM
aji-166	478	7	.	.	PUNCT
aji-166	479	1	https://doi.org/10.1001/jama.2012.6698	https://doi.org/10.1001/jama.2012.6698	PROPN
aji-166	479	2	swanson	swanson	PROPN
aji-166	479	3	,	,	PUNCT
aji-166	479	4	k.	k.	PROPN
aji-166	480	1	v.	v.	PROPN
aji-166	480	2	,	,	PUNCT
aji-166	480	3	deng	deng	PROPN
aji-166	480	4	,	,	PUNCT
aji-166	480	5	m.	m.	NOUN
aji-166	480	6	,	,	PUNCT
aji-166	480	7	&	&	CCONJ
aji-166	480	8	ting	ting	PROPN
aji-166	480	9	,	,	PUNCT
aji-166	480	10	j.	j.	PROPN
aji-166	480	11	p.	p.	PROPN
aji-166	480	12	(	(	PUNCT
aji-166	480	13	2019	2019	NUM
aji-166	480	14	)	)	PUNCT
aji-166	480	15	.	.	PUNCT
aji-166	481	1	the	the	DET
aji-166	481	2	nlrp3	nlrp3	ADJ
aji-166	481	3	inflammasome	inflammasome	NOUN
aji-166	481	4	:	:	PUNCT
aji-166	481	5	molecular	molecular	ADJ
aji-166	481	6	activation	activation	NOUN
aji-166	481	7	and	and	CCONJ
aji-166	481	8	regulation	regulation	NOUN
aji-166	481	9	to	to	ADP
aji-166	481	10	therapeutics	therapeutic	NOUN
aji-166	481	11	.	.	PUNCT
aji-166	482	1	nature	nature	NOUN
aji-166	482	2	reviews	review	VERB
aji-166	482	3	immunology	immunology	NOUN
aji-166	482	4	,	,	PUNCT
aji-166	482	5	19(8	19(8	NUM
aji-166	482	6	)	)	PUNCT
aji-166	482	7	,	,	PUNCT
aji-166	482	8	477489	477489	NUM
aji-166	482	9	.	.	PUNCT
aji-166	483	1	https://doi.org/10.1038/s41577-0190165-0	https://doi.org/10.1038/s41577-0190165-0	PROPN
aji-166	483	2	tanwar	tanwar	PROPN
aji-166	483	3	,	,	PUNCT
aji-166	483	4	s.	s.	PROPN
aji-166	483	5	,	,	PUNCT
aji-166	483	6	rhodes	rhodes	PROPN
aji-166	483	7	,	,	PUNCT
aji-166	483	8	f.	f.	PROPN
aji-166	483	9	,	,	PUNCT
aji-166	483	10	srivastava	srivastava	PROPN
aji-166	483	11	,	,	PUNCT
aji-166	483	12	a.	a.	NOUN
aji-166	483	13	,	,	PUNCT
aji-166	483	14	trembling	tremble	VERB
aji-166	483	15	,	,	PUNCT
aji-166	483	16	p.m.	p.m.	NOUN
aji-166	483	17	,	,	PUNCT
aji-166	483	18	rosenberg	rosenberg	PROPN
aji-166	483	19	,	,	PUNCT
aji-166	483	20	w.m	w.m	PROPN
aji-166	483	21	.	.	PROPN
aji-166	483	22	(	(	PUNCT
aji-166	483	23	2020	2020	NUM
aji-166	483	24	)	)	PUNCT
aji-166	483	25	.	.	PUNCT
aji-166	484	1	inflammation	inflammation	NOUN
aji-166	484	2	and	and	CCONJ
aji-166	484	3	fibrosis	fibrosis	NOUN
aji-166	484	4	in	in	ADP
aji-166	484	5	chronic	chronic	ADJ
aji-166	484	6	liver	liver	NOUN
aji-166	484	7	diseases	disease	NOUN
aji-166	484	8	,	,	PUNCT
aji-166	484	9	including	include	VERB
aji-166	484	10	non	non	ADJ
aji-166	484	11	-	-	ADJ
aji-166	484	12	alcoholic	alcoholic	ADJ
aji-166	484	13	fatty	fatty	NOUN
aji-166	484	14	liver	liver	NOUN
aji-166	484	15	disease	disease	NOUN
aji-166	484	16	and	and	CCONJ
aji-166	484	17	hepatitis	hepatitis	PROPN
aji-166	484	18	c.	c.	PROPN
aji-166	484	19	world	world	PROPN
aji-166	484	20	j	j	PROPN
aji-166	484	21	adavba	adavba	PROPN
aji-166	484	22	;	;	PUNCT
aji-166	484	23	asian	asian	PROPN
aji-166	484	24	j.	j.	PROPN
aji-166	484	25	immunol	immunol	PROPN
aji-166	484	26	.	.	PROPN
aji-166	484	27	,	,	PUNCT
aji-166	484	28	vol	vol	NOUN
aji-166	484	29	.	.	PROPN
aji-166	484	30	8	8	NUM
aji-166	484	31	,	,	PUNCT
aji-166	484	32	no	no	INTJ
aji-166	484	33	.	.	NOUN
aji-166	484	34	1	1	NUM
aji-166	484	35	,	,	PUNCT
aji-166	484	36	pp	pp	ADJ
aji-166	484	37	.	.	PUNCT
aji-166	485	1	120	120	NUM
aji-166	485	2	-	-	SYM
aji-166	485	3	133	133	NUM
aji-166	485	4	,	,	PUNCT
aji-166	485	5	2025	2025	NUM
aji-166	485	6	;	;	PUNCT
aji-166	485	7	article	article	NOUN
aji-166	485	8	no.aji.136909	no.aji.136909	NOUN
aji-166	485	9	133	133	NUM
aji-166	485	10	gastroenterol	gastroenterol	NOUN
aji-166	485	11	,	,	PUNCT
aji-166	485	12	26(2	26(2	NUM
aji-166	485	13	):	):	PUNCT
aji-166	485	14	109	109	NUM
aji-166	485	15	-	-	SYM
aji-166	485	16	133	133	NUM
aji-166	485	17	[	[	X
aji-166	485	18	pmid	pmid	X
aji-166	485	19	:	:	PUNCT
aji-166	485	20	31969775	31969775	NUM
aji-166	485	21	doi	doi	NOUN
aji-166	485	22	:	:	PUNCT
aji-166	485	23	10.3748	10.3748	NUM
aji-166	485	24	/	/	SYM
aji-166	485	25	wjg.v26.i2.109	wjg.v26.i2.109	VERB
aji-166	485	26	]	]	X
aji-166	485	27	teh	teh	NOUN
aji-166	485	28	,	,	PUNCT
aji-166	485	29	y.	y.	PROPN
aji-166	485	30	c.	c.	PROPN
aji-166	485	31	,	,	PUNCT
aji-166	485	32	chooi	chooi	PROPN
aji-166	485	33	,	,	PUNCT
aji-166	485	34	m.	m.	NOUN
aji-166	485	35	y.	y.	PROPN
aji-166	485	36	,	,	PUNCT
aji-166	485	37	&	&	CCONJ
aji-166	485	38	chong	chong	PROPN
aji-166	485	39	,	,	PUNCT
aji-166	485	40	s.	s.	PROPN
aji-166	485	41	z.	z.	PROPN
aji-166	485	42	(	(	PUNCT
aji-166	485	43	2023	2023	NUM
aji-166	485	44	)	)	PUNCT
aji-166	485	45	.	.	PUNCT
aji-166	486	1	behind	behind	ADP
aji-166	486	2	the	the	DET
aji-166	486	3	monocyte	monocyte	NOUN
aji-166	486	4	’s	’s	PART
aji-166	486	5	mystique	mystique	NOUN
aji-166	486	6	:	:	PUNCT
aji-166	486	7	uncovering	uncover	VERB
aji-166	486	8	their	their	PRON
aji-166	486	9	developmental	developmental	ADJ
aji-166	486	10	trajectories	trajectory	NOUN
aji-166	486	11	and	and	CCONJ
aji-166	486	12	fates	fate	NOUN
aji-166	486	13	.	.	PUNCT
aji-166	487	1	discovery	discovery	NOUN
aji-166	487	2	immunology	immunology	NOUN
aji-166	487	3	,	,	PUNCT
aji-166	487	4	2(1	2(1	NUM
aji-166	487	5	)	)	PUNCT
aji-166	487	6	,	,	PUNCT
aji-166	487	7	kyad008	kyad008	PROPN
aji-166	487	8	.	.	PUNCT
aji-166	487	9	https://doi.org/10.1093/discim/kyad008	https://doi.org/10.1093/discim/kyad008	PROPN
aji-166	487	10	thuya	thuya	PROPN
aji-166	487	11	,	,	PUNCT
aji-166	487	12	w.	w.	PROPN
aji-166	487	13	l.	l.	PROPN
aji-166	487	14	,	,	PUNCT
aji-166	487	15	cao	cao	PROPN
aji-166	487	16	,	,	PUNCT
aji-166	487	17	y.	y.	PROPN
aji-166	487	18	,	,	PUNCT
aji-166	487	19	ho	ho	PROPN
aji-166	487	20	,	,	PUNCT
aji-166	487	21	p.	p.	PROPN
aji-166	487	22	c.	c.	PROPN
aji-166	487	23	l.	l.	PROPN
aji-166	487	24	,	,	PUNCT
aji-166	487	25	wong	wong	PROPN
aji-166	487	26	,	,	PUNCT
aji-166	487	27	a.	a.	PROPN
aji-166	487	28	l.	l.	PROPN
aji-166	487	29	a.	a.	PROPN
aji-166	487	30	,	,	PUNCT
aji-166	487	31	wang	wang	PROPN
aji-166	487	32	,	,	PUNCT
aji-166	487	33	l.	l.	PROPN
aji-166	487	34	,	,	PUNCT
aji-166	487	35	zhou	zhou	PROPN
aji-166	487	36	,	,	PUNCT
aji-166	487	37	j.	j.	PROPN
aji-166	487	38	,	,	PUNCT
aji-166	487	39	nicot	nicot	PROPN
aji-166	487	40	,	,	PUNCT
aji-166	487	41	c.	c.	PROPN
aji-166	487	42	,	,	PUNCT
aji-166	487	43	&	&	CCONJ
aji-166	487	44	goh	goh	PROPN
aji-166	487	45	,	,	PUNCT
aji-166	487	46	b.	b.	PROPN
aji-166	487	47	c.	c.	PROPN
aji-166	487	48	(	(	PUNCT
aji-166	487	49	2025	2025	NUM
aji-166	487	50	)	)	PUNCT
aji-166	487	51	.	.	PUNCT
aji-166	488	1	insights	insight	NOUN
aji-166	488	2	into	into	ADP
aji-166	488	3	il-6	il-6	NOUN
aji-166	488	4	/	/	SYM
aji-166	488	5	jak	jak	PROPN
aji-166	488	6	/	/	SYM
aji-166	488	7	stat3	stat3	NOUN
aji-166	488	8	signaling	signal	VERB
aji-166	488	9	in	in	ADP
aji-166	488	10	the	the	DET
aji-166	488	11	tumor	tumor	NOUN
aji-166	488	12	microenvironment	microenvironment	NOUN
aji-166	488	13	:	:	PUNCT
aji-166	488	14	implications	implication	NOUN
aji-166	488	15	for	for	ADP
aji-166	488	16	cancer	cancer	NOUN
aji-166	488	17	therapy	therapy	NOUN
aji-166	488	18	.	.	PUNCT
aji-166	489	1	cytokine	cytokine	VERB
aji-166	489	2	&	&	CCONJ
aji-166	489	3	growth	growth	NOUN
aji-166	489	4	factor	factor	NOUN
aji-166	489	5	reviews	review	NOUN
aji-166	489	6	.	.	PUNCT
aji-166	490	1	https://doi.org/10.1016/j.cytogfr.2025.01.00	https://doi.org/10.1016/j.cytogfr.2025.01.00	PROPN
aji-166	490	2	3	3	NUM
aji-166	491	1	tso	tso	PROPN
aji-166	491	2	f.	f.	PROPN
aji-166	491	3	y.	y.	PROPN
aji-166	491	4	,	,	PUNCT
aji-166	491	5	kang	kang	PROPN
aji-166	491	6	g.	g.	PROPN
aji-166	491	7	,	,	PUNCT
aji-166	491	8	kwon	kwon	PROPN
aji-166	491	9	e.	e.	PROPN
aji-166	491	10	h.	h.	PROPN
aji-166	491	11	,	,	PUNCT
aji-166	491	12	julius	julius	PROPN
aji-166	491	13	p.	p.	PROPN
aji-166	491	14	,	,	PUNCT
aji-166	491	15	li	li	PROPN
aji-166	491	16	q.	q.	PROPN
aji-166	491	17	,	,	PUNCT
aji-166	491	18	west	west	PROPN
aji-166	491	19	j.	j.	PROPN
aji-166	491	20	t.	t.	PROPN
aji-166	491	21	,	,	PUNCT
aji-166	491	22	et	et	PROPN
aji-166	491	23	al	al	PROPN
aji-166	491	24	.	.	PUNCT
aji-166	492	1	(	(	PUNCT
aji-166	492	2	2018	2018	NUM
aji-166	492	3	)	)	PUNCT
aji-166	492	4	.	.	PUNCT
aji-166	493	1	brain	brain	NOUN
aji-166	493	2	is	be	AUX
aji-166	493	3	a	a	DET
aji-166	493	4	potential	potential	ADJ
aji-166	493	5	sanctuary	sanctuary	NOUN
aji-166	493	6	for	for	ADP
aji-166	493	7	subtype	subtype	NOUN
aji-166	493	8	c	c	NOUN
aji-166	493	9	hiv-1	hiv-1	X
aji-166	493	10	irrespective	irrespective	ADV
aji-166	493	11	of	of	ADP
aji-166	493	12	art	art	NOUN
aji-166	493	13	treatment	treatment	NOUN
aji-166	493	14	outcome	outcome	NOUN
aji-166	493	15	.	.	PUNCT
aji-166	494	1	plos	plos	PROPN
aji-166	494	2	one	one	NUM
aji-166	494	3	13	13	NUM
aji-166	494	4	:	:	PUNCT
aji-166	494	5	e0201325	e0201325	PROPN
aji-166	494	6	.	.	PROPN
aji-166	494	7	10.1371	10.1371	NUM
aji-166	494	8	/	/	SYM
aji-166	494	9	journal.pone.0201325	journal.pone.0201325	PROPN
aji-166	494	10	tumino	tumino	PROPN
aji-166	494	11	,	,	PUNCT
aji-166	494	12	n.	n.	NOUN
aji-166	494	13	,	,	PUNCT
aji-166	494	14	fiore	fiore	NOUN
aji-166	494	15	,	,	PUNCT
aji-166	494	16	p.	p.	NOUN
aji-166	494	17	f.	f.	PROPN
aji-166	494	18	,	,	PUNCT
aji-166	494	19	pelosi	pelosi	PROPN
aji-166	494	20	,	,	PUNCT
aji-166	494	21	a.	a.	NOUN
aji-166	494	22	,	,	PUNCT
aji-166	494	23	moretta	moretta	PROPN
aji-166	494	24	,	,	PUNCT
aji-166	494	25	l.	l.	PROPN
aji-166	494	26	,	,	PUNCT
aji-166	494	27	&	&	CCONJ
aji-166	494	28	vacca	vacca	PROPN
aji-166	494	29	,	,	PUNCT
aji-166	494	30	p.	p.	NOUN
aji-166	494	31	(	(	PUNCT
aji-166	494	32	2022	2022	NUM
aji-166	494	33	)	)	PUNCT
aji-166	494	34	.	.	PUNCT
aji-166	495	1	myeloid	myeloid	ADJ
aji-166	495	2	derived	derive	VERB
aji-166	495	3	suppressor	suppressor	NOUN
aji-166	495	4	cells	cell	NOUN
aji-166	495	5	in	in	ADP
aji-166	495	6	tumor	tumor	NOUN
aji-166	495	7	microenvironment	microenvironment	NOUN
aji-166	495	8	:	:	PUNCT
aji-166	495	9	interaction	interaction	NOUN
aji-166	495	10	with	with	ADP
aji-166	495	11	innate	innate	ADJ
aji-166	495	12	lymphoid	lymphoid	ADJ
aji-166	495	13	cells	cell	NOUN
aji-166	495	14	.	.	PUNCT
aji-166	496	1	seminars	seminar	NOUN
aji-166	496	2	in	in	ADP
aji-166	496	3	immunology	immunology	NOUN
aji-166	496	4	,	,	PUNCT
aji-166	496	5	61	61	NUM
aji-166	496	6	-	-	SYM
aji-166	496	7	64	64	NUM
aji-166	496	8	,	,	PUNCT
aji-166	496	9	101668	101668	NUM
aji-166	496	10	.	.	PUNCT
aji-166	497	1	https://doi.org/10.1016/j.smim.2022.10166	https://doi.org/10.1016/j.smim.2022.10166	ADJ
aji-166	497	2	8	8	NUM
aji-166	497	3	wang	wang	PROPN
aji-166	497	4	,	,	PUNCT
aji-166	497	5	j.	j.	PROPN
aji-166	497	6	,	,	PUNCT
aji-166	497	7	silverberg	silverberg	PROPN
aji-166	497	8	,	,	PUNCT
aji-166	497	9	m.	m.	NOUN
aji-166	497	10	j.	j.	PROPN
aji-166	497	11	,	,	PUNCT
aji-166	497	12	&	&	CCONJ
aji-166	497	13	abrams	abrams	PROPN
aji-166	497	14	,	,	PUNCT
aji-166	497	15	d.	d.	PROPN
aji-166	497	16	i.	i.	PROPN
aji-166	497	17	(	(	PUNCT
aji-166	497	18	2014	2014	NUM
aji-166	497	19	)	)	PUNCT
aji-166	497	20	.	.	PUNCT
aji-166	498	1	non	non	ADJ
aji-166	498	2	-	-	ADJ
aji-166	498	3	aids	aids	ADJ
aji-166	498	4	-	-	PUNCT
aji-166	498	5	defining	define	VERB
aji-166	498	6	malignancies	malignancy	NOUN
aji-166	498	7	in	in	ADP
aji-166	498	8	the	the	DET
aji-166	498	9	hiv	hiv	PROPN
aji-166	498	10	-	-	PUNCT
aji-166	498	11	infected	infect	VERB
aji-166	498	12	population	population	NOUN
aji-166	498	13	.	.	PUNCT
aji-166	499	1	current	current	ADJ
aji-166	499	2	infectious	infectious	ADJ
aji-166	499	3	disease	disease	NOUN
aji-166	499	4	reports	report	VERB
aji-166	499	5	,	,	PUNCT
aji-166	499	6	16(6	16(6	NUM
aji-166	499	7	)	)	PUNCT
aji-166	499	8	,	,	PUNCT
aji-166	499	9	406	406	NUM
aji-166	499	10	.	.	PUNCT
aji-166	500	1	https://doi.org/10.1007/s11908-014-0406-0	https://doi.org/10.1007/s11908-014-0406-0	NUM
aji-166	500	2	wong	wong	PROPN
aji-166	500	3	,	,	PUNCT
aji-166	500	4	k.	k.	PROPN
aji-166	500	5	l.	l.	PROPN
aji-166	500	6	,	,	PUNCT
aji-166	500	7	tai	tai	PROPN
aji-166	500	8	,	,	PUNCT
aji-166	500	9	j.	j.	PROPN
aji-166	500	10	j.	j.	PROPN
aji-166	500	11	y.	y.	PROPN
aji-166	500	12	,	,	PUNCT
aji-166	500	13	wong	wong	PROPN
aji-166	500	14	,	,	PUNCT
aji-166	500	15	w.	w.	PROPN
aji-166	500	16	,	,	PUNCT
aji-166	500	17	han	han	PROPN
aji-166	500	18	,	,	PUNCT
aji-166	500	19	h.	h.	PROPN
aji-166	500	20	,	,	PUNCT
aji-166	500	21	sem	sem	PROPN
aji-166	500	22	,	,	PUNCT
aji-166	500	23	x.	x.	PROPN
aji-166	500	24	,	,	PUNCT
aji-166	500	25	yeap	yeap	PROPN
aji-166	500	26	,	,	PUNCT
aji-166	500	27	w.	w.	PROPN
aji-166	500	28	,	,	PUNCT
aji-166	500	29	kourilsky	kourilsky	PROPN
aji-166	500	30	,	,	PUNCT
aji-166	500	31	p.	p.	PROPN
aji-166	500	32	,	,	PUNCT
aji-166	500	33	&	&	CCONJ
aji-166	500	34	wong	wong	PROPN
aji-166	500	35	,	,	PUNCT
aji-166	500	36	s.	s.	PROPN
aji-166	500	37	(	(	PUNCT
aji-166	500	38	2011	2011	NUM
aji-166	500	39	)	)	PUNCT
aji-166	500	40	.	.	PUNCT
aji-166	501	1	gene	gene	NOUN
aji-166	501	2	expression	expression	NOUN
aji-166	501	3	profiling	profiling	NOUN
aji-166	501	4	reveals	reveal	VERB
aji-166	501	5	the	the	DET
aji-166	501	6	defining	define	VERB
aji-166	501	7	features	feature	NOUN
aji-166	501	8	of	of	ADP
aji-166	501	9	the	the	DET
aji-166	501	10	classical	classical	ADJ
aji-166	501	11	,	,	PUNCT
aji-166	501	12	intermediate	intermediate	ADJ
aji-166	501	13	,	,	PUNCT
aji-166	501	14	and	and	CCONJ
aji-166	501	15	nonclassical	nonclassical	ADJ
aji-166	501	16	human	human	ADJ
aji-166	501	17	monocyte	monocyte	NOUN
aji-166	501	18	subsets	subset	NOUN
aji-166	501	19	.	.	PUNCT
aji-166	502	1	blood	blood	NOUN
aji-166	502	2	,	,	PUNCT
aji-166	502	3	118(5	118(5	NUM
aji-166	502	4	)	)	PUNCT
aji-166	502	5	,	,	PUNCT
aji-166	502	6	e16	e16	PROPN
aji-166	502	7	-	-	PUNCT
aji-166	502	8	e31	e31	PROPN
aji-166	502	9	.	.	PUNCT
aji-166	503	1	https://doi.org/10.1182/blood2010-12-326355	https://doi.org/10.1182/blood2010-12-326355	PROPN
aji-166	503	2	yvan	yvan	PROPN
aji-166	503	3	-	-	PUNCT
aji-166	503	4	charvet	charvet	PROPN
aji-166	503	5	,	,	PUNCT
aji-166	503	6	l.	l.	PROPN
aji-166	503	7	,	,	PUNCT
aji-166	503	8	ranalletta	ranalletta	NOUN
aji-166	503	9	,	,	PUNCT
aji-166	503	10	m.	m.	NOUN
aji-166	503	11	,	,	PUNCT
aji-166	503	12	wang	wang	PROPN
aji-166	503	13	,	,	PUNCT
aji-166	503	14	n.	n.	PROPN
aji-166	503	15	,	,	PUNCT
aji-166	503	16	han	han	PROPN
aji-166	503	17	,	,	PUNCT
aji-166	503	18	s.	s.	PROPN
aji-166	503	19	,	,	PUNCT
aji-166	503	20	terasaka	terasaka	ADV
aji-166	503	21	,	,	PUNCT
aji-166	503	22	n.	n.	PROPN
aji-166	503	23	,	,	PUNCT
aji-166	503	24	li	li	PROPN
aji-166	503	25	,	,	PUNCT
aji-166	503	26	r.	r.	PROPN
aji-166	503	27	,	,	PUNCT
aji-166	503	28	welch	welch	PROPN
aji-166	503	29	,	,	PUNCT
aji-166	503	30	c.	c.	PROPN
aji-166	503	31	,	,	PUNCT
aji-166	503	32	&	&	CCONJ
aji-166	503	33	tall	tall	ADJ
aji-166	503	34	,	,	PUNCT
aji-166	503	35	a.	a.	PROPN
aji-166	503	36	r.	r.	PROPN
aji-166	503	37	(	(	PUNCT
aji-166	503	38	2007	2007	NUM
aji-166	503	39	)	)	PUNCT
aji-166	503	40	.	.	PUNCT
aji-166	504	1	combined	combine	VERB
aji-166	504	2	deficiency	deficiency	NOUN
aji-166	504	3	of	of	ADP
aji-166	504	4	abca1	abca1	NOUN
aji-166	504	5	and	and	CCONJ
aji-166	504	6	abcg1	abcg1	ADV
aji-166	504	7	promotes	promote	VERB
aji-166	504	8	foam	foam	NOUN
aji-166	504	9	cell	cell	NOUN
aji-166	504	10	accumulation	accumulation	NOUN
aji-166	504	11	and	and	CCONJ
aji-166	504	12	accelerates	accelerate	VERB
aji-166	504	13	atherosclerosis	atherosclerosis	NOUN
aji-166	504	14	in	in	ADP
aji-166	504	15	mice	mouse	NOUN
aji-166	504	16	.	.	PUNCT
aji-166	505	1	the	the	DET
aji-166	505	2	journal	journal	NOUN
aji-166	505	3	of	of	ADP
aji-166	505	4	clinical	clinical	ADJ
aji-166	505	5	investigation	investigation	NOUN
aji-166	505	6	,	,	PUNCT
aji-166	505	7	117(12	117(12	NUM
aji-166	505	8	)	)	PUNCT
aji-166	505	9	,	,	PUNCT
aji-166	505	10	3900–3908	3900–3908	NUM
aji-166	505	11	.	.	PUNCT
aji-166	506	1	https://doi.org/10.1172/jci33372	https://doi.org/10.1172/jci33372	PROPN
aji-166	506	2	zhou	zhou	PROPN
aji-166	506	3	,	,	PUNCT
aji-166	506	4	d.	d.	PROPN
aji-166	506	5	,	,	PUNCT
aji-166	506	6	duan	duan	PROPN
aji-166	506	7	,	,	PUNCT
aji-166	506	8	z.	z.	PROPN
aji-166	506	9	,	,	PUNCT
aji-166	506	10	li	li	PROPN
aji-166	506	11	,	,	PUNCT
aji-166	506	12	z.	z.	PROPN
aji-166	506	13	,	,	PUNCT
aji-166	506	14	ge	ge	PROPN
aji-166	506	15	,	,	PUNCT
aji-166	506	16	f.	f.	PROPN
aji-166	506	17	,	,	PUNCT
aji-166	506	18	wei	wei	PROPN
aji-166	506	19	,	,	PUNCT
aji-166	506	20	r.	r.	PROPN
aji-166	506	21	,	,	PUNCT
aji-166	506	22	&	&	CCONJ
aji-166	506	23	kong	kong	PROPN
aji-166	506	24	,	,	PUNCT
aji-166	506	25	l.	l.	PROPN
aji-166	506	26	(	(	PUNCT
aji-166	506	27	2022	2022	NUM
aji-166	506	28	)	)	PUNCT
aji-166	506	29	.	.	PUNCT
aji-166	507	1	the	the	DET
aji-166	507	2	significance	significance	NOUN
aji-166	507	3	of	of	ADP
aji-166	507	4	glycolysis	glycolysis	NOUN
aji-166	507	5	in	in	ADP
aji-166	507	6	tumor	tumor	NOUN
aji-166	507	7	progression	progression	NOUN
aji-166	507	8	and	and	CCONJ
aji-166	507	9	its	its	PRON
aji-166	507	10	relationship	relationship	NOUN
aji-166	507	11	with	with	ADP
aji-166	507	12	the	the	DET
aji-166	507	13	tumor	tumor	NOUN
aji-166	507	14	microenvironment	microenvironment	NOUN
aji-166	507	15	.	.	PUNCT
aji-166	508	1	frontiers	frontier	NOUN
aji-166	508	2	in	in	ADP
aji-166	508	3	pharmacology	pharmacology	NOUN
aji-166	508	4	,	,	PUNCT
aji-166	508	5	13	13	NUM
aji-166	508	6	,	,	PUNCT
aji-166	508	7	1091779	1091779	NUM
aji-166	508	8	.	.	PUNCT
aji-166	509	1	https://doi.org/10.3389/fphar.2022.109177	https://doi.org/10.3389/fphar.2022.109177	PROPN
aji-166	509	2	9	9	NUM
aji-166	509	3	ziegler	ziegler	NOUN
aji-166	509	4	-	-	NOUN
aji-166	509	5	heitbrock	heitbrock	NOUN
aji-166	509	6	,	,	PUNCT
aji-166	509	7	loems	loems	PROPN
aji-166	509	8	&	&	CCONJ
aji-166	509	9	ancuta	ancuta	PROPN
aji-166	509	10	,	,	PUNCT
aji-166	509	11	petronela	petronela	PROPN
aji-166	509	12	&	&	CCONJ
aji-166	509	13	crowe	crowe	PROPN
aji-166	509	14	,	,	PUNCT
aji-166	509	15	suzanne	suzanne	PROPN
aji-166	509	16	&	&	CCONJ
aji-166	509	17	dalod	dalod	PROPN
aji-166	509	18	,	,	PUNCT
aji-166	509	19	marc	marc	PROPN
aji-166	509	20	&	&	CCONJ
aji-166	509	21	grau	grau	PROPN
aji-166	509	22	,	,	PUNCT
aji-166	509	23	veronika	veronika	PROPN
aji-166	509	24	&	&	CCONJ
aji-166	509	25	hart	hart	PROPN
aji-166	509	26	,	,	PUNCT
aji-166	509	27	derek	derek	PROPN
aji-166	509	28	&	&	CCONJ
aji-166	509	29	leenen	leenen	PROPN
aji-166	509	30	,	,	PUNCT
aji-166	509	31	pieter	pieter	NOUN
aji-166	509	32	&	&	CCONJ
aji-166	509	33	liu	liu	PROPN
aji-166	509	34	,	,	PUNCT
aji-166	509	35	wen	wen	PROPN
aji-166	509	36	&	&	CCONJ
aji-166	509	37	macpherson	macpherson	PROPN
aji-166	509	38	,	,	PUNCT
aji-166	509	39	gordon	gordon	PROPN
aji-166	509	40	&	&	CCONJ
aji-166	509	41	scherberich	scherberich	PROPN
aji-166	509	42	,	,	PUNCT
aji-166	509	43	juergen	juergen	PROPN
aji-166	509	44	&	&	CCONJ
aji-166	509	45	schmitz	schmitz	PROPN
aji-166	509	46	,	,	PUNCT
aji-166	509	47	juergen	juergen	PROPN
aji-166	509	48	&	&	CCONJ
aji-166	509	49	shortman	shortman	PROPN
aji-166	509	50	,	,	PUNCT
aji-166	509	51	ken	ken	PROPN
aji-166	509	52	&	&	CCONJ
aji-166	509	53	sozzani	sozzani	PROPN
aji-166	509	54	,	,	PUNCT
aji-166	509	55	silvano	silvano	PROPN
aji-166	509	56	&	&	CCONJ
aji-166	509	57	strobl	strobl	PROPN
aji-166	509	58	,	,	PUNCT
aji-166	509	59	herbert	herbert	PROPN
aji-166	509	60	&	&	CCONJ
aji-166	509	61	zembala	zembala	PROPN
aji-166	509	62	,	,	PUNCT
aji-166	509	63	marek	marek	PROPN
aji-166	509	64	&	&	CCONJ
aji-166	509	65	austyn	austyn	PROPN
aji-166	509	66	,	,	PUNCT
aji-166	509	67	jonathan	jonathan	PROPN
aji-166	509	68	&	&	CCONJ
aji-166	509	69	lutz	lutz	PROPN
aji-166	509	70	,	,	PUNCT
aji-166	509	71	manfred	manfred	PROPN
aji-166	509	72	.	.	PUNCT
aji-166	510	1	(	(	PUNCT
aji-166	510	2	2010	2010	NUM
aji-166	510	3	)	)	PUNCT
aji-166	510	4	.	.	PUNCT
aji-166	511	1	nomenclature	nomenclature	NOUN
aji-166	511	2	of	of	ADP
aji-166	511	3	monocytes	monocyte	NOUN
aji-166	511	4	and	and	CCONJ
aji-166	511	5	dendritic	dendritic	ADJ
aji-166	511	6	cells	cell	NOUN
aji-166	511	7	in	in	ADP
aji-166	511	8	blood	blood	NOUN
aji-166	511	9	.	.	PUNCT
aji-166	512	1	blood	blood	NOUN
aji-166	512	2	.	.	PUNCT
aji-166	513	1	116	116	NUM
aji-166	513	2	.	.	PUNCT
aji-166	513	3	e74	e74	NOUN
aji-166	513	4	-	-	PUNCT
aji-166	513	5	80	80	NUM
aji-166	513	6	.	.	PUNCT
aji-166	513	7	10.1182	10.1182	NUM
aji-166	513	8	/	/	SYM
aji-166	513	9	blood-2010	blood-2010	NOUN
aji-166	513	10	-	-	PUNCT
aji-166	513	11	02	02	NUM
aji-166	513	12	-	-	PUNCT
aji-166	513	13	258558	258558	NUM
aji-166	513	14	.	.	PUNCT
aji-166	514	1	disclaimer	disclaimer	ADJ
aji-166	514	2	/	/	SYM
aji-166	514	3	publisher	publisher	NOUN
aji-166	514	4	’s	’s	PART
aji-166	514	5	note	note	NOUN
aji-166	514	6	:	:	PUNCT
aji-166	514	7	the	the	DET
aji-166	514	8	statements	statement	NOUN
aji-166	514	9	,	,	PUNCT
aji-166	514	10	opinions	opinion	NOUN
aji-166	514	11	and	and	CCONJ
aji-166	514	12	data	datum	NOUN
aji-166	514	13	contained	contain	VERB
aji-166	514	14	in	in	ADP
aji-166	514	15	all	all	DET
aji-166	514	16	publications	publication	NOUN
aji-166	514	17	are	be	AUX
aji-166	514	18	solely	solely	ADV
aji-166	514	19	those	those	PRON
aji-166	514	20	of	of	ADP
aji-166	514	21	the	the	DET
aji-166	514	22	individual	individual	ADJ
aji-166	514	23	author(s	author(s	PROPN
aji-166	514	24	)	)	PUNCT
aji-166	514	25	and	and	CCONJ
aji-166	514	26	contributor(s	contributor(s	NOUN
aji-166	514	27	)	)	PUNCT
aji-166	514	28	and	and	CCONJ
aji-166	514	29	not	not	PART
aji-166	514	30	of	of	ADP
aji-166	514	31	the	the	DET
aji-166	514	32	publisher	publisher	NOUN
aji-166	514	33	and/or	and/or	CCONJ
aji-166	514	34	the	the	DET
aji-166	514	35	editor(s	editor(s	NOUN
aji-166	514	36	)	)	PUNCT
aji-166	514	37	.	.	PUNCT
aji-166	515	1	this	this	DET
aji-166	515	2	publisher	publisher	NOUN
aji-166	515	3	and/or	and/or	CCONJ
aji-166	515	4	the	the	DET
aji-166	515	5	editor(s	editor(s	NOUN
aji-166	515	6	)	)	PUNCT
aji-166	515	7	disclaim	disclaim	VERB
aji-166	515	8	responsibility	responsibility	NOUN
aji-166	515	9	for	for	ADP
aji-166	515	10	any	any	DET
aji-166	515	11	injury	injury	NOUN
aji-166	515	12	to	to	ADP
aji-166	515	13	people	people	NOUN
aji-166	515	14	or	or	CCONJ
aji-166	515	15	property	property	NOUN
aji-166	515	16	resulting	result	VERB
aji-166	515	17	from	from	ADP
aji-166	515	18	any	any	DET
aji-166	515	19	ideas	idea	NOUN
aji-166	515	20	,	,	PUNCT
aji-166	515	21	methods	method	NOUN
aji-166	515	22	,	,	PUNCT
aji-166	515	23	instructions	instruction	NOUN
aji-166	515	24	or	or	CCONJ
aji-166	515	25	products	product	NOUN
aji-166	515	26	referred	refer	VERB
aji-166	515	27	to	to	ADP
aji-166	515	28	in	in	ADP
aji-166	515	29	the	the	DET
aji-166	515	30	content	content	NOUN
aji-166	515	31	.	.	PUNCT
aji-166	516	1	_	_	PUNCT
aji-166	517	1	_	_	PUNCT
aji-166	518	1	_	_	PUNCT
aji-166	519	1	_	_	PUNCT
aji-166	520	1	_	_	PUNCT
aji-166	521	1	_	_	PUNCT
aji-166	522	1	_	_	PUNCT
aji-166	523	1	_	_	PUNCT
aji-166	524	1	_	_	PUNCT
aji-166	525	1	_	_	PUNCT
aji-166	526	1	_	_	PUNCT
aji-166	527	1	_	_	PUNCT
aji-166	528	1	_	_	PUNCT
aji-166	529	1	_	_	PUNCT
aji-166	530	1	_	_	PUNCT
aji-166	531	1	_	_	PUNCT
aji-166	532	1	_	_	PUNCT
aji-166	533	1	_	_	PUNCT
aji-166	534	1	_	_	PUNCT
aji-166	535	1	_	_	PUNCT
aji-166	536	1	_	_	PUNCT
aji-166	537	1	_	_	PUNCT
aji-166	538	1	_	_	PUNCT
aji-166	539	1	_	_	PUNCT
aji-166	540	1	_	_	PUNCT
aji-166	541	1	_	_	PUNCT
aji-166	542	1	_	_	PUNCT
aji-166	543	1	_	_	PUNCT
aji-166	544	1	_	_	PUNCT
aji-166	545	1	_	_	PUNCT
aji-166	546	1	_	_	PUNCT
aji-166	547	1	_	_	PUNCT
aji-166	548	1	_	_	PUNCT
aji-166	549	1	_	_	PUNCT
aji-166	550	1	_	_	PUNCT
aji-166	551	1	_	_	PUNCT
aji-166	552	1	_	_	PUNCT
aji-166	553	1	_	_	PUNCT
aji-166	554	1	_	_	PUNCT
aji-166	555	1	_	_	PUNCT
aji-166	556	1	_	_	PUNCT
aji-166	557	1	_	_	PUNCT
aji-166	558	1	_	_	PUNCT
aji-166	559	1	_	_	PUNCT
aji-166	560	1	_	_	PUNCT
aji-166	561	1	_	_	PUNCT
aji-166	562	1	_	_	PUNCT
aji-166	563	1	_	_	PUNCT
aji-166	564	1	_	_	PUNCT
aji-166	565	1	_	_	PUNCT
aji-166	566	1	_	_	PUNCT
aji-166	567	1	_	_	PUNCT
aji-166	568	1	_	_	PUNCT
aji-166	569	1	_	_	PUNCT
aji-166	570	1	_	_	PUNCT
aji-166	571	1	_	_	PUNCT
aji-166	572	1	_	_	PUNCT
aji-166	573	1	_	_	PUNCT
aji-166	574	1	_	_	PUNCT
aji-166	575	1	_	_	PUNCT
aji-166	576	1	_	_	PUNCT
aji-166	577	1	_	_	PUNCT
aji-166	578	1	_	_	PUNCT
aji-166	579	1	_	_	PUNCT
aji-166	580	1	_	_	PUNCT
aji-166	581	1	_	_	PUNCT
aji-166	582	1	_	_	PUNCT
aji-166	583	1	_	_	PUNCT
aji-166	584	1	_	_	PUNCT
aji-166	585	1	_	_	PUNCT
aji-166	586	1	_	_	PUNCT
aji-166	587	1	_	_	PUNCT
aji-166	588	1	_	_	PUNCT
aji-166	589	1	_	_	PUNCT
aji-166	590	1	_	_	PUNCT
aji-166	591	1	_	_	PUNCT
aji-166	592	1	_	_	PUNCT
aji-166	593	1	_	_	PUNCT
aji-166	594	1	_	_	PUNCT
aji-166	595	1	_	_	PUNCT
aji-166	596	1	_	_	PUNCT
aji-166	597	1	©	©	PRON
aji-166	597	2	copyright	copyright	NOUN
aji-166	597	3	(	(	PUNCT
aji-166	597	4	2025	2025	NUM
aji-166	597	5	):	):	PUNCT
aji-166	597	6	author(s	author(s	NOUN
aji-166	597	7	)	)	PUNCT
aji-166	597	8	.	.	PUNCT
aji-166	598	1	the	the	DET
aji-166	598	2	licensee	licensee	NOUN
aji-166	598	3	is	be	AUX
aji-166	598	4	the	the	DET
aji-166	598	5	journal	journal	PROPN
aji-166	598	6	publisher	publisher	NOUN
aji-166	598	7	.	.	PUNCT
aji-166	599	1	this	this	PRON
aji-166	599	2	is	be	AUX
aji-166	599	3	an	an	DET
aji-166	599	4	open	open	ADJ
aji-166	599	5	access	access	NOUN
aji-166	599	6	article	article	NOUN
aji-166	599	7	distributed	distribute	VERB
aji-166	599	8	under	under	ADP
aji-166	599	9	the	the	DET
aji-166	599	10	terms	term	NOUN
aji-166	599	11	of	of	ADP
aji-166	599	12	the	the	DET
aji-166	599	13	creative	creative	ADJ
aji-166	599	14	commons	common	NOUN
aji-166	599	15	attribution	attribution	NOUN
aji-166	599	16	license	license	NOUN
aji-166	599	17	(	(	PUNCT
aji-166	599	18	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-166	599	19	)	)	PUNCT
aji-166	599	20	,	,	PUNCT
aji-166	599	21	which	which	PRON
aji-166	599	22	permits	permit	VERB
aji-166	599	23	unrestricted	unrestricted	ADJ
aji-166	599	24	use	use	NOUN
aji-166	599	25	,	,	PUNCT
aji-166	599	26	distribution	distribution	NOUN
aji-166	599	27	,	,	PUNCT
aji-166	599	28	and	and	CCONJ
aji-166	599	29	reproduction	reproduction	NOUN
aji-166	599	30	in	in	ADP
aji-166	599	31	any	any	DET
aji-166	599	32	medium	medium	NOUN
aji-166	599	33	,	,	PUNCT
aji-166	599	34	provided	provide	VERB
aji-166	599	35	the	the	DET
aji-166	599	36	original	original	ADJ
aji-166	599	37	work	work	NOUN
aji-166	599	38	is	be	AUX
aji-166	599	39	properly	properly	ADV
aji-166	599	40	cited	cite	VERB
aji-166	599	41	.	.	PUNCT
aji-166	600	1	peer	peer	NOUN
aji-166	600	2	-	-	PUNCT
aji-166	600	3	review	review	NOUN
aji-166	600	4	history	history	NOUN
aji-166	600	5	:	:	PUNCT
aji-166	600	6	the	the	DET
aji-166	600	7	peer	peer	NOUN
aji-166	600	8	review	review	NOUN
aji-166	600	9	history	history	NOUN
aji-166	600	10	for	for	ADP
aji-166	600	11	this	this	DET
aji-166	600	12	paper	paper	NOUN
aji-166	600	13	can	can	AUX
aji-166	600	14	be	be	AUX
aji-166	600	15	accessed	access	VERB
aji-166	600	16	here	here	ADV
aji-166	600	17	:	:	PUNCT
aji-166	600	18	https://pr.sdiarticle5.com/review-history/136909	https://pr.sdiarticle5.com/review-history/136909	X
aji-166	600	19	https://pr.sdiarticle5.com/review-history/136909	https://pr.sdiarticle5.com/review-history/136909	X